No.,Class,SMILES,pIC50,Y-Label,MW,RBN,nCIC,nHDon,nHAcc,ALogP,TPSA,Qm,Energy,Dipole moment,HOMO,LUMO,HOMO-LUMO gap,Article Title,Reference,fp,desc,MW,ExactMolWt,LogP,HBA,HBD,TPSA,AromaticRings,RotatableBonds,HeavyAtoms,QED,FractionCSP3,RingCount,pIC50_pred,IC50_pred_nM
1,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)[H],8.287779590057651,Inactive,232.31,2,2,3,4,1.285,72.19,0.279746515,-765.0037552,4.082,-0.20209,-0.02786,0.17423,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-72,[0 0 0 ... 0 0 0],"[232.283, 232.121177752, 1.3531999999999995, 3, 2, 72.19, 1, 2, 17, 0.5969362176118972, 0.38461538461538464, 2]",232.283,232.121177752,1.3531999999999995,3,2,72.19,1,2,17,0.5969362176118972,0.38461538461538464,2,8.30792185803158,4.921280755977949
2,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)C,8.347284794632522,Inactive,246.34,2,2,2,4,1.491,63.4,0.266307833,-804.3133762,3.5147,-0.20061,-0.02513,0.17548,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-73,[0 0 0 ... 0 0 0],"[246.30999999999997, 246.136827816, 1.6954, 3, 1, 63.4, 1, 2, 18, 0.6377623317255606, 0.42857142857142855, 2]",246.30999999999997,246.136827816,1.6954,3,1,63.4,1,2,18,0.6377623317255606,0.42857142857142855,2,8.331772631059023,4.658299085770226
3,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CC,8.341717423968634,Inactive,260.37,3,2,2,4,1.84,63.4,0.260490282,-843.6297884,3.4409,-0.20041,-0.02487,0.17554,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-74,[0 0 0 ... 0 0 0],"[260.337, 260.15247788, 2.0854999999999997, 3, 1, 63.4, 1, 3, 19, 0.6682584507029834, 0.4666666666666667, 2]",260.337,260.15247788,2.0854999999999997,3,1,63.4,1,3,19,0.6682584507029834,0.4666666666666667,2,8.322243550392136,4.761638813536154
4,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CCC,8.275639738301319,Inactive,274.4,4,2,2,4,2.364,63.4,0.254351286,-882.9436553,3.3887,-0.20029,-0.02451,0.17578,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-75,[0 0 0 ... 0 0 0],"[274.36400000000003, 274.168127944, 2.475600000000001, 3, 1, 63.4, 1, 4, 20, 0.6773851595423633, 0.5, 2]",274.36400000000003,274.168127944,2.475600000000001,3,1,63.4,1,4,20,0.6773851595423633,0.5,2,8.284999008140325,5.188012237872707
5,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CCCC,8.255484686147076,Inactive,288.43,5,2,2,4,2.82,63.4,0.2489596,-922.2559103,3.3545,-0.20019,-0.02435,0.17584,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-76,[0 0 0 ... 0 0 0],"[288.3910000000001, 288.183778008, 2.8657000000000012, 3, 1, 63.4, 1, 5, 21, 0.6690854838865019, 0.5294117647058824, 2]",288.3910000000001,288.183778008,2.8657000000000012,3,1,63.4,1,5,21,0.6690854838865019,0.5294117647058824,2,8.279338662862052,5.256072379868812
6,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CCCCC,8.2856320052432,Inactive,302.46,6,2,2,4,3.276,63.4,0.244476583,-961.5659108,3.3565,-0.20017,-0.02465,0.17552,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-77,[0 0 0 ... 0 0 0],"[302.4180000000001, 302.199428072, 3.2558000000000025, 3, 1, 63.4, 1, 6, 22, 0.49820138394346425, 0.5555555555555556, 2]",302.4180000000001,302.199428072,3.2558000000000025,3,1,63.4,1,6,22,0.49820138394346425,0.5555555555555556,2,8.275190144188297,5.306520615938213
7,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CCCCCC,8.236880613624288,Inactive,316.49,7,2,2,4,3.732,63.4,0.241038176,-1000.875988,3.4609,-0.20056,-0.02583,0.17473,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-78,[0 0 0 ... 0 0 0],"[316.44500000000016, 316.215078136, 3.645900000000003, 3, 1, 63.4, 1, 7, 23, 0.47430939390798, 0.5789473684210527, 2]",316.44500000000016,316.215078136,3.645900000000003,3,1,63.4,1,7,23,0.47430939390798,0.5789473684210527,2,8.264630812402384,5.437123372614806
8,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CCCCCCC,8.250280008800894,Inactive,330.52,8,2,2,4,4.188,63.4,0.236312148,-1040.191691,3.3053,-0.20005,-0.0239,0.17615,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-79,[0 0 0 ... 0 0 0],"[330.4720000000002, 330.2307282, 4.036000000000003, 3, 1, 63.4, 1, 8, 24, 0.4444036007682271, 0.6, 2]",330.4720000000002,330.2307282,4.036000000000003,3,1,63.4,1,8,24,0.4444036007682271,0.6,2,8.259940679339165,5.496159412499693
9,Non-Steroid,O=C1N(C(CCC1(C2=CC=C(C=C2)N)CC)=O)CCCCCCCC,8.236880613624288,Inactive,344.55,9,2,2,4,4.645,63.4,0.233669175,-1079.507784,3.509,-0.2011,-0.02705,0.17405,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-80,[0 0 0 ... 0 0 0],"[344.49900000000025, 344.246378264, 4.426100000000004, 3, 1, 63.4, 1, 9, 25, 0.40944071297409945, 0.6190476190476191, 2]",344.49900000000025,344.246378264,4.426100000000004,3,1,63.4,1,9,25,0.40944071297409945,0.6190476190476191,2,8.262021967850702,5.4698829396979916
11,Non-Steroid,O=C1N(CC(C)=O)C(CCC1(CC)C2=CC=C(N)C=C2)=O,8.316600916799707,Inactive,288.38,4,2,2,5,1.146,80.47,0.277914439,-956.9580187,0.9267,-0.20029,-0.02343,0.17686,"1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase",Biochem Pharmacol. 1988;37(11):2167-81,[0 0 0 ... 0 0 0],"[288.347, 288.14739249999997, 1.6546, 4, 1, 80.47, 1, 4, 21, 0.6745673119443948, 0.4375, 2]",288.347,288.14739249999997,1.6546,4,1,80.47,1,4,21,0.6745673119443948,0.4375,2,8.313471003660114,4.858799703790103
12,Steroid,CC12C(C(CC3C2CCC4(C)C3CCC4=O)=O)=CC(OC=O)CC1,8.366427528603348,Inactive,330.46,2,4,0,4,2.524,60.44,0.21583812,-1078.657224,7.0237,-0.24364,-0.05752,0.18612,3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors,Steroids. 1989;54(3):299-311,[0 0 0 ... 0 0 0],"[330.4240000000001, 330.18310931199994, 3.238900000000002, 4, 0, 60.440000000000005, 0, 2, 24, 0.7293620693449865, 0.75, 4]",330.4240000000001,330.18310931199994,3.238900000000002,4,0,60.440000000000005,0,2,24,0.7293620693449865,0.75,4,8.314664916941881,4.845460784378773
13,Steroid,CC12C(C(CC3C2CCC4(C)C3CCC4=O)=O)=CC(OC(C)=O)CC1,8.261101686010912,Inactive,344.49,2,4,0,4,2.571,60.44,0.229051377,-1117.990586,2.6763,-0.23947,-0.0491,0.19037,3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors,Steroids. 1989;54(3):299-312,[0 0 0 ... 0 0 0],"[344.45100000000014, 344.19875937599994, 3.629000000000003, 4, 0, 60.440000000000005, 0, 1, 25, 0.6816293019238052, 0.7619047619047619, 4]",344.45100000000014,344.19875937599994,3.629000000000003,4,0,60.440000000000005,0,1,25,0.6816293019238052,0.7619047619047619,4,8.245405363930791,5.683222198000628
17,Steroid,CC12CCCC=C1C(CC3C2CCC4(C3CCC4=O)C)=O,8.238857977398489,Inactive,286.45,0,4,0,2,3.294,34.14,0.206658234,-890.1128367,4.5421,-0.23207,-0.03819,0.19388,3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors,Steroids. 1989;54(3):299-313,[0 0 0 ... 0 0 0],"[286.41499999999996, 286.193280072, 4.087400000000003, 2, 0, 34.14, 0, 0, 21, 0.6719379087230692, 0.7894736842105263, 4]",286.41499999999996,286.193280072,4.087400000000003,2,0,34.14,0,0,21,0.6719379087230692,0.7894736842105263,4,8.235477577146685,5.814634527984089
18,Steroid,C[C@@]12C([C@@H](CCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.414102717872563,Inactive,376.63,3,5,0,1,6.632,17.07,0.184103,-1125.784825,4.5716,-0.22907,-0.04191,0.18716,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-8,[0 0 0 ... 0 0 0],"[376.58400000000023, 376.27661577199996, 6.767300000000007, 1, 0, 17.07, 1, 3, 28, 0.5688608043996504, 0.6666666666666666, 5]",376.58400000000023,376.27661577199996,6.767300000000007,1,0,17.07,1,3,28,0.5688608043996504,0.6666666666666666,5,8.442896976666226,3.6066418963094558
19,Steroid,C[C@@]12C([C@@H](CCCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.468784292915547,Inactive,390.66,4,5,0,1,7.088,17.07,0.183352821,-1165.098418,4.5741,-0.22838,-0.04106,0.18732,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-9,[0 0 0 ... 0 0 0],"[390.6110000000003, 390.29226583599996, 7.157400000000007, 1, 0, 17.07, 1, 4, 29, 0.5329366933925441, 0.6785714285714286, 5]",390.6110000000003,390.29226583599996,7.157400000000007,1,0,17.07,1,4,29,0.5329366933925441,0.6785714285714286,5,8.428056088306784,3.7320195635998443
20,Steroid,C[C@@]12C([C@@H](CCCCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.459855661348179,Inactive,404.69,5,5,0,1,7.544,17.07,0.182803286,-1204.410682,4.5546,-0.22818,-0.04088,0.1873,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-10,[0 0 0 ... 0 0 0],"[404.6380000000003, 404.30791589999995, 7.547500000000007, 1, 0, 17.07, 1, 5, 30, 0.4630286475587707, 0.6896551724137931, 5]",404.6380000000003,404.30791589999995,7.547500000000007,1,0,17.07,1,5,30,0.4630286475587707,0.6896551724137931,5,8.429514150119958,3.7195110210754607
21,Steroid,C[C@@]12C([C@@H](CCCCCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.487874574224758,Inactive,418.72,6,5,0,1,8.0,17.07,0.182626068,-1243.720665,4.3153,-0.22834,-0.04102,0.18732,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-11,[0 0 0 ... 0 0 0],"[418.66500000000036, 418.32356596399995, 7.937600000000008, 1, 0, 17.07, 1, 6, 31, 0.428495652222561, 0.7, 5]",418.66500000000036,418.32356596399995,7.937600000000008,1,0,17.07,1,6,31,0.428495652222561,0.7,5,8.454990698245508,3.50759386465148
22,Steroid,C[C@@]12C([C@H](CCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.525957094677969,Inactive,376.63,3,5,0,1,6.632,17.07,0.185752359,-1125.768533,4.495,-0.2276,-0.04198,0.18562,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-12,[0 0 0 ... 0 0 0],"[376.58400000000023, 376.27661577199996, 6.767300000000007, 1, 0, 17.07, 1, 3, 28, 0.5688608043996504, 0.6666666666666666, 5]",376.58400000000023,376.27661577199996,6.767300000000007,1,0,17.07,1,3,28,0.5688608043996504,0.6666666666666666,5,8.442896976666226,3.6066418963094558
23,Steroid,C[C@@]12C([C@H](CCCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.451291028989324,Inactive,390.66,4,5,0,1,7.088,17.07,0.183647642,-1165.092657,4.4677,-0.22761,-0.04143,0.18618,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-13,[0 0 0 ... 0 0 0],"[390.6110000000003, 390.29226583599996, 7.157400000000007, 1, 0, 17.07, 1, 4, 29, 0.5329366933925441, 0.6785714285714286, 5]",390.6110000000003,390.29226583599996,7.157400000000007,1,0,17.07,1,4,29,0.5329366933925441,0.6785714285714286,5,8.428056088306784,3.7320195635998443
24,Steroid,C[C@@]12C([C@H](CCCCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.412326492307123,Inactive,404.69,5,5,0,1,7.544,17.07,0.184608186,-1204.394614,4.4995,-0.22757,-0.04153,0.18604,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-14,[0 0 0 ... 0 0 0],"[404.6380000000003, 404.30791589999995, 7.547500000000007, 1, 0, 17.07, 1, 5, 30, 0.4630286475587707, 0.6896551724137931, 5]",404.6380000000003,404.30791589999995,7.547500000000007,1,0,17.07,1,5,30,0.4630286475587707,0.6896551724137931,5,8.429514150119958,3.7195110210754607
25,Steroid,C[C@@]12C([C@H](CCCCCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.475371863557278,Inactive,418.72,6,5,0,1,8.0,17.07,0.184413507,-1243.704504,4.6418,-0.22755,-0.0415,0.18605,"6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships",J Steroid Biochem Mol Biol. 1998 Oct;67(1):41-15,[0 0 0 ... 0 0 0],"[418.66500000000036, 418.32356596399995, 7.937600000000008, 1, 0, 17.07, 1, 6, 31, 0.428495652222561, 0.7, 5]",418.66500000000036,418.32356596399995,7.937600000000008,1,0,17.07,1,6,31,0.428495652222561,0.7,5,8.454990698245508,3.50759386465148
26,Steroid,CC12C(CCC2=O)C3[C@H](C(F)4F)[C@H]4C5=CC(CCC5(C)C3CC1)=O,8.226264579575219,Inactive,334.44,0,5,0,4,2.611,34.14,0.228266708,-1126.65157,5.4097,-0.23815,-0.05657,0.18158,"6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors",Biochem Biophys Res Commun. 1991;177(1):401-6,[0 0 0 ... 0 0 0],"[334.4060000000001, 334.174436448, 4.188500000000004, 2, 0, 34.14, 0, 0, 24, 0.6655786521653276, 0.8, 5]",334.4060000000001,334.174436448,4.188500000000004,2,0,34.14,0,0,24,0.6655786521653276,0.8,5,8.2288994386105,5.903377577377774
27,Steroid,CC12C(CCC2=O)C3[C@H](C4)[C@H]4C5=CCCCC5(C)C3CC1,8.165966789804358,Active,284.48,0,5,0,1,4.111,17.07,0.19124051,-854.1686113,3.0077,-0.22279,-0.01167,0.21112,"6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors",Biochem Biophys Res Commun. 1991;177(1):401-7,[0 0 0 ... 0 0 0],"[284.44300000000004, 284.214015516, 4.764300000000005, 1, 0, 17.07, 0, 0, 21, 0.5858725268385402, 0.85, 5]",284.44300000000004,284.214015516,4.764300000000005,1,0,17.07,0,0,21,0.5858725268385402,0.85,5,8.233156629642046,5.845792158275653
28,Steroid,CC12C(CCC2O)C3[C@H](C4)[C@H]4C5=CCCCC5(C)C3CC1,8.254251150912134,Inactive,286.5,0,5,1,1,4.15,20.23,0.185290627,-855.3610891,1.5374,-0.21969,0.02437,0.24406,"6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors",Biochem Biophys Res Commun. 1991;177(1):401-8,[0 0 0 ... 0 0 0],"[286.459, 286.22966558, 4.556100000000004, 1, 1, 20.23, 0, 0, 21, 0.6474071906234734, 0.9, 5]",286.459,286.22966558,4.556100000000004,1,1,20.23,0,0,21,0.6474071906234734,0.9,5,8.304464343536132,4.960616533988944
29,Steroid,O=C1CCCC2(C)C1=CCC3C2CCC4(C)C3CCC4=O,8.224855234569844,Inactive,286.45,0,4,0,2,3.294,34.14,0.206982404,-890.1134876,4.399,-0.23176,-0.03316,0.1986,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-8,[0 0 0 ... 0 0 0],"[286.415, 286.193280072, 4.087400000000003, 2, 0, 34.14, 0, 0, 21, 0.6719379087230692, 0.7894736842105263, 4]",286.415,286.193280072,4.087400000000003,2,0,34.14,0,0,21,0.6719379087230692,0.7894736842105263,4,8.235477577146685,5.814634527984089
30,Steroid,O=C1CCCC2(C)C1=CCC3C2CCC4(C)C3CCC4O,8.301029995663981,Inactive,288.47,0,4,1,2,3.333,37.3,0.20257049,-891.3042535,3.6828,-0.23064,-0.03654,0.1941,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-9,[0 0 0 ... 0 0 0],"[288.431, 288.208930136, 3.879200000000003, 2, 1, 37.3, 0, 0, 21, 0.7342296115534325, 0.8421052631578947, 4]",288.431,288.208930136,3.879200000000003,2,1,37.3,0,0,21,0.7342296115534325,0.8421052631578947,4,8.293896347640587,5.082807386244899
31,Steroid,OC1CCCC2(C)C1=CCC3C2CCC4(C)C3CCC4=O,8.183570305539794,Active,288.47,0,4,1,2,3.333,37.3,0.202784735,-891.310661,1.6404,-0.23145,-0.01402,0.21743,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-10,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.8792000000000035, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.43100000000004,288.208930136,3.8792000000000035,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.222543415241438,5.990410511088821
32,Steroid,CC12C(C(OC(C)=O)CCC2)=CCC3C1CCC4(C)C3CCC4=O,8.221848749616356,Inactive,330.51,2,4,0,3,3.712,43.37,0.213627759,-1043.995215,2.1348,-0.23034,-0.01284,0.2175,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-11,[0 0 0 ... 0 0 0],"[330.4680000000001, 330.21949481999997, 4.450000000000004, 3, 0, 43.370000000000005, 0, 1, 24, 0.5268094332325617, 0.8095238095238095, 4]",330.4680000000001,330.21949481999997,4.450000000000004,3,0,43.370000000000005,0,1,24,0.5268094332325617,0.8095238095238095,4,8.232884166959492,5.849460774865985
33,Steroid,O=C1C=C2[C@@H](OC(C)=O)CCCC2(C)C3C1C(CCC4=O)C4(C)CC3,8.395528089706705,Inactive,344.49,2,4,0,4,2.782,60.44,0.231256642,-1118.009509,2.7929,-0.23212,-0.05124,0.18088,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-12,[0 0 0 ... 0 0 0],"[344.45100000000014, 344.198759376, 3.629000000000003, 4, 0, 60.440000000000005, 0, 1, 25, 0.6816293019238052, 0.7619047619047619, 4]",344.45100000000014,344.198759376,3.629000000000003,4,0,60.440000000000005,0,1,25,0.6816293019238052,0.7619047619047619,4,8.337796414546114,4.594133228512588
34,Steroid,O[C@H]1CCCC2(C)C1=CC(C3C2CCC4(C)C3CCC4=O)=O,8.283941583716755,Inactive,302.45,0,4,1,3,2.403,54.37,0.220046271,-965.3450502,4.8826,-0.22817,-0.05074,0.17743,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-13,[0 0 0 ... 0 0 0],"[302.41400000000004, 302.18819469199997, 3.058200000000002, 3, 1, 54.37, 0, 0, 22, 0.7479907013785353, 0.7894736842105263, 4]",302.41400000000004,302.18819469199997,3.058200000000002,3,1,54.37,0,0,22,0.7479907013785353,0.7894736842105263,4,8.295096208514462,5.068784079287477
35,Steroid,O=C1CCCC2(C)C1=CC(C3C2CCC4(C)C3CCC4=O)=O,8.264106016122115,Inactive,300.43,0,4,0,3,2.363,51.21,0.223815391,-964.143136,4.3743,-0.23278,-0.07762,0.15516,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-14,[0 0 0 ... 0 0 0],"[300.398, 300.17254462799997, 3.2664000000000017, 3, 0, 51.21, 0, 0, 22, 0.6896763188469792, 0.7368421052631579, 4]",300.398,300.17254462799997,3.2664000000000017,3,0,51.21,0,0,22,0.6896763188469792,0.7368421052631579,4,8.30818942616966,4.918249696559523
36,Steroid,O=C1CCCC2(C1=CC(C3C2CCC4(C3CC[C@@H]4O)C)=O)C,8.372211818798183,Inactive,302.45,0,4,1,3,2.403,54.37,0.220073958,-965.3173827,5.036,-0.23662,-0.07824,0.15838,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-15,[0 0 0 ... 0 0 0],"[302.41400000000004, 302.18819469199997, 3.058200000000001, 3, 1, 54.37, 0, 0, 22, 0.7479907013785353, 0.7894736842105263, 4]",302.41400000000004,302.18819469199997,3.058200000000001,3,1,54.37,0,0,22,0.7479907013785353,0.7894736842105263,4,8.379227619079769,4.176114339898275
37,Steroid,O=C1CCCC2(CO)C1=CC(C3C2CCC4(C)C3CCC4=O)=O,8.364641054073347,Inactive,316.43,1,4,1,4,1.272,71.44,0.228522085,-1039.345172,5.6466,-0.22962,-0.07411,0.15551,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-16,[0 0 0 ... 0 0 0],"[316.3970000000001, 316.16745924799994, 2.2388000000000003, 4, 1, 71.44, 0, 1, 23, 0.8051148630114217, 0.7368421052631579, 4]",316.3970000000001,316.16745924799994,2.2388000000000003,4,1,71.44,0,1,23,0.8051148630114217,0.7368421052631579,4,8.355006729872748,4.415636047844586
38,Steroid,O=C1CCCC2(C=O)C1=CC(C3C2CCC4(C)C3CCC4=O)=O,8.367296796294871,Inactive,314.41,1,4,0,4,1.529,68.28,0.230267333,-1038.140159,4.7368,-0.23893,-0.09129,0.14764,4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors,J Steroid Biochem Mol Biol. 1996;58(4):431-17,[0 0 0 ... 0 0 0],"[314.3810000000001, 314.15180918399994, 2.4454000000000002, 4, 0, 68.28, 0, 1, 23, 0.6971868677832186, 0.6842105263157895, 4]",314.3810000000001,314.15180918399994,2.4454000000000002,4,0,68.28,0,1,23,0.6971868677832186,0.6842105263157895,4,8.3315232158774,4.66097511378813
39,Steroid,CC12C(C(C)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.462975004804038,Inactive,298.46,0,4,0,2,3.296,34.14,0.213611875,-928.2343375,2.7604,-0.23198,-0.06448,0.1675,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-602,[0 0 0 ... 0 0 0],"[298.42600000000004, 298.193280072, 4.253500000000003, 2, 0, 34.14, 0, 0, 22, 0.6695977993795551, 0.7, 4]",298.42600000000004,298.193280072,4.253500000000003,2,0,34.14,0,0,22,0.6695977993795551,0.7,4,8.441212859272751,3.620654969943706
40,Steroid,CC12C(C(CC)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.467381229551243,Inactive,312.49,1,4,0,2,3.752,34.14,0.211005784,-967.5455623,2.7489,-0.23117,-0.06515,0.16602,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-603,[0 0 0 ... 0 0 0],"[312.45300000000003, 312.208930136, 4.643600000000004, 2, 0, 34.14, 0, 1, 23, 0.7063784338378765, 0.7142857142857143, 4]",312.45300000000003,312.208930136,4.643600000000004,2,0,34.14,0,1,23,0.7063784338378765,0.7142857142857143,4,8.42046824135619,3.797797100991042
41,Steroid,CC12C(C(CCC)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.455722372778284,Inactive,326.52,2,4,0,2,4.208,34.14,0.209228037,-1006.859104,2.8604,-0.23123,-0.06302,0.16821,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-604,[0 0 0 ... 0 0 0],"[326.4800000000001, 326.2245802, 5.033700000000004, 2, 0, 34.14, 0, 2, 24, 0.7126620325345314, 0.7272727272727273, 4]",326.4800000000001,326.2245802,5.033700000000004,2,0,34.14,0,2,24,0.7126620325345314,0.7272727272727273,4,8.423022806062209,3.7755236403572563
42,Steroid,CC12C(C(CCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.44651091318946,Inactive,340.55,3,4,0,2,4.664,34.14,0.20739207,-1046.171336,2.8899,-0.23108,-0.06278,0.1683,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-605,[0 0 0 ... 0 0 0],"[340.5070000000001, 340.240230264, 5.423800000000005, 2, 0, 34.14, 0, 3, 25, 0.6868380124572508, 0.7391304347826086, 4]",340.5070000000001,340.240230264,5.423800000000005,2,0,34.14,0,3,25,0.6868380124572508,0.7391304347826086,4,8.424715254394238,3.760839032533781
43,Steroid,CC12C(C(CCCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.436806484379652,Inactive,354.58,4,4,0,2,5.12,34.14,0.205965667,-1085.481251,2.8842,-0.23088,-0.06259,0.16829,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-606,[0 0 0 ... 0 0 0],"[354.53400000000016, 354.255880328, 5.813900000000006, 2, 0, 34.14, 0, 4, 26, 0.5966495672708454, 0.75, 4]",354.53400000000016,354.255880328,5.813900000000006,2,0,34.14,0,4,26,0.5966495672708454,0.75,4,8.424715254394238,3.760839032533781
44,Steroid,CC12C(C(CCCCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.431919190487823,Inactive,368.61,5,4,0,2,5.577,34.14,0.20474073,-1124.79079,2.8449,-0.23103,-0.06272,0.16831,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-607,[0 0 0 ... 0 0 0],"[368.5610000000002, 368.27153039199993, 6.204000000000006, 2, 0, 34.14, 0, 5, 27, 0.5410642379130094, 0.76, 4]",368.5610000000002,368.27153039199993,6.204000000000006,2,0,34.14,0,5,27,0.5410642379130094,0.76,4,8.415356463557861,3.842762433637712
45,Steroid,CC12C(C(CCCCCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(CC1)=O,8.47281731188935,Inactive,382.64,6,4,0,2,6.033,34.14,0.20257097,-1164.108691,2.8889,-0.23117,-0.06262,0.16855,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-608,[0 0 0 ... 0 0 0],"[382.58800000000025, 382.28718045599993, 6.594100000000007, 2, 0, 34.14, 0, 6, 28, 0.48530967624087834, 0.7692307692307693, 4]",382.58800000000025,382.28718045599993,6.594100000000007,2,0,34.14,0,6,28,0.48530967624087834,0.7692307692307693,4,8.443346084774548,3.6029141609488966
46,Steroid,CC12C(C(C)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.504349074970575,Inactive,296.44,0,4,0,2,3.272,34.14,0.208818152,-927.0087622,3.5819,-0.23383,-0.06672,0.16711,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-609,[0 0 0 ... 0 0 0],"[296.40999999999997, 296.177630008, 4.029500000000003, 2, 0, 34.14, 0, 0, 22, 0.6760895538895387, 0.6, 4]",296.40999999999997,296.177630008,4.029500000000003,2,0,34.14,0,0,22,0.6760895538895387,0.6,4,8.461230693445396,3.4575566663951003
47,Steroid,CC12C(C(CC)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.3588481891316,Inactive,310.47,1,4,0,2,3.729,34.14,0.206468245,-966.3208649,3.6395,-0.234,-0.06642,0.16758,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-610,[0 0 0 ... 0 0 0],"[310.43699999999995, 310.193280072, 4.4196000000000035, 2, 0, 34.14, 0, 1, 23, 0.7182192814593186, 0.6190476190476191, 4]",310.43699999999995,310.193280072,4.4196000000000035,2,0,34.14,0,1,23,0.7182192814593186,0.6190476190476191,4,8.363065041407319,4.334459591966968
48,Steroid,CC12C(C(CCC)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.397940008672037,Inactive,324.5,2,4,0,2,4.185,34.14,0.204699519,-1005.633869,3.7096,-0.23301,-0.06516,0.16785,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-611,[0 0 0 ... 0 0 0],"[324.464, 324.208930136, 4.809700000000004, 2, 0, 34.14, 0, 2, 24, 0.730248679767248, 0.6363636363636364, 4]",324.464,324.208930136,4.809700000000004,2,0,34.14,0,2,24,0.730248679767248,0.6363636363636364,4,8.381723997760655,4.152178374784007
49,Steroid,CC12C(C(CCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.4434490584395,Inactive,338.53,3,4,0,2,4.641,34.14,0.203059109,-1044.946211,3.7241,-0.23283,-0.06493,0.1679,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-612,[0 0 0 ... 0 0 0],"[338.49100000000004, 338.2245802, 5.199800000000005, 2, 0, 34.14, 0, 3, 25, 0.7085623172416405, 0.6521739130434783, 4]",338.49100000000004,338.2245802,5.199800000000005,2,0,34.14,0,3,25,0.7085623172416405,0.6521739130434783,4,8.397229700114325,4.006547536524347
50,Steroid,CC12C(C(CCCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.414102717872563,Inactive,352.56,4,4,0,2,5.097,34.14,0.201621328,-1084.255819,3.7383,-0.2328,-0.06483,0.16797,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-613,[0 0 0 ... 0 0 0],"[352.5180000000001, 352.240230264, 5.589900000000005, 2, 0, 34.14, 0, 4, 26, 0.6180700346178966, 0.6666666666666666, 4]",352.5180000000001,352.240230264,5.589900000000005,2,0,34.14,0,4,26,0.6180700346178966,0.6666666666666666,4,8.397229700114325,4.006547536524347
51,Steroid,CC12C(C(CCCCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.419112835579527,Inactive,366.59,5,4,0,2,5.553,34.14,0.200771033,-1123.565612,3.6753,-0.23281,-0.0649,0.16791,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-614,[0 0 0 ... 0 0 0],"[366.54500000000013, 366.25588032799993, 5.980000000000006, 2, 0, 34.14, 0, 5, 27, 0.5608842295256364, 0.68, 4]",366.54500000000013,366.25588032799993,5.980000000000006,2,0,34.14,0,5,27,0.5608842295256364,0.68,4,8.397229700114325,4.006547536524347
52,Steroid,CC12C(C(CCCCCCC)=CC3C2CCC4(C)C3CCC4=O)=CC(C=C1)=O,8.439104816294453,Inactive,380.62,6,4,0,2,6.01,34.14,0.197689281,-1162.889755,3.6375,-0.23319,-0.06599,0.1672,"6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships",Steroids. 1997;62(8-9):595-615,[0 0 0 ... 0 0 0],"[380.5720000000002, 380.27153039199993, 6.370100000000006, 2, 0, 34.14, 0, 6, 28, 0.5017013065610553, 0.6923076923076923, 4]",380.5720000000002,380.27153039199993,6.370100000000006,2,0,34.14,0,6,28,0.5017013065610553,0.6923076923076923,4,8.435226518546255,3.670907839964148
53,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H]4C5=CC(CC[C@]5(CO4)C3CC1)=O,8.360857563980318,Inactive,300.43,0,5,0,3,1.868,43.37,0.20823563,-964.1026761,1.9339,-0.23681,-0.05416,0.18265,"6beta,19-Bridged androstenedione analogs as aromatase inhibitors",Steroids. 2009;74(12):884-9,[0 0 0 ... 0 0 0],"[300.3980000000001, 300.17254462799997, 3.076200000000002, 3, 0, 43.370000000000005, 0, 0, 22, 0.69029317604578, 0.7894736842105263, 5]",300.3980000000001,300.17254462799997,3.076200000000002,3,0,43.370000000000005,0,0,22,0.69029317604578,0.7894736842105263,5,8.315742801731906,4.8334496428459826
57,Non-Steroid,O=C1C=COC2=C(CN3C=NC=C3)C=CC(C#N)=C21,8.179155868974,Active,251.26,2,3,0,4,0.944,71.82,0.217811071,-853.5712841,6.7331,-0.23983,-0.08895,0.15088,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-80,[0 0 0 ... 0 0 0],"[251.24500000000003, 251.069476528, 1.9094799999999998, 5, 0, 71.82, 3, 2, 19, 0.6970312562137172, 0.07142857142857142, 3]",251.24500000000003,251.069476528,1.9094799999999998,5,0,71.82,3,2,19,0.6970312562137172,0.07142857142857142,3,8.159707053088127,6.922977926821104
58,Non-Steroid,O=C1C=COC2=C(CN3C=NC=C3)C=CC([N+]([O-])=O)=C21,8.224855234569844,Inactive,271.25,3,3,0,5,0.959,93.85,0.227277276,-965.8188732,6.3324,-0.23983,-0.0879,0.15193,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-81,[0 0 0 ... 0 0 0],"[271.2320000000001, 271.05930576800006, 1.9459999999999997, 6, 0, 91.16999999999999, 3, 3, 20, 0.5359426015845717, 0.07692307692307693, 3]",271.2320000000001,271.05930576800006,1.9459999999999997,6,0,91.16999999999999,3,3,20,0.5359426015845717,0.07692307692307693,3,8.241575530020434,5.733561430427782
59,Non-Steroid,BrC1=C2C(OC=CC2=O)=C(CN3C=NC=C3)C=C1,8.245821385400793,Inactive,305.14,2,3,0,3,1.813,48.03,0.196813296,-3332.432014,3.9472,-0.23339,-0.06911,0.16428,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-82,[0 0 0 ... 0 0 0],"[305.131, 303.98473962800006, 2.800300000000001, 4, 0, 48.03, 3, 2, 18, 0.7312430226638732, 0.07692307692307693, 3]",305.131,303.98473962800006,2.800300000000001,4,0,48.03,3,2,18,0.7312430226638732,0.07692307692307693,3,8.217758876488304,6.056770578063035
60,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=C(CN4C=NC=C4)C=CC(C#N)=C31,8.132736947129581,Active,301.32,2,4,0,4,2.52,71.82,0.207112235,-1007.229108,7.0319,-0.23748,-0.0929,0.14458,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-83,[0 0 0 ... 0 0 0],"[301.30500000000006, 301.08512659200005, 3.062680000000001, 5, 0, 71.82, 4, 2, 23, 0.533385875082084, 0.05555555555555555, 4]",301.30500000000006,301.08512659200005,3.062680000000001,5,0,71.82,4,2,23,0.533385875082084,0.05555555555555555,4,8.137941934223006,7.278771162153465
61,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=C(CN4C=NC=C4)C=CC([N+]([O-])=O)=C31,8.130889194765137,Active,321.31,3,4,0,5,2.535,93.85,0.215336343,-1119.476756,6.6374,-0.23741,-0.09182,0.14559,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-84,[0 0 0 ... 0 0 0],"[321.2920000000001, 321.074955832, 3.0992000000000015, 6, 0, 91.16999999999999, 4, 3, 24, 0.32834513050861935, 0.058823529411764705, 4]",321.2920000000001,321.074955832,3.0992000000000015,6,0,91.16999999999999,4,3,24,0.32834513050861935,0.058823529411764705,4,8.222048983930849,5.997234298335486
62,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=C(CN4C=NC=C4)C=CC(Br)=C31,8.151773307812324,Active,355.2,2,4,0,3,3.389,48.03,0.189524424,-3486.089492,4.4184,-0.23125,-0.07737,0.15388,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-85,[0 0 0 ... 0 0 0],"[355.19100000000003, 354.00038969200006, 3.953500000000002, 4, 0, 48.03, 4, 2, 22, 0.5117248787124429, 0.058823529411764705, 4]",355.19100000000003,354.00038969200006,3.953500000000002,4,0,48.03,4,2,22,0.5117248787124429,0.058823529411764705,4,8.192653830550954,6.417208786208021
63,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=C(C#N)C=CC(CN4C=NC=C4)=C31,8.248853964209266,Inactive,301.32,2,4,0,4,2.52,71.82,0.209511294,-1007.230107,4.5532,-0.21942,-0.09823,0.12119,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-86,[0 0 0 ... 0 0 0],"[301.305, 301.085126592, 3.062680000000001, 5, 0, 71.82, 4, 2, 23, 0.533385875082084, 0.05555555555555555, 4]",301.305,301.085126592,3.062680000000001,5,0,71.82,4,2,23,0.533385875082084,0.05555555555555555,4,8.143041116430334,7.193808680580876
64,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=C([N+]([O-])=O)C=CC(CN4C=NC=C4)=C31,8.220892309744627,Active,321.31,3,4,0,5,2.535,93.85,0.218942886,-1119.478281,4.7357,-0.22023,-0.10633,0.1139,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-87,[0 0 0 ... 0 0 0],"[321.292, 321.07495583200006, 3.0992000000000015, 6, 0, 91.17, 4, 3, 24, 0.32834513050861935, 0.058823529411764705, 4]",321.292,321.07495583200006,3.0992000000000015,6,0,91.17,4,3,24,0.32834513050861935,0.058823529411764705,4,8.222048983930849,5.997234298335486
65,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=C(Br)C=CC(CN4C=NC=C4)=C31,8.21990802155277,Active,355.2,2,4,0,3,3.389,48.03,0.192697697,-3486.091966,4.9816,-0.21297,-0.08365,0.12932,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-88,[0 0 0 ... 0 0 0],"[355.1910000000001, 354.00038969200006, 3.9535000000000027, 4, 0, 48.03, 4, 2, 22, 0.5117248787124429, 0.058823529411764705, 4]",355.1910000000001,354.00038969200006,3.9535000000000027,4,0,48.03,4,2,22,0.5117248787124429,0.058823529411764705,4,8.192653830550954,6.417208786208021
66,Non-Steroid,O=C1C=COC2=CC(CN3C=NC=C3)=CC=C21,8.154901959985743,Active,226.25,2,3,0,3,1.065,48.03,0.213454222,-761.3376919,5.4168,-0.22878,-0.0635,0.16528,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-89,[0 0 0 ... 0 0 0],"[226.235, 226.07422756, 2.0378, 4, 0, 48.03, 3, 2, 17, 0.671405255652193, 0.07692307692307693, 3]",226.235,226.07422756,2.0378,4,0,48.03,3,2,17,0.671405255652193,0.07692307692307693,3,8.189888445795566,6.458200950495161
67,Non-Steroid,O=C1C=COC2=CC(CN3C=NN=C3)=CC=C21,8.26505636708669,Inactive,227.24,2,3,0,4,0.541,60.92,0.232724115,-777.3607627,7.1874,-0.25387,-0.06945,0.18442,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-90,[0 0 0 ... 0 0 0],"[227.223, 227.069476528, 1.4327999999999999, 5, 0, 60.92, 3, 2, 17, 0.6640971082413873, 0.08333333333333333, 3]",227.223,227.069476528,1.4327999999999999,5,0,60.92,3,2,17,0.6640971082413873,0.08333333333333333,3,8.191161504716785,6.439297574461532
68,Non-Steroid,O=C1C2=C(C=CC=C2)OC3=CC(CN4C=NC=C4)=CC=C31,8.193214106416404,Active,276.31,2,4,0,3,2.641,48.03,0.203960909,-914.9951135,5.5119,-0.22736,-0.07261,0.15475,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-91,[0 0 0 ... 0 0 0],"[276.295, 276.089877624, 3.1910000000000016, 4, 0, 48.03, 4, 2, 21, 0.528192006706474, 0.058823529411764705, 4]",276.295,276.089877624,3.1910000000000016,4,0,48.03,4,2,21,0.528192006706474,0.058823529411764705,4,8.366931218669896,4.296044599258788
70,Non-Steroid,O=C1C(CN2C=NC=C2)=C(C3=CC=CC=C3)OC4=CC(OC)=CC=C41,8.203450829472398,Active,332.38,4,4,0,4,2.757,57.26,0.205101098,-1106.921141,6.64,-0.20649,-0.06416,0.14233,"A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase",J Med Chem. 2001 Mar 1;44(5):672-92,[0 0 0 ... 0 0 0],"[332.3590000000001, 332.11609237199997, 3.7134000000000027, 5, 0, 57.260000000000005, 4, 4, 25, 0.571481103896921, 0.1, 4]",332.3590000000001,332.11609237199997,3.7134000000000027,5,0,57.260000000000005,4,4,25,0.571481103896921,0.1,4,8.20715792823635,6.20643300471708
72,Steroid,O=C1CCC2C3[C@H](OC(C)=O)C(C4=CC(CCC4(C)C3CCC21C)=O)=O,8.27771792198676,Inactive,358.47,2,4,0,5,1.918,77.51,0.240634885,-1192.015295,3.492,-0.24394,-0.09682,0.14712,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-85,[0 0 0 ... 0 0 0],"[358.4340000000001, 358.1780239319999, 2.8080000000000007, 5, 0, 77.51, 0, 1, 26, 0.6737154220574997, 0.7142857142857143, 4]",358.4340000000001,358.1780239319999,2.8080000000000007,5,0,77.51,0,1,26,0.6737154220574997,0.7142857142857143,4,8.269383852410636,5.37794241426186
73,Steroid,O=C1CCC2C3[C@H](O)C(C4=CC(CCC4(C)C3CCC21C)=O)=O,8.304640283255823,Inactive,316.43,0,4,1,4,1.539,71.44,0.231804255,-1039.352247,3.5669,-0.23888,-0.10375,0.13513,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-86,[0 0 0 ... 0 0 0],"[316.39700000000005, 316.16745924799994, 2.2372000000000005, 4, 1, 71.44, 0, 0, 23, 0.7437610313890208, 0.7368421052631579, 4]",316.39700000000005,316.16745924799994,2.2372000000000005,4,1,71.44,0,0,23,0.7437610313890208,0.7368421052631579,4,8.278701941504908,5.263783986050317
74,Steroid,O=C1CCC2C3CC(C4=CC(C(C)(C)CC4(C)C3CCC21C)=O)=O,8.185560694582964,Active,328.49,0,4,0,3,3.032,51.21,0.219250615,-1042.764415,4.3997,-0.23954,-0.08785,0.15169,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-87,[0 0 0 ... 0 0 0],"[328.45200000000006, 328.20384475599997, 3.9025000000000034, 3, 0, 51.21, 0, 0, 24, 0.6773968240101178, 0.7619047619047619, 4]",328.45200000000006,328.20384475599997,3.9025000000000034,3,0,51.21,0,0,24,0.6773968240101178,0.7619047619047619,4,8.225845180142123,5.945040531551893
75,Steroid,O=C1CCC2C3CC(C4=C(OC)C(C(C)(C)CC4(C)C3CCC21C)=O)=O,8.242509347913112,Inactive,358.52,1,4,0,4,2.533,60.44,0.220366411,-1157.27566,4.0065,-0.23589,-0.06683,0.16906,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-88,[0 0 0 ... 0 0 0],"[358.4780000000001, 358.21440943999994, 3.8766000000000034, 4, 0, 60.440000000000005, 0, 1, 26, 0.7136528623482876, 0.7727272727272727, 4]",358.4780000000001,358.21440943999994,3.8766000000000034,4,0,60.440000000000005,0,1,26,0.7136528623482876,0.7727272727272727,4,8.23305182539326,5.84720303916737
76,Steroid,O=C1CCC2C3CC(C4=C(O)C(C(C)(C)CC4(C)C3CCC21C)=O)=O,8.196778715372892,Active,344.49,0,4,1,4,2.469,71.44,0.230580396,-1117.985188,3.1177,-0.23194,-0.08505,0.14689,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-89,[0 0 0 ... 0 0 0],"[344.45100000000014, 344.19875937599994, 3.7882000000000033, 4, 1, 71.44, 0, 0, 25, 0.7255947071902247, 0.7619047619047619, 4]",344.45100000000014,344.19875937599994,3.7882000000000033,4,1,71.44,0,0,25,0.7255947071902247,0.7619047619047619,4,8.23808018981197,5.77989315370817
77,Steroid,O=C1CCC2C3CC(C4=CC(C(O)=CC4(C)C3CCC21C)=O)=O,8.279690831049871,Inactive,314.41,0,4,1,4,1.566,71.44,0.2359588,-1038.129553,7.2091,-0.24305,-0.08952,0.15353,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-90,[0 0 0 ... 0 0 0],"[314.38100000000003, 314.15180918399994, 2.9281000000000015, 4, 1, 71.44, 0, 0, 23, 0.7460002471697047, 0.631578947368421, 4]",314.38100000000003,314.15180918399994,2.9281000000000015,4,1,71.44,0,0,23,0.7460002471697047,0.631578947368421,4,8.263847687617206,5.446936500683119
79,Steroid,O=C1CCC2C3CC(C4=CC([C@H](OC(C)=O)CC4(C)C3CCC21C)=O)=O,8.349836188672777,Inactive,358.47,2,4,0,5,1.851,77.51,0.239237981,-1192.017126,5.5214,-0.2461,-0.09403,0.15207,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-91,[0 0 0 ... 0 0 0],"[358.43400000000014, 358.1780239319999, 2.8080000000000016, 5, 0, 77.51, 0, 1, 26, 0.6737154220574997, 0.7142857142857143, 4]",358.43400000000014,358.1780239319999,2.8080000000000016,5,0,77.51,0,1,26,0.6737154220574997,0.7142857142857143,4,8.29224342967633,5.10218933146895
81,Steroid,O=C1CCC2C3CC(C4=C(OC)C(CCC4(C)C3CCC21C)=O)=O,8.244203628888876,Inactive,330.46,1,4,0,4,1.654,60.44,0.2233456,-1078.652092,4.4379,-0.23824,-0.07202,0.16622,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-92,[0 0 0 ... 0 0 0],"[330.4240000000001, 330.18310931199994, 3.2405000000000017, 4, 0, 60.440000000000005, 0, 1, 24, 0.740359213791149, 0.75, 4]",330.4240000000001,330.18310931199994,3.2405000000000017,4,0,60.440000000000005,0,1,24,0.740359213791149,0.75,4,8.253215647179092,5.581929574429558
82,Steroid,O=C1CCC2C3CC(C4=C(OCC)C(CCC4(C)C3CCC21C)=O)=O,8.27190707707259,Inactive,344.49,2,4,0,4,2.003,60.44,0.221660113,-1117.971792,4.2125,-0.23694,-0.07102,0.16592,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-93,[0 0 0 ... 0 0 0],"[344.4510000000001, 344.19875937599994, 3.630600000000003, 4, 0, 60.440000000000005, 0, 2, 25, 0.7673235534403766, 0.7619047619047619, 4]",344.4510000000001,344.19875937599994,3.630600000000003,4,0,60.440000000000005,0,2,25,0.7673235534403766,0.7619047619047619,4,8.25538061790457,5.554172733656495
83,Steroid,O=C1CCC2C3CC(C4=C(O)C(CCC4(C)C3CCC21C)=O)=O,8.198099696659426,Active,316.43,0,4,1,4,1.589,71.44,0.23608817,-1039.362653,3.2756,-0.23414,-0.08451,0.14963,"A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships",Steroids. 1994;59(10):579-94,[0 0 0 ... 0 0 0],"[316.39700000000005, 316.16745924799994, 3.1521000000000017, 4, 1, 71.44, 0, 0, 23, 0.7449557179516122, 0.7368421052631579, 4]",316.39700000000005,316.16745924799994,3.1521000000000017,4,1,71.44,0,0,23,0.7449557179516122,0.7368421052631579,4,8.231075100332781,5.8738776977162726
85,Steroid,O=C1CCC2C3C(C)C4=CC(CCC4(C)C3CCC21C)=O,8.182947265712572,Active,286.45,0,4,0,2,3.089,34.14,0.21331566,-890.1276448,2.3291,-0.2317,-0.04493,0.18677,An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors,Eur J Med Chem. 2009;44(10):4121-7,[0 0 0 ... 0 0 0],"[286.41499999999996, 286.193280072, 3.9433000000000034, 2, 0, 34.14, 0, 0, 21, 0.6755883923370424, 0.7894736842105263, 4]",286.41499999999996,286.193280072,3.9433000000000034,2,0,34.14,0,0,21,0.6755883923370424,0.7894736842105263,4,8.261588193702508,5.475348998402244
86,Non-Steroid,CC12C(CCC2=O)C3C(C)C(OC4(C)C3CC1)=CC(CC4)=O,8.30026857018213,Inactive,302.45,0,4,0,3,2.297,43.37,0.233202375,-965.324832,3.8818,-0.23342,-0.04354,0.18988,An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors,Eur J Med Chem. 2009;44(10):4121-8,[0 0 0 ... 0 0 0],"[302.4140000000001, 302.18819469199997, 3.669800000000003, 3, 0, 43.370000000000005, 0, 0, 22, 0.6854822130810305, 0.7894736842105263, 4]",302.4140000000001,302.18819469199997,3.669800000000003,3,0,43.370000000000005,0,0,22,0.6854822130810305,0.7894736842105263,4,8.248545328721686,5.642280479629007
87,Non-Steroid,CC(OC1=CC=C(C(/C(CC)=C2SC(C=C/2)=O)CC)C=C1)=O,8.317884873642447,Inactive,316.45,6,2,0,3,4.465,71.61,0.229497357,-1321.81779,6.0323,-0.22568,-0.0774,0.14828,An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors,Eur J Med Chem. 2009;44(10):4121-9,[0 1 0 ... 0 0 0],"[316.422, 316.11331549999994, 4.599200000000004, 4, 0, 43.370000000000005, 1, 5, 22, 0.5880130773102241, 0.3333333333333333, 2]",316.422,316.11331549999994,4.599200000000004,4,0,43.370000000000005,1,5,22,0.5880130773102241,0.3333333333333333,2,8.285081306585578,5.187029206987702
90,Non-Steroid,CC1C(C)(CCC2=CC(OC2)=O)C3CCC=C4C3(COC4=O)CC1O,8.408976657920725,Inactive,346.46,3,4,1,5,2.63,72.83,0.228812961,-1153.865907,7.1258,-0.25722,-0.04601,0.21121,An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors,Eur J Med Chem. 2009;44(10):4121-10,[0 0 0 ... 0 0 0],"[346.4230000000001, 346.1780239319999, 2.536400000000001, 5, 1, 72.83, 0, 3, 25, 0.7951982304033404, 0.7, 4]",346.4230000000001,346.1780239319999,2.536400000000001,5,1,72.83,0,3,25,0.7951982304033404,0.7,4,8.409790946433523,3.8923246225611914
91,Non-Steroid,CC1=C(C#N)C=C(C2=N1)C(NC3=CC=C(Cl)C=C3)OC4=C2C=C([N+]([O-])=O)C=C4,8.20980140039857,Active,392.82,3,4,1,6,4.741,103.76,0.22047978,-1674.616193,0.8725,-0.22415,-0.09126,0.13289,An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors,Eur J Med Chem. 2009;44(10):4121-11,[0 0 0 ... 0 0 0],"[392.8020000000002, 392.067617956, 4.993400000000003, 6, 1, 101.07999999999998, 3, 3, 28, 0.49714251291845685, 0.1, 4]",392.8020000000002,392.067617956,4.993400000000003,6,1,101.07999999999998,3,3,28,0.49714251291845685,0.1,4,8.1404513992316,7.236833832783191
92,Non-Steroid,CCCC(OC1=CC(OC(CCC)=O)=CC2=C1C(C)=CC(O2)=O)=O,8.425449356684817,Inactive,332.38,8,2,0,6,4.128,82.81,0.285724727,-1149.345993,6.7146,-0.23497,-0.06601,0.16896,An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors,Eur J Med Chem. 2009;44(10):4121-12,[0 1 0 ... 0 0 0],"[332.35200000000003, 332.1259883599999, 3.5124200000000023, 6, 0, 82.81, 2, 6, 24, 0.45716499236507674, 0.3888888888888889, 2]",332.35200000000003,332.1259883599999,3.5124200000000023,6,0,82.81,2,6,24,0.45716499236507674,0.3888888888888889,2,8.360850573455261,4.356617448764649
94,Non-Steroid,O=C1NC(CCC1(CC)C2=CC=NC=C2)=O,8.301029995663981,Inactive,218.28,2,2,1,4,0.881,59.06,0.2574193,-725.6871887,2.8394,-0.25592,-0.04013,0.21579,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-4,[0 0 0 ... 0 0 0],"[218.25600000000003, 218.105527688, 1.1659999999999997, 3, 1, 59.06, 1, 2, 16, 0.7578116528852396, 0.4166666666666667, 2]",218.25600000000003,218.105527688,1.1659999999999997,3,1,59.06,1,2,16,0.7578116528852396,0.4166666666666667,2,8.309793827445688,4.900113871930449
95,Non-Steroid,O=C1NC(CCC1(CC)C2=CC=C(N)C=C2)=O,8.29269303390247,Inactive,232.31,2,2,3,4,1.285,72.19,0.280323364,-765.0073915,4.8141,-0.20616,-0.02447,0.18169,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-5,[0 0 0 ... 0 0 0],"[232.28300000000002, 232.121177752, 1.3531999999999997, 3, 2, 72.19, 1, 2, 17, 0.5969362176118972, 0.38461538461538464, 2]",232.28300000000002,232.121177752,1.3531999999999997,3,2,72.19,1,2,17,0.5969362176118972,0.38461538461538464,2,8.30792185803158,4.921280755977949
96,Non-Steroid,O=C(CCC(C)1C2=CC=NC=C2)NC1=O,8.44239248693278,Inactive,204.25,1,2,1,4,0.425,59.06,0.266011074,-686.3752002,3.1001,-0.25734,-0.0385,0.21884,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-6,[0 0 0 ... 0 0 0],"[204.22899999999998, 204.089877624, 0.7758999999999998, 3, 1, 59.06, 1, 1, 15, 0.6874235825308643, 0.36363636363636365, 2]",204.22899999999998,204.089877624,0.7758999999999998,3,1,59.06,1,1,15,0.6874235825308643,0.36363636363636365,2,8.384736897637486,4.123472498317417
97,Non-Steroid,O=C(CCC(CCC)1C2=CC=NC=C2)NC1=O,8.282175711599955,Inactive,232.31,3,2,1,4,1.337,59.06,0.249797788,-765.0007871,2.7786,-0.25568,-0.04002,0.21566,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-7,[0 0 0 ... 0 0 0],"[232.28300000000004, 232.121177752, 1.5560999999999998, 3, 1, 59.06, 1, 3, 17, 0.8043817392315606, 0.46153846153846156, 2]",232.28300000000004,232.121177752,1.5560999999999998,3,1,59.06,1,3,17,0.8043817392315606,0.46153846153846156,2,8.295870985955425,5.059749475402395
98,Non-Steroid,O=C(CCC(CCCC)1C2=CC=NC=C2)NC1=O,8.267771946364356,Inactive,246.34,4,2,1,4,1.794,59.06,0.243809472,-804.313076,2.8042,-0.25546,-0.03992,0.21554,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-8,[0 0 0 ... 0 0 0],"[246.31000000000003, 246.136827816, 1.9462, 3, 1, 59.06, 1, 4, 18, 0.8259321333673324, 0.5, 2]",246.31000000000003,246.136827816,1.9462,3,1,59.06,1,4,18,0.8259321333673324,0.5,2,8.294445453180058,5.076384937571398
99,Non-Steroid,O=C(CCC(CCCCC)1C2=CC=NC=C2)NC1=O,8.25165224474116,Inactive,260.37,5,2,1,4,2.25,59.06,0.239266077,-843.6238912,3.5678,-0.25666,-0.03613,0.22053,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-9,[0 0 0 ... 0 0 0],"[260.33700000000005, 260.15247788, 2.3362999999999996, 3, 1, 59.06, 1, 5, 19, 0.6526884603861656, 0.5333333333333333, 2]",260.33700000000005,260.15247788,2.3362999999999996,3,1,59.06,1,5,19,0.6526884603861656,0.5333333333333333,2,8.264449032531084,5.439399631012398
100,Non-Steroid,O=C(CCC(CCCCCC)1C2=CC=NC=C2)NC1=O,8.264106016122115,Inactive,274.4,6,2,1,4,2.706,59.06,0.234772952,-882.9336201,3.636,-0.25655,-0.03603,0.22052,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-10,[0 0 0 ... 0 0 0],"[274.3640000000001, 274.168127944, 2.726400000000001, 3, 1, 59.06, 1, 6, 20, 0.6406826778748144, 0.5625, 2]",274.3640000000001,274.168127944,2.726400000000001,3,1,59.06,1,6,20,0.6406826778748144,0.5625,2,8.260024240713175,5.4951020137272915
101,Non-Steroid,O=C(CCC(CCCCCCC)1C2=CC=NC=C2)NC1=O,8.260044156835887,Inactive,288.43,7,2,1,4,3.162,59.06,0.229740289,-922.2489737,2.9075,-0.25521,-0.03975,0.21546,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-11,[0 0 0 ... 0 0 0],"[288.391, 288.183778008, 3.116500000000001, 3, 1, 59.06, 1, 7, 21, 0.619230424027078, 0.5882352941176471, 2]",288.391,288.183778008,3.116500000000001,3,1,59.06,1,7,21,0.619230424027078,0.5882352941176471,2,8.258321487116396,5.516689143845699
102,Non-Steroid,O=C(CCC(CCCCCCCC)1C2=CC=NC=C2)NC1=O,8.188325408687179,Active,302.46,8,2,1,4,3.618,59.06,0.226230583,-961.5524047,3.4013,-0.25444,-0.0404,0.21404,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-12,[0 0 0 ... 0 0 0],"[302.418, 302.19942807199993, 3.5066000000000015, 3, 1, 59.06, 1, 8, 22, 0.5903168960043121, 0.6111111111111112, 2]",302.418,302.19942807199993,3.5066000000000015,3,1,59.06,1,8,22,0.5903168960043121,0.6111111111111112,2,8.251366299946147,5.605749670300484
103,Non-Steroid,O=C(CCC(CCCCCCCCC)1C2=CC=NC=C2)NC1=O,8.250280008800894,Inactive,316.49,9,2,1,4,4.075,59.06,0.22272851,-1000.877848,2.7263,-0.25546,-0.03958,0.21588,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-13,[0 0 0 ... 0 0 0],"[316.445, 316.215078136, 3.8967000000000027, 3, 1, 59.06, 1, 9, 23, 0.5550841188365646, 0.631578947368421, 2]",316.445,316.215078136,3.8967000000000027,3,1,59.06,1,9,23,0.5550841188365646,0.631578947368421,2,8.251836745867722,5.599680575869179
104,Non-Steroid,O=C1N(C(CCC1(C2=CC=NC=C2)CC)=O)C,8.3445850552086,Inactive,232.31,2,2,0,4,1.087,50.27,0.245089242,-764.9971512,2.5124,-0.25447,-0.03717,0.2173,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-14,[0 0 0 ... 0 0 0],"[232.283, 232.121177752, 1.5082, 3, 0, 50.27, 1, 2, 17, 0.7261184880612406, 0.46153846153846156, 2]",232.283,232.121177752,1.5082,3,0,50.27,1,2,17,0.7261184880612406,0.46153846153846156,2,8.33364460047313,4.638263310227995
105,Non-Steroid,O=C1N(CC)C(CCC1(CC)C2=CC=NC=C2)=O,8.466667888174385,Inactive,246.34,3,2,0,4,1.436,50.27,0.240547,-804.3135474,2.4426,-0.25415,-0.03674,0.21741,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-15,[0 0 0 ... 0 0 0],"[246.31, 246.136827816, 1.8983, 3, 0, 50.27, 1, 3, 18, 0.7652885044829236, 0.5, 2]",246.31,246.136827816,1.8983,3,0,50.27,1,3,18,0.7652885044829236,0.5,2,8.42406714810981,3.7664555971600406
106,Non-Steroid,O=C1N(CCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.345954603462316,Inactive,260.37,4,2,0,4,1.96,50.27,0.235410846,-843.6274828,2.4858,-0.25412,-0.0364,0.21772,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-16,[0 0 0 ... 0 0 0],"[260.337, 260.15247788, 2.2884, 3, 0, 50.27, 1, 4, 19, 0.7803902771583815, 0.5333333333333333, 2]",260.337,260.15247788,2.2884,3,0,50.27,1,4,19,0.7803902771583815,0.5333333333333333,2,8.315206634313862,4.839420565114003
107,Non-Steroid,O=C1N(CCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.35675069901751,Inactive,274.4,5,2,0,4,2.416,50.27,0.231040333,-882.9397258,2.4533,-0.25387,-0.03618,0.21769,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-17,[0 0 0 ... 0 0 0],"[274.364, 274.168127944, 2.6785000000000005, 3, 0, 50.27, 1, 5, 20, 0.7756232436776385, 0.5625, 2]",274.364,274.168127944,2.6785000000000005,3,0,50.27,1,5,20,0.7756232436776385,0.5625,2,8.304029639353656,4.965584316041387
108,Non-Steroid,O=C1N(CCCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.329960141834427,Inactive,288.43,6,2,0,4,2.872,50.27,0.227531156,-922.2497754,2.4873,-0.25382,-0.03621,0.21761,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-18,[0 0 0 ... 0 0 0],"[288.39099999999996, 288.183778008, 3.0686000000000018, 3, 0, 50.27, 1, 6, 21, 0.5968591413669703, 0.5882352941176471, 2]",288.39099999999996,288.183778008,3.0686000000000018,3,0,50.27,1,6,21,0.5968591413669703,0.5882352941176471,2,8.285046353470621,5.1874466889769115
109,Non-Steroid,O=C1N(CCCCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.2856320052432,Inactive,302.46,7,2,0,4,3.328,50.27,0.224869938,-961.5632344,2.6638,-0.25506,-0.03296,0.2221,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-19,[0 0 0 ... 0 0 0],"[302.418, 302.19942807199993, 3.458700000000002, 3, 0, 50.27, 1, 7, 22, 0.5722927732921237, 0.6111111111111112, 2]",302.418,302.19942807199993,3.458700000000002,3,0,50.27,1,7,22,0.5722927732921237,0.6111111111111112,2,8.280621561652712,5.240568937824937
110,Non-Steroid,O=C1N(CCCCCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.234785438913192,Inactive,316.49,8,2,0,4,3.784,50.27,0.222877961,-1000.872776,2.7854,-0.25592,-0.03601,0.21991,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-20,[0 0 0 ... 0 0 0],"[316.445, 316.21507813599993, 3.8488000000000033, 3, 0, 50.27, 1, 8, 23, 0.5405053890728113, 0.631578947368421, 2]",316.445,316.21507813599993,3.8488000000000033,3,0,50.27,1,8,23,0.5405053890728113,0.631578947368421,2,8.261812648753272,5.4725199221394565
111,Non-Steroid,O=C1N(CCCCCCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.214890214875727,Active,330.52,9,2,0,4,4.241,50.27,0.214958019,-1040.149336,3.8516,-0.23229,-0.02709,0.2052,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-21,[0 0 0 ... 0 0 0],"[330.472, 330.2307282, 4.238900000000004, 3, 0, 50.27, 1, 9, 24, 0.5025058044919951, 0.65, 2]",330.472,330.2307282,4.238900000000004,3,0,50.27,1,9,24,0.5025058044919951,0.65,2,8.261812648753272,5.4725199221394565
112,Non-Steroid,O=C1N(CCCCCCCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.257834491622507,Inactive,344.55,10,2,0,4,4.697,50.27,0.21468893,-1079.451164,1.8411,-0.23688,-0.02596,0.21092,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-22,[0 0 0 ... 0 0 0],"[344.49899999999997, 344.246378264, 4.629000000000005, 3, 0, 50.27, 1, 10, 25, 0.4591868840609468, 0.6666666666666666, 2]",344.49899999999997,344.246378264,4.629000000000005,3,0,50.27,1,10,25,0.4591868840609468,0.6666666666666666,2,8.267554185170273,5.40064728863751
113,Non-Steroid,O=C1N(CCCCCCCCCC)C(CCC1(CC)C2=CC=NC=C2)=O,8.301029995663981,Inactive,358.58,11,2,0,4,5.153,50.27,0.21309755,-1118.789376,2.8197,-0.23296,-0.03514,0.19782,"Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents",J Med Chem. 1987;30(9):1550-23,[0 0 0 ... 0 0 0],"[358.526, 358.262028328, 5.019100000000005, 3, 0, 50.27, 1, 11, 26, 0.4121388361614197, 0.6818181818181818, 2]",358.526,358.262028328,5.019100000000005,3,0,50.27,1,11,26,0.4121388361614197,0.6818181818181818,2,8.26963547368181,5.374827447737567
114,Steroid,O=C1CCC2C3C(C=C4CCCCC4(C)C3CCC21C)=O,8.293152974049777,Inactive,286.45,0,4,0,2,3.504,34.14,0.210451511,-890.1338648,4.8893,-0.22818,-0.04952,0.17866,"Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase",Biochem Biophys Res Commun. 1992;186(1):32-9,[0 0 0 ... 0 0 0],"[286.4149999999999, 286.193280072, 4.087400000000003, 2, 0, 34.14, 0, 0, 21, 0.6719379087230691, 0.7894736842105263, 4]",286.4149999999999,286.193280072,4.087400000000003,2,0,34.14,0,0,21,0.6719379087230691,0.7894736842105263,4,8.282523793407496,5.217665177752688
115,Steroid,CC12C(CCC2=O)C3C(C=C4CCCCC4(CO)C3CC1)=O,8.412326492307123,Inactive,302.45,1,4,1,3,2.414,54.37,0.216872042,-965.3333534,6.6756,-0.22195,-0.04328,0.17867,"Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase",Biochem Biophys Res Commun. 1992;186(1):32-10,[0 0 0 ... 0 0 0],"[302.41400000000004, 302.18819469199997, 3.059800000000002, 3, 1, 54.37, 0, 1, 22, 0.8096758652820699, 0.7894736842105263, 4]",302.41400000000004,302.18819469199997,3.059800000000002,3,1,54.37,0,1,22,0.8096758652820699,0.7894736842105263,4,8.36010723755672,4.364080594859905
116,Steroid,CC12C(C3CCC4=CC([C@H](C)CC4(C3CC2)C)=O)CCC1=O,8.198099696659426,Active,300.48,0,4,0,2,3.756,34.14,0.21064836,-929.432138,4.7954,-0.22993,-0.0451,0.18483,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-9,[0 0 0 ... 0 0 0],"[300.44200000000006, 300.208930136, 4.333400000000004, 2, 0, 34.14, 0, 0, 22, 0.666890035800204, 0.8, 4]",300.44200000000006,300.208930136,4.333400000000004,2,0,34.14,0,0,22,0.666890035800204,0.8,4,8.2288994386105,5.903377577377774
117,Steroid,CC12C(C3CCC4=CC([C@H](CC)CC4(C3CC2)C)=O)CCC1=O,8.199368224774929,Active,314.51,1,4,0,2,4.213,34.14,0.20863734,-968.7444165,4.8371,-0.22993,-0.04551,0.18442,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-10,[0 0 0 ... 0 0 0],"[314.4690000000001, 314.2245802, 4.723500000000004, 2, 0, 34.14, 0, 1, 23, 0.7013194281770768, 0.8095238095238095, 4]",314.4690000000001,314.2245802,4.723500000000004,2,0,34.14,0,1,23,0.7013194281770768,0.8095238095238095,4,8.243713475078065,5.70540561141314
118,Steroid,CC12C(C3CCC4=CC([C@H](CCC)CC4(C3CC2)C)=O)CCC1=O,8.233910975868133,Inactive,328.54,2,4,0,2,4.669,34.14,0.2065545,-1008.058277,4.8657,-0.23011,-0.04564,0.18447,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-11,[0 0 0 ... 0 0 0],"[328.4960000000001, 328.240230264, 5.113600000000004, 2, 0, 34.14, 0, 2, 24, 0.7053206907275269, 0.8181818181818182, 4]",328.4960000000001,328.240230264,5.113600000000004,2,0,34.14,0,2,24,0.7053206907275269,0.8181818181818182,4,8.24648025224152,5.669173491759777
119,Steroid,CC12C(C3CCC4=CC([C@H](CCCC)CC4(C3CC2)C)=O)CCC1=O,8.24302611837902,Inactive,342.57,3,4,0,2,5.125,34.14,0.204829898,-1047.370582,4.8424,-0.22987,-0.04553,0.18434,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-12,[0 0 0 ... 0 0 0],"[342.5230000000001, 342.255880328, 5.503700000000006, 2, 0, 34.14, 0, 3, 25, 0.6780525315473498, 0.8260869565217391, 4]",342.5230000000001,342.255880328,5.503700000000006,2,0,34.14,0,3,25,0.6780525315473498,0.8260869565217391,4,8.252017141678854,5.597355082010865
120,Steroid,CC12C(C3CCC4=CC([C@H](CCCCC)CC4(C3CC2)C)=O)CCC1=O,8.22967903327053,Inactive,356.6,4,4,0,2,5.581,34.14,0.203943177,-1086.681522,5.0633,-0.2322,-0.04711,0.18509,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-13,[0 0 0 ... 0 0 0],"[356.5500000000001, 356.27153039199993, 5.893800000000006, 2, 0, 34.14, 0, 4, 26, 0.5882037156391221, 0.8333333333333334, 4]",356.5500000000001,356.27153039199993,5.893800000000006,2,0,34.14,0,4,26,0.5882037156391221,0.8333333333333334,4,8.252017141678854,5.597355082010865
121,Steroid,CC12C(C3CCC4=CC([C@H](CCCCCC)CC4(C3CC2)C)=O)CCC1=O,8.30251201850668,Inactive,370.63,5,4,0,2,6.037,34.14,0.202734077,-1125.99086,5.1427,-0.2324,-0.04755,0.18485,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-14,[0 0 0 ... 0 0 0],"[370.57700000000017, 370.28718045599993, 6.283900000000006, 2, 0, 34.14, 0, 5, 27, 0.5333657270748895, 0.84, 4]",370.57700000000017,370.28718045599993,6.283900000000006,2,0,34.14,0,5,27,0.5333657270748895,0.84,4,8.252017141678854,5.597355082010865
123,Steroid,CC12C(C3CCC4=CC(C(C)=CC4(C3CC2)C)=O)CCC1=O,8.203450829472398,Active,298.46,0,4,0,2,3.717,34.14,0.210283375,-928.2227464,3.9473,-0.23336,-0.05536,0.178,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-15,[0 0 0 ... 0 0 0],"[298.42600000000004, 298.193280072, 4.253500000000003, 2, 0, 34.14, 0, 0, 22, 0.6695977993795551, 0.7, 4]",298.42600000000004,298.193280072,4.253500000000003,2,0,34.14,0,0,22,0.6695977993795551,0.7,4,8.225977593522897,5.943228206149997
124,Steroid,CC12C(C3CCC4=CC(C(CC)=CC4(C3CC2)C)=O)CCC1=O,8.220567390814917,Active,312.49,1,4,0,2,4.173,34.14,0.208481275,-967.5359858,3.9727,-0.23337,-0.05635,0.17702,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-16,[0 0 0 ... 0 0 0],"[312.4530000000001, 312.208930136, 4.643600000000004, 2, 0, 34.14, 0, 1, 23, 0.7063784338378764, 0.7142857142857143, 4]",312.4530000000001,312.208930136,4.643600000000004,2,0,34.14,0,1,23,0.7063784338378764,0.7142857142857143,4,8.226466975649736,5.936534887035944
125,Steroid,CC12C(C3CCC4=CC(C(CCC)=CC4(C3CC2)C)=O)CCC1=O,8.239806640881039,Inactive,326.52,2,4,0,2,4.629,34.14,0.206436667,-1006.848882,3.7712,-0.23233,-0.05431,0.17802,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-17,[0 0 0 ... 0 0 0],"[326.4800000000001, 326.2245802, 5.033700000000005, 2, 0, 34.14, 0, 2, 24, 0.7126620325345314, 0.7272727272727273, 4]",326.4800000000001,326.2245802,5.033700000000005,2,0,34.14,0,2,24,0.7126620325345314,0.7272727272727273,4,8.24085474803516,5.743085104478023
126,Steroid,CC12C(C3CCC4=CC(C(CCCC)=CC4(C3CC2)C)=O)CCC1=O,8.241452782259797,Inactive,340.55,3,4,0,2,5.086,34.14,0.204853895,-1046.161317,3.6996,-0.23221,-0.05416,0.17805,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-18,[0 0 0 ... 0 0 0],"[340.5070000000001, 340.240230264, 5.423800000000005, 2, 0, 34.14, 0, 3, 25, 0.6868380124572508, 0.7391304347826086, 4]",340.5070000000001,340.240230264,5.423800000000005,2,0,34.14,0,3,25,0.6868380124572508,0.7391304347826086,4,8.246391637472493,5.670330365210335
127,Steroid,CC12C(C3CCC4=CC(C(CCCCC)=CC4(C3CC2)C)=O)CCC1=O,8.21260958602044,Active,354.58,4,4,0,2,5.542,34.14,0.203527817,-1085.470968,3.7349,-0.23236,-0.05429,0.17807,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-19,[0 0 0 ... 0 0 0],"[354.53400000000016, 354.25588032799993, 5.813900000000006, 2, 0, 34.14, 0, 4, 26, 0.5966495672708454, 0.75, 4]",354.53400000000016,354.25588032799993,5.813900000000006,2,0,34.14,0,4,26,0.5966495672708454,0.75,4,8.240355859569803,5.749686167386869
128,Steroid,CC12C(C3CCC4=CC(C(CCCCCC)=CC4(C3CC2)C)=O)CCC1=O,8.185367322797317,Active,368.61,5,4,0,2,5.998,34.14,0.202278968,-1124.780567,3.6245,-0.23217,-0.05411,0.17806,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-20,[0 0 0 ... 0 0 0],"[368.5610000000002, 368.27153039199993, 6.204000000000007, 2, 0, 34.14, 0, 5, 27, 0.5410642379130093, 0.76, 4]",368.5610000000002,368.27153039199993,6.204000000000007,2,0,34.14,0,5,27,0.5410642379130093,0.76,4,8.23014016950953,5.886536354230701
129,Steroid,CC12C(C3CCC4=CC(C(CCCCCCC)=CC4(C3CC2)C)=O)CCC1=O,8.206332196863768,Active,382.64,6,4,0,2,6.454,34.14,0.200502045,-1164.097158,3.6594,-0.23215,-0.05405,0.1781,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-21,[0 0 0 ... 0 0 0],"[382.5880000000002, 382.28718045599993, 6.594100000000007, 2, 0, 34.14, 0, 6, 28, 0.48530967624087834, 0.7692307692307693, 4]",382.5880000000002,382.28718045599993,6.594100000000007,2,0,34.14,0,6,28,0.48530967624087834,0.7692307692307693,4,8.258129790726219,5.519124732756693
130,Steroid,C[C@]12C(C3CCC4=CC(C(OC)=C[C@@]4(C3CC2)C)=O)CCC1=O,8.224855234569844,Inactive,314.46,1,4,0,3,2.772,43.37,0.217046061,-1003.411605,2.9221,-0.22879,-0.05992,0.16887,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-22,[0 0 0 ... 0 0 0],"[314.4250000000001, 314.18819469199997, 3.837500000000003, 3, 0, 43.370000000000005, 0, 1, 23, 0.7383952728970892, 0.7, 4]",314.4250000000001,314.18819469199997,3.837500000000003,3,0,43.370000000000005,0,1,23,0.7383952728970892,0.7,4,8.258856619977514,5.50989572669508
131,Steroid,C[C@]12C(C3CCC4=CC(C(OCC)=C[C@@]4(C3CC2)C)=O)CCC1=O,8.322896305411517,Inactive,328.49,2,4,0,3,3.121,43.37,0.215398577,-1042.731119,2.8245,-0.229,-0.05935,0.16965,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-23,[0 0 0 ... 0 0 1],"[328.4520000000001, 328.20384475599997, 4.227600000000003, 3, 0, 43.370000000000005, 0, 2, 24, 0.7617633461129969, 0.7142857142857143, 4]",328.4520000000001,328.20384475599997,4.227600000000003,3,0,43.370000000000005,0,2,24,0.7617633461129969,0.7142857142857143,4,8.28224581807046,5.221005875281681
132,Steroid,C[C@]12C(C3CCC4=CC(C(OCCCC)=C[C@@]4(C3CC2)C)=O)CCC1=O,8.34402565294428,Inactive,356.55,4,4,0,3,4.101,43.37,0.210763828,-1121.356312,2.9861,-0.23064,-0.06001,0.17063,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-24,[0 0 0 ... 0 0 0],"[356.50600000000014, 356.23514488399996, 5.007800000000005, 3, 0, 43.370000000000005, 0, 4, 26, 0.6652441923108847, 0.7391304347826086, 4]",356.50600000000014,356.23514488399996,5.007800000000005,3,0,43.370000000000005,0,4,26,0.6652441923108847,0.7391304347826086,4,8.302057142002798,4.988188513890122
134,Steroid,O=C1CCC(C2CCC3=C4)C1(C)CCC2C3(C)C=C(Br)C4=O,8.241452782259797,Inactive,363.32,0,4,0,2,3.723,34.14,0.203369756,-3460.00987,7.3193,-0.24192,-0.06667,0.17525,"Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione",J Steroid Biochem Mol Biol. 2009;116(3-5):191-25,[0 0 0 ... 0 0 0],"[363.295, 362.088142076, 4.586000000000005, 2, 0, 34.14, 0, 0, 22, 0.6310724734232077, 0.6842105263157895, 4]",363.295,362.088142076,4.586000000000005,2,0,34.14,0,0,22,0.6310724734232077,0.6842105263157895,4,8.24195588202362,5.728542216523573
135,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CC([C@@H]5C[C@]4(COC5)C3CC1)=O,8.101229924222892,Active,314.46,0,5,0,3,2.341,43.37,0.202125939,-1003.422749,2.8461,-0.23451,-0.0511,0.18341,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-15,[0 0 0 ... 0 0 0],"[314.42500000000007, 314.18819469199997, 3.323800000000002, 3, 0, 43.370000000000005, 0, 0, 23, 0.6886791395969644, 0.8, 5]",314.42500000000007,314.18819469199997,3.323800000000002,3,0,43.370000000000005,0,0,23,0.6886791395969644,0.8,5,8.156022758602841,6.981958151305533
136,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=C(O)C(CC1)=O,8.141351611412963,Active,302.45,0,4,1,3,2.731,54.37,0.224496958,-965.3585778,1.6072,-0.22157,-0.05289,0.16868,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-16,[0 0 0 ... 0 0 0],"[302.4140000000001, 302.18819469199997, 3.973100000000003, 3, 1, 54.37, 0, 0, 22, 0.7362676475612524, 0.7894736842105263, 4]",302.4140000000001,302.18819469199997,3.973100000000003,3,1,54.37,0,0,22,0.7362676475612524,0.7894736842105263,4,8.19274263083604,6.415896792299018
137,Steroid,C[C@@]12C(CCCC2=O)C3[C@H](SC4=CC=C(N)C=C4)CC5=CC(C=C[C@]5(C)C3CC1)=O,8.16927578491311,Active,421.65,2,5,2,3,4.541,85.46,0.21098223,-1612.793501,6.2183,-0.20807,-0.05347,0.1546,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-17,[0 0 0 ... 0 0 0],"[421.6060000000003, 421.207550232, 5.606500000000005, 4, 1, 60.160000000000004, 1, 2, 30, 0.6309475649766388, 0.5384615384615384, 5]",421.6060000000003,421.207550232,5.606500000000005,4,1,60.160000000000004,1,2,30,0.6309475649766388,0.5384615384615384,5,8.204469722670295,6.2449688626778475
138,Non-Steroid,O=C([C@@](CC1)(CC)C2=CC=C(N)C=C2)NC1=O,8.27904420247403,Inactive,232.31,2,2,3,4,1.285,72.19,0.27968097,-765.0034968,3.5406,-0.20169,-0.02522,0.17647,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-18,[0 0 0 ... 0 0 0],"[232.28300000000002, 232.121177752, 1.3532, 3, 2, 72.19, 1, 2, 17, 0.5969362176118972, 0.38461538461538464, 2]",232.28300000000002,232.121177752,1.3532,3,2,72.19,1,2,17,0.5969362176118972,0.38461538461538464,2,8.30792185803158,4.921280755977949
139,Non-Steroid,CC(C)(C#N)C1=CC(CN2N=CN=C2)=CC(C(C)(C#N)C)=C1,8.120982367334344,Active,293.41,4,2,0,4,2.966,78.29,0.23153822,-932.9716506,5.1303,-0.26492,-0.03608,0.22884,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-19,[0 0 0 ... 0 0 0],"[293.374, 293.164045608, 2.9287600000000014, 5, 0, 78.28999999999999, 2, 4, 22, 0.8678513137549794, 0.4117647058823529, 2]",293.374,293.164045608,2.9287600000000014,5,0,78.28999999999999,2,4,22,0.8678513137549794,0.4117647058823529,2,8.12565809874806,7.487587338911528
140,Non-Steroid,N#CC1=CC=C(C(C2=CC=C(C#N)C=C2)N3N=CN=C3)C=C1,8.052866762651991,Active,285.33,3,3,0,4,2.749,78.29,0.198560091,-928.1459025,2.5939,-0.27305,-0.07828,0.19477,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-20,[0 1 0 ... 0 0 0],"[285.31, 285.101445352, 2.65916, 5, 0, 78.29, 3, 3, 22, 0.7407442417149674, 0.058823529411764705, 3]",285.31,285.101445352,2.65916,5,0,78.29,3,3,22,0.7407442417149674,0.058823529411764705,3,8.100519941747148,7.933778259590931
141,Non-Steroid,ClC(C=C1)=CC=C1C(N2N=CN=C2)C3=CC(N(C)N=N4)=C4C=C3,8.043555059496608,Active,324.8,3,4,0,4,3.467,61.42,0.192008889,-1406.191733,3.3158,-0.25002,-0.06127,0.18875,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-21,[0 1 0 ... 0 0 0],"[324.77500000000003, 324.08902209600006, 2.8509, 6, 0, 61.42, 4, 3, 23, 0.5811314334288238, 0.125, 4]",324.77500000000003,324.08902209600006,2.8509,6,0,61.42,4,3,23,0.5811314334288238,0.125,4,8.079630405678115,8.324719219668248
142,Non-Steroid,O=C(C=C(C1=CC=CC=C1)O2)C3=C2C=C(O)C=C3O,8.304640283255823,Inactive,254.25,1,3,2,4,2.602,70.67,0.270056586,-878.522087,3.668,-0.22078,-0.06925,0.15153,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-22,[0 0 0 ... 0 0 0],"[254.24099999999999, 254.0579088, 2.8712000000000013, 4, 2, 70.67, 3, 1, 19, 0.700091545915688, 0.0, 3]",254.24099999999999,254.0579088,2.8712000000000013,4,2,70.67,3,1,19,0.700091545915688,0.0,3,8.232963304721121,5.848394974866322
143,Non-Steroid,O=C(C=C(C1=CC=CC=C1)O2)C3=C2C(O)=C(O)C=C3,8.370627377549148,Inactive,254.25,1,3,2,4,2.602,70.67,0.259431172,-878.5003565,4.0774,-0.21799,-0.0605,0.15749,Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase,J Steroid Biochem Mol Biol. 1997;61(3-6):107-23,[0 0 0 ... 0 0 0],"[254.24099999999999, 254.0579088, 2.8712000000000018, 4, 2, 70.67, 3, 1, 19, 0.6549078898083047, 0.0, 3]",254.24099999999999,254.0579088,2.8712000000000018,4,2,70.67,3,1,19,0.6549078898083047,0.0,3,8.306644775062408,4.93577353405086
144,Non-Steroid,[H]C1=C([H])C=CC(C(OC2=CC([H])=CC([H])=C23)=CC3=O)=C1,8.365363533362673,Inactive,222.25,1,3,0,2,3.137,30.21,0.197197926,-728.0713413,4.1954,-0.23325,-0.06582,0.16743,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-61,[0 0 0 ... 0 0 0],"[222.243, 222.06807956, 3.4600000000000017, 2, 0, 30.21, 3, 1, 17, 0.6307722261623976, 0.0, 3]",222.243,222.06807956,3.4600000000000017,2,0,30.21,3,1,17,0.6307722261623976,0.0,3,8.228216784678706,5.912664208982578
145,Non-Steroid,[H]C1=C([H])C=CC(C(OC2=CC(O)=CC([H])=C23)=CC3=O)=C1,8.173991966846375,Active,238.25,1,3,1,3,2.869,50.44,0.235791893,-803.2888059,3.2273,-0.23181,-0.06281,0.169,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-62,[0 0 0 ... 0 0 0],"[238.242, 238.06299418, 3.1656000000000013, 3, 1, 50.440000000000005, 3, 1, 18, 0.707998047535363, 0.0, 3]",238.242,238.06299418,3.1656000000000013,3,1,50.440000000000005,3,1,18,0.707998047535363,0.0,3,8.197737067377602,6.342535878524949
146,Non-Steroid,[H]C1=C(O)C=CC(C(OC2=CC(O)=CC(O)=C23)=CC3=O)=C1,8.256678261040161,Inactive,270.25,1,3,3,5,2.334,90.9,0.303465567,-953.7398156,5.0463,-0.21714,-0.06368,0.15346,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-63,[0 0 0 ... 0 0 0],"[270.24, 270.05282342000004, 2.5768000000000004, 5, 3, 90.9, 3, 1, 20, 0.6318329361180623, 0.0, 3]",270.24,270.05282342000004,2.5768000000000004,5,3,90.9,3,1,20,0.6318329361180623,0.0,3,8.232148297025258,5.8593805212271715
147,Non-Steroid,OC1=C(O)C=CC(C(OC2=CC(O)=CC(O)=C23)=CC3=O)=C1,8.227618233182895,Inactive,286.25,1,3,4,6,2.067,111.13,0.328207452,-1028.949983,3.8405,-0.21595,-0.06438,0.15157,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-64,[0 0 0 ... 0 0 0],"[286.23900000000003, 286.04773804, 2.2824, 6, 4, 111.13, 3, 1, 21, 0.5106223467843569, 0.0, 3]",286.23900000000003,286.04773804,2.2824,6,4,111.13,3,1,21,0.5106223467843569,0.0,3,8.230324040703525,5.8840446454475135
148,Non-Steroid,O=C(C1)C2=C([H])C=C([H])C=C2OC1C3=CC([H])=C([H])C=C3,8.313352925875616,Inactive,224.27,1,3,0,2,3.1,26.3,0.188678793,-729.2749941,2.5211,-0.2326,-0.05641,0.17619,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-65,[0 0 0 ... 0 0 0],"[224.259, 224.083729624, 3.3931000000000013, 2, 0, 26.3, 2, 1, 17, 0.7417295882600524, 0.13333333333333333, 3]",224.259,224.083729624,3.3931000000000013,2,0,26.3,2,1,17,0.7417295882600524,0.13333333333333333,3,8.24579269317357,5.678155827324565
149,Non-Steroid,O=C(C1)C2=C([H])C=C(O)C=C2OC1C3=CC([H])=C([H])C=C3,8.250280008800894,Inactive,240.27,1,3,1,3,2.833,46.53,0.225177867,-804.4936726,1.839,-0.22977,-0.04787,0.1819,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-66,[0 0 0 ... 0 0 0],"[240.25799999999998, 240.078644244, 3.098700000000002, 3, 1, 46.53, 2, 1, 18, 0.8326826582212098, 0.13333333333333333, 3]",240.25799999999998,240.078644244,3.098700000000002,3,1,46.53,2,1,18,0.8326826582212098,0.13333333333333333,3,8.227036713902432,5.928752026389567
150,Non-Steroid,O=C(C1)C2=C(O)C=C(O)C=C2OC1C3=CC([H])=C(O)C=C3,8.297895981578064,Inactive,272.27,1,3,3,5,2.298,86.99,0.289203219,-954.9423655,2.5914,-0.22186,-0.05263,0.16923,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-67,[0 0 0 ... 0 0 0],"[272.256, 272.06847348400004, 2.5099, 5, 3, 86.99000000000001, 2, 1, 20, 0.7421139126791213, 0.13333333333333333, 3]",272.256,272.06847348400004,2.5099,5,3,86.99000000000001,2,1,20,0.7421139126791213,0.13333333333333333,3,8.23094129546908,5.875687701123882
151,Non-Steroid,O=C(C1)C2=C(O)C=C(O)C=C2OC1C3=CC(O)=C(O)C=C3,8.206080550578456,Active,288.27,1,3,4,6,2.03,107.22,0.315623758,-1030.159131,3.9638,-0.21518,-0.05157,0.16361,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-68,[0 0 0 ... 0 0 0],"[288.255, 288.063388104, 2.2155000000000005, 6, 4, 107.22000000000001, 2, 1, 21, 0.5992714485146342, 0.13333333333333333, 3]",288.255,288.063388104,2.2155000000000005,6,4,107.22000000000001,2,1,21,0.5992714485146342,0.13333333333333333,3,8.232286042030681,5.857522398559315
152,Non-Steroid,O=C(C1)C2=C(O)C=C(O)C=C2OC1C3=CC(O)=C(OC)C=C3,8.261101686010912,Inactive,302.3,2,3,3,6,2.281,96.22,0.29487425,-1069.466554,4.3583,-0.21167,-0.05071,0.16096,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-69,[0 0 0 ... 0 0 0],"[302.28200000000004, 302.079038168, 2.5185000000000004, 6, 3, 96.22000000000001, 2, 2, 22, 0.7885404127535282, 0.1875, 3]",302.28200000000004,302.079038168,2.5185000000000004,6,3,96.22000000000001,2,2,22,0.7885404127535282,0.1875,3,8.24380100044785,5.704255890566685
154,Non-Steroid,[H]C1=CC(O)=CC([H])=C1C(/C=C/C2=CC([H])=C([H])C=C2)=O,8.345411644323827,Inactive,224.27,3,2,1,2,3.435,37.3,0.203089448,-729.2521033,4.9237,-0.22847,-0.06816,0.16031,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-70,[0 0 0 ... 0 0 0],"[224.259, 224.083729624, 3.2883000000000013, 2, 1, 37.3, 2, 3, 17, 0.6412736177915347, 0.0, 2]",224.259,224.083729624,3.2883000000000013,2,1,37.3,2,3,17,0.6412736177915347,0.0,2,8.263137086613963,5.455856178471247
159,Non-Steroid,OC1=CC(OC)=CC(O)=C1C(/C=C/C2=CC([H])=C([H])C=C2)=O,8.314736341229528,Inactive,270.3,4,2,2,4,3.151,66.76,0.250427059,-919.0039675,5.2695,-0.21211,-0.07886,0.13325,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-71,[0 0 0 ... 0 0 0],"[270.284, 270.089208928, 3.0025000000000013, 4, 2, 66.75999999999999, 2, 4, 20, 0.6617234466745804, 0.0625, 2]",270.284,270.089208928,3.0025000000000013,4,2,66.75999999999999,2,4,20,0.6617234466745804,0.0625,2,8.264149049068127,5.443158125959955
160,Non-Steroid,[H]C1=CC(O)=CC(O)=C1C(/C=C/C2=CC([H])=C(O)C=C2)=O,8.350575185334414,Inactive,256.27,3,2,3,4,2.9,77.76,0.26771471,-879.6869175,4.7419,-0.2187,-0.07036,0.14834,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-72,[0 0 0 ... 0 0 0],"[256.257, 256.073558864, 2.6995000000000005, 4, 3, 77.75999999999999, 2, 3, 19, 0.5825029725741742, 0.0, 2]",256.257,256.073558864,2.6995000000000005,4,3,77.75999999999999,2,3,19,0.5825029725741742,0.0,2,8.256713535525556,5.537152242363495
161,Non-Steroid,OC1=CC(O)=CC(O)=C1C(/C=C/C2=CC([H])=C(O)C=C2)=O,8.2529747500705,Inactive,272.27,3,2,4,5,2.632,97.99,0.29929525,-954.9155943,5.974,-0.21333,-0.07552,0.13781,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-73,[0 0 0 ... 0 0 0],"[272.25600000000003, 272.068473484, 2.4051, 5, 4, 97.99000000000001, 2, 3, 20, 0.5078021958672847, 0.0, 2]",272.25600000000003,272.068473484,2.4051,5,4,97.99000000000001,2,3,20,0.5078021958672847,0.0,2,8.251560788179912,5.603239833513126
162,Non-Steroid,OC1=CC(O)=CC(O)=C1C(/C=C/C2=CC(O)=C(O)C=C2)=O,8.255484686147076,Inactive,288.27,3,2,5,6,2.365,118.22,0.325242545,-1030.131771,7.0576,-0.21263,-0.07469,0.13794,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-74,[0 0 0 ... 0 0 0],"[288.255, 288.063388104, 2.1107, 6, 5, 118.22, 2, 3, 21, 0.3351830044490491, 0.0, 2]",288.255,288.063388104,2.1107,6,5,118.22,2,3,21,0.3351830044490491,0.0,2,8.280631969121515,5.240443353903206
163,Non-Steroid,OC1=CC(O)=CC(O)=C1C(/C=C/C2=CC(O)=C(OC)C=C2)=O,8.33571682898496,Inactive,302.3,4,2,4,6,2.616,107.22,0.304112528,-1069.439312,7.6916,-0.21171,-0.07356,0.13815,Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities,Life Sci. 2001;68(7):751-75,[0 0 0 ... 0 0 0],"[302.28200000000004, 302.079038168, 2.4137000000000004, 6, 4, 107.22, 2, 4, 22, 0.5101494774619595, 0.0625, 2]",302.28200000000004,302.079038168,2.4137000000000004,6,4,107.22,2,4,22,0.5101494774619595,0.0625,2,8.281408107539997,5.231086391391412
164,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(C)C1=O,8.44239248693278,Inactive,204.25,1,2,1,4,0.425,59.06,0.265953148,-686.3752333,3.0963,-0.2573,-0.03852,0.21878,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-9,[0 0 0 ... 0 0 0],"[204.22899999999998, 204.089877624, 0.7759, 3, 1, 59.06, 1, 1, 15, 0.6874235825308643, 0.36363636363636365, 2]",204.22899999999998,204.089877624,0.7759,3,1,59.06,1,1,15,0.6874235825308643,0.36363636363636365,2,8.384736897637486,4.123472498317417
165,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.301029995663981,Inactive,218.28,2,2,1,4,0.881,59.06,0.257261167,-725.682727,3.3783,-0.25752,-0.0386,0.21892,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-10,[0 0 0 ... 0 0 0],"[218.25599999999997, 218.105527688, 1.166, 3, 1, 59.06, 1, 2, 16, 0.7578116528852396, 0.4166666666666667, 2]",218.25599999999997,218.105527688,1.166,3,1,59.06,1,2,16,0.7578116528852396,0.4166666666666667,2,8.309793827445688,4.900113871930449
166,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCC)C1=O,8.282175711599955,Inactive,232.31,3,2,1,4,1.337,59.06,0.249750606,-765.0007625,2.7943,-0.25579,-0.03999,0.2158,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-11,[0 0 0 ... 0 0 0],"[232.28299999999996, 232.121177752, 1.5561, 3, 1, 59.06, 1, 3, 17, 0.8043817392315605, 0.46153846153846156, 2]",232.28299999999996,232.121177752,1.5561,3,1,59.06,1,3,17,0.8043817392315605,0.46153846153846156,2,8.295870985955425,5.059749475402395
167,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCCC)C1=O,8.267771946364356,Inactive,246.34,4,2,1,4,1.794,59.06,0.243631167,-804.313044,2.8322,-0.25555,-0.03973,0.21582,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-12,[0 0 0 ... 0 0 0],"[246.30999999999995, 246.136827816, 1.9462, 3, 1, 59.06, 1, 4, 18, 0.8259321333673324, 0.5, 2]",246.30999999999995,246.136827816,1.9462,3,1,59.06,1,4,18,0.8259321333673324,0.5,2,8.294445453180058,5.076384937571398
168,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCCCC)C1=O,8.25165224474116,Inactive,260.37,5,2,1,4,2.25,59.06,0.238453513,-843.6227315,2.8416,-0.2555,-0.03954,0.21596,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-13,[0 0 0 ... 0 0 0],"[260.33699999999993, 260.15247788, 2.3363000000000005, 3, 1, 59.06, 1, 5, 19, 0.6526884603861655, 0.5333333333333333, 2]",260.33699999999993,260.15247788,2.3363000000000005,3,1,59.06,1,5,19,0.6526884603861655,0.5333333333333333,2,8.264449032531084,5.439399631012398
169,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCCCCC)C1=O,8.264106016122115,Inactive,274.4,6,2,1,4,2.706,59.06,0.234881952,-882.9322917,2.8448,-0.25531,-0.0397,0.21561,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-14,[0 0 0 ... 0 0 0],"[274.364, 274.168127944, 2.726400000000001, 3, 1, 59.06, 1, 6, 20, 0.6406826778748144, 0.5625, 2]",274.364,274.168127944,2.726400000000001,3,1,59.06,1,6,20,0.6406826778748144,0.5625,2,8.260024240713175,5.4951020137272915
170,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCCCCCC)C1=O,8.260044156835887,Inactive,288.43,7,2,1,4,3.162,59.06,0.229411,-922.2489258,2.9021,-0.25528,-0.03938,0.2159,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-15,[0 0 0 ... 0 0 0],"[288.39099999999996, 288.183778008, 3.116500000000002, 3, 1, 59.06, 1, 7, 21, 0.6192304240270778, 0.5882352941176471, 2]",288.39099999999996,288.183778008,3.116500000000002,3,1,59.06,1,7,21,0.6192304240270778,0.5882352941176471,2,8.258321487116396,5.516689143845699
171,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCCCCCCC)C1=O,8.188325408687179,Active,302.46,8,2,1,4,3.618,59.06,0.227223688,-961.5569588,2.8909,-0.2526,-0.04072,0.21188,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-16,[0 0 0 ... 0 0 0],"[302.418, 302.19942807199993, 3.5066000000000024, 3, 1, 59.06, 1, 8, 22, 0.5903168960043121, 0.6111111111111112, 2]",302.418,302.19942807199993,3.5066000000000024,3,1,59.06,1,8,22,0.5903168960043121,0.6111111111111112,2,8.251366299946147,5.605749670300484
172,Non-Steroid,O=C(N1)CC[C@@](C2=CC=NC=C2)(CCCCCCCCC)C1=O,8.250280008800894,Inactive,316.49,9,2,1,4,4.075,59.06,0.224106804,-1000.865935,2.581,-0.25517,-0.04141,0.21376,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-17,[0 0 0 ... 0 0 0],"[316.44500000000005, 316.21507813599993, 3.8967000000000036, 3, 1, 59.06, 1, 9, 23, 0.5550841188365645, 0.631578947368421, 2]",316.44500000000005,316.21507813599993,3.8967000000000036,3,1,59.06,1,9,23,0.5550841188365645,0.631578947368421,2,8.251836745867722,5.599680575869179
173,Non-Steroid,O=C(N1C)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.3445850552086,Inactive,232.31,2,2,0,4,1.087,50.27,0.244496576,-764.9932166,3.0536,-0.25716,-0.03845,0.21871,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-18,[0 0 0 ... 0 0 0],"[232.283, 232.121177752, 1.5082, 3, 0, 50.27, 1, 2, 17, 0.7261184880612406, 0.46153846153846156, 2]",232.283,232.121177752,1.5082,3,0,50.27,1,2,17,0.7261184880612406,0.46153846153846156,2,8.33364460047313,4.638263310227995
174,Non-Steroid,O=C(N1CC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.466667888174385,Inactive,246.34,3,2,0,4,1.436,50.27,0.240013417,-804.3097917,3.0128,-0.25682,-0.03826,0.21856,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-19,[0 0 0 ... 0 0 0],"[246.31, 246.136827816, 1.8982999999999999, 3, 0, 50.27, 1, 3, 18, 0.7652885044829236, 0.5, 2]",246.31,246.136827816,1.8982999999999999,3,0,50.27,1,3,18,0.7652885044829236,0.5,2,8.42406714810981,3.7664555971600406
175,Non-Steroid,O=C(N1CCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.345954603462316,Inactive,260.37,4,2,0,4,1.96,50.27,0.234962769,-843.6236888,3.0135,-0.25663,-0.03771,0.21892,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-20,[0 0 0 ... 0 0 0],"[260.337, 260.15247788, 2.2884, 3, 0, 50.27, 1, 4, 19, 0.7803902771583815, 0.5333333333333333, 2]",260.337,260.15247788,2.2884,3,0,50.27,1,4,19,0.7803902771583815,0.5333333333333333,2,8.315206634313862,4.839420565114003
176,Non-Steroid,O=C(N1CCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.35675069901751,Inactive,274.4,5,2,0,4,2.416,50.27,0.230618452,-882.9359238,2.9859,-0.25657,-0.03793,0.21864,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-21,[0 0 0 ... 0 0 0],"[274.36400000000003, 274.168127944, 2.6785000000000005, 3, 0, 50.27, 1, 5, 20, 0.7756232436776385, 0.5625, 2]",274.36400000000003,274.168127944,2.6785000000000005,3,0,50.27,1,5,20,0.7756232436776385,0.5625,2,8.304029639353656,4.965584316041387
177,Non-Steroid,O=C(N1CCCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.329960141834427,Inactive,288.43,6,2,0,4,2.872,50.27,0.227376333,-922.2459509,2.9808,-0.25636,-0.03707,0.21929,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-22,[0 0 0 ... 0 0 0],"[288.3910000000001, 288.183778008, 3.0686000000000018, 3, 0, 50.27, 1, 6, 21, 0.5968591413669704, 0.5882352941176471, 2]",288.3910000000001,288.183778008,3.0686000000000018,3,0,50.27,1,6,21,0.5968591413669704,0.5882352941176471,2,8.285046353470621,5.1874466889769115
178,Non-Steroid,O=C(N1CCCCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.2856320052432,Inactive,302.46,7,2,0,4,3.328,50.27,0.224911771,-961.555868,2.976,-0.25675,-0.03824,0.21851,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-23,[0 0 0 ... 0 0 0],"[302.4180000000001, 302.19942807199993, 3.458700000000002, 3, 0, 50.27, 1, 7, 22, 0.5722927732921237, 0.6111111111111112, 2]",302.4180000000001,302.19942807199993,3.458700000000002,3,0,50.27,1,7,22,0.5722927732921237,0.6111111111111112,2,8.280621561652712,5.240568937824937
179,Non-Steroid,O=C(N1CCCCCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.234785438913192,Inactive,316.49,8,2,0,4,3.784,50.27,0.221467431,-1000.871528,2.9787,-0.25686,-0.03917,0.21769,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-24,[0 0 0 ... 0 0 0],"[316.4450000000001, 316.21507813599993, 3.8488000000000033, 3, 0, 50.27, 1, 8, 23, 0.5405053890728113, 0.631578947368421, 2]",316.4450000000001,316.21507813599993,3.8488000000000033,3,0,50.27,1,8,23,0.5405053890728113,0.631578947368421,2,8.261812648753272,5.4725199221394565
180,Non-Steroid,O=C(N1CCCCCCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.214890214875727,Active,330.52,9,2,0,4,4.241,50.27,0.218054426,-1040.196558,2.705,-0.25809,-0.03841,0.21968,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-25,[0 0 0 ... 0 0 0],"[330.4720000000001, 330.23072819999993, 4.238900000000004, 3, 0, 50.27, 1, 9, 24, 0.502505804491995, 0.65, 2]",330.4720000000001,330.23072819999993,4.238900000000004,3,0,50.27,1,9,24,0.502505804491995,0.65,2,8.261812648753272,5.4725199221394565
181,Non-Steroid,O=C(N1CCCCCCCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.257834491622507,Inactive,344.55,10,2,0,4,4.697,50.27,0.215393965,-1079.497816,2.9829,-0.25395,-0.03997,0.21398,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-26,[0 0 0 ... 0 0 0],"[344.4990000000001, 344.24637826399993, 4.629000000000005, 3, 0, 50.27, 1, 10, 25, 0.4591868840609468, 0.6666666666666666, 2]",344.4990000000001,344.24637826399993,4.629000000000005,3,0,50.27,1,10,25,0.4591868840609468,0.6666666666666666,2,8.267554185170273,5.40064728863751
182,Non-Steroid,O=C(N1CCCCCCCCCC)CC[C@@](C2=CC=NC=C2)(CC)C1=O,8.301029995663981,Inactive,358.58,11,2,0,4,5.153,50.27,0.213657217,-1118.806189,2.6121,-0.25449,-0.03951,0.21498,"Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives",J Med Chem. 1990;33(9):2673-27,[0 0 0 ... 0 0 0],"[358.52600000000007, 358.26202832799993, 5.019100000000005, 3, 0, 50.27, 1, 11, 26, 0.4121388361614197, 0.6818181818181818, 2]",358.52600000000007,358.26202832799993,5.019100000000005,3,0,50.27,1,11,26,0.4121388361614197,0.6818181818181818,2,8.26963547368181,5.374827447737567
183,Non-Steroid,O=C1C(CC2=CC=NC=C2)=C(N)C3=CC(OC)=CC=C31,8.263131054648865,Inactive,266.32,3,3,2,4,1.443,65.21,0.233568706,-878.0696265,6.6961,-0.20449,-0.06697,0.13752,Design and synthesis of a new type of non steroidal human aromatase inhibitors,Bioorg Med Chem Lett. 1998;8(9):1041-4,[0 1 0 ... 0 0 0],"[266.3, 266.105527688, 2.199, 4, 1, 65.21000000000001, 2, 3, 20, 0.9245350255965253, 0.125, 3]",266.3,266.105527688,2.199,4,1,65.21000000000001,2,3,20,0.9245350255965253,0.125,3,8.257496736191893,5.527175617095768
184,Non-Steroid,O=C(C1=CC=CC=C1C/2C3=CC=CC=C3)C2=C/C4=CC=NC=C4,8.214890214875727,Active,297.37,2,4,0,2,3.94,29.96,0.172963184,-939.236668,5.4383,-0.23922,-0.09006,0.14916,Design and synthesis of a new type of non steroidal human aromatase inhibitors,Bioorg Med Chem Lett. 1998;8(9):1041-4,[0 0 0 ... 0 0 0],"[297.357, 297.1153641, 4.493400000000003, 2, 0, 29.96, 3, 2, 23, 0.6521367526949566, 0.047619047619047616, 4]",297.357,297.1153641,4.493400000000003,2,0,29.96,3,2,23,0.6521367526949566,0.047619047619047616,4,8.239192983234153,5.765102281976674
186,Non-Steroid,CC1=NC2=C(C=N1)C(N3C=CN=C3)C4=CC=CC=C42,8.255707016877324,Inactive,248.31,1,4,0,3,1.413,43.6,0.200728774,-797.8325719,3.6258,-0.22824,-0.065,0.16324,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-803,[0 0 0 ... 0 0 0],"[248.28900000000002, 248.106196384, 2.5996200000000007, 4, 0, 43.6, 3, 1, 19, 0.5197826959198787, 0.13333333333333333, 4]",248.28900000000002,248.106196384,2.5996200000000007,4,0,43.6,3,1,19,0.5197826959198787,0.13333333333333333,4,8.216372167838406,6.076140843658706
187,Non-Steroid,O=C1C2=CC=CC=C2C3=C1C=C(CN4C=CN=C4)N=N3,8.34008379993015,Inactive,262.29,2,4,0,4,1.838,60.67,0.199653467,-871.8043173,4.3501,-0.23056,-0.11039,0.12017,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-804,[0 1 0 ... 0 0 0],"[262.272, 262.08546094, 1.9327999999999992, 5, 0, 60.67, 3, 2, 20, 0.553553543274382, 0.06666666666666667, 4]",262.272,262.08546094,1.9327999999999992,5,0,60.67,3,2,20,0.553553543274382,0.06666666666666667,4,8.290565484313992,5.121940341835625
188,Non-Steroid,[H]C1(N2C=CN=C2)C3=CC=CC=C3C4=C1C=CC=C4,8.255707016877324,Inactive,232.3,1,4,0,1,2.807,17.82,0.153213467,-726.4346139,4.0836,-0.22065,-0.04164,0.17901,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-805,[0 0 0 ... 0 0 0],"[232.286, 232.100048384, 3.5012000000000016, 2, 0, 17.82, 3, 1, 18, 0.49086302881451477, 0.0625, 4]",232.286,232.100048384,3.5012000000000016,2,0,17.82,3,1,18,0.49086302881451477,0.0625,4,8.222887632523289,5.985664455211855
189,Non-Steroid,C12=CC=CC=C1C3=C(C=CC=C3)C2(N4C=CN=C4)C5=CC=CC=C5,8.146910470148134,Active,308.4,2,5,0,1,4.247,17.82,0.147460475,-957.4771752,4.2701,-0.21594,-0.04326,0.17268,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-806,[0 0 0 ... 0 0 0],"[308.384, 308.131348512, 4.703700000000003, 2, 0, 17.82, 4, 2, 24, 0.46187798697237525, 0.045454545454545456, 5]",308.384,308.131348512,4.703700000000003,2,0,17.82,4,2,24,0.46187798697237525,0.045454545454545456,5,8.187052802173895,6.500506514060608
190,Non-Steroid,C12=CC=CC=C1C3=C(C=CC=C3)C2(N4N=CN=C4)C5=CC=CC=C5,8.267606240177031,Inactive,309.39,2,5,0,2,4.12,30.71,0.155576718,-973.5164622,3.4091,-0.22452,-0.0437,0.18082,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-807,[0 0 0 ... 0 0 0],"[309.372, 309.12659748000004, 4.098700000000002, 3, 0, 30.71, 4, 2, 24, 0.49137726349920663, 0.047619047619047616, 5]",309.372,309.12659748000004,4.098700000000002,3,0,30.71,4,2,24,0.49137726349920663,0.047619047619047616,5,8.204442895256276,6.24535464133003
191,Non-Steroid,O=C1OC2=CC(OC)=CC=C2C=C1CN3C=CN=C3,8.255707016877324,Inactive,256.28,3,3,0,4,1.52,57.26,0.233651548,-875.8787459,8.1916,-0.21408,-0.0732,0.14088,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-808,[0 0 0 ... 0 0 0],"[256.26099999999997, 256.084792244, 2.0463999999999998, 5, 0, 57.26, 3, 3, 19, 0.6728349870006699, 0.14285714285714285, 3]",256.26099999999997,256.084792244,2.0463999999999998,5,0,57.26,3,3,19,0.6728349870006699,0.14285714285714285,3,8.223357312767625,5.979194585567913
192,Non-Steroid,O=C1OC2=CC=CC=C2C(CN3C=CN=C3)=C1,8.245651664288982,Inactive,226.25,2,3,0,3,1.537,48.03,0.220467259,-761.3507101,6.8661,-0.23288,-0.07528,0.1576,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-809,[0 0 0 ... 0 0 0],"[226.23499999999999, 226.07422756, 2.0378, 4, 0, 48.03, 3, 2, 17, 0.6280730023818015, 0.07692307692307693, 3]",226.23499999999999,226.07422756,2.0378,4,0,48.03,3,2,17,0.6280730023818015,0.07692307692307693,3,8.2176470306664,6.058330606452067
193,Non-Steroid,O=C1OC2=CC(OC)=CC=C2C(CN3C=CN=C3)=C1,8.183758700008218,Active,256.28,3,3,0,4,1.52,57.26,0.240563516,-875.8744088,8.6729,-0.22829,-0.06807,0.16022,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-810,[0 0 0 ... 0 0 0],"[256.26099999999997, 256.084792244, 2.0463999999999998, 5, 0, 57.26, 3, 3, 19, 0.6728349870006699, 0.14285714285714285, 3]",256.26099999999997,256.084792244,2.0463999999999998,5,0,57.26,3,3,19,0.6728349870006699,0.14285714285714285,3,8.215967377635906,6.081806835228609
194,Non-Steroid,O=C1OC2=CC(OC)=CC=C2C(CN3N=CN=C3)=C1,8.26440110030182,Inactive,257.27,3,3,0,5,1.393,70.15,0.253635467,-891.9113908,8.2927,-0.23136,-0.06815,0.16321,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-811,[0 0 0 ... 0 0 0],"[257.24899999999997, 257.080041212, 1.4414, 6, 0, 70.15, 3, 3, 19, 0.6638919150245608, 0.15384615384615385, 3]",257.24899999999997,257.080041212,1.4414,6,0,70.15,3,3,19,0.6638919150245608,0.15384615384615385,3,8.249785147022203,5.626195939786139
195,Non-Steroid,O=C1OC2=CC=CC=C2C(OCCN3C=CN=C3)=C1,8.213248577854438,Active,256.28,4,3,0,4,1.143,57.26,0.226374419,-875.8818112,5.6827,-0.23509,-0.06184,0.17325,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-812,[0 0 0 ... 0 0 0],"[256.26099999999997, 256.084792244, 2.0685, 5, 0, 57.26, 3, 4, 19, 0.6704060905573914, 0.14285714285714285, 3]",256.26099999999997,256.084792244,2.0685,5,0,57.26,3,4,19,0.6704060905573914,0.14285714285714285,3,8.221691347002238,6.00217499159766
196,Non-Steroid,O=C1OC2=CC(OC)=CC=C2C(OCCN3C=CN=C3)=C1,8.397940008672037,Inactive,286.31,5,3,0,5,1.126,66.49,0.243514743,-990.4054725,7.4344,-0.22647,-0.05416,0.17231,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-813,[0 0 0 ... 0 0 0],"[286.287, 286.095356928, 2.0770999999999997, 6, 0, 66.49000000000001, 3, 5, 21, 0.6717203122519285, 0.2, 3]",286.287,286.095356928,2.0770999999999997,6,0,66.49000000000001,3,5,21,0.6717203122519285,0.2,3,8.342294581202404,4.546795471727425
197,Non-Steroid,O=C1OC2=CC(OC3=CC=CC=C3)=CC=C2C(CN4C=CN=C4)=C1,8.137272471682026,Active,318.35,4,4,0,4,3.097,57.26,0.225236579,-1067.615226,8.3947,-0.2289,-0.07006,0.15884,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-814,[0 0 0 ... 0 0 0],"[318.332, 318.100442308, 3.8301000000000016, 5, 0, 57.26, 4, 4, 24, 0.5366095142325211, 0.05263157894736842, 4]",318.332,318.100442308,3.8301000000000016,5,0,57.26,4,4,24,0.5366095142325211,0.05263157894736842,4,8.190813342310092,6.444461858879417
198,Non-Steroid,O=C1OC2=CC(OC)=CC(CN3C=CN=C3)=C2C=C1,8.169411331314855,Active,256.28,3,3,0,4,1.56,57.26,0.234125839,-875.8719905,7.1373,-0.22849,-0.07212,0.15637,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-815,[0 0 0 ... 0 0 0],"[256.26099999999997, 256.084792244, 2.0463999999999998, 5, 0, 57.26, 3, 3, 19, 0.6728349870006699, 0.14285714285714285, 3]",256.26099999999997,256.084792244,2.0463999999999998,5,0,57.26,3,3,19,0.6728349870006699,0.14285714285714285,3,8.25348181321497,5.578509625649012
199,Non-Steroid,O=C1OC2=CC=C(CN3C=CN=C3)C=C2C=C1,8.164943898279883,Active,226.25,2,3,0,3,1.576,48.03,0.221419185,-761.351995,3.158,-0.23169,-0.07602,0.15567,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-816,[0 0 0 ... 0 0 0],"[226.235, 226.07422756, 2.0378, 4, 0, 48.03, 3, 2, 17, 0.6280730023818015, 0.07692307692307693, 3]",226.235,226.07422756,2.0378,4,0,48.03,3,2,17,0.6280730023818015,0.07692307692307693,3,8.219944561673891,6.026365085967644
200,Non-Steroid,O=C1OC2=CC(CN3C=CN=C3)=CC=C2C=C1,8.209714835966759,Active,226.25,2,3,0,3,1.576,48.03,0.221903926,-761.3516999,2.9715,-0.23085,-0.0757,0.15515,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-817,[0 0 0 ... 0 0 0],"[226.235, 226.07422756, 2.0378, 4, 0, 48.03, 3, 2, 17, 0.6280730023818015, 0.07692307692307693, 3]",226.235,226.07422756,2.0378,4,0,48.03,3,2,17,0.6280730023818015,0.07692307692307693,3,8.223533677609979,5.976766957159595
201,Non-Steroid,O=C1OC2=CC(CN3N=CN=C3)=CC=C2C=C1,8.346787486224656,Inactive,227.24,2,3,0,4,1.449,60.92,0.2369405,-777.3888218,3.781,-0.24352,-0.07558,0.16794,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-818,[0 0 0 ... 0 0 0],"[227.22300000000004, 227.069476528, 1.4328, 5, 0, 60.92, 3, 2, 17, 0.6212365201715234, 0.08333333333333333, 3]",227.22300000000004,227.069476528,1.4328,5,0,60.92,3,2,17,0.6212365201715234,0.08333333333333333,3,8.290139464838468,5.126967154318891
202,Non-Steroid,O=C1OC2=CC(OCN3C=CN=C3)=CC=C2C=C1,8.346787486224656,Inactive,242.25,3,3,0,4,1.607,57.26,0.2371995,-836.5616672,6.6114,-0.23361,-0.0696,0.16401,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-819,[0 0 0 ... 0 0 0],"[242.23400000000004, 242.06914218, 2.026, 5, 0, 57.26, 3, 3, 18, 0.6592178316760893, 0.07692307692307693, 3]",242.23400000000004,242.06914218,2.026,5,0,57.26,3,3,18,0.6592178316760893,0.07692307692307693,3,8.286479929101683,5.170351521708778
203,Non-Steroid,O=C1OC2=C(CN3C=CN=C3)C(OC)=CC=C2C=C1,8.346787486224656,Inactive,256.28,3,3,0,4,1.56,57.26,0.230264742,-875.8775298,8.0892,-0.21111,-0.07165,0.13946,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-820,[0 0 0 ... 0 0 0],"[256.26099999999997, 256.084792244, 2.0463999999999998, 5, 0, 57.260000000000005, 3, 3, 19, 0.6728349870006699, 0.14285714285714285, 3]",256.26099999999997,256.084792244,2.0463999999999998,5,0,57.260000000000005,3,3,19,0.6728349870006699,0.14285714285714285,3,8.281965583007706,5.224375895206366
204,Non-Steroid,O=C1OC2=CC=CC=C2C(CN3C=CN=C3)=C1C4=CC=CC=C4,8.276544327964814,Inactive,302.35,3,4,0,3,3.015,48.03,0.189458973,-992.4004175,2.6435,-0.22791,-0.07804,0.14987,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-821,[0 0 0 ... 0 0 0],"[302.33299999999997, 302.105527688, 3.7048000000000023, 4, 0, 48.03, 4, 3, 23, 0.5420664581286583, 0.05263157894736842, 4]",302.33299999999997,302.105527688,3.7048000000000023,4,0,48.03,4,3,23,0.5420664581286583,0.05263157894736842,4,8.225090520555943,5.955380018423195
205,Non-Steroid,O=C1OC2=CC=CC(C3=CC=CC=C3)=C2C(CN4C=CN=C4)=C1,8.15676722190199,Active,302.35,3,4,0,3,3.055,48.03,0.190535027,-992.3969327,7.8408,-0.22729,-0.07272,0.15457,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-822,[0 0 0 ... 0 0 0],"[302.33299999999997, 302.105527688, 3.7048000000000023, 4, 0, 48.03, 4, 3, 23, 0.5420664581286583, 0.05263157894736842, 4]",302.33299999999997,302.105527688,3.7048000000000023,4,0,48.03,4,3,23,0.5420664581286583,0.05263157894736842,4,8.199580814454837,6.315666450674736
206,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC=C3)=CC=C2C(CN4C=CN=C4)=C1,8.16621562534352,Active,332.38,5,4,0,4,3.104,57.26,0.213233195,-1106.926588,8.9223,-0.22745,-0.0673,0.16015,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-823,[0 0 0 ... 0 0 0],"[332.35900000000004, 332.116092372, 3.6168000000000022, 5, 0, 57.26, 4, 5, 25, 0.523871393705378, 0.1, 4]",332.35900000000004,332.116092372,3.6168000000000022,5,0,57.26,4,5,25,0.523871393705378,0.1,4,8.187981794687833,6.486616244068485
207,Non-Steroid,S=C1OC2=CC=C(CN3C=CN=C3)C=C2C=C1,8.22548303427145,Inactive,242.32,2,3,0,2,2.476,63.05,0.194535704,-1084.303862,4.1079,-0.22152,-0.09181,0.12971,"Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors",J Med Chem. 2004 Dec 30;47(27):6792-824,[0 0 0 ... 0 0 0],"[242.30300000000003, 242.05138394, 3.407090000000002, 4, 0, 30.96, 3, 2, 17, 0.645179282054099, 0.07692307692307693, 3]",242.30300000000003,242.05138394,3.407090000000002,4,0,30.96,3,2,17,0.645179282054099,0.07692307692307693,3,8.182212766173793,6.5733572165492795
208,Non-Steroid,O=S(OC1=CC=C(C(N2N=CN=C2)C3=CC=C(OS(=O)(N)=O)C=C3)C=C1)(N)=O,8.258332019840534,Inactive,425.49,7,3,4,10,0.713,186.25,0.333072512,-2101.932812,3.5737,-0.25565,-0.04083,0.21482,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-38,[0 1 0 ... 0 0 0],"[425.44800000000015, 425.0463752, 0.0803999999999997, 9, 2, 169.49, 3, 7, 28, 0.5358608491088769, 0.06666666666666667, 3]",425.44800000000015,425.0463752,0.0803999999999997,9,2,169.49,3,7,28,0.5358608491088769,0.06666666666666667,3,8.17430411668857,6.694156838711616
209,Non-Steroid,O=S(OC1=CC=CC(C(N2N=CN=C2)C3=CC=CC(OS(=O)(N)=O)=C3)=C1)(N)=O,8.154631242846643,Active,425.49,7,3,4,10,0.713,186.25,0.330082372,-2101.932474,2.0691,-0.26105,-0.03302,0.22803,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-39,[0 1 0 ... 0 0 0],"[425.4480000000002, 425.04637519999994, 0.0803999999999997, 9, 2, 169.49, 3, 7, 28, 0.5358608491088769, 0.06666666666666667, 3]",425.4480000000002,425.04637519999994,0.0803999999999997,9,2,169.49,3,7,28,0.5358608491088769,0.06666666666666667,3,8.17978637693634,6.6101851333139106
210,Non-Steroid,BrC1=C(OS(=O)(N)=O)C=CC(C(N2N=CN=C2)C3=CC=C(OS(=O)(N)=O)C(Br)=C3)=C1,8.132736947129581,Active,583.27,7,3,4,10,2.21,186.25,0.331160233,-7244.136558,3.1941,-0.25799,-0.05014,0.20785,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-40,[0 1 0 ... 0 0 0],"[583.2400000000002, 580.8673993360001, 1.6054000000000004, 9, 2, 169.49, 3, 7, 30, 0.4228682285244055, 0.06666666666666667, 3]",583.2400000000002,580.8673993360001,1.6054000000000004,9,2,169.49,3,7,30,0.4228682285244055,0.06666666666666667,3,8.17405358026564,6.6980196875951385
213,Non-Steroid,O=S(OC1=CC=C(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)C=C1)(N)=O,8.103140107579122,Active,355.41,5,3,2,7,1.731,132.27,0.276163,-1515.039962,3.1301,-0.26021,-0.06169,0.19852,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-41,[0 1 0 ... 0 0 0],"[355.3790000000001, 355.07391027600005, 1.36978, 7, 1, 123.89000000000001, 3, 5, 25, 0.7369098380856877, 0.0625, 3]",355.3790000000001,355.07391027600005,1.36978,7,1,123.89000000000001,3,5,25,0.7369098380856877,0.0625,3,8.112818181750889,7.712262769032379
214,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)=C1,8.101229924222892,Active,389.85,5,3,2,7,2.396,132.27,0.272857763,-1974.630596,5.5628,-0.26177,-0.06699,0.19478,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-42,[0 1 0 ... 0 0 0],"[389.8240000000001, 389.034937924, 2.02318, 7, 1, 123.88999999999999, 3, 5, 26, 0.7113646520946422, 0.0625, 3]",389.8240000000001,389.034937924,2.02318,7,1,123.88999999999999,3,5,26,0.7113646520946422,0.0625,3,8.096824619035367,8.001573169767044
215,Non-Steroid,BrC1=C(OS(=O)(N)=O)C=CC(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)=C1,8.069413690221253,Active,434.3,5,3,2,7,2.48,132.27,0.274268026,-4086.141475,5.3025,-0.26036,-0.06727,0.19309,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-43,[0 1 0 ... 0 0 0],"[434.2750000000001, 432.9844223440001, 2.1322800000000006, 7, 1, 123.88999999999999, 3, 5, 26, 0.6562984258296404, 0.0625, 3]",434.2750000000001,432.9844223440001,2.1322800000000006,7,1,123.88999999999999,3,5,26,0.6562984258296404,0.0625,3,8.097302897011044,7.992766081782797
216,Non-Steroid,OC1=CC=CC(C(N2N=CN=C2)C3=CC=CC(O)=C3)=C1,8.251068504763314,Inactive,267.31,3,3,2,4,2.457,71.17,0.232044152,-894.0959369,1.3939,-0.22377,-0.01724,0.20653,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-44,[0 1 0 ... 0 0 0],"[267.288, 267.100776656, 2.327, 5, 2, 71.17, 3, 3, 20, 0.7636615367610797, 0.06666666666666667, 3]",267.288,267.100776656,2.327,5,2,71.17,3,3,20,0.7636615367610797,0.06666666666666667,3,8.19591943975449,6.369136554087363
217,Non-Steroid,OC1=CC=C(C(N2N=CN=C2)C3=CC=C(O)C=C3)C=C1,8.17072325090617,Active,267.31,3,3,2,4,2.457,71.17,0.230451788,-894.0960313,3.9733,-0.2213,-0.01876,0.20254,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-45,[0 1 0 ... 0 0 0],"[267.288, 267.100776656, 2.327, 5, 2, 71.17, 3, 3, 20, 0.7636615367610797, 0.06666666666666667, 3]",267.288,267.100776656,2.327,5,2,71.17,3,3,20,0.7636615367610797,0.06666666666666667,3,8.164870298493133,6.84115927146721
218,Non-Steroid,OC1=C(Br)C=C(C(N2N=CN=C2)C3=CC=C(O)C(Br)=C3)C=C1,8.096910013008056,Active,425.09,3,3,2,4,3.954,71.17,0.222553152,-6036.305314,2.1194,-0.23195,-0.03367,0.19828,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-46,[0 1 0 ... 0 0 0],"[425.0800000000001, 422.92180079199994, 3.852000000000001, 5, 2, 71.17, 3, 3, 22, 0.6692931803004876, 0.06666666666666667, 3]",425.0800000000001,422.92180079199994,3.852000000000001,5,2,71.17,3,3,22,0.6692931803004876,0.06666666666666667,3,8.126497247667512,7.473133702596258
219,Non-Steroid,OC1=C(OC)C=CC(C(N2N=CN=C2)C3=CC=C(OC)C(O)=C3)=C1,8.16927578491311,Active,327.37,5,3,2,6,2.424,89.63,0.249332585,-1123.128237,3.352,-0.20666,-0.01166,0.195,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-47,[0 1 0 ... 0 0 0],"[327.3400000000001, 327.121906024, 2.3442, 7, 2, 89.63000000000001, 3, 5, 24, 0.7474952449448193, 0.17647058823529413, 3]",327.3400000000001,327.121906024,2.3442,7,2,89.63000000000001,3,5,24,0.7474952449448193,0.17647058823529413,3,8.179490652302817,6.614687746975557
220,Non-Steroid,OC1=C(OC)C=C(C(N2N=CN=C2)C3=CC=C(O)C(OC)=C3)C=C1,8.17603296718528,Active,327.37,5,3,2,6,2.424,89.63,0.249849439,-1123.137734,4.3322,-0.2083,-0.00733,0.20097,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-48,[0 1 0 ... 0 0 0],"[327.3400000000001, 327.121906024, 2.3442, 7, 2, 89.63000000000001, 3, 5, 24, 0.7474952449448193, 0.17647058823529413, 3]",327.3400000000001,327.121906024,2.3442,7,2,89.63000000000001,3,5,24,0.7474952449448193,0.17647058823529413,3,8.174824359745234,6.686142683132872
221,Non-Steroid,OC1=CC=C(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)C=C1,8.089233298736113,Active,276.32,3,3,1,4,2.603,74.73,0.214570152,-911.1209821,4.0206,-0.23478,-0.06604,0.16874,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-49,[0 1 0 ... 0 0 0],"[276.29900000000004, 276.101111004, 2.493080000000001, 5, 1, 74.72999999999999, 3, 3, 21, 0.7971334678699918, 0.0625, 3]",276.29900000000004,276.101111004,2.493080000000001,5,1,74.72999999999999,3,3,21,0.7971334678699918,0.0625,3,8.102594243957432,7.89597484416963
222,Non-Steroid,OC1=C(Cl)C=C(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)C=C1,8.083039022569398,Active,310.76,3,3,1,4,3.268,74.73,0.210101273,-1370.71268,3.5518,-0.24117,-0.06953,0.17164,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-50,[0 1 0 ... 0 0 0],"[310.744, 310.062138652, 3.1464800000000013, 5, 1, 74.72999999999999, 3, 3, 22, 0.8060861952976802, 0.0625, 3]",310.744,310.062138652,3.1464800000000013,5,1,74.72999999999999,3,3,22,0.8060861952976802,0.0625,3,8.09472946553584,8.040268175400554
223,Non-Steroid,OC1=C(Br)C=C(C(N2N=CN=C2)C3=CC=C(C#N)C=C3)C=C1,8.05825371954857,Active,355.21,3,3,1,4,3.352,74.73,0.210034182,-3482.222264,3.5678,-0.23948,-0.06926,0.17022,"Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity",J Med Chem. 2008;51(14):4226-51,[0 1 0 ... 0 0 0],"[355.1950000000001, 354.011623072, 3.255580000000001, 5, 1, 74.72999999999999, 3, 3, 22, 0.7826600987378547, 0.0625, 3]",355.1950000000001,354.011623072,3.255580000000001,5,1,74.72999999999999,3,3,22,0.7826600987378547,0.0625,3,8.081934531332317,8.280669830651263
265,Non-Steroid,OC(C1=CC=C(F)C=C1)(C2=CC(C=CC(OC)=C3)=C3O2)C4=CN=CC=C4,8.133325966906716,Active,349.38,4,4,1,5,3.911,55.49,0.218104619,-1190.088906,5.0984,-0.20387,-0.02808,0.17579,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-22,[0 0 0 ... 1 0 0],"[349.36100000000005, 349.111421592, 4.259700000000003, 4, 1, 55.49, 4, 4, 26, 0.5980641811374422, 0.09523809523809523, 4]",349.36100000000005,349.111421592,4.259700000000003,4,1,55.49,4,4,26,0.5980641811374422,0.09523809523809523,4,8.206953487615273,6.2093553207207535
266,Non-Steroid,OC(C1=CC=C(Cl)C=C1)(C2=CC(C=CC(OC)=C3)=C3O2)C4=CN=CC=C4,8.136094272509188,Active,365.83,4,4,1,4,4.37,55.49,0.20111531,-1550.451703,5.6711,-0.20543,-0.03099,0.17444,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-23,[0 0 0 ... 1 0 0],"[365.8160000000001, 365.081871052, 4.774000000000004, 4, 1, 55.49, 4, 4, 26, 0.5654331021157802, 0.09523809523809523, 4]",365.8160000000001,365.081871052,4.774000000000004,4,1,55.49,4,4,26,0.5654331021157802,0.09523809523809523,4,8.1885906619726,6.477528582705006
267,Non-Steroid,OC(C1=CC=C(OC)C=C1)(C2=CC(C=CC(OC)=C3)=C3O2)C4=CN=CC=C4,8.16775429731547,Active,361.42,5,4,1,5,3.689,64.72,0.21726937,-1205.378215,3.7814,-0.19875,-0.02329,0.17546,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-24,[0 0 0 ... 1 0 0],"[361.39700000000005, 361.13140808800006, 4.1292000000000035, 5, 1, 64.72, 4, 5, 27, 0.5789804350749518, 0.13636363636363635, 4]",361.39700000000005,361.13140808800006,4.1292000000000035,5,1,64.72,4,5,27,0.5789804350749518,0.13636363636363635,4,8.216256610145471,6.077757806961792
268,Non-Steroid,COC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(OC)C=C3)N4C=NC=C4,8.16202940890224,Active,334.4,5,4,0,4,3.681,49.42,0.216658674,-1108.098025,4.3335,-0.20228,-0.01876,0.18352,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-25,[0 1 0 ... 0 0 0],"[334.375, 334.131742436, 4.284200000000003, 5, 0, 49.42, 4, 5, 25, 0.5463465533085768, 0.15, 4]",334.375,334.131742436,4.284200000000003,5,0,49.42,4,5,25,0.5463465533085768,0.15,4,8.145022586514473,7.161061664449825
269,Non-Steroid,FC(C=C1)=CC=C1C(C2=CC(C=CC(OC)=C3)=C3O2)N4C=NC=N4,8.136094272509188,Active,323.35,4,4,0,5,3.776,53.08,0.215561721,-1108.098329,4.7486,-0.20464,-0.02376,0.18088,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-26,[0 1 0 ... 0 0 0],"[323.327, 323.1070049080001, 3.809700000000004, 5, 0, 53.08, 4, 4, 24, 0.5729239003924371, 0.1111111111111111, 4]",323.327,323.1070049080001,3.809700000000004,5,0,53.08,4,4,24,0.5729239003924371,0.1111111111111111,4,8.144466263075339,7.17024073381344
270,Non-Steroid,ClC(C=C1)=CC=C1C(C2=CC(C=CC(OC)=C3)=C3O2)N4C=NC=N4,8.133325966906716,Active,339.8,4,4,0,4,4.235,53.08,0.209093263,-1469.208379,3.8367,-0.2063,-0.03061,0.17569,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-27,[0 1 0 ... 0 0 0],"[339.782, 339.0774543680001, 4.324000000000003, 5, 0, 53.08, 4, 4, 24, 0.5552124782259484, 0.1111111111111111, 4]",339.782,339.0774543680001,4.324000000000003,5,0,53.08,4,4,24,0.5552124782259484,0.1111111111111111,4,8.12354480118459,7.524111085387113
271,Non-Steroid,COC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(OC)C=C3)N4C=NC=N4,8.16202940890224,Active,335.39,5,4,0,5,3.554,62.31,0.226372452,-1124.136104,4.3722,-0.20116,-0.02038,0.18078,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-28,[0 1 0 ... 0 0 0],"[335.363, 335.1269914040001, 3.6792000000000025, 6, 0, 62.31, 4, 5, 25, 0.5566140689662363, 0.15789473684210525, 4]",335.363,335.1269914040001,3.6792000000000025,6,0,62.31,4,5,25,0.5566140689662363,0.15789473684210525,4,8.151689343973828,7.051973246583847
272,Non-Steroid,COC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(C#N)C=C3)N4C=NC=N4,8.096910013008056,Active,330.37,4,4,0,5,3.449,76.87,0.225043385,-1101.85498,5.0287,-0.21072,-0.06239,0.14833,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-29,[0 1 0 ... 0 0 0],"[330.34700000000004, 330.11167568800005, 3.5422800000000025, 6, 0, 76.87, 4, 4, 25, 0.5717807991995215, 0.10526315789473684, 4]",330.34700000000004,330.11167568800005,3.5422800000000025,6,0,76.87,4,4,25,0.5717807991995215,0.10526315789473684,4,8.112659701776483,7.715077592361217
273,Non-Steroid,COC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C([N+]([O-])=O)C=C3)N4C=NC=N4,8.206080550578456,Active,350.36,5,4,0,6,3.465,98.9,0.236795625,-1214.112985,5.1366,-0.21167,-0.09553,0.11614,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-30,[0 1 0 ... 0 0 0],"[350.33400000000006, 350.10150492800005, 3.578800000000003, 7, 0, 96.22, 4, 5, 26, 0.4030812735444883, 0.1111111111111111, 4]",350.33400000000006,350.10150492800005,3.578800000000003,7,0,96.22,4,5,26,0.4030812735444883,0.1111111111111111,4,8.169521290733643,6.768286114460809
274,Non-Steroid,CC(C=C1)=CC=C1C(C2=CC(C=CC(OC)=C3)=C3O2)N4C=NC=N4,8.154901959985743,Active,319.39,4,4,0,4,4.056,53.08,0.221266463,-1048.931107,4.459,-0.20178,-0.02123,0.18055,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-31,[0 1 0 ... 0 0 0],"[319.364, 319.1320767840001, 3.9790200000000038, 5, 0, 53.08, 4, 4, 24, 0.5707693809284206, 0.15789473684210525, 4]",319.364,319.1320767840001,3.9790200000000038,5,0,53.08,4,4,24,0.5707693809284206,0.15789473684210525,4,8.149130707725751,7.0936424155519635
275,Non-Steroid,COC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(C(F)(F)F)C=C3)N4C=NC=N4,8.16202940890224,Active,373.36,4,4,0,7,4.512,53.08,0.232897463,-1346.649106,3.9235,-0.20673,-0.03936,0.16737,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-32,[0 1 0 ... 0 0 0],"[373.334, 373.1038113480001, 4.689400000000003, 5, 0, 53.08, 4, 4, 27, 0.5208104994180297, 0.15789473684210525, 4]",373.334,373.1038113480001,4.689400000000003,5,0,53.08,4,4,27,0.5208104994180297,0.15789473684210525,4,8.164975325404772,6.839505050684088
276,Non-Steroid,COC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(CC)C=C3)N4C=NC=N4,8.22840554628655,Inactive,333.42,5,4,0,4,4.513,53.08,0.217534182,-1088.244723,4.4938,-0.20185,-0.02168,0.18017,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-33,[0 1 0 ... 0 0 0],"[333.391, 333.1477268480001, 4.233000000000004, 5, 0, 53.08, 4, 5, 25, 0.5482167682000089, 0.2, 4]",333.391,333.1477268480001,4.233000000000004,5,0,53.08,4,5,25,0.5482167682000089,0.2,4,8.170084583734972,6.759513134501831
277,Non-Steroid,OC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(Cl)C=C3)N4C=NC=N4,8.233910975868133,Inactive,325.77,3,4,1,4,3.984,64.08,0.221010086,-1429.902235,3.6989,-0.20926,-0.03117,0.17809,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-34,[0 1 0 ... 0 0 0],"[325.755, 325.0618043040001, 4.021000000000003, 5, 1, 64.08000000000001, 4, 3, 23, 0.6175860065784431, 0.058823529411764705, 4]",325.755,325.0618043040001,4.021000000000003,5,1,64.08000000000001,4,3,23,0.6175860065784431,0.058823529411764705,4,8.115012702951026,7.673390446537541
278,Non-Steroid,OC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C(C#N)C=C3)N4C=NC=N4,8.11356737242492,Active,316.34,3,4,1,5,3.198,87.87,0.237872056,-1062.548781,4.5423,-0.21386,-0.06308,0.15078,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-35,[0 1 0 ... 0 0 0],"[316.32, 316.09602562400005, 3.2392800000000026, 6, 1, 87.87, 4, 3, 24, 0.6266165739994413, 0.05555555555555555, 4]",316.32,316.09602562400005,3.2392800000000026,6,1,87.87,4,3,24,0.6266165739994413,0.05555555555555555,4,8.095640410739575,8.02342115569943
279,Non-Steroid,OC1=CC(O2)=C(C=C1)C=C2C(C3=CC=C([N+]([O-])=O)C=C3)N4C=NC=N4,8.141351611412963,Active,336.33,4,4,1,6,3.214,109.9,0.250188568,-1174.806815,4.6355,-0.21487,-0.09614,0.11873,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-36,[0 1 0 ... 0 0 0],"[336.307, 336.08585486400005, 3.275800000000003, 7, 1, 107.22, 4, 4, 25, 0.4525136642192408, 0.058823529411764705, 4]",336.307,336.08585486400005,3.275800000000003,7,1,107.22,4,4,25,0.4525136642192408,0.058823529411764705,4,8.143805183503266,7.181163527852231
280,Non-Steroid,CC(C)(C#N)C1=CC(C(C)(C#N)C)=CC(CN2C=NC=N2)=C1,8.206080550578456,Active,293.41,4,2,0,4,2.966,78.29,0.232477,-932.9721075,5.2012,-0.26549,-0.03658,0.22891,"Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation",J Med Chem. 2006;49(3):1016-37,[0 0 0 ... 0 0 0],"[293.37399999999997, 293.16404560800004, 2.9287600000000014, 5, 0, 78.29, 2, 4, 22, 0.8678513137549793, 0.4117647058823529, 2]",293.37399999999997,293.16404560800004,2.9287600000000014,5,0,78.29,2,4,22,0.8678513137549793,0.4117647058823529,2,8.12565809874806,7.487587338911528
281,Non-Steroid,O=C1C(C(N2CCCC2)C3=CC=C(C=C3)[N+]([O-])=O)=COC4=CC=CC=C41,8.063486257521106,Active,350.4,4,4,0,5,3.39,79.27,0.201864659,-1183.255072,7.2061,-0.22712,-0.08114,0.14598,Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach,J Med Chem. 2005;48(23):7282-9,[0 1 0 ... 0 0 0],"[350.3740000000001, 350.126657056, 3.8864000000000027, 5, 0, 76.59, 3, 4, 26, 0.5269518888956809, 0.25, 4]",350.3740000000001,350.126657056,3.8864000000000027,5,0,76.59,3,4,26,0.5269518888956809,0.25,4,8.153931436972067,7.015660474572442
283,Non-Steroid,O=C1C(C(N2CCCC2)C3=CC=C(C=C3)Br)=COC4=CC=CC=C41,8.136082623042139,Active,384.29,3,4,0,3,4.244,33.45,0.178934238,-3549.857171,4.0645,-0.21765,-0.05433,0.16332,Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach,J Med Chem. 2005;48(23):7282-10,[0 1 0 ... 0 0 0],"[384.27300000000014, 383.052090916, 4.740700000000004, 3, 0, 33.45, 3, 3, 24, 0.6541485495462543, 0.25, 4]",384.27300000000014,383.052090916,4.740700000000004,3,0,33.45,3,3,24,0.6541485495462543,0.25,4,8.159394516598583,6.927961784627103
285,Non-Steroid,O=C1C(C(N2CCCC2)C3=CC=C(C=C3)C#N)=COC4=CC=CC=C41,8.157390760389438,Active,330.41,3,4,0,4,3.374,57.24,0.190017953,-1070.996553,7.0059,-0.22524,-0.05943,0.16581,Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach,J Med Chem. 2005;48(23):7282-11,[0 1 0 ... 0 0 0],"[330.38700000000006, 330.136827816, 3.8498800000000033, 4, 0, 57.24, 3, 3, 25, 0.7317575302514729, 0.23809523809523808, 4]",330.38700000000006,330.136827816,3.8498800000000033,4,0,57.24,3,3,25,0.7317575302514729,0.23809523809523808,4,8.131665547182081,7.38472713526068
337,Steroid,CC12C(CCC2=O)C3C=CC4=C(C5=CC=CCC5=S)C(CCC4(C)C3CC1)=O,8.119068707521988,Active,392.6,1,5,0,2,4.064,66.23,0.194941893,-1518.111712,5.9392,-0.20283,-0.09171,0.11112,"Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione",Steroids. 1995;60(5):423-7,[0 0 0 ... 0 0 0],"[392.56400000000025, 392.18100113599996, 5.489800000000005, 3, 0, 34.14, 0, 1, 28, 0.553450754724334, 0.56, 5]",392.56400000000025,392.18100113599996,5.489800000000005,3,0,34.14,0,1,28,0.553450754724334,0.56,5,8.183094833769886,6.560020042111695
338,Steroid,CC12C(CCC2=O)C3C=CC4=C(C5=CC=CCC5=S)C(C=CC4(C)C3CC1)=O,8.143447119530343,Active,390.58,1,5,0,2,4.04,66.23,0.190578407,-1516.887218,6.2854,-0.20399,-0.09202,0.11197,"Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione",Steroids. 1995;60(5):423-8,[0 0 0 ... 0 0 0],"[390.5480000000002, 390.16535107199996, 5.265800000000005, 3, 0, 34.14, 0, 1, 28, 0.5724077103876352, 0.48, 5]",390.5480000000002,390.16535107199996,5.265800000000005,3,0,34.14,0,1,28,0.5724077103876352,0.48,5,8.169078471021106,6.775190782003643
339,Steroid,CC12C(CCC2=O)C3CCC4=C(C5=CC=CCC5=S)C(C=CC4(C)C3CC1)=O,8.200588452924745,Active,392.6,1,5,0,2,4.485,66.23,0.193599036,-1518.105303,5.71,-0.20698,-0.09116,0.11582,"Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione",Steroids. 1995;60(5):423-9,[0 0 0 ... 0 0 0],"[392.5640000000002, 392.18100113599996, 5.489800000000006, 3, 0, 34.14, 0, 1, 28, 0.553450754724334, 0.56, 5]",392.5640000000002,392.18100113599996,5.489800000000006,3,0,34.14,0,1,28,0.553450754724334,0.56,5,8.190752730206585,6.445361339910375
340,Steroid,CC12C(CCC2=O)C3CCC4=C(C5=CC=CCC5=S)C(CCC4(C)C3CC1)=O,8.171035592294306,Active,394.62,1,5,0,2,4.508,66.23,0.200065224,-1519.319682,5.501,-0.20616,-0.09217,0.11399,"Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione",Steroids. 1995;60(5):423-10,[0 0 0 ... 0 0 0],"[394.58000000000027, 394.19665119999996, 5.713800000000006, 3, 0, 34.14, 0, 1, 28, 0.5339555334792514, 0.64, 5]",394.58000000000027,394.19665119999996,5.713800000000006,3,0,34.14,0,1,28,0.5339555334792514,0.64,5,8.189514873477895,6.463758568966071
341,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C(C3=CC=NC=C3)/[H],8.337047724304826,Inactive,221.27,1,3,0,2,2.656,29.96,0.18424375,-708.1912821,3.467,-0.24888,-0.08897,0.15991,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-81,[0 0 0 ... 0 0 0],"[221.25900000000001, 221.084063972, 2.904000000000001, 2, 0, 29.96, 2, 1, 17, 0.6929082664181561, 0.06666666666666667, 3]",221.25900000000001,221.084063972,2.904000000000001,2,0,29.96,2,1,17,0.6929082664181561,0.06666666666666667,3,8.277358655497304,5.280090234465776
342,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C([H])/C3=CC=NC=C3,8.27904420247403,Inactive,221.27,1,3,0,2,2.656,29.96,0.184247143,-708.1912818,3.4668,-0.24888,-0.08898,0.1599,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-82,[0 0 0 ... 0 0 0],"[221.25900000000001, 221.084063972, 2.904000000000001, 2, 0, 29.96, 2, 1, 17, 0.6929082664181561, 0.06666666666666667, 3]",221.25900000000001,221.084063972,2.904000000000001,2,0,29.96,2,1,17,0.6929082664181561,0.06666666666666667,3,8.277358655497304,5.280090234465776
343,Non-Steroid,O=C(C1=CC=CC(OC)=C1C/2)C2=C(C3=CC=NC=C3)/[H],8.333643771468738,Inactive,251.3,2,3,0,3,2.64,39.19,0.199128313,-822.7146648,5.003,-0.23213,-0.08504,0.14709,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-83,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
344,Non-Steroid,O=C(C1=CC=CC(OC)=C1C/2)C2=C([H])/C3=CC=NC=C3,8.26505636708669,Inactive,251.3,2,3,0,3,2.64,39.19,0.199127781,-822.7146647,5.0029,-0.23213,-0.08504,0.14709,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-84,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
345,Non-Steroid,O=C(C1=CC=C(OC)C=C1C/2)C2=C(C3=CC=NC=C3)/[H],8.274189707042423,Inactive,251.3,2,3,0,3,2.64,39.19,0.2085795,-822.7160605,4.9269,-0.23324,-0.08271,0.15053,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-85,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
346,Non-Steroid,O=C(C1=CC=C(OC)C=C1C/2)C2=C([H])/C3=CC=NC=C3,8.283941583716755,Inactive,251.3,2,3,0,3,2.64,39.19,0.208580844,-822.7160606,4.9273,-0.23324,-0.0827,0.15054,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-86,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
347,Non-Steroid,O=C(C1=CC=CC(O)=C1C/2)C2=C(C3=CC=NC=C3)/[H],8.331839926783555,Inactive,237.27,1,3,1,3,2.389,50.19,0.212546,-783.4079301,4.7283,-0.236,-0.08661,0.14939,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-87,[0 0 0 ... 0 0 0],"[237.25799999999998, 237.078978592, 2.6096000000000004, 3, 1, 50.19, 2, 1, 18, 0.7754731200266453, 0.06666666666666667, 3]",237.25799999999998,237.078978592,2.6096000000000004,3,1,50.19,2,1,18,0.7754731200266453,0.06666666666666667,3,8.271141740601458,5.3562181820022525
349,Non-Steroid,O=C1C(CC2=CC=NC=C2)CC3=CC=CC=C31,8.321522495821112,Inactive,223.29,2,3,0,2,2.696,29.96,0.186071467,-709.4105757,3.5872,-0.24478,-0.05979,0.18499,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-88,[0 0 0 ... 0 0 0],"[223.275, 223.099714036, 2.6793000000000013, 2, 0, 29.96, 2, 2, 17, 0.7830922732574321, 0.2, 3]",223.275,223.099714036,2.6793000000000013,2,0,29.96,2,2,17,0.7830922732574321,0.2,3,8.267997921833391,5.395132041635023
350,Non-Steroid,O=C1C(CC2=CC=NC=C2)CC3=C(OC)C=CC=C31,8.31391168372342,Inactive,253.32,3,3,0,3,2.679,39.19,0.198870853,-823.926897,3.052,-0.23566,-0.05835,0.17731,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-89,[0 0 0 ... 0 0 0],"[253.301, 253.11027872, 2.687900000000001, 3, 0, 39.19, 2, 3, 19, 0.8438646379742457, 0.25, 3]",253.301,253.11027872,2.687900000000001,3,0,39.19,2,3,19,0.8438646379742457,0.25,3,8.271346704961681,5.353690922598317
351,Non-Steroid,O=C1C(CC2=CC=NC=C2)CC3=CC(OC)=CC=C31,8.262130109193974,Inactive,253.32,3,3,0,3,2.679,39.19,0.206948853,-823.93573,4.7794,-0.23415,-0.04894,0.18521,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-90,[0 0 0 ... 0 0 0],"[253.301, 253.11027872, 2.687900000000001, 3, 0, 39.19, 2, 3, 19, 0.8438646379742457, 0.25, 3]",253.301,253.11027872,2.687900000000001,3,0,39.19,2,3,19,0.8438646379742457,0.25,3,8.263701018598828,5.448776339269793
352,Non-Steroid,O=C1C(CC2=CC=NC=C2)CC3=C(O)C=CC=C31,8.269480098873668,Inactive,239.29,2,3,1,3,2.428,50.19,0.213151323,-784.6262362,2.2178,-0.23583,-0.05992,0.17591,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-91,[0 0 0 ... 0 0 0],"[239.274, 239.094628656, 2.384900000000001, 3, 1, 50.19, 2, 2, 18, 0.8749590188980465, 0.2, 3]",239.274,239.094628656,2.384900000000001,3,1,50.19,2,2,18,0.8749590188980465,0.2,3,8.245364440007753,5.683757757893659
353,Non-Steroid,O=C1C(CC2=CC=NC=C2)CC3=CC(O)=CC=C31,8.298301051217685,Inactive,239.29,2,3,1,3,2.428,50.19,0.220858581,-784.6290999,4.1181,-0.23867,-0.05116,0.18751,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-92,[0 0 0 ... 0 0 0],"[239.274, 239.094628656, 2.384900000000001, 3, 1, 50.19, 2, 2, 18, 0.8749590188980465, 0.2, 3]",239.274,239.094628656,2.384900000000001,3,1,50.19,2,2,18,0.8749590188980465,0.2,3,8.263606915811101,5.4499571062823255
354,Non-Steroid,C12=CC=CC=C1CC(CC3=CC=NC=C3)C2,8.250280008800894,Inactive,209.31,2,3,0,1,3.477,12.89,0.168165097,-635.3902568,2.3984,-0.23245,-0.02054,0.21191,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-93,[0 0 0 ... 0 0 0],"[209.292, 209.12044948, 3.0391000000000012, 1, 0, 12.89, 2, 2, 16, 0.7404900651404868, 0.26666666666666666, 3]",209.292,209.12044948,3.0391000000000012,1,0,12.89,2,2,16,0.7404900651404868,0.26666666666666666,3,8.25697477854956,5.533822456996142
355,Non-Steroid,COC1=C(CC(CC2=CC=NC=C2)C3)C3=CC=C1,8.284513103430106,Inactive,239.34,3,3,0,2,3.46,22.12,0.183737257,-749.9124782,3.6735,-0.21468,-0.01845,0.19623,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-94,[0 0 0 ... 0 0 0],"[239.318, 239.131014164, 3.0477000000000016, 2, 0, 22.12, 2, 3, 18, 0.8209623531781414, 0.3125, 3]",239.318,239.131014164,3.0477000000000016,2,0,22.12,2,3,18,0.8209623531781414,0.3125,3,8.25545552212755,5.553214869499402
356,Non-Steroid,COC1=CC=C2C(CC(CC3=CC=NC=C3)C2)=C1,8.179155868974,Active,239.34,3,3,0,2,3.46,22.12,0.191171771,-749.9114886,2.7154,-0.20979,-0.01932,0.19047,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-95,[0 0 0 ... 0 0 0],"[239.31799999999998, 239.131014164, 3.0477000000000016, 2, 0, 22.12, 2, 3, 18, 0.8209623531781414, 0.3125, 3]",239.31799999999998,239.131014164,3.0477000000000016,2,0,22.12,2,3,18,0.8209623531781414,0.3125,3,8.25545552212755,5.553214869499402
357,Non-Steroid,OC1=C(CC(CC2=CC=NC=C2)C3)C3=CC=C1,8.221848749616356,Inactive,225.31,2,3,1,2,3.209,33.12,0.195660656,-710.6052826,2.0407,-0.21773,-0.02312,0.19461,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-96,[0 0 0 ... 0 0 0],"[225.29099999999997, 225.1153641, 2.744700000000001, 2, 1, 33.120000000000005, 2, 2, 17, 0.8521110688696386, 0.26666666666666666, 3]",225.29099999999997,225.1153641,2.744700000000001,2,1,33.120000000000005,2,2,17,0.8521110688696386,0.26666666666666666,3,8.23573683205691,5.8111644799933995
358,Non-Steroid,OC1=CC=C2C(CC(CC3=CC=NC=C3)C2)=C1,8.242509347913112,Inactive,225.31,2,3,1,2,3.209,33.12,0.202814438,-710.6050215,3.2848,-0.21195,-0.02046,0.19149,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-97,[0 0 0 ... 0 0 0],"[225.29100000000003, 225.1153641, 2.744700000000001, 2, 1, 33.120000000000005, 2, 2, 17, 0.8521110688696387, 0.26666666666666666, 3]",225.29100000000003,225.1153641,2.744700000000001,2,1,33.120000000000005,2,2,17,0.8521110688696387,0.26666666666666666,3,8.25715827572433,5.531484812061402
359,Non-Steroid,C12=CC=CC=C1CC(CC3=CC=NC=C3)CC2,8.227618233182895,Inactive,223.34,2,3,0,1,3.933,12.89,0.167613412,-674.7063818,2.7114,-0.23429,-0.01906,0.21523,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-98,[0 0 0 ... 0 0 0],"[223.319, 223.136099544, 3.4292000000000016, 1, 0, 12.89, 2, 2, 17, 0.7597808056951476, 0.3125, 3]",223.319,223.136099544,3.4292000000000016,1,0,12.89,2,2,17,0.7597808056951476,0.3125,3,8.250210159217675,5.62069268721758
360,Non-Steroid,COC1=C(CCC(CC2=CC=NC=C2)C3)C3=CC=C1,8.2055713513207,Active,253.37,3,3,0,2,3.916,22.12,0.180305447,-789.2312886,3.4452,-0.21133,-0.01837,0.19296,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-99,[0 0 0 ... 0 0 0],"[253.34500000000003, 253.146664228, 3.437800000000002, 2, 0, 22.12, 2, 3, 19, 0.8356589805718903, 0.35294117647058826, 3]",253.34500000000003,253.146664228,3.437800000000002,2,0,22.12,2,3,19,0.8356589805718903,0.35294117647058826,3,8.23875376392181,5.770935708894091
361,Non-Steroid,COC1=CC=C2C(CCC(CC3=CC=NC=C3)C2)=C1,8.177944945826134,Active,253.37,3,3,0,2,3.916,22.12,0.188273632,-789.2286469,2.4032,-0.21,-0.01786,0.19214,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-100,[0 0 0 ... 0 0 0],"[253.345, 253.146664228, 3.437800000000002, 2, 0, 22.12, 2, 3, 19, 0.8356589805718901, 0.35294117647058826, 3]",253.345,253.146664228,3.437800000000002,2,0,22.12,2,3,19,0.8356589805718901,0.35294117647058826,3,8.23567651496471,5.811971621000173
362,Non-Steroid,COC1=CC=C(CCC(CC2=CC=NC=C2)C3)C3=C1,8.270306313551282,Inactive,253.37,3,3,0,2,3.916,22.12,0.187329,-789.2305248,3.0409,-0.20872,-0.01952,0.1892,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-101,[0 0 0 ... 0 0 0],"[253.345, 253.146664228, 3.437800000000002, 2, 0, 22.12, 2, 3, 19, 0.8356589805718901, 0.35294117647058826, 3]",253.345,253.146664228,3.437800000000002,2,0,22.12,2,3,19,0.8356589805718901,0.35294117647058826,3,8.256407781729353,5.541051903738463
363,Non-Steroid,OC1=C(CCC(CC2=CC=NC=C2)C3)C3=CC=C1,8.202336155501285,Active,239.34,2,3,1,2,3.665,33.12,0.193004629,-749.9237288,2.9254,-0.21325,-0.02227,0.19098,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-102,[0 0 0 ... 0 0 0],"[239.318, 239.131014164, 3.134800000000002, 2, 1, 33.120000000000005, 2, 2, 18, 0.8730089982464926, 0.3125, 3]",239.318,239.131014164,3.134800000000002,2,1,33.120000000000005,2,2,18,0.8730089982464926,0.3125,3,8.21733232025439,6.062722351641631
364,Non-Steroid,OC1=CC=C2C(CCC(CC3=CC=NC=C3)C2)=C1,8.21289825085174,Active,239.34,2,3,1,2,3.665,33.12,0.198731229,-749.9222541,2.0211,-0.21288,-0.01859,0.19429,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-103,[0 0 0 ... 0 0 0],"[239.318, 239.131014164, 3.134800000000001, 2, 1, 33.120000000000005, 2, 2, 18, 0.8730089982464926, 0.3125, 3]",239.318,239.131014164,3.134800000000001,2,1,33.120000000000005,2,2,18,0.8730089982464926,0.3125,3,8.242541364676018,5.720824636704359
365,Non-Steroid,OC1=CC=C(CCC(CC2=CC=NC=C2)C3)C3=C1,8.230175562522609,Inactive,239.34,2,3,1,2,3.665,33.12,0.197520029,-749.9239565,3.7105,-0.211,-0.01935,0.19165,"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins",J Med Chem. 1994;37(9):1275-104,[0 0 0 ... 0 0 0],"[239.318, 239.131014164, 3.134800000000001, 2, 1, 33.120000000000005, 2, 2, 18, 0.8730089982464926, 0.3125, 3]",239.318,239.131014164,3.134800000000001,2,1,33.120000000000005,2,2,18,0.8730089982464926,0.3125,3,8.248690902795664,5.640389522812076
374,Non-Steroid,[H][C@@]1(C2=CC=C(C#N)C=C2)CCCC3=CN=CN13,8.071092309756047,Active,223.3,1,3,0,2,2.271,41.61,0.203041367,-705.563887,5.4966,-0.21988,-0.05834,0.16154,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-88,[0 0 0 ... 0 0 0],"[223.27899999999997, 223.110947416, 2.68048, 3, 0, 41.61, 2, 1, 17, 0.7454496699795194, 0.2857142857142857, 3]",223.27899999999997,223.110947416,2.68048,3,0,41.61,2,1,17,0.7454496699795194,0.2857142857142857,3,8.139930196375243,7.245524071451922
375,Non-Steroid,[H][C@]1(C2=CC=C(C#N)C=C2)CCCC3=CN=CN13,8.209714835966759,Active,223.3,1,3,0,2,2.271,41.61,0.2024048,-705.5644837,5.6807,-0.21834,-0.0611,0.15724,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-89,[0 0 0 ... 0 0 0],"[223.27899999999997, 223.110947416, 2.68048, 3, 0, 41.61, 2, 1, 17, 0.7454496699795194, 0.2857142857142857, 3]",223.27899999999997,223.110947416,2.68048,3,0,41.61,2,1,17,0.7454496699795194,0.2857142857142857,3,8.139930196375243,7.245524071451922
376,Non-Steroid,C=C(N1C=NC=C1)C2=CC=C(C#N)C=C2,8.038578905933552,Active,195.24,2,2,0,2,1.635,41.61,0.20268925,-626.9079095,3.0932,-0.23773,-0.07807,0.15966,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-90,[0 0 0 ... 0 0 0],"[195.225, 195.079647288, 2.2737800000000004, 3, 0, 41.61, 2, 2, 15, 0.7371873524661311, 0.0, 2]",195.225,195.079647288,2.2737800000000004,3,0,41.61,2,2,15,0.7371873524661311,0.0,2,8.067551411177208,8.559503795060593
377,Non-Steroid,N#CC(C=C1)=CC2=C1C(N3C=NC=C3)=CCC2,8.068542129310995,Active,221.28,1,3,0,2,2.152,41.61,0.2012385,-704.3422045,5.3357,-0.22991,-0.07503,0.15488,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-91,[0 0 0 ... 0 0 0],"[221.26299999999998, 221.095297352, 2.590180000000001, 3, 0, 41.61, 2, 1, 17, 0.7422994404599719, 0.14285714285714285, 3]",221.26299999999998,221.095297352,2.590180000000001,3,0,41.61,2,1,17,0.7422994404599719,0.14285714285714285,3,8.09796774161973,7.98053962651847
378,Non-Steroid,N#CC(C=C1)=CC=C1C2(C3=CC=C(C#N)C=C3)CCCC4=CN=CN24,8.178486471595226,Active,324.41,2,4,0,3,3.59,65.4,0.202483,-1028.846633,5.4767,-0.22807,-0.0683,0.15977,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-92,[0 0 0 ... 0 0 0],"[324.38700000000006, 324.13749651200004, 3.754660000000003, 4, 0, 65.4, 3, 2, 25, 0.7207562562659776, 0.19047619047619047, 4]",324.38700000000006,324.13749651200004,3.754660000000003,4,0,65.4,3,2,25,0.7207562562659776,0.19047619047619047,4,8.15168331856981,7.052071086377958
379,Non-Steroid,[H]C(C1=CC=C(C#N)C=C1)(N2C=NC=C2)C3=CC=C(C#N)C=C3,8.072629636960976,Active,284.34,3,3,0,3,2.877,65.4,0.188232941,-912.1086278,2.251,-0.2405,-0.07439,0.16611,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-93,[0 1 0 ... 0 0 0],"[284.322, 284.106196384, 3.264160000000002, 4, 0, 65.4, 3, 3, 22, 0.7410656625437521, 0.05555555555555555, 3]",284.322,284.106196384,3.264160000000002,4,0,65.4,3,3,22,0.7410656625437521,0.05555555555555555,3,8.09391258928613,8.055405565205463
380,Non-Steroid,BrC(C=C1)=CC=C1/N=C(N2C=NC=C2)\C3=CC=C(C#N)C=C3,8.090979145788843,Active,351.22,3,3,0,3,3.836,53.97,0.19710203,-3445.110899,1.498,-0.23426,-0.09809,0.13617,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-94,[0 0 0 ... 0 0 0],"[351.2070000000001, 350.01670845200005, 4.143880000000002, 4, 0, 53.97, 3, 2, 22, 0.5146047754289998, 0.0, 3]",351.2070000000001,350.01670845200005,4.143880000000002,4,0,53.97,3,2,22,0.5146047754289998,0.0,3,8.10070934503372,7.930318956941575
381,Non-Steroid,N#CC(C=C1)=C2C(C=CC=C2)=C1CN3C=NC=C3,8.060480747381382,Active,233.29,2,3,0,2,2.294,41.61,0.177885655,-742.4625545,4.8996,-0.23204,-0.07774,0.1543,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-95,[0 0 0 ... 0 0 0],"[233.27399999999997, 233.095297352, 2.9562800000000005, 3, 0, 41.61, 3, 2, 18, 0.6824704654183068, 0.06666666666666667, 3]",233.27399999999997,233.095297352,2.9562800000000005,3,0,41.61,3,2,18,0.6824704654183068,0.06666666666666667,3,8.102445588597616,7.898678032768031
382,Non-Steroid,CC1=C(C)OC2=C(C#N)C=CC(CN3C=NC=C3)=C21,8.072629636960976,Active,251.31,2,3,0,3,2.321,54.75,0.217858844,-818.8847634,6.1509,-0.2309,-0.05935,0.17155,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-96,[0 0 0 ... 1 0 0],"[251.28900000000002, 251.105862036, 3.166120000000001, 4, 0, 54.75, 3, 2, 19, 0.7025533426052624, 0.2, 3]",251.28900000000002,251.105862036,3.166120000000001,4,0,54.75,3,2,19,0.7025533426052624,0.2,3,8.112104902757508,7.724939685515423
383,Non-Steroid,N#CC1=CC=CC=C1CN2C=NC=C2,8.18575240426808,Active,183.23,2,2,0,2,1.386,41.61,0.188362435,-588.818899,7.0467,-0.22319,-0.06486,0.15833,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-97,[0 0 0 ... 0 0 0],"[183.214, 183.079647288, 1.80308, 3, 0, 41.61, 2, 2, 14, 0.7119802256009078, 0.09090909090909091, 2]",183.214,183.079647288,1.80308,3,0,41.61,2,2,14,0.7119802256009078,0.09090909090909091,2,8.173329582193995,6.709195048751802
385,Non-Steroid,BrC(C=C1)=CC=C1CN2C=NC=C2,8.1505805862031,Active,237.11,2,2,0,1,2.255,17.82,0.168551545,-3067.682367,3.1738,-0.22666,-0.02759,0.19907,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-98,[0 0 0 ... 0 0 0],"[237.1, 235.994910388, 2.6939, 2, 0, 17.82, 2, 2, 13, 0.7846419207807221, 0.1, 2]",237.1,235.994910388,2.6939,2,0,17.82,2,2,13,0.7846419207807221,0.1,2,8.174527982901129,6.690707084166544
386,Non-Steroid,O=C(C(C=C1)=CC=C1CN2C=NC=C2)C3=CC=CC=C3,8.096910013008056,Active,262.33,4,3,0,2,2.911,34.89,0.174094029,-840.9610793,5.9121,-0.22543,-0.06997,0.15546,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-99,[0 0 0 ... 0 0 0],"[262.312, 262.110613068, 3.1624000000000017, 3, 0, 34.89, 3, 4, 20, 0.6768584607856077, 0.058823529411764705, 3]",262.312,262.110613068,3.1624000000000017,3,0,34.89,3,4,20,0.6768584607856077,0.058823529411764705,3,8.122218697208986,7.547120824005187
387,Non-Steroid,O=[N+](C(C=C1)=CC=C1CN2C=NC=C2)[O-],8.083019952679617,Active,203.22,3,2,0,3,1.401,63.64,0.211058333,-701.0784952,4.0308,-0.23523,-0.09585,0.13938,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-100,[0 0 0 ... 0 0 0],"[203.201, 203.069476528, 1.8396, 4, 0, 60.959999999999994, 2, 3, 15, 0.5644437319980604, 0.1, 2]",203.201,203.069476528,1.8396,4,0,60.959999999999994,2,3,15,0.5644437319980604,0.1,2,8.151203655157715,7.059864160669521
388,Non-Steroid,N#CC(C=C1)=CC=C1CN2C=NC=C2,8.096910013008056,Active,183.23,2,2,0,2,1.386,41.61,0.189839652,-588.8203971,3.9609,-0.23373,-0.06177,0.17196,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-101,[0 0 0 ... 0 0 0],"[183.214, 183.079647288, 1.80308, 3, 0, 41.61, 2, 2, 14, 0.7119802256009078, 0.09090909090909091, 2]",183.214,183.079647288,1.80308,3,0,41.61,2,2,14,0.7119802256009078,0.09090909090909091,2,8.110129170625589,7.76016274607665
389,Non-Steroid,CC(C1=CC=C(C#N)C=C1)(C)N2C=NC=C2,8.114638779968487,Active,211.29,2,2,0,2,1.968,41.61,0.201296552,-667.4453331,5.6411,-0.22724,-0.05952,0.16772,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-102,[0 0 0 ... 0 0 0],"[211.26800000000003, 211.110947416, 2.5381800000000005, 3, 0, 41.61, 2, 2, 16, 0.7655644270094178, 0.23076923076923078, 2]",211.26800000000003,211.110947416,2.5381800000000005,3,0,41.61,2,2,16,0.7655644270094178,0.23076923076923078,2,8.147104758998054,7.126810989455438
390,Non-Steroid,N#CC(C=C1)=CC=C1C2(CCCC2)N3C=NC=C3,8.090443970758825,Active,237.33,2,3,0,2,2.644,41.61,0.189762848,-744.8593718,5.9907,-0.22693,-0.05791,0.16902,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-103,[0 0 0 ... 0 0 0],"[237.30599999999995, 237.12659748, 3.0723800000000008, 3, 0, 41.61, 2, 2, 18, 0.805066418148779, 0.3333333333333333, 3]",237.30599999999995,237.12659748,3.0723800000000008,3,0,41.61,2,2,18,0.805066418148779,0.3333333333333333,3,8.167140585875465,6.805490218685895
391,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3C=NC=N3,8.099086932262331,Active,285.33,3,3,0,4,2.749,78.29,0.200074212,-928.1439239,2.0553,-0.27418,-0.07429,0.19989,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-104,[0 1 0 ... 0 0 0],"[285.31, 285.10144535200004, 2.659160000000001, 5, 0, 78.29, 3, 3, 22, 0.7407442417149674, 0.058823529411764705, 3]",285.31,285.10144535200004,2.659160000000001,5,0,78.29,3,3,22,0.7407442417149674,0.058823529411764705,3,8.100519941747148,7.933778259590931
392,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3N=NC=C3,8.101274818410506,Active,285.33,3,3,0,4,2.966,78.29,0.177799606,-928.1191646,1.8479,-0.27153,-0.0776,0.19393,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-105,[0 1 0 ... 0 0 0],"[285.31, 285.101445352, 2.659160000000001, 5, 0, 78.29, 3, 3, 22, 0.7407442417149674, 0.058823529411764705, 3]",285.31,285.101445352,2.659160000000001,5,0,78.29,3,3,22,0.7407442417149674,0.058823529411764705,3,8.103558089187992,7.878470456868981
393,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3N=NC=N3,8.045757490560675,Active,286.32,3,3,0,5,2.839,91.18,0.188937406,-944.1537878,4.3211,-0.27308,-0.07654,0.19654,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-106,[0 1 0 ... 0 0 0],"[286.298, 286.09669432, 2.0541599999999995, 6, 0, 91.18, 3, 3, 22, 0.7344845416409409, 0.0625, 3]",286.298,286.09669432,2.0541599999999995,6,0,91.18,3,3,22,0.7344845416409409,0.0625,3,8.08776932978689,8.170162043203646
394,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CN=CN=C2)C3=CC=C(C#N)C=C3,8.145693958198919,Active,296.35,3,3,0,4,3.068,73.36,0.190733086,-950.2210109,3.4471,-0.26624,-0.07124,0.195,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-107,[0 1 0 ... 0 0 0],"[296.333, 296.106196384, 3.4001600000000014, 4, 0, 73.36, 3, 3, 23, 0.7421266287593155, 0.05263157894736842, 3]",296.333,296.106196384,3.4001600000000014,4,0,73.36,3,3,23,0.7421266287593155,0.05263157894736842,3,8.143600275060525,7.184552537586281
395,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CN=CC=C2)C3=CC=C(C#N)C=C3,8.101823516502323,Active,295.36,3,3,0,3,3.696,60.47,0.182077694,-934.1828206,5.7852,-0.25992,-0.06559,0.19433,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-108,[0 1 0 ... 0 0 0],"[295.34499999999997, 295.11094741600004, 4.005160000000003, 3, 0, 60.47, 3, 3, 23, 0.7332579260688172, 0.05, 3]",295.34499999999997,295.11094741600004,4.005160000000003,3,0,60.47,3,3,23,0.7332579260688172,0.05,3,8.142222738047499,7.207377372282562
396,Non-Steroid,N#CC(C=C1)=CC=C1/C(N2C=NC=N2)=C3CCCCC/3,8.115204636051018,Active,264.36,2,3,0,3,3.353,54.5,0.198551389,-838.3116475,5.9722,-0.2432,-0.06611,0.17709,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-109,[0 0 1 ... 0 0 0],"[264.33199999999994, 264.137496512, 3.373280000000002, 4, 0, 54.5, 2, 2, 20, 0.8351914181883958, 0.3125, 3]",264.33199999999994,264.137496512,3.373280000000002,4,0,54.5,2,2,20,0.8351914181883958,0.3125,3,8.186051112805375,6.515517073959267
398,Non-Steroid,N#CC(C=C1)=CC=C1C(N2C=NC=N2)(CC)C3=CC=C(C#N)C=C3,8.111259039317108,Active,313.39,4,3,0,4,3.478,78.29,0.202363077,-1006.765014,3.5741,-0.27269,-0.07591,0.19678,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-110,[0 0 0 ... 0 0 0],"[313.36400000000003, 313.13274548000004, 3.2233600000000022, 5, 0, 78.28999999999999, 3, 4, 24, 0.7405366065080138, 0.15789473684210525, 3]",313.36400000000003,313.13274548000004,3.2233600000000022,5,0,78.28999999999999,3,4,24,0.7405366065080138,0.15789473684210525,3,8.12882966233141,7.433106197747597
399,Non-Steroid,FC(C1=CC=C(C#N)C=C1)(N2C=NC=N2)C3=CC=C(C#N)C=C3,8.10292299679058,Active,303.32,3,3,0,5,3.056,78.29,0.210161,-1027.378804,2.1414,-0.27532,-0.08285,0.19247,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-111,[0 0 0 ... 0 0 0],"[303.30000000000007, 303.09202354, 2.740360000000001, 5, 0, 78.28999999999999, 3, 3, 23, 0.7449750345129788, 0.058823529411764705, 3]",303.30000000000007,303.09202354,2.740360000000001,5,0,78.28999999999999,3,3,23,0.7449750345129788,0.058823529411764705,3,8.119072286026917,7.6019973517121455
400,Non-Steroid,FC(C1=CC=C(C#N)C=C1)(N2N=NC=C2)C3=CC=C(C#N)C=C3,8.114638779968487,Active,303.32,3,3,0,5,3.272,78.29,0.188824212,-1027.350748,3.8763,-0.27382,-0.08367,0.19015,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-112,[0 0 0 ... 0 0 0],"[303.30000000000007, 303.09202354, 2.740360000000001, 5, 0, 78.28999999999999, 3, 3, 23, 0.7449750345129788, 0.058823529411764705, 3]",303.30000000000007,303.09202354,2.740360000000001,5,0,78.28999999999999,3,3,23,0.7449750345129788,0.058823529411764705,3,8.13587165658494,7.313551828297146
401,Non-Steroid,FC(C1=CC=C(C#N)C=C1)(N2N=NC=N2)C3=CC=C(C#N)C=C3,8.123782159408357,Active,304.31,3,3,0,6,3.145,91.18,0.19683025,-1043.382901,3.0501,-0.27773,-0.08019,0.19754,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-113,[0 0 0 ... 0 0 0],"[304.28800000000007, 304.087272508, 2.1353599999999995, 6, 0, 91.18, 3, 3, 23, 0.7389153322793632, 0.0625, 3]",304.28800000000007,304.087272508,2.1353599999999995,6,0,91.18,3,3,23,0.7389153322793632,0.0625,3,8.140956199924279,7.228427010712295
402,Non-Steroid,FC(C1=CC=C(C#N)C=C1)(N2C=NC=C2)C3=CC=C(C#N)C=C3,8.084072788302883,Active,302.33,3,3,0,4,3.183,65.4,0.200681824,-1011.343457,1.6544,-0.24563,-0.0819,0.16373,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-114,[0 0 0 ... 0 0 0],"[302.31200000000007, 302.096774572, 3.345360000000001, 4, 0, 65.4, 3, 3, 23, 0.7449331652797178, 0.05555555555555555, 3]",302.31200000000007,302.096774572,3.345360000000001,4,0,65.4,3,3,23,0.7449331652797178,0.05555555555555555,3,8.108884629297373,7.782432645743264
403,Non-Steroid,O=C1C2=C(C=CC=C2)CC/C1=C\C3=CC=NC=C3,8.298432014944073,Inactive,235.3,1,3,0,2,3.112,29.96,0.182274419,-747.5029346,3.548,-0.24771,-0.07977,0.16794,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-115,[0 0 0 ... 0 0 0],"[235.28599999999997, 235.099714036, 3.294100000000002, 2, 0, 29.96, 2, 1, 18, 0.7097881601750337, 0.125, 3]",235.28599999999997,235.099714036,3.294100000000002,2,0,29.96,2,1,18,0.7097881601750337,0.125,3,8.282240034386147,5.221075406100313
404,Non-Steroid,O=C1C2=C(C(OC)=CC=C2)CC/C1=C\C3=CC=NC=C3,8.2839966563652,Inactive,265.33,2,3,0,3,3.096,39.19,0.195728114,-862.0251136,5.0585,-0.22698,-0.07597,0.15101,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-116,[0 0 0 ... 0 0 0],"[265.31199999999995, 265.11027872, 3.3027000000000015, 3, 0, 39.19, 2, 2, 20, 0.7819886294803063, 0.17647058823529413, 3]",265.31199999999995,265.11027872,3.3027000000000015,3,0,39.19,2,2,20,0.7819886294803063,0.17647058823529413,3,8.28234857899954,5.219770649028926
405,Non-Steroid,O=C1C2=C(C=C(OC)C=C2)CC/C1=C\C3=CC=NC=C3,8.296708621881338,Inactive,265.33,2,3,0,3,3.096,39.19,0.204739486,-862.0281043,4.7074,-0.23055,-0.07304,0.15751,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-117,[0 0 0 ... 0 0 0],"[265.31199999999995, 265.11027872, 3.3027000000000015, 3, 0, 39.19, 2, 2, 20, 0.7819886294803063, 0.17647058823529413, 3]",265.31199999999995,265.11027872,3.3027000000000015,3,0,39.19,2,2,20,0.7819886294803063,0.17647058823529413,3,8.28234857899954,5.219770649028926
407,Non-Steroid,O=C1C2=C(C(O)=CC=C2)CC/C1=C\C3=CC=NC=C3,8.210419287835574,Active,251.3,1,3,1,3,2.845,50.19,0.208318344,-822.7187218,4.7333,-0.23075,-0.07761,0.15314,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-118,[0 0 0 ... 0 0 0],"[251.28499999999997, 251.094628656, 2.9997000000000007, 3, 1, 50.19, 2, 1, 19, 0.7925275768859943, 0.125, 3]",251.28499999999997,251.094628656,2.9997000000000007,3,1,50.19,2,1,19,0.7925275768859943,0.125,3,8.247675997056195,5.65358600105643
408,Non-Steroid,O=C1C2=C(C=C(O)C=C2)CC/C1=C\C3=CC=NC=C3,8.2958494831602,Inactive,251.3,1,3,1,3,2.845,50.19,0.216879813,-822.7217322,4.0482,-0.23475,-0.07441,0.16034,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-119,[0 0 0 ... 0 0 0],"[251.28499999999997, 251.094628656, 2.9997000000000007, 3, 1, 50.19, 2, 1, 19, 0.7925275768859943, 0.125, 3]",251.28499999999997,251.094628656,2.9997000000000007,3,1,50.19,2,1,19,0.7925275768859943,0.125,3,8.28405305731167,5.199324730360331
410,Non-Steroid,O=C1C2=C(C=CC=C2)CC/C1=C/C3=CC=NC=C3,8.30803489723264,Inactive,235.3,1,3,0,2,3.112,29.96,0.182982581,-747.4997003,5.2738,-0.24209,-0.08146,0.16063,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-120,[0 0 0 ... 0 0 0],"[235.28599999999997, 235.099714036, 3.294100000000002, 2, 0, 29.96, 2, 1, 18, 0.7097881601750337, 0.125, 3]",235.28599999999997,235.099714036,3.294100000000002,2,0,29.96,2,1,18,0.7097881601750337,0.125,3,8.282240034386147,5.221075406100313
411,Non-Steroid,O=C1C2=C(C(CCCC3)=C3C=C2)CC/C1=C\C4=CC=NC=C4,8.301029995663981,Inactive,289.4,1,4,0,2,4.626,29.96,0.186080927,-903.5590054,4.5863,-0.24081,-0.07481,0.166,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-121,[0 0 0 ... 0 0 0],"[289.378, 289.146664228, 4.172900000000003, 2, 0, 29.96, 2, 1, 22, 0.7373774593761563, 0.3, 4]",289.378,289.146664228,4.172900000000003,2,0,29.96,2,1,22,0.7373774593761563,0.3,4,8.267841876906905,5.397070897142359
412,Non-Steroid,O=C1C2=C(C=CC(OC)=C2)CC/C1=C\C3=CC=NC=C3,8.29929628285498,Inactive,265.33,2,3,0,3,3.096,39.19,0.202721086,-862.0262968,2.7926,-0.22474,-0.07888,0.14586,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-122,[0 0 0 ... 0 0 0],"[265.31199999999995, 265.11027872, 3.3027000000000015, 3, 0, 39.19, 2, 2, 20, 0.7819886294803063, 0.17647058823529413, 3]",265.31199999999995,265.11027872,3.3027000000000015,3,0,39.19,2,2,20,0.7819886294803063,0.17647058823529413,3,8.28234857899954,5.219770649028926
414,Non-Steroid,O=C1C2=C(C=CC(O)=C2)CC/C1=C\C3=CC=NC=C3,8.175223537524454,Active,251.3,1,3,1,3,2.845,50.19,0.215530438,-822.719563,2.3591,-0.22867,-0.08095,0.14772,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-123,[0 0 0 ... 0 0 0],"[251.28499999999997, 251.094628656, 2.9997000000000007, 3, 1, 50.19, 2, 1, 19, 0.7925275768859943, 0.125, 3]",251.28499999999997,251.094628656,2.9997000000000007,3,1,50.19,2,1,19,0.7925275768859943,0.125,3,8.28405305731167,5.199324730360331
416,Non-Steroid,O=C1C2=C(C=CC=C2)C/C1=C([H])\C3=CC=NC=C3,8.337242168318426,Inactive,221.27,1,3,0,2,2.656,29.96,0.184246536,-708.1912819,3.4669,-0.24888,-0.08897,0.15991,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-124,[0 0 0 ... 0 0 0],"[221.259, 221.084063972, 2.904000000000001, 2, 0, 29.96, 2, 1, 17, 0.692908266418156, 0.06666666666666667, 3]",221.259,221.084063972,2.904000000000001,2,0,29.96,2,1,17,0.692908266418156,0.06666666666666667,3,8.277358655497304,5.280090234465776
417,Non-Steroid,O=C1C2=C(C=CC=C2)C/C1=C(C3=CC=NC=C3)\[H],8.279014255846262,Inactive,221.27,1,3,0,2,2.656,29.96,0.184245857,-708.1912819,3.467,-0.24888,-0.08897,0.15991,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-125,[0 0 0 ... 0 0 0],"[221.259, 221.084063972, 2.904000000000001, 2, 0, 29.96, 2, 1, 17, 0.692908266418156, 0.06666666666666667, 3]",221.259,221.084063972,2.904000000000001,2,0,29.96,2,1,17,0.692908266418156,0.06666666666666667,3,8.277358655497304,5.280090234465776
418,Non-Steroid,O=C1C2=C(C(OC)=CC=C2)C/C1=C(C3=CC=NC=C3)/[H],8.33348201944512,Inactive,251.3,2,3,0,3,2.64,39.19,0.199127844,-822.7146649,5.003,-0.23213,-0.08504,0.14709,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-126,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
419,Non-Steroid,O=C1C2=C(C(OC)=CC=C2)C/C1=C(C3=CC=NC=C3)\[H],8.265200170411154,Inactive,251.3,2,3,0,3,2.64,39.19,0.199127844,-822.7146649,5.003,-0.23213,-0.08504,0.14709,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-127,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
420,Non-Steroid,O=C1C2=C(C=C(OC)C=C2)C/C1=C(C3=CC=NC=C3)/[H],8.274088367704952,Inactive,251.3,2,3,0,3,2.64,39.19,0.208581281,-822.7160604,4.9274,-0.23324,-0.0827,0.15054,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-128,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
421,Non-Steroid,O=C1C2=C(C=C(OC)C=C2)C/C1=C([H])/C3=CC=NC=C3,8.2839966563652,Inactive,251.3,2,3,0,3,2.64,39.19,0.208580844,-822.7160605,4.9274,-0.23324,-0.0827,0.15054,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-129,[0 0 0 ... 0 0 0],"[251.285, 251.094628656, 2.912600000000001, 3, 0, 39.19, 2, 2, 19, 0.7702793289169177, 0.125, 3]",251.285,251.094628656,2.912600000000001,3,0,39.19,2,2,19,0.7702793289169177,0.125,3,8.281251720054534,5.232970421218144
422,Non-Steroid,O=C1C2=C(C=C(O)C=C2)C/C1=C(C3=CC=NC=C3)/[H],8.331614083309999,Inactive,237.27,1,3,1,3,2.389,50.19,0.222192138,-783.409728,4.2716,-0.23755,-0.08395,0.1536,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-130,[0 0 0 ... 0 0 0],"[237.25799999999998, 237.078978592, 2.6096000000000004, 3, 1, 50.19, 2, 1, 18, 0.7754731200266453, 0.06666666666666667, 3]",237.25799999999998,237.078978592,2.6096000000000004,3,1,50.19,2,1,18,0.7754731200266453,0.06666666666666667,3,8.280874432019607,5.237518475702847
424,Non-Steroid,ClC1=CC=C(C(N2C=NC=C2)C3=CC=C(N=CN4)C4=C3)C=C1,8.133712660915805,Active,308.79,3,4,1,2,3.299,46.5,0.1968026,-1334.83824,6.4389,-0.21978,-0.02926,0.19052,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-131,[0 1 0 ... 0 0 0],"[308.772, 308.082874096, 4.050500000000001, 3, 1, 46.5, 4, 3, 22, 0.6203773890845408, 0.058823529411764705, 4]",308.772,308.082874096,4.050500000000001,3,1,46.5,4,3,22,0.6203773890845408,0.058823529411764705,4,8.109872491342932,7.764750558794123
425,Non-Steroid,ClC1=CC=C(C(N2C=NC=N2)([H])C3=CC=C(N=NN4C)C4=C3)C=C1,8.053056729302174,Active,324.8,3,4,0,4,3.467,61.42,0.191999194,-1406.192084,2.5151,-0.24149,-0.05234,0.18915,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-132,[0 1 0 ... 0 0 0],"[324.77500000000003, 324.089022096, 2.8509, 6, 0, 61.42, 4, 3, 23, 0.5811314334288238, 0.125, 4]",324.77500000000003,324.089022096,2.8509,6,0,61.42,4,3,23,0.5811314334288238,0.125,4,8.079630405678115,8.324719219668248
426,Non-Steroid,[H]C(C1=CC=C(Cl)C=C1)(N2C=NC=N2)C3=CC(N=NN4C)=C4C=C3,8.075720713938118,Active,324.8,3,4,0,4,3.467,61.42,0.190914111,-1406.191876,6.3051,-0.24381,-0.05295,0.19086,Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes,Bioorg Med Chem. 1998;6(4):377-133,[0 1 0 ... 0 0 0],"[324.7750000000001, 324.089022096, 2.8509, 6, 0, 61.42, 4, 3, 23, 0.5811314334288238, 0.125, 4]",324.7750000000001,324.089022096,2.8509,6,0,61.42,4,3,23,0.5811314334288238,0.125,4,8.122171477820553,7.547941441855001
427,Non-Steroid,CC(C)(C1=CC=C(CN(N2C=NC=C2)CC3=CC=CC4=C3C=CC=C4)C=C1)C,8.272606191131255,Inactive,369.55,6,4,0,2,5.61,21.06,0.170941545,-1133.14617,3.6266,-0.21249,-0.03948,0.17301,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-58,[0 0 0 ... 0 0 0],"[369.5120000000001, 369.22049786400004, 5.6722000000000055, 3, 0, 21.060000000000002, 4, 5, 28, 0.4516679339947775, 0.24, 4]",369.5120000000001,369.22049786400004,5.6722000000000055,3,0,21.060000000000002,4,5,28,0.4516679339947775,0.24,4,8.238651286786395,5.772297592968161
428,Non-Steroid,ClC1=CC=C(CN(N2C=NC=C2)CC3=CC=CC4=C3C=CC=C4)C(Cl)=C1,8.267771946364356,Inactive,382.31,5,4,0,2,5.538,21.06,0.15069186,-1895.079885,4.068,-0.21484,-0.04267,0.17217,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-59,[0 0 0 ... 0 0 0],"[382.2940000000001, 381.079952904, 5.681500000000004, 3, 0, 21.060000000000002, 4, 5, 26, 0.4427397637637241, 0.09523809523809523, 4]",382.2940000000001,381.079952904,5.681500000000004,3,0,21.060000000000002,4,5,26,0.4427397637637241,0.09523809523809523,4,8.193005228521153,6.412018570358841
429,Non-Steroid,CC(C)(C)C(C=C1)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.246758210868624,Inactive,395.59,7,4,0,2,6.22,21.06,0.169590356,-1210.564907,4.3466,-0.2177,-0.02981,0.18789,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-60,[0 0 0 ... 0 0 0],"[395.55, 395.23614792800004, 6.186000000000007, 3, 0, 21.060000000000002, 4, 6, 30, 0.38825573492455717, 0.2222222222222222, 4]",395.55,395.23614792800004,6.186000000000007,3,0,21.060000000000002,4,6,30,0.38825573492455717,0.2222222222222222,4,8.236278803239452,5.803917048910462
430,Non-Steroid,N1(N(CC2=CC=CC=C2)CC3=CC=C(C4=CC=CC=C4)C=C3)C=NC=C1,8.227618233182895,Inactive,339.47,6,4,0,2,4.819,21.06,0.155455553,-1053.310822,4.0702,-0.221,-0.02946,0.19154,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-61,[0 0 0 ... 0 0 0],"[339.442, 339.17354767200004, 4.888500000000004, 3, 0, 21.060000000000002, 4, 6, 26, 0.4986518979804265, 0.08695652173913043, 4]",339.442,339.17354767200004,4.888500000000004,3,0,21.060000000000002,4,6,26,0.4986518979804265,0.08695652173913043,4,8.206143773647916,6.220943060977517
431,Non-Steroid,CC1=CC=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.257376324118015,Inactive,353.5,6,4,0,2,5.306,21.06,0.162612,-1092.625852,4.1157,-0.22102,-0.02951,0.19151,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-62,[0 0 0 ... 0 0 0],"[353.46900000000005, 353.18919773600004, 5.196920000000005, 3, 0, 21.060000000000002, 4, 6, 27, 0.4751231016906953, 0.125, 4]",353.46900000000005,353.18919773600004,5.196920000000005,3,0,21.060000000000002,4,6,27,0.4751231016906953,0.125,4,8.228439884143253,5.909627620873748
432,Non-Steroid,ClC1=CC=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.185560694582964,Active,373.91,6,4,0,2,5.484,21.06,0.154325468,-1512.903211,4.4362,-0.22102,-0.03333,0.18769,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-63,[0 0 0 ... 0 0 0],"[373.887, 373.13457532000007, 5.5419000000000045, 3, 0, 21.060000000000002, 4, 6, 27, 0.44200101020617266, 0.08695652173913043, 4]",373.887,373.13457532000007,5.5419000000000045,3,0,21.060000000000002,4,6,27,0.44200101020617266,0.08695652173913043,4,8.200773935970384,6.29833946056633
433,Non-Steroid,FC1=CC=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.198099696659426,Active,357.46,6,4,0,3,5.025,21.06,0.163726787,-1152.542892,4.322,-0.21993,-0.03226,0.18767,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-64,[0 0 0 ... 0 0 0],"[357.432, 357.16412586, 5.027600000000005, 3, 0, 21.060000000000002, 4, 6, 27, 0.4826373546379063, 0.08695652173913043, 4]",357.432,357.16412586,5.027600000000005,3,0,21.060000000000002,4,6,27,0.4826373546379063,0.08695652173913043,4,8.21619498890149,6.078620230002955
434,Non-Steroid,CC(C=C1)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.247369502068667,Inactive,353.5,6,4,0,2,5.306,21.06,0.16639532,-1092.629091,4.4085,-0.22008,-0.02872,0.19136,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-65,[0 0 0 ... 0 0 0],"[353.46900000000005, 353.18919773600004, 5.196920000000005, 3, 0, 21.060000000000002, 4, 6, 27, 0.4751231016906953, 0.125, 4]",353.46900000000005,353.18919773600004,5.196920000000005,3,0,21.060000000000002,4,6,27,0.4751231016906953,0.125,4,8.20448558572725,6.244740762870716
435,Non-Steroid,ClC(C=C1)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.227083160764419,Inactive,373.91,6,4,0,2,5.484,21.06,0.153672128,-1512.905371,2.0003,-0.22225,-0.03414,0.18811,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-66,[0 0 0 ... 0 0 0],"[373.887, 373.13457532000007, 5.5419000000000045, 3, 0, 21.060000000000002, 4, 6, 27, 0.44200101020617266, 0.08695652173913043, 4]",373.887,373.13457532000007,5.5419000000000045,3,0,21.060000000000002,4,6,27,0.44200101020617266,0.08695652173913043,4,8.176819637554381,6.655495014418605
436,Non-Steroid,FC(C=C1)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.17255018319399,Active,357.46,6,4,0,3,5.025,21.06,0.168450468,-1152.543935,3.1039,-0.22283,-0.03104,0.19179,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-67,[0 0 0 ... 0 0 0],"[357.432, 357.16412586, 5.027600000000005, 3, 0, 21.060000000000002, 4, 6, 27, 0.4826373546379063, 0.08695652173913043, 4]",357.432,357.16412586,5.027600000000005,3,0,21.060000000000002,4,6,27,0.4826373546379063,0.08695652173913043,4,8.192240690485487,6.423316318312736
437,Non-Steroid,COC1=CC=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.235000680775098,Inactive,369.5,7,4,0,3,4.803,30.29,0.168239529,-1167.832441,5.6553,-0.21773,-0.02752,0.19021,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-68,[0 0 0 ... 0 0 0],"[369.468, 369.18411235600007, 4.8971000000000044, 4, 0, 30.29, 4, 7, 28, 0.4642390447083526, 0.125, 4]",369.468,369.18411235600007,4.8971000000000044,4,0,30.29,4,7,28,0.4642390447083526,0.125,4,8.226707486860866,5.9332481588570065
438,Non-Steroid,COC(C=C1)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.235427236007151,Inactive,369.5,7,4,0,3,4.803,30.29,0.17132402,-1167.831075,4.3387,-0.21288,-0.03031,0.18257,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-69,[0 0 0 ... 0 0 0],"[369.468, 369.18411235600007, 4.8971000000000044, 4, 0, 30.29, 4, 7, 28, 0.4642390447083526, 0.125, 4]",369.468,369.18411235600007,4.8971000000000044,4,0,30.29,4,7,28,0.4642390447083526,0.125,4,8.202753188444863,6.269700734267895
439,Non-Steroid,ClC(C=C1Cl)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.264584186348403,Inactive,408.35,6,4,0,2,6.148,21.06,0.151051872,-1972.497562,2.7762,-0.22177,-0.03713,0.18464,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-70,[0 0 0 ... 0 0 0],"[408.33200000000005, 407.09560296800004, 6.195300000000006, 3, 0, 21.060000000000002, 4, 6, 28, 0.37907651992302493, 0.08695652173913043, 4]",408.33200000000005,407.09560296800004,6.195300000000006,3,0,21.060000000000002,4,6,28,0.37907651992302493,0.08695652173913043,4,8.191542862861132,6.433645647452891
440,Non-Steroid,FC(C=C1F)=CC=C1CN(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.190041055623263,Active,375.45,6,4,0,4,5.23,21.06,0.17680366,-1251.774849,2.9655,-0.21942,-0.03169,0.18773,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-71,[0 0 0 ... 0 0 0],"[375.422, 375.15470404800004, 5.166700000000005, 3, 0, 21.060000000000002, 4, 6, 28, 0.46374438092734754, 0.08695652173913043, 4]",375.422,375.15470404800004,5.166700000000005,3,0,21.060000000000002,4,6,28,0.46374438092734754,0.08695652173913043,4,8.192240690485487,6.423316318312736
441,Non-Steroid,ClC(C=C1Cl)=CC=C1CN(CC2=CC=C(C(C)(C)C)C=C2)N3C=NC=C3,8.235214607606764,Inactive,388.37,6,3,0,2,6.03,21.06,0.170061469,-1898.695485,4.1864,-0.22182,-0.0386,0.18322,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-72,[0 0 0 ... 0 0 0],"[388.3420000000001, 387.12690309600004, 5.825800000000005, 3, 0, 21.060000000000002, 3, 5, 26, 0.5487200057017294, 0.2857142857142857, 3]",388.3420000000001,387.12690309600004,5.825800000000005,3,0,21.060000000000002,3,5,26,0.5487200057017294,0.2857142857142857,3,8.185351387167028,6.526023191920411
442,Non-Steroid,CC(C)(C)C(C=C1)=CC=C1CN(CC2=CC=CS2)N3C=NC=C3,8.205054059028928,Active,325.52,6,3,0,2,4.655,49.3,0.181541261,-1300.261801,3.4637,-0.21774,-0.0192,0.19854,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-73,[0 0 0 ... 0 0 0],"[325.481, 325.161268736, 4.580500000000004, 4, 0, 21.060000000000002, 3, 5, 23, 0.6844132682926164, 0.3157894736842105, 3]",325.481,325.161268736,4.580500000000004,4,0,21.060000000000002,3,5,23,0.6844132682926164,0.3157894736842105,3,8.226546021782005,5.935454474000731
443,Non-Steroid,CC(C)(C)C(C=C1)=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.221848749616356,Inactive,394.6,7,4,0,1,6.68,17.82,0.17044735,-1194.564937,4.6776,-0.2181,-0.0318,0.1863,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-74,[0 1 0 ... 0 0 0],"[394.562, 394.24089896000004, 6.874100000000007, 2, 0, 17.82, 4, 6, 30, 0.34863581030795965, 0.25, 4]",394.562,394.24089896000004,6.874100000000007,2,0,17.82,4,6,30,0.34863581030795965,0.25,4,8.262817808134933,5.4598686124267735
444,Non-Steroid,N1(C(CC2=CC=CC=C2)CC3=CC=C(C4=CC=CC=C4)C=C3)C=NC=C1,8.22023931623131,Active,338.48,6,4,0,1,5.28,17.82,0.157867271,-1037.308966,4.4225,-0.21942,-0.03027,0.18915,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-75,[0 1 0 ... 0 0 0],"[338.454, 338.178298704, 5.576600000000005, 2, 0, 17.82, 4, 6, 26, 0.44881566187367583, 0.125, 4]",338.454,338.178298704,5.576600000000005,2,0,17.82,4,6,26,0.44881566187367583,0.125,4,8.208223815279624,6.191219260548095
445,Non-Steroid,CC1=CC=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.22308341717869,Inactive,352.51,6,4,0,1,5.766,17.82,0.16492949,-1076.631282,4.5985,-0.21891,-0.03522,0.18369,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-76,[0 1 0 ... 0 0 0],"[352.48100000000005, 352.19394876800004, 5.885020000000006, 2, 0, 17.82, 4, 6, 27, 0.42324275864701993, 0.16, 4]",352.48100000000005,352.19394876800004,5.885020000000006,2,0,17.82,4,6,27,0.42324275864701993,0.16,4,8.23052117265479,5.881374406621098
446,Non-Steroid,ClC1=CC=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.224566254271954,Inactive,372.92,6,4,0,1,5.944,17.82,0.156511313,-1496.910162,5.3825,-0.21961,-0.02817,0.19144,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-77,[0 1 0 ... 0 0 0],"[372.899, 372.13932635200007, 6.230000000000006, 2, 0, 17.82, 4, 6, 27, 0.39195444472437535, 0.125, 4]",372.899,372.13932635200007,6.230000000000006,2,0,17.82,4,6,27,0.39195444472437535,0.125,4,8.216119141095668,6.079681929584019
447,Non-Steroid,FC1=CC=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.231859407654174,Inactive,356.47,6,4,0,2,5.485,17.82,0.164613438,-1136.545594,5.1985,-0.21867,-0.03109,0.18758,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-78,[0 1 0 ... 0 0 0],"[356.444, 356.16887689200007, 5.715700000000005, 2, 0, 17.82, 4, 6, 27, 0.4322003305001075, 0.125, 4]",356.444,356.16887689200007,5.715700000000005,2,0,17.82,4,6,27,0.4322003305001075,0.125,4,8.218275030533198,6.049576451136658
448,Non-Steroid,CC(C=C1)=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.230665066310195,Inactive,352.51,6,4,0,1,5.766,17.82,0.168346392,-1076.633543,4.4773,-0.21872,-0.02615,0.19257,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-79,[0 1 0 ... 0 0 0],"[352.48100000000005, 352.19394876800004, 5.885020000000006, 2, 0, 17.82, 4, 6, 27, 0.42324275864701993, 0.16, 4]",352.48100000000005,352.19394876800004,5.885020000000006,2,0,17.82,4,6,27,0.42324275864701993,0.16,4,8.206566874238787,6.214885413254024
449,Non-Steroid,FC(C=C1)=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.157477670724482,Active,356.47,6,4,0,2,5.485,17.82,0.170448104,-1136.5428,3.7034,-0.22146,-0.03436,0.1871,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-80,[0 1 0 ... 0 0 0],"[356.444, 356.16887689200007, 5.715700000000005, 2, 0, 17.82, 4, 6, 27, 0.4322003305001075, 0.125, 4]",356.444,356.16887689200007,5.715700000000005,2,0,17.82,4,6,27,0.4322003305001075,0.125,4,8.194320732117195,6.39262557408487
450,Non-Steroid,COC1=CC=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.201181619199465,Active,368.51,7,4,0,2,5.263,27.05,0.169289923,-1151.838797,4.8961,-0.21444,-0.03221,0.18223,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-81,[0 1 0 ... 0 0 0],"[368.48, 368.1888633880001, 5.585200000000006, 3, 0, 27.05, 4, 7, 28, 0.4253713306200474, 0.16, 4]",368.48,368.1888633880001,5.585200000000006,3,0,27.05,4,7,28,0.4253713306200474,0.16,4,8.228788775372402,5.904882017671693
451,Non-Steroid,COC(C=C1)=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.23847127084064,Inactive,368.51,7,4,0,2,5.263,27.05,0.173513423,-1151.838173,3.1928,-0.21234,-0.03321,0.17913,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-82,[0 1 0 ... 0 0 0],"[368.48, 368.1888633880001, 5.585200000000006, 3, 0, 27.05, 4, 7, 28, 0.4253713306200474, 0.16, 4]",368.48,368.1888633880001,5.585200000000006,3,0,27.05,4,7,28,0.4253713306200474,0.16,4,8.2048344769564,6.239726054049536
452,Non-Steroid,ClC(C=C1Cl)=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.228664033375448,Inactive,407.36,6,4,0,1,6.608,17.82,0.153322458,-1956.504237,3.7933,-0.22172,-0.03696,0.18476,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-83,[0 1 0 ... 0 0 0],"[407.34400000000005, 406.10035400000004, 6.883400000000006, 2, 0, 17.82, 4, 6, 28, 0.3405575076732145, 0.125, 4]",407.34400000000005,406.10035400000004,6.883400000000006,2,0,17.82,4,6,28,0.3405575076732145,0.125,4,8.214958425230119,6.095952506623021
453,Non-Steroid,FC(C=C1F)=CC=C1CC(CC2=CC=C(C3=CC=CC=C3)C=C2)N4C=NC=C4,8.181442462950777,Active,374.46,6,4,0,3,5.691,17.82,0.177350354,-1235.778203,3.9658,-0.2206,-0.03013,0.19047,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-84,[0 1 0 ... 0 0 0],"[374.434, 374.15945508000004, 5.854800000000005, 2, 0, 17.82, 4, 6, 28, 0.4135866627532292, 0.125, 4]",374.434,374.15945508000004,5.854800000000005,2,0,17.82,4,6,28,0.4135866627532292,0.125,4,8.196402020628732,6.362063205088279
464,Non-Steroid,N1(N(C/C=C/C2=CC=CC=C2)CC3=CC=CC4=C3C=CC=C4)C=NC=N1,8.31116011150815,Inactive,340.46,6,4,0,3,4.55,33.95,0.162477065,-1069.329132,3.3367,-0.20968,-0.04485,0.16483,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-85,[0 0 0 ... 0 0 0],"[340.43, 340.16879664000004, 4.282900000000003, 4, 0, 33.95, 4, 6, 26, 0.5251714378418396, 0.09090909090909091, 4]",340.43,340.16879664000004,4.282900000000003,4,0,33.95,4,6,26,0.5251714378418396,0.09090909090909091,4,8.271837247380448,5.347647258706496
470,Non-Steroid,ClC1=CC(Cl)=CC=C1CN(C/C=C/C2=CC=CC=C2)N3C=NC=N3,8.321823852625744,Inactive,359.28,6,3,0,3,4.971,33.95,0.15891295,-1834.882037,3.3026,-0.22919,-0.04641,0.18278,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-86,[0 0 0 ... 0 0 0],"[359.26000000000005, 358.07520187200004, 4.436500000000004, 4, 0, 33.95, 3, 6, 24, 0.6527124109750895, 0.1111111111111111, 3]",359.26000000000005,358.07520187200004,4.436500000000004,4,0,33.95,3,6,24,0.6527124109750895,0.1111111111111111,3,8.217028459048441,6.066965718352432
471,Non-Steroid,CC(C)(C)C(C=C1)=CC=C1CN(C/C=C/C2=CC=CC=C2)N3C=NC=N3,8.276064366776716,Inactive,346.52,7,3,0,3,5.042,33.95,0.178661865,-1072.948691,3.4221,-0.22682,-0.04396,0.18286,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-87,[0 0 0 ... 0 0 0],"[346.478, 346.21574683200004, 4.427200000000004, 4, 0, 33.95, 3, 6, 26, 0.6621138264633212, 0.2727272727272727, 3]",346.478,346.21574683200004,4.427200000000004,4,0,33.95,3,6,26,0.6621138264633212,0.2727272727272727,3,8.26221991573861,5.467390379688844
473,Non-Steroid,CC(C)(C)C(C=C1)=CC=C1CN(CC2=CC=CS2)N3C=NC=N3,8.298017923200911,Inactive,326.51,6,3,0,3,4.528,62.19,0.190935911,-1316.303,2.9305,-0.23091,-0.01917,0.21174,CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors,Bioorg Med Chem. 2008;16(18):8349-88,[0 0 0 ... 0 0 0],"[326.469, 326.156517704, 3.975500000000003, 5, 0, 33.95, 3, 5, 23, 0.711114608475639, 0.3333333333333333, 3]",326.469,326.156517704,3.975500000000003,5,0,33.95,3,5,23,0.711114608475639,0.3333333333333333,3,8.260335618980317,5.491163575251257
474,Non-Steroid,O=C(CCC1(C2=CC=C(N)C=C2)C3CCCCC3)NC1=O,8.185560694582964,Active,286.41,2,3,3,4,2.534,72.19,0.248446674,-921.0474531,3.7561,-0.20095,-0.02658,0.17437,Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type,J Steroid Biochem Mol Biol. 1992;43(7):641-8,[0 0 1 ... 0 0 0],"[286.37499999999994, 286.168127944, 2.5235000000000003, 3, 2, 72.19, 1, 2, 21, 0.6479270113054579, 0.5294117647058824, 3]",286.37499999999994,286.168127944,2.5235000000000003,3,2,72.19,1,2,21,0.6479270113054579,0.5294117647058824,3,8.249816240613336,5.625793143109684
475,Non-Steroid,O=C(NC1=O)CC[C@@]1(C2CCCCC2)C3=CC=C(C=C3)N,8.165966789804358,Active,286.41,2,3,3,4,2.534,72.19,0.248412674,-921.0475454,3.7481,-0.20095,-0.02653,0.17442,Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type,J Steroid Biochem Mol Biol. 1992;43(7):641-9,[0 0 1 ... 0 0 0],"[286.37499999999994, 286.168127944, 2.5234999999999994, 3, 2, 72.19, 1, 2, 21, 0.6479270113054579, 0.5294117647058824, 3]",286.37499999999994,286.168127944,2.5234999999999994,3,2,72.19,1,2,21,0.6479270113054579,0.5294117647058824,3,8.249816240613336,5.625793143109684
476,Non-Steroid,O=C(NC1=O)CC[C@]1(C2CCCCC2)C3=CC=C(C=C3)N,8.272683091399138,Inactive,286.41,2,3,3,4,2.534,72.19,0.248417302,-921.0475408,3.7306,-0.20092,-0.0265,0.17442,Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type,J Steroid Biochem Mol Biol. 1992;43(7):641-10,[0 0 1 ... 0 0 0],"[286.37499999999994, 286.168127944, 2.5234999999999994, 3, 2, 72.19, 1, 2, 21, 0.6479270113054579, 0.5294117647058824, 3]",286.37499999999994,286.168127944,2.5234999999999994,3,2,72.19,1,2,21,0.6479270113054579,0.5294117647058824,3,8.249816240613336,5.625793143109684
477,Non-Steroid,O=C(CCC1(C2=CC=C(N)C=C2)CC)NC1=O,8.353420015791782,Inactive,232.31,2,2,3,4,1.285,72.19,0.279753545,-765.0037556,4.0846,-0.20207,-0.02786,0.17421,Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type,J Steroid Biochem Mol Biol. 1992;43(7):641-11,[0 0 0 ... 0 0 0],"[232.28299999999996, 232.121177752, 1.3532, 3, 2, 72.19, 1, 2, 17, 0.5969362176118971, 0.38461538461538464, 2]",232.28299999999996,232.121177752,1.3532,3,2,72.19,1,2,17,0.5969362176118971,0.38461538461538464,2,8.30792185803158,4.921280755977949
478,Non-Steroid,O=C(NC1=O)CC[C@]1(CC)C2=CC=C(C=C2)N,8.325943333410386,Inactive,232.31,2,2,3,4,1.285,72.19,0.279679727,-765.0034969,3.5405,-0.20171,-0.02522,0.17649,Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type,J Steroid Biochem Mol Biol. 1992;43(7):641-12,[0 0 0 ... 0 0 0],"[232.28300000000002, 232.121177752, 1.3531999999999995, 3, 2, 72.19, 1, 2, 17, 0.5969362176118972, 0.38461538461538464, 2]",232.28300000000002,232.121177752,1.3531999999999995,3,2,72.19,1,2,17,0.5969362176118972,0.38461538461538464,2,8.30792185803158,4.921280755977949
479,Non-Steroid,O=C(NC1=O)CC[C@@]1(CC)C2=CC=C(C=C2)N,8.464478248269382,Inactive,232.31,2,2,3,4,1.285,72.19,0.277617848,-765.006292,4.5103,-0.20721,-0.02476,0.18245,Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type,J Steroid Biochem Mol Biol. 1992;43(7):641-13,[0 0 0 ... 0 0 0],"[232.28300000000002, 232.121177752, 1.3531999999999995, 3, 2, 72.19, 1, 2, 17, 0.5969362176118972, 0.38461538461538464, 2]",232.28300000000002,232.121177752,1.3531999999999995,3,2,72.19,1,2,17,0.5969362176118972,0.38461538461538464,2,8.30792185803158,4.921280755977949
480,Non-Steroid,NC(C1=CC(OC)=CC=C12)=C(CC3=CC=NC=C3)C2=O,8.263131054648865,Inactive,266.32,3,3,2,4,1.443,65.21,0.233794618,-878.0695778,6.635,-0.20425,-0.06671,0.13754,Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site,Eur J Med Chem. 1998;33(6):451-62,[0 1 0 ... 0 0 0],"[266.3, 266.105527688, 2.199, 4, 1, 65.21000000000001, 2, 3, 20, 0.9245350255965253, 0.125, 3]",266.3,266.105527688,2.199,4,1,65.21000000000001,2,3,20,0.9245350255965253,0.125,3,8.257496736191893,5.527175617095768
481,Non-Steroid,NC(C1=CC(OC)=C(OC)C=C12)=C(CC3=CC=NC=C3)C2=O,8.28156906720413,Inactive,296.35,4,3,2,5,1.427,74.44,0.240194,-992.5828456,4.7969,-0.2042,-0.07007,0.13413,Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site,Eur J Med Chem. 1998;33(6):451-63,[0 0 0 ... 0 0 0],"[296.326, 296.11609237199997, 2.2076000000000002, 5, 1, 74.44, 2, 4, 22, 0.9359418088742812, 0.17647058823529413, 3]",296.326,296.11609237199997,2.2076000000000002,5,1,74.44,2,4,22,0.9359418088742812,0.17647058823529413,3,8.259920582373722,5.496413753013103
482,Non-Steroid,NC(C1=CC(OC)=C(OC)C(OC)=C12)=C(CC3=CC=NC=C3)C2=O,8.277037465902554,Inactive,326.38,5,3,2,6,1.41,83.67,0.241006071,-1107.098089,3.1726,-0.20394,-0.06965,0.13429,Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site,Eur J Med Chem. 1998;33(6):451-64,[0 0 0 ... 0 0 0],"[326.35200000000003, 326.126657056, 2.2161999999999997, 6, 1, 83.67000000000002, 2, 5, 24, 0.906814641849314, 0.2222222222222222, 3]",326.35200000000003,326.126657056,2.2161999999999997,6,1,83.67000000000002,2,5,24,0.906814641849314,0.2222222222222222,3,8.271700806938943,5.3493275701279215
483,Non-Steroid,[H]/C1=C(\[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C3([H])[H]                                  ,8.244859506678468,Inactive,207.29,1,3,0,1,3.227,12.89,0.163101862,-634.1668751,2.4271,-0.2072,-0.04643,0.16077,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-15,[0 0 0 ... 0 0 0],"[207.27599999999995, 207.104799416, 3.5684000000000022, 1, 0, 12.89, 2, 1, 16, 0.6962767839928745, 0.13333333333333333, 3]",207.27599999999995,207.104799416,3.5684000000000022,1,0,12.89,2,1,16,0.6962767839928745,0.13333333333333333,3,8.260116621814161,5.493933245512987
484,Non-Steroid,[H]/C1=C(\[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=C([H])N=C2[H])C([H])([H])C3([H])[H]                                  ,8.263621694884005,Inactive,207.29,1,3,0,1,3.227,12.89,0.163103,-634.1668817,2.4269,-0.20721,-0.04644,0.16077,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-16,[0 0 0 ... 0 0 0],"[207.27599999999995, 207.104799416, 3.5684000000000022, 1, 0, 12.89, 2, 1, 16, 0.6962767839928745, 0.13333333333333333, 3]",207.27599999999995,207.104799416,3.5684000000000022,1,0,12.89,2,1,16,0.6962767839928745,0.13333333333333333,3,8.260116621814161,5.493933245512987
485,Non-Steroid,[H]/C1=C(\[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C([H])([H])C3([H])[H]                       ,8.285521523549354,Inactive,221.32,1,3,0,1,3.683,12.89,0.163008344,-673.4855335,2.8495,-0.20925,-0.04863,0.16062,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-17,[0 0 0 ... 0 0 0],"[221.30299999999994, 221.12044948, 3.9585000000000026, 1, 0, 12.89, 2, 1, 17, 0.7099667210489353, 0.1875, 3]",221.30299999999994,221.12044948,3.9585000000000026,1,0,12.89,2,1,17,0.7099667210489353,0.1875,3,8.255853507253955,5.548128264298001
486,Non-Steroid,[H]/C1=C(\[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=C([H])N=C2[H])C([H])([H])C([H])([H])C3([H])[H]                       ,8.265891689584892,Inactive,221.32,1,3,0,1,3.683,12.89,0.162540813,-673.4833246,2.0751,-0.21234,-0.0413,0.17104,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-18,[0 0 0 ... 0 0 0],"[221.30299999999994, 221.12044948, 3.9585000000000026, 1, 0, 12.89, 2, 1, 17, 0.7099667210489353, 0.1875, 3]",221.30299999999994,221.12044948,3.9585000000000026,1,0,12.89,2,1,17,0.7099667210489353,0.1875,3,8.255853507253955,5.548128264298001
487,Non-Steroid,[F]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H]                                  ,8.252187002126474,Inactive,225.28,1,3,0,2,3.432,12.89,0.186579759,-733.4062176,2.5924,-0.20546,-0.05449,0.15097,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-19,[0 0 0 ... 0 0 0],"[225.26600000000002, 225.095377604, 3.7075000000000022, 1, 0, 12.89, 2, 1, 17, 0.7206096880402029, 0.13333333333333333, 3]",225.26600000000002,225.095377604,3.7075000000000022,1,0,12.89,2,1,17,0.7206096880402029,0.13333333333333333,3,8.24997480298485,5.623739522084864
488,Non-Steroid,[F]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])N=C3[H]                                  ,8.251517322501531,Inactive,225.28,1,3,0,2,3.432,12.89,0.187139483,-733.4058657,1.2424,-0.2055,-0.05314,0.15236,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-20,[0 0 0 ... 0 0 0],"[225.26600000000002, 225.095377604, 3.707500000000003, 1, 0, 12.89, 2, 1, 17, 0.7206096880402029, 0.13333333333333333, 3]",225.26600000000002,225.095377604,3.707500000000003,1,0,12.89,2,1,17,0.7206096880402029,0.13333333333333333,3,8.24997480298485,5.623739522084864
489,Non-Steroid,[Cl]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H]                                 ,8.269977968713452,Inactive,241.73,1,3,0,1,3.891,12.89,0.161915931,-1093.768923,2.6008,-0.20935,-0.06027,0.14908,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-21,[0 0 0 ... 0 0 0],"[241.721, 241.065827064, 4.2218000000000035, 1, 0, 12.89, 2, 1, 17, 0.7284947750365725, 0.13333333333333333, 3]",241.721,241.065827064,4.2218000000000035,1,0,12.89,2,1,17,0.7284947750365725,0.13333333333333333,3,8.243440826181633,5.708988574132676
490,Non-Steroid,[Cl]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])N=C3[H]                                 ,8.26820622393864,Inactive,241.73,1,3,0,1,3.891,12.89,0.162521517,-1093.768572,1.2905,-0.20937,-0.05903,0.15034,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-22,[0 0 0 ... 0 0 0],"[241.721, 241.065827064, 4.2218000000000035, 1, 0, 12.89, 2, 1, 17, 0.7284947750365725, 0.13333333333333333, 3]",241.721,241.065827064,4.2218000000000035,1,0,12.89,2,1,17,0.7284947750365725,0.13333333333333333,3,8.243440826181633,5.708988574132676
491,Non-Steroid,[Br]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H]                                 ,8.291898926501004,Inactive,286.18,1,3,0,1,3.975,12.89,0.167576345,-3205.27775,2.5875,-0.2089,-0.06056,0.14834,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-23,[0 0 0 ... 0 0 0],"[286.17199999999997, 285.015311484, 4.330900000000003, 1, 0, 12.89, 2, 1, 17, 0.7599724024080565, 0.13333333333333333, 3]",286.17199999999997,285.015311484,4.330900000000003,1,0,12.89,2,1,17,0.7599724024080565,0.13333333333333333,3,8.255852613843993,5.548139677655439
492,Non-Steroid,[Br]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])N=C3[H],8.289668290912562,Inactive,286.18,1,3,0,1,3.975,12.89,0.168191759,-3205.277388,1.2519,-0.20892,-0.05934,0.14958,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-24,[0 0 0 ... 0 0 0],"[286.17199999999997, 285.015311484, 4.330900000000003, 1, 0, 12.89, 2, 1, 17, 0.7599724024080565, 0.13333333333333333, 3]",286.17199999999997,285.015311484,4.330900000000003,1,0,12.89,2,1,17,0.7599724024080565,0.13333333333333333,3,8.255852613843993,5.548139677655439
493,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C3([H])[H]           ,8.27038796098682,Inactive,237.32,2,3,0,2,3.21,22.12,0.188603697,-748.6902481,1.8878,-0.19513,-0.04117,0.15396,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-25,[0 0 0 ... 0 0 0],"[237.30199999999996, 237.1153641, 3.5770000000000017, 2, 0, 22.12, 2, 2, 18, 0.7961277050796469, 0.1875, 3]",237.30199999999996,237.1153641,3.5770000000000017,2,0,22.12,2,2,18,0.7961277050796469,0.1875,3,8.258492769145168,5.51451383782555
494,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=C([H])N=C2[H])C([H])([H])C3([H])[H]           ,8.27949796216551,Inactive,237.32,2,3,0,2,3.21,22.12,0.188584788,-748.6902535,1.8888,-0.19514,-0.04114,0.154,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-26,[0 0 0 ... 0 0 0],"[237.30199999999996, 237.1153641, 3.5770000000000017, 2, 0, 22.12, 2, 2, 18, 0.7961277050796469, 0.1875, 3]",237.30199999999996,237.1153641,3.5770000000000017,2,0,22.12,2,2,18,0.7961277050796469,0.1875,3,8.258492769145168,5.51451383782555
495,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C([H])([H])C3([H])[H],8.225707790033887,Inactive,251.35,2,3,0,2,3.666,22.12,0.185658944,-788.0088961,4.2729,-0.19644,-0.04286,0.15358,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-27,[0 0 0 ... 0 0 0],"[251.32899999999995, 251.131014164, 3.967100000000002, 2, 0, 22.12, 2, 2, 19, 0.8054271099024288, 0.23529411764705882, 3]",251.32899999999995,251.131014164,3.967100000000002,2,0,22.12,2,2,19,0.8054271099024288,0.23529411764705882,3,8.257593106222831,5.525949271807577
496,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=C([H])N=C2[H])C([H])([H])C([H])([H])C3([H])[H],8.267771946364356,Inactive,251.35,2,3,0,2,3.666,22.12,0.185175556,-788.0066138,2.8265,-0.199,-0.03548,0.16352,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-28,[0 0 0 ... 0 0 0],"[251.32899999999995, 251.131014164, 3.967100000000002, 2, 0, 22.12, 2, 2, 19, 0.8054271099024288, 0.23529411764705882, 3]",251.32899999999995,251.131014164,3.967100000000002,2,0,22.12,2,2,19,0.8054271099024288,0.23529411764705882,3,8.257593106222831,5.525949271807577
497,Non-Steroid,[H]C=1C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C2C=1C([H])([H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H],8.22121413571156,Active,281.38,3,3,0,3,3.65,31.35,0.19859155,-902.5237024,5.2492,-0.1954,-0.04314,0.15226,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-29,[0 0 0 ... 0 0 0],"[281.35499999999996, 281.14157884800005, 3.9757000000000033, 3, 0, 31.35, 2, 3, 21, 0.8525489030450842, 0.2777777777777778, 3]",281.35499999999996,281.14157884800005,3.9757000000000033,3,0,31.35,2,3,21,0.8525489030450842,0.2777777777777778,3,8.238425783495144,5.775295582025112
498,Non-Steroid,[H]/C1=C(\OC([H])([H])C([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C3([H])[H] ,8.288195575582598,Inactive,251.35,3,3,0,2,3.559,22.12,0.189811333,-788.0073575,1.7261,-0.19366,-0.04033,0.15333,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-30,[0 0 0 ... 0 0 0],"[251.32899999999998, 251.131014164, 3.967100000000002, 2, 0, 22.12, 2, 3, 19, 0.8231799399577301, 0.23529411764705882, 3]",251.32899999999998,251.131014164,3.967100000000002,2,0,22.12,2,3,19,0.8231799399577301,0.23529411764705882,3,8.258475813187003,5.51472914263638
499,Non-Steroid,[H]/C1=C(\OC([H])([H])C([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=C([H])N=C2[H])C([H])([H])C3([H])[H] ,8.291185032800751,Inactive,251.35,3,3,0,2,3.559,22.12,0.18980075,-788.0073609,1.7244,-0.19366,-0.04034,0.15332,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-31,[0 0 0 ... 0 0 0],"[251.32899999999998, 251.131014164, 3.967100000000002, 2, 0, 22.12, 2, 3, 19, 0.8231799399577301, 0.23529411764705882, 3]",251.32899999999998,251.131014164,3.967100000000002,2,0,22.12,2,3,19,0.8231799399577301,0.23529411764705882,3,8.258475813187003,5.51472914263638
500,Non-Steroid,[H]/C1=C(/C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H])C([H])([H])[H]             ,8.267155495538672,Inactive,221.32,1,3,0,1,3.713,12.89,0.181565031,-673.4907162,3.1141,-0.20162,-0.05137,0.15025,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-32,[0 0 0 ... 0 0 0],"[221.303, 221.12044948, 3.876820000000003, 1, 0, 12.89, 2, 1, 17, 0.7118473231031847, 0.1875, 3]",221.303,221.12044948,3.876820000000003,1,0,12.89,2,1,17,0.7118473231031847,0.1875,3,8.252093812591752,5.596367004882709
501,Non-Steroid,[H]/C1=C(/C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])N=C3[H])C([H])([H])[H]             ,8.272683091399138,Inactive,221.32,1,3,0,1,3.713,12.89,0.181968781,-673.4902576,2.5205,-0.20174,-0.04996,0.15178,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-33,[0 0 0 ... 0 0 0],"[221.303, 221.12044948, 3.876820000000003, 1, 0, 12.89, 2, 1, 17, 0.7118473231031847, 0.1875, 3]",221.303,221.12044948,3.876820000000003,1,0,12.89,2,1,17,0.7118473231031847,0.1875,3,8.252093812591752,5.596367004882709
502,Non-Steroid,[H]/C1=C(\[H])C(=C3/C(=C1/[H])C(=C([H])C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C3([H])[H])C([H])([H])[H]             ,8.273594108385796,Inactive,221.32,1,3,0,1,3.713,12.89,0.172743375,-673.4849413,2.5959,-0.20537,-0.04421,0.16116,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-34,[0 0 0 ... 0 0 0],"[221.30299999999994, 221.12044948, 3.876820000000002, 1, 0, 12.89, 2, 1, 17, 0.7118473231031845, 0.1875, 3]",221.30299999999994,221.12044948,3.876820000000002,1,0,12.89,2,1,17,0.7118473231031845,0.1875,3,8.233363786836584,5.843004397485449
503,Non-Steroid,[H]/C1=C(\[H])C(=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=C([H])N=C2[H])C([H])([H])C3([H])[H])C([H])([H])[H]             ,8.309928318928087,Inactive,221.32,1,3,0,1,3.713,12.89,0.172717281,-673.4849495,2.5946,-0.20538,-0.0442,0.16118,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-35,[0 0 0 ... 0 0 0],"[221.30299999999994, 221.12044948, 3.876820000000003, 1, 0, 12.89, 2, 1, 17, 0.7118473231031845, 0.1875, 3]",221.30299999999994,221.12044948,3.876820000000003,1,0,12.89,2,1,17,0.7118473231031845,0.1875,3,8.233363786836584,5.843004397485449
504,Non-Steroid,[F]C=1C([H])=C([H])C([H])=C2C=1C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H]                ,8.240912501634545,Inactive,225.28,1,3,0,2,3.432,12.89,0.176128241,-733.4064262,1.6561,-0.2097,-0.05784,0.15186,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-36,[0 0 0 ... 0 0 0],"[225.26600000000002, 225.095377604, 3.7075000000000022, 1, 0, 12.89, 2, 1, 17, 0.7206096880402029, 0.13333333333333333, 3]",225.26600000000002,225.095377604,3.7075000000000022,1,0,12.89,2,1,17,0.7206096880402029,0.13333333333333333,3,8.227888055343787,5.917141359963395
505,Non-Steroid,[F]C=1C([H])=C([H])C([H])=C2C=1C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])N=C3[H]                ,8.171035592294306,Active,225.28,1,3,0,2,3.432,12.89,0.176575724,-733.4060069,2.3204,-0.20989,-0.05636,0.15353,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-37,[0 0 0 ... 0 0 0],"[225.26600000000002, 225.095377604, 3.707500000000003, 1, 0, 12.89, 2, 1, 17, 0.7206096880402029, 0.13333333333333333, 3]",225.26600000000002,225.095377604,3.707500000000003,1,0,12.89,2,1,17,0.7206096880402029,0.13333333333333333,3,8.227888055343787,5.917141359963395
506,Non-Steroid,[Cl]C=1C([H])=C([H])C([H])=C2C=1C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])C([H])=C3[H]               ,8.16202940890224,Active,241.73,1,3,0,1,3.891,12.89,0.162302828,-1093.769568,1.1484,-0.21185,-0.06089,0.15096,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-38,[0 0 0 ... 0 0 0],"[241.721, 241.065827064, 4.2218000000000035, 1, 0, 12.89, 2, 1, 17, 0.7284947750365725, 0.13333333333333333, 3]",241.721,241.065827064,4.2218000000000035,1,0,12.89,2,1,17,0.7284947750365725,0.13333333333333333,3,8.20206738757656,6.279609133031648
507,Non-Steroid,[Cl]C=1C([H])=C([H])C([H])=C2C=1C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])N=C3[H]               ,8.177944945826134,Active,241.73,1,3,0,1,3.891,12.89,0.162748034,-1093.769122,2.6318,-0.21207,-0.05945,0.15262,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-39,[0 0 0 ... 0 0 0],"[241.721, 241.065827064, 4.2218000000000035, 1, 0, 12.89, 2, 1, 17, 0.7284947750365725, 0.13333333333333333, 3]",241.721,241.065827064,4.2218000000000035,1,0,12.89,2,1,17,0.7284947750365725,0.13333333333333333,3,8.20206738757656,6.279609133031648
508,Non-Steroid,[H]/C1=C(\[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=NC([H])=C2[H])C([H])([H])C3([H])[H]             ,8.286179854468521,Inactive,207.29,1,3,0,1,3.227,12.89,0.168234172,-634.167722,3.4634,-0.2141,-0.05428,0.15982,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-40,[0 0 0 ... 0 0 0],"[207.27599999999995, 207.104799416, 3.5684000000000022, 1, 0, 12.89, 2, 1, 16, 0.6962767839928745, 0.13333333333333333, 3]",207.27599999999995,207.104799416,3.5684000000000022,1,0,12.89,2,1,16,0.6962767839928745,0.13333333333333333,3,8.255202337434996,5.556453222665088
510,Non-Steroid,[H]/C1=C(\[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=NC([H])=C2[H])C([H])([H])C([H])([H])C3([H])[H]  ,8.20851380214497,Active,221.32,1,3,0,1,3.683,12.89,0.167383938,-673.4860808,3.1964,-0.21578,-0.05416,0.16162,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-41,[0 0 0 ... 0 0 0],"[221.30299999999994, 221.12044948, 3.9585000000000026, 1, 0, 12.89, 2, 1, 17, 0.7099667210489353, 0.1875, 3]",221.30299999999994,221.12044948,3.9585000000000026,1,0,12.89,2,1,17,0.7099667210489353,0.1875,3,8.25093922287479,5.611264971065258
512,Non-Steroid,[F]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=NC([H])=C3[H]             ,8.214890214875727,Active,225.28,1,3,0,2,3.432,12.89,0.191542345,-733.4067696,2.235,-0.21243,-0.06052,0.15191,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-42,[0 0 0 ... 0 0 0],"[225.26600000000002, 225.095377604, 3.707500000000003, 1, 0, 12.89, 2, 1, 17, 0.7206096880402029, 0.13333333333333333, 3]",225.26600000000002,225.095377604,3.707500000000003,1,0,12.89,2,1,17,0.7206096880402029,0.13333333333333333,3,8.245060518605685,5.687736671434516
514,Non-Steroid,[Cl]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=NC([H])=C3[H]                                ,8.244037766668162,Inactive,241.73,1,3,0,1,3.891,12.89,0.166735552,-1093.76933,1.4833,-0.21628,-0.06606,0.15022,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-43,[0 0 0 ... 0 0 0],"[241.721, 241.065827064, 4.2218000000000035, 1, 0, 12.89, 2, 1, 17, 0.7284947750365725, 0.13333333333333333, 3]",241.721,241.065827064,4.2218000000000035,1,0,12.89,2,1,17,0.7284947750365725,0.13333333333333333,3,8.238526541802468,5.773955842438655
515,Non-Steroid,[Br]/C1=C(\[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=NC([H])=C3[H]                                ,8.262130109193974,Inactive,286.18,1,3,0,1,3.975,12.89,0.172421621,-3205.278138,1.5806,-0.21567,-0.06633,0.14934,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-44,[0 0 0 ... 0 0 0],"[286.17199999999997, 285.015311484, 4.330900000000003, 1, 0, 12.89, 2, 1, 17, 0.7599724024080565, 0.13333333333333333, 3]",286.17199999999997,285.015311484,4.330900000000003,1,0,12.89,2,1,17,0.7599724024080565,0.13333333333333333,3,8.250938329464828,5.61127651430466
517,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=NC([H])=C2[H])C([H])([H])C3([H])[H]                     ,8.265243597231647,Inactive,237.32,2,3,0,2,3.21,22.12,0.192954636,-748.6912188,3.1246,-0.2011,-0.04913,0.15197,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-45,[0 0 0 ... 0 0 0],"[237.30199999999996, 237.1153641, 3.5770000000000017, 2, 0, 22.12, 2, 2, 18, 0.7961277050796469, 0.1875, 3]",237.30199999999996,237.1153641,3.5770000000000017,2,0,22.12,2,2,18,0.7961277050796469,0.1875,3,8.253578484766003,5.577268018435112
518,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C2=C([H])C([H])=NC([H])=C2[H])C([H])([H])C([H])([H])C3([H])[H]          ,8.214890214875727,Active,251.35,2,3,0,2,3.666,22.12,0.189596444,-788.0096125,4.7636,-0.20152,-0.04857,0.15295,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-46,[0 0 0 ... 0 0 0],"[251.32899999999995, 251.131014164, 3.967100000000002, 2, 0, 22.12, 2, 2, 19, 0.8054271099024288, 0.23529411764705882, 3]",251.32899999999995,251.131014164,3.967100000000002,2,0,22.12,2,2,19,0.8054271099024288,0.23529411764705882,3,8.252678821843666,5.588833585609395
520,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=NC([H])=C3[H]                     ,8.183570305539794,Active,237.32,2,3,0,2,3.21,22.12,0.193556515,-748.6951997,4.8963,-0.20701,-0.05728,0.14973,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-47,[0 0 0 ... 0 0 0],"[237.302, 237.1153641, 3.5770000000000026, 2, 0, 22.12, 2, 2, 18, 0.7961277050796469, 0.1875, 3]",237.302,237.1153641,3.5770000000000026,2,0,22.12,2,2,18,0.7961277050796469,0.1875,3,8.233923396938497,5.8354802435435715
522,Non-Steroid,[H]C=1C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C2C=1C([H])([H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=NC([H])=C3[H] ,8.152072308945439,Active,281.38,3,3,0,3,3.65,31.35,0.2022231,-902.5245175,5.499,-0.20009,-0.04897,0.15112,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-48,[0 0 0 ... 0 0 0],"[281.35499999999996, 281.14157884800005, 3.9757000000000033, 3, 0, 31.35, 2, 3, 21, 0.8525489030450842, 0.2777777777777778, 3]",281.35499999999996,281.14157884800005,3.9757000000000033,3,0,31.35,2,3,21,0.8525489030450842,0.2777777777777778,3,8.223460469613162,5.977774531593128
523,Non-Steroid,[H]/C1=C(/C([H])=C2/C(=C1/[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])C([H])=NC([H])=C3[H])C([H])([H])[H]                       ,8.22967903327053,Inactive,221.32,1,3,0,1,3.713,12.89,0.186017469,-673.4912795,3.8452,-0.2086,-0.05733,0.15127,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-49,[0 0 0 ... 0 0 0],"[221.303, 221.12044948, 3.876820000000003, 1, 0, 12.89, 2, 1, 17, 0.7118473231031847, 0.1875, 3]",221.303,221.12044948,3.876820000000003,1,0,12.89,2,1,17,0.7118473231031847,0.1875,3,8.23712849870977,5.792572808802518
525,Non-Steroid,[H]/C1=C(\OC([H])([H])[H])C([H])=C3/C(=C1/[H])C(=C([H])C=2[S]C([H])=NC=2[H])C([H])([H])C3([H])[H]                               ,8.270550734954973,Inactive,243.35,2,3,0,2,3.108,50.36,0.1988029,-1069.454478,1.8955,-0.19469,-0.04815,0.14654,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-50,[0 0 0 ... 0 0 0],"[243.33099999999996, 243.071785036, 3.6385000000000023, 3, 0, 22.12, 2, 2, 17, 0.8030599527518955, 0.21428571428571427, 3]",243.33099999999996,243.071785036,3.6385000000000023,3,0,22.12,2,2,17,0.8030599527518955,0.21428571428571427,3,8.247626602878734,5.654229044251448
527,Non-Steroid,[F]C=1C([H])=C([H])C2=C(C=1[H])C([H])([H])C([H])([H])C2=C([H])C3=C([H])N=C([H])N=C3[H]                         ,8.290065218578107,Inactive,226.27,1,3,0,3,2.804,25.78,0.196952571,-749.4456016,2.3649,-0.21394,-0.06312,0.15082,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-51,[0 0 0 ... 0 0 0],"[226.25400000000002, 226.090626572, 3.102500000000002, 2, 0, 25.78, 2, 1, 17, 0.746287526827293, 0.14285714285714285, 3]",226.25400000000002,226.090626572,3.102500000000002,2,0,25.78,2,1,17,0.746287526827293,0.14285714285714285,3,8.254304215617438,5.56795586818279
528,Non-Steroid,[F]C=1C([H])=C([H])C2=C(C=1[H])C([H])([H])C([H])([H])C2=C([H])C3=C4/C(=C(/[H])C([H])=C3[H])C([H])=NC([H])=C4[H],8.211642991938474,Active,275.34,1,4,0,2,4.341,12.89,0.178423143,-887.0444574,2.1986,-0.20831,-0.05816,0.15015,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-52,[0 0 0 ... 0 0 0],"[275.326, 275.11102766799996, 4.860700000000004, 1, 0, 12.89, 3, 1, 21, 0.6176843651807405, 0.10526315789473684, 4]",275.326,275.11102766799996,4.860700000000004,1,0,12.89,3,1,21,0.6176843651807405,0.10526315789473684,4,8.229546612177574,5.894587079482418
530,Non-Steroid,[H]/C1=C(\[H])C([H])=C2/C(=C1/[H])C(C3=C2C([H])=C([H])C([H])=C3[H])=C([H])C4=C([H])C([H])=C([H])N=C4[H]                         ,8.274263514797923,Inactive,255.33,1,4,0,1,3.833,12.89,0.142048939,-786.6038646,2.0259,-0.2145,-0.07019,0.14431,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-53,[0 0 0 ... 0 0 0],"[255.32000000000002, 255.104799416, 4.650900000000004, 1, 0, 12.89, 3, 1, 20, 0.48215264463785856, 0.0, 4]",255.32000000000002,255.104799416,4.650900000000004,1,0,12.89,3,1,20,0.48215264463785856,0.0,4,8.24898224942499,5.636606934130492
531,Non-Steroid,[H]/C1=C(\[H])C([H])=C2/C(=C1/[H])C(C3=C2C([H])=C([H])C([H])=C3[H])=C([H])C4=C([H])C([H])=NC([H])=C4[H]                         ,8.254749539261205,Inactive,255.33,1,4,0,1,3.833,12.89,0.146177061,-786.6040483,2.3036,-0.21849,-0.07622,0.14227,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-54,[0 0 0 ... 0 0 0],"[255.32000000000002, 255.104799416, 4.650900000000004, 1, 0, 12.89, 3, 1, 20, 0.48215264463785856, 0.0, 4]",255.32000000000002,255.104799416,4.650900000000004,1,0,12.89,3,1,20,0.48215264463785856,0.0,4,8.244067965045826,5.7007505123265005
533,Non-Steroid,C[C@H](C1=CC=CC=C1/2)CC2=C/C3=CN=CC=C3,8.255484686147076,Inactive,221.32,1,3,0,1,3.478,12.89,0.164307375,-673.481317,2.4016,-0.20732,-0.04662,0.1607,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-55,[0 0 0 ... 0 0 0],"[221.303, 221.12044948, 4.129400000000003, 1, 0, 12.89, 2, 1, 17, 0.7052226093465374, 0.1875, 3]",221.303,221.12044948,4.129400000000003,1,0,12.89,2,1,17,0.7052226093465374,0.1875,3,8.272289951714038,5.3420758276504605
534,Non-Steroid,C12=CC=CC=C1/C(C[C@@H]2C3=CC=CC=C3)=C/C4=CC=CN=C4,8.268292487542467,Inactive,283.39,2,4,0,1,4.511,12.89,0.157502026,-865.2159336,2.2798,-0.20922,-0.04837,0.16085,Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies,Eur J Med Chem. 2010;45(9):4307-56,[0 0 0 ... 0 0 0],"[283.374, 283.136099544, 5.157800000000004, 1, 0, 12.89, 3, 2, 22, 0.6329093810607135, 0.09523809523809523, 4]",283.374,283.136099544,5.157800000000004,1,0,12.89,3,2,22,0.6329093810607135,0.09523809523809523,4,8.280090622231059,5.246979625166241
535,Non-Steroid,ClC(C(Cl)=C1)=CC=C1SC(CN2C=NC=C2)C3=CC=C(OC)C=C3,8.119068707521988,Active,379.33,6,3,0,2,5.038,52.35,0.172394375,-2198.832762,3.1366,-0.2194,-0.04536,0.17404,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-50,[0 1 0 ... 0 0 0],"[379.3120000000001, 378.03603949199993, 5.732100000000004, 4, 0, 27.05, 3, 6, 24, 0.5118435228309136, 0.16666666666666666, 3]",379.3120000000001,378.03603949199993,5.732100000000004,4,0,27.05,3,6,24,0.5118435228309136,0.16666666666666666,3,8.152241489504428,7.043013332148679
536,Non-Steroid,OC(C=C(OCO1)C1=C2)=C2C(C3=CC(OCO4)=C4C=C3)N5C=NC=C5,8.118969277450589,Active,338.34,3,5,1,6,2.388,74.97,0.249446308,-1179.895385,4.5199,-0.20256,-0.01777,0.18479,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-51,[0 1 0 ... 0 0 0],"[338.31899999999996, 338.0902715480001, 2.6837999999999997, 7, 1, 74.97, 3, 3, 25, 0.791321694625098, 0.16666666666666666, 5]",338.31899999999996,338.0902715480001,2.6837999999999997,7,1,74.97,3,3,25,0.791321694625098,0.16666666666666666,5,8.141572995982207,7.218168301572939
537,Non-Steroid,OC(C=C(OCO1)C1=C2)=C2C(C3=CC=C(F)C=C3)N4C=NC=C4,8.082193994905241,Active,312.32,3,4,1,5,2.825,56.51,0.235302694,-1090.600217,4.1808,-0.20607,-0.03133,0.17474,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-52,[0 1 0 ... 0 0 0],"[312.3, 312.09102049600006, 3.0942000000000007, 5, 1, 56.51, 3, 3, 23, 0.8072334041982482, 0.11764705882352941, 4]",312.3,312.09102049600006,3.0942000000000007,5,1,56.51,3,3,23,0.8072334041982482,0.11764705882352941,4,8.127164901239167,7.461653862635686
538,Non-Steroid,OC(C=C(OCO1)C1=C2)=C2C(C3=CC=C(OC)C=C3)N4C=NC=C4,8.139085075961884,Active,324.36,4,4,1,5,2.603,65.74,0.2338165,-1105.889711,6.0472,-0.19952,-0.01173,0.18779,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-53,[0 1 0 ... 0 0 0],"[324.336, 324.11100699200006, 2.9637000000000002, 6, 1, 65.74000000000001, 3, 4, 24, 0.7990922483181496, 0.16666666666666666, 4]",324.336,324.11100699200006,2.9637000000000002,6,1,65.74000000000001,3,4,24,0.7990922483181496,0.16666666666666666,4,8.134387982137657,7.338579744810136
539,Non-Steroid,O=CC1=C(CN2C=NC=C2)C3=CC([N+]([O-])=O)=CC=C3N1CC4=CC=CC=C4,8.172594458925655,Active,360.4,6,4,0,4,3.535,85.64,0.178837395,-1216.059536,3.7586,-0.22535,-0.10128,0.12407,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-54,[0 0 0 ... 0 0 0],"[360.3730000000001, 360.122240372, 3.655100000000002, 6, 0, 82.96000000000001, 4, 6, 27, 0.2984201566219259, 0.1, 4]",360.3730000000001,360.122240372,3.655100000000002,6,0,82.96000000000001,4,6,27,0.2984201566219259,0.1,4,8.198813487974446,6.326835051775861
540,Non-Steroid,CC1=C(CCN2C=CN=C2)C(N3C=CN=C3)=C4C(C=CC(Cl)=C4)=N1,8.153803421140783,Active,337.84,4,4,0,3,2.631,48.53,0.197124025,-1429.502244,4.0312,-0.22586,-0.0795,0.14636,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-55,[0 0 0 ... 0 0 0],"[337.814, 337.109423192, 3.8215200000000022, 5, 0, 48.53, 4, 4, 24, 0.568474494633843, 0.16666666666666666, 4]",337.814,337.109423192,3.8215200000000022,5,0,48.53,4,4,24,0.568474494633843,0.16666666666666666,4,8.153970989391572,7.015021567742148
541,Non-Steroid,COC1=CC=C(C2=CN=NN2CC3=CC=CO3)C=C1,8.258955742214656,Inactive,255.3,4,3,0,4,2.785,53.08,0.201820938,-855.9440001,5.5173,-0.21822,-0.01886,0.19936,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-56,[0 0 0 ... 0 0 0],"[255.277, 255.100776656, 2.5950000000000006, 5, 0, 53.080000000000005, 3, 4, 19, 0.7186858079034918, 0.14285714285714285, 3]",255.277,255.100776656,2.5950000000000006,5,0,53.080000000000005,3,4,19,0.7186858079034918,0.14285714285714285,3,8.245520501623943,5.6817156940285924
542,Non-Steroid,C1(C2=CN=CC=C2)=NC(C3=CC=CN=C3)=CC(C4=CC=CC=C4)=C1,8.363443592927856,Inactive,309.39,3,4,0,3,3.79,38.67,0.162169128,-973.5345314,6.2551,-0.23268,-0.05843,0.17425,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-57,[0 0 0 ... 0 0 0],"[309.372, 309.12659748000004, 4.872600000000003, 3, 0, 38.67, 4, 3, 24, 0.5415581590504079, 0.0, 4]",309.372,309.12659748000004,4.872600000000003,3,0,38.67,4,3,24,0.5415581590504079,0.0,4,8.295137915917328,5.068297322771773
543,Non-Steroid,COC1=CC=C(N=C(C=C(Cl)C=C2)C2=C3NC4=CC=CN=C4)C3=C1,8.1475696353948,Active,335.81,3,4,1,4,4.401,47.04,0.210797342,-1432.125998,5.1531,-0.20232,-0.07981,0.12251,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-58,[0 0 0 ... 0 0 0],"[335.79400000000004, 335.08253974800004, 5.188600000000003, 4, 1, 47.04, 4, 3, 24, 0.5233594316448495, 0.05263157894736842, 4]",335.79400000000004,335.08253974800004,5.188600000000003,4,1,47.04,4,3,24,0.5233594316448495,0.05263157894736842,4,8.192142450927435,6.424769468556108
544,Non-Steroid,OC1=CC=C(CC2=C(C=CC(OC)=C3O)C3=CN=C2)C=C1,8.1226803718329,Active,281.33,3,3,2,4,3.011,62.58,0.225184667,-937.2387353,1.1087,-0.20673,-0.0476,0.15913,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-59,[0 0 0 ... 0 0 0],"[281.311, 281.10519334, 3.245400000000002, 4, 2, 62.58, 3, 3, 21, 0.7732879916853204, 0.11764705882352941, 3]",281.311,281.10519334,3.245400000000002,4,2,62.58,3,3,21,0.7732879916853204,0.11764705882352941,3,8.243925316870616,5.702623285889956
545,Non-Steroid,COC1=C(O)C2=CN=CC(CC3=CC=CC([N+]([O-])=O)=C3)=C2C=C1,8.232556780695596,Inactive,310.33,4,3,1,5,3.173,88.17,0.19815373,-1066.399663,4.2682,-0.21249,-0.05659,0.1559,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-60,[0 0 0 ... 0 0 0],"[310.309, 310.095356928, 3.448000000000002, 5, 1, 85.49000000000001, 3, 4, 23, 0.588993519200952, 0.11764705882352941, 3]",310.309,310.095356928,3.448000000000002,5,1,85.49000000000001,3,4,23,0.588993519200952,0.11764705882352941,3,8.232027369802278,5.861012264896228
546,Non-Steroid,O=[N+](C1=CC=C2C(N=C(C3=NC=CC=C3)N2CCC4=CC=NC=C4)=C1)[O-],8.245821385400793,Inactive,345.39,5,4,0,5,3.403,89.42,0.23173,-1157.189129,6.74,-0.2399,-0.08245,0.15745,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-61,[0 0 0 ... 0 0 0],"[345.362, 345.12257472, 3.6442000000000014, 6, 0, 86.74, 4, 5, 26, 0.4069457804347225, 0.10526315789473684, 4]",345.362,345.12257472,3.6442000000000014,6,0,86.74,4,5,26,0.4069457804347225,0.10526315789473684,4,8.239869683180116,5.756126329568405
547,Non-Steroid,OC1=CC=C(C2=NC(C3=CC=CN=C3)=C(C4=CC=C(Cl)C=C4)N2)C=C1,8.135401023489027,Active,347.82,3,4,2,3,4.645,61.8,0.207260615,-1470.247442,7.5456,-0.19567,-0.04826,0.14741,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-62,[0 0 0 ... 0 0 0],"[347.80500000000006, 347.08253974800004, 5.1647000000000025, 3, 2, 61.800000000000004, 4, 3, 25, 0.5374384652714329, 0.0, 4]",347.80500000000006,347.08253974800004,5.1647000000000025,3,2,61.800000000000004,4,3,25,0.5374384652714329,0.0,4,8.186888121940532,6.502971910151279
548,Non-Steroid,ClC(C(Cl)=NN=C1)=C1N/N=C(C2=CC=C(OC)C=C2)\C3=CC=CC=C3,8.279690831049871,Inactive,373.26,5,3,1,5,4.832,59.4,0.188676,-1908.888589,7.8433,-0.2086,-0.0612,0.1474,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-63,[0 0 0 ... 0 0 0],"[373.2430000000001, 372.054466428, 4.656500000000002, 5, 1, 59.400000000000006, 3, 5, 25, 0.5222304836120178, 0.05555555555555555, 3]",373.2430000000001,372.054466428,4.656500000000002,5,1,59.400000000000006,3,5,25,0.5222304836120178,0.05555555555555555,3,8.25273689296197,5.588086332000517
549,Non-Steroid,O=[N+](C1=CC=CC(CC2=C(C=CC=C3)C3=CN=N2)=C1)[O-],8.354105161526284,Inactive,265.29,3,3,0,4,2.997,71.6,0.199229871,-892.8045083,7.921,-0.23803,-0.08728,0.15075,Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors,J Med Chem. 2009;52(1):143-64,[0 0 0 ... 0 0 0],"[265.27200000000005, 265.085126592, 3.128800000000002, 4, 0, 68.92, 3, 3, 20, 0.5385831326141193, 0.06666666666666667, 3]",265.27200000000005,265.085126592,3.128800000000002,4,0,68.92,3,3,20,0.5385831326141193,0.06666666666666667,3,8.295219446517999,5.0673459348138525
550,Steroid,CC12C(C3CC(C4=CC(CCC4(C3CC2)C)=O)CCCCC)CCC1=O,8.177944945826134,Active,356.6,4,4,0,2,5.37,34.14,0.20415079,-1086.676606,4.7971,-0.22973,-0.04618,0.18355,"Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain",Steroids. 1995;60(8):506-11,[0 0 0 ... 0 0 0],"[356.5500000000002, 356.271530392, 5.893800000000006, 2, 0, 34.14, 0, 4, 26, 0.5882037156391221, 0.8333333333333334, 4]",356.5500000000002,356.271530392,5.893800000000006,2,0,34.14,0,4,26,0.5882037156391221,0.8333333333333334,4,8.23985797142081,5.756281558975912
551,Steroid,CC12C(C3CC(C4=CC(CCC4(C3CC2)C)=O)CCCCCC)CCC1=O,8.196097104799357,Active,370.63,5,4,0,2,5.827,34.14,0.203339738,-1125.985817,4.8449,-0.22956,-0.04615,0.18341,"Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain",Steroids. 1995;60(8):506-11,[0 0 0 ... 0 0 0],"[370.5770000000002, 370.287180456, 6.283900000000006, 2, 0, 34.14, 0, 5, 27, 0.5333657270748895, 0.84, 4]",370.5770000000002,370.287180456,6.283900000000006,2,0,34.14,0,5,27,0.5333657270748895,0.84,4,8.23985797142081,5.756281558975912
552,Steroid,CC12C(C3CC(C4=CC(CCC4(C3CC2)C)=O)CCCCCCCC)CCC1=O,8.240730567537,Inactive,398.69,7,4,0,2,6.739,34.14,0.200029155,-1204.616559,4.995,-0.22916,-0.04557,0.18359,"Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain",Steroids. 1995;60(8):506-11,[0 0 0 ... 0 0 0],"[398.6310000000003, 398.318480584, 7.064100000000008, 2, 0, 34.14, 0, 7, 29, 0.42995022459515475, 0.8518518518518519, 4]",398.6310000000003,398.318480584,7.064100000000008,2,0,34.14,0,7,29,0.42995022459515475,0.8518518518518519,4,8.266408634123918,5.414911535664309
556,Non-Steroid,N#CC(C=CC(CN1C=NC=N1)=C2)=C2C3=CC=C(OS(=O)(N)=O)C=C3,8.060532166698685,Active,355.41,5,3,2,7,1.637,132.27,0.276044605,-1515.047491,6.7317,-0.24868,-0.0675,0.18118,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-70,[0 0 0 ... 0 0 0],"[355.3790000000001, 355.073910276, 1.4473799999999999, 7, 1, 123.89000000000001, 3, 5, 25, 0.7384309521512445, 0.0625, 3]",355.3790000000001,355.073910276,1.4473799999999999,7,1,123.89000000000001,3,5,25,0.7384309521512445,0.0625,3,8.07987921172781,8.319951378031764
557,Non-Steroid,N#CC(C=CC(CN1C=NC=N1)=C2)=C2C3=CC=C(OS(=O)(N(C)C)=O)C=C3,8.031468955014875,Active,383.47,6,3,0,7,2.451,109.49,0.254977977,-1593.665041,4.0684,-0.2445,-0.06472,0.17978,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-71,[0 0 0 ... 0 0 0],"[383.4330000000001, 383.105210404, 2.05028, 7, 0, 101.11000000000001, 3, 6, 27, 0.6456255005362632, 0.16666666666666666, 3]",383.4330000000001,383.105210404,2.05028,7,0,101.11000000000001,3,6,27,0.6456255005362632,0.16666666666666666,3,8.0492907628725,8.927076102859207
558,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=C(C#N)C=CC(CN3C=NC=N3)=C2)=C1,8.031468955014875,Active,389.85,5,3,2,7,2.302,132.27,0.272568105,-1974.636671,7.2755,-0.25193,-0.07219,0.17974,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-72,[0 0 0 ... 0 0 0],"[389.82400000000007, 389.0349379240001, 2.10078, 7, 1, 123.89000000000001, 3, 5, 26, 0.7120344481596745, 0.0625, 3]",389.82400000000007,389.0349379240001,2.10078,7,1,123.89000000000001,3,5,26,0.7120344481596745,0.0625,3,8.057855747151335,8.752744532622248
559,Non-Steroid,ClC1=C(OS(=O)(N(C)C)=O)C=CC(C2=C(C#N)C=CC(CN3C=NC=N3)=C2)=C1,8.064503377140376,Active,417.91,6,3,0,7,3.115,109.49,0.25414125,-2053.255509,6.9458,-0.2499,-0.07125,0.17865,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-73,[0 0 0 ... 0 0 0],"[417.8780000000001, 417.0662380520001, 2.703680000000001, 7, 0, 101.11000000000001, 3, 6, 28, 0.6107211781200325, 0.16666666666666666, 3]",417.8780000000001,417.0662380520001,2.703680000000001,7,0,101.11000000000001,3,6,28,0.6107211781200325,0.16666666666666666,3,8.061587267117183,8.677861868475663
560,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=C(C2=C(C#N)C=CC(CN3C=NC=N3)=C2)C=C1,8.024295661593959,Active,389.85,5,3,2,7,2.302,132.27,0.271862316,-1974.639239,6.0399,-0.24925,-0.07047,0.17878,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-74,[0 0 0 ... 0 0 0],"[389.82400000000007, 389.0349379240001, 2.1007800000000003, 7, 1, 123.89000000000001, 3, 5, 26, 0.7120344481596745, 0.0625, 3]",389.82400000000007,389.0349379240001,2.1007800000000003,7,1,123.89000000000001,3,5,26,0.7120344481596745,0.0625,3,8.057855747151335,8.752744532622248
562,Non-Steroid,O=S(OC1=CC=C(C2=CC=C(C#N)C(CN3C=NC=N3)=C2)C=C1)(N)=O,8.170407608497287,Active,355.41,5,3,2,7,1.637,132.27,0.278517658,-1515.051856,2.5009,-0.24989,-0.07666,0.17323,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-75,[0 0 0 ... 0 0 0],"[355.379, 355.07391027600005, 1.4473799999999994, 7, 1, 123.88999999999999, 3, 5, 25, 0.7384309521512445, 0.0625, 3]",355.379,355.07391027600005,1.4473799999999994,7,1,123.88999999999999,3,5,25,0.7384309521512445,0.0625,3,8.150967763586946,7.063699841013313
563,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=CC=C(C#N)C(CN3C=NC=N3)=C2)=C1,8.165220363647153,Active,389.85,5,3,2,7,2.302,132.27,0.275097763,-1974.641036,3.0152,-0.25389,-0.08135,0.17254,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-76,[0 0 0 ... 0 0 0],"[389.82400000000007, 389.0349379240001, 2.1007800000000003, 7, 1, 123.89000000000001, 3, 5, 26, 0.7120344481596745, 0.0625, 3]",389.82400000000007,389.0349379240001,2.1007800000000003,7,1,123.89000000000001,3,5,26,0.7120344481596745,0.0625,3,8.136675188548042,7.300032799753541
564,Non-Steroid,O=S(OC1=CC=C(C2=CC(C#N)=CC(CN3C=NC=N3)=C2)C=C1)(N)=O,8.183570305539794,Active,355.41,5,3,2,7,1.637,132.27,0.278237711,-1515.05014,4.9547,-0.25432,-0.07098,0.18334,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-77,[0 0 0 ... 0 0 0],"[355.379, 355.07391027600005, 1.4473799999999994, 7, 1, 123.88999999999999, 3, 5, 25, 0.7384309521512445, 0.0625, 3]",355.379,355.07391027600005,1.4473799999999994,7,1,123.88999999999999,3,5,25,0.7384309521512445,0.0625,3,8.149061333057498,7.094775652140744
565,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=CC(C#N)=CC(CN3C=NC=N3)=C2)=C1,8.148930701478921,Active,389.85,5,3,2,7,2.302,132.27,0.275558737,-1974.63966,5.7361,-0.2539,-0.07115,0.18275,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-78,[0 0 0 ... 0 0 0],"[389.82400000000007, 389.0349379240001, 2.1007800000000003, 7, 1, 123.89000000000001, 3, 5, 26, 0.7120344481596745, 0.0625, 3]",389.82400000000007,389.0349379240001,2.1007800000000003,7,1,123.89000000000001,3,5,26,0.7120344481596745,0.0625,3,8.128115280960253,7.445343153424526
566,Non-Steroid,O=S(OC1=CC=C(C2=CC=CC(CN3C=NC=N3)=C2)C=C1)(N)=O,8.183051984927017,Active,330.4,5,3,2,6,1.758,108.48,0.267162297,-1422.809103,3.8193,-0.23476,-0.04195,0.19281,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-79,[0 0 0 ... 0 0 0],"[330.369, 330.078661308, 1.5756999999999992, 6, 1, 100.1, 3, 5, 23, 0.7652362956200643, 0.06666666666666667, 3]",330.369,330.078661308,1.5756999999999992,6,1,100.1,3,5,23,0.7652362956200643,0.06666666666666667,3,8.19737935001992,6.347762216684104
567,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=CC=CC(CN3C=NC=N3)=C2)=C1,8.145396312780894,Active,364.84,5,3,2,6,2.423,108.48,0.263709054,-1882.398848,4.0669,-0.23976,-0.04937,0.19039,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-80,[0 0 0 ... 0 0 0],"[364.8140000000001, 364.03968895600013, 2.2291, 6, 1, 100.1, 3, 5, 24, 0.7477785898976175, 0.06666666666666667, 3]",364.8140000000001,364.03968895600013,2.2291,6,1,100.1,3,5,24,0.7477785898976175,0.06666666666666667,3,8.152572447217556,7.037648189940634
568,Non-Steroid,O=S(OC1=CC=C(C2=C(C#N)C=C(CN3C=NC=N3)C=C2)C=C1)(N)=O,8.183978776638211,Active,355.41,5,3,2,7,1.637,132.27,0.275397342,-1515.048118,5.2745,-0.24956,-0.06953,0.18003,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-81,[0 0 0 ... 0 0 0],"[355.379, 355.07391027600005, 1.4473799999999994, 7, 1, 123.88999999999999, 3, 5, 25, 0.7384309521512445, 0.0625, 3]",355.379,355.07391027600005,1.4473799999999994,7,1,123.88999999999999,3,5,25,0.7384309521512445,0.0625,3,8.163871541930785,6.856910140125239
569,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=C(C#N)C=C(CN3C=NC=N3)C=C2)=C1,8.204581351648564,Active,389.85,5,3,2,7,2.302,132.27,0.271754526,-1974.636705,5.6088,-0.25327,-0.07365,0.17962,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-82,[0 0 0 ... 0 0 0],"[389.82400000000007, 389.0349379240001, 2.10078, 7, 1, 123.89000000000001, 3, 5, 26, 0.7120344481596745, 0.0625, 3]",389.82400000000007,389.0349379240001,2.10078,7,1,123.89000000000001,3,5,26,0.7120344481596745,0.0625,3,8.163912210574539,6.856268068464037
570,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=CC(C#N)=CC=C2CN3C=NC=N3)=C1,8.059421443332823,Active,389.85,5,3,2,7,2.302,132.27,0.267015684,-1974.633956,4.5546,-0.26304,-0.07697,0.18607,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-83,[0 0 0 ... 0 0 0],"[389.82400000000007, 389.0349379240001, 2.1007800000000003, 7, 1, 123.89000000000001, 3, 5, 26, 0.7120344481596745, 0.0625, 3]",389.82400000000007,389.0349379240001,2.1007800000000003,7,1,123.89000000000001,3,5,26,0.7120344481596745,0.0625,3,8.115696599378268,7.661316439703331
571,Non-Steroid,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(C3=CC=C(OS(=O)(N)=O)C=C3)=C1,8.102203073022809,Active,397.5,6,3,2,7,2.551,132.27,0.271067,-1632.987837,4.9391,-0.24163,-0.04826,0.19337,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-84,[0 0 0 ... 0 0 0],"[397.46000000000015, 397.12086046799993, 2.3768800000000008, 7, 1, 123.89000000000001, 3, 6, 28, 0.6808545008228193, 0.21052631578947367, 3]",397.46000000000015,397.12086046799993,2.3768800000000008,7,1,123.89000000000001,3,6,28,0.6808545008228193,0.21052631578947367,3,8.105621002171922,7.84113620434848
572,Non-Steroid,ClC1=C(OS(=O)(N)=O)C=CC(C2=CC(C(C)(C)C#N)=CC(CN3C=NC=N3)=C2)=C1,8.021231745514743,Active,431.94,6,3,2,7,3.216,132.27,0.268272553,-2092.576645,7.255,-0.24277,-0.05434,0.18843,Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template,J Med Chem. 2010;53(5):2155-85,[0 0 0 ... 0 0 0],"[431.90500000000014, 431.08188811600013, 3.030280000000002, 7, 1, 123.89000000000001, 3, 6, 29, 0.6391496623368301, 0.21052631578947367, 3]",431.90500000000014,431.08188811600013,3.030280000000002,7,1,123.89000000000001,3,6,29,0.6391496623368301,0.21052631578947367,3,8.090307678006441,8.122548664255762
573,Non-Steroid,O=C(C1=C(CN2C=NC=C2)C=CC=C1)C3=CC=CC=C3,8.203994092123821,Active,262.33,4,3,0,2,2.911,34.89,0.167612618,-840.9547961,3.2155,-0.22461,-0.06937,0.15524,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-2,[0 0 0 ... 0 0 0],"[262.312, 262.110613068, 3.1624000000000017, 3, 0, 34.89, 3, 4, 20, 0.6768584607856077, 0.058823529411764705, 3]",262.312,262.110613068,3.1624000000000017,3,0,34.89,3,4,20,0.6768584607856077,0.058823529411764705,3,8.185445838692978,6.524604049260262
574,Non-Steroid,O=C(C1=CC(CN2C=NC=C2)=CC=C1)C3=CC=CC=C3,8.089552916288797,Active,262.33,4,3,0,2,2.911,34.89,0.173454324,-840.9608933,4.0608,-0.2257,-0.07088,0.15482,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-3,[0 0 0 ... 0 0 0],"[262.31200000000007, 262.110613068, 3.1624000000000017, 3, 0, 34.89, 3, 4, 20, 0.6768584607856079, 0.058823529411764705, 3]",262.31200000000007,262.110613068,3.1624000000000017,3,0,34.89,3,4,20,0.6768584607856079,0.058823529411764705,3,8.125719144616584,7.486534932841402
575,Non-Steroid,O=C(C1=C(CN2C=NC=C2)C=CC=C1)C3=CC=C(C4=CC=CC=C4)C=C3,8.181442462950777,Active,338.43,5,4,0,2,4.429,34.89,0.162479523,-1072.012764,3.7238,-0.22429,-0.07332,0.15097,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-4,[0 0 0 ... 0 0 0],"[338.41, 338.14191319599996, 4.829400000000004, 3, 0, 34.89, 4, 5, 26, 0.4885866696427487, 0.043478260869565216, 4]",338.41,338.14191319599996,4.829400000000004,3,0,34.89,4,5,26,0.4885866696427487,0.043478260869565216,4,8.17233789248008,6.724532664539392
576,Non-Steroid,O=C(C1=CC(CN2C=NC=C2)=CC=C1)C3=CC=C(C4=CC=CC=C4)C=C3,8.082193994905241,Active,338.43,5,4,0,2,4.429,34.89,0.167097841,-1072.018724,4.6146,-0.22542,-0.07332,0.1521,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-5,[0 0 0 ... 0 0 0],"[338.4100000000001, 338.14191319599996, 4.829400000000004, 3, 0, 34.89, 4, 5, 26, 0.48858666964274866, 0.043478260869565216, 4]",338.4100000000001,338.14191319599996,4.829400000000004,3,0,34.89,4,5,26,0.48858666964274866,0.043478260869565216,4,8.112611198403686,7.715939284593831
578,Non-Steroid,O=C(C1=CC(CN2C=NC=C2)=CC=C1[N+]([O-])=O)C3=CC=CC=C3,8.124438815300776,Active,307.33,5,3,0,4,2.805,80.71,0.198636528,-1045.452054,4.1434,-0.23623,-0.10009,0.13614,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-6,[0 0 0 ... 0 0 0],"[307.309, 307.095691276, 3.0706000000000016, 5, 0, 78.03, 3, 5, 23, 0.41208956678203024, 0.058823529411764705, 3]",307.309,307.095691276,3.0706000000000016,5,0,78.03,3,5,23,0.41208956678203024,0.058823529411764705,3,8.145332734401508,7.155949475888673
579,Non-Steroid,O=C(C1=CC([N+]([O-])=O)=CC=C1CN2C=NC=C2)C3=CC=CC=C3,8.119947075343205,Active,307.33,5,3,0,4,2.805,80.71,0.174875333,-1045.334418,1.9783,-0.22278,-0.08251,0.14027,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-7,[0 0 0 ... 0 0 0],"[307.309, 307.095691276, 3.0706000000000016, 5, 0, 78.03, 3, 5, 23, 0.41208956678203024, 0.058823529411764705, 3]",307.309,307.095691276,3.0706000000000016,5,0,78.03,3,5,23,0.41208956678203024,0.058823529411764705,3,8.139798382955615,7.24772350592511
580,Non-Steroid,O=C(C1=CC([N+]([O-])=O)=CC=C1CN2C=NC=C2)C3=CC=C(C4=CC=CC=C4)C=C3,8.110584738226557,Active,383.43,6,4,0,4,4.324,80.71,0.188141674,-1276.516048,0.301,-0.22569,-0.10284,0.12285,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-8,[0 0 0 ... 0 0 0],"[383.4070000000001, 383.126991404, 4.737600000000004, 5, 0, 78.03, 4, 6, 29, 0.27371711269940435, 0.043478260869565216, 4]",383.4070000000001,383.126991404,4.737600000000004,5,0,78.03,4,6,29,0.27371711269940435,0.043478260869565216,4,8.13590451159938,7.312998568303879
581,Non-Steroid,O=C(C1=CC(Br)=CC=C1CN2C=NC=C2)C3=CC=CC=C3,8.193959836443598,Active,341.22,4,3,0,2,3.659,34.89,0.172078529,-3412.062699,3.2048,-0.21933,-0.07797,0.14136,Imidazolylmethylbenzophenones as highly potent aromatase inhibitors,J Med Chem. 2007;50(15):3420-9,[0 0 0 ... 0 0 0],"[341.208, 340.021125136, 3.924900000000002, 3, 0, 34.89, 3, 4, 21, 0.6743039694596252, 0.058823529411764705, 3]",341.208,340.021125136,3.924900000000002,3,0,34.89,3,4,21,0.6743039694596252,0.058823529411764705,3,8.17210913000657,6.7280757119697085
584,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=CC=C3)OC4=CC(OC)=CC=C41,8.203450829472398,Active,332.38,4,4,0,4,2.757,57.26,0.205363829,-1106.923257,8.307,-0.20956,-0.06619,0.14337,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-80,[0 0 0 ... 0 0 0],"[332.3590000000001, 332.11609237199997, 3.7134000000000027, 5, 0, 57.260000000000005, 4, 4, 25, 0.571481103896921, 0.1, 4]",332.3590000000001,332.11609237199997,3.7134000000000027,5,0,57.260000000000005,4,4,25,0.571481103896921,0.1,4,8.20715792823635,6.20643300471708
585,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C([N+]([O-])=O)C=C3)OC4=CC(OC)=CC=C41,8.198740245616262,Active,377.38,5,4,0,6,2.651,103.08,0.227758581,-1311.420002,7.8495,-0.21566,-0.10768,0.10798,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-81,[0 0 0 ... 0 0 0],"[377.3560000000001, 377.10117058, 3.6216000000000017, 7, 0, 100.4, 4, 5, 28, 0.3888881547163797, 0.1, 4]",377.3560000000001,377.10117058,3.6216000000000017,7,0,100.4,4,5,28,0.3888881547163797,0.1,4,8.19595432664499,6.3686249416805785
586,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C(Br)C=C3)OC4=CC(OC)=CC=C41,8.268635599573948,Inactive,411.27,4,4,0,4,3.505,57.26,0.20663261,-3678.026975,8.0166,-0.21324,-0.07279,0.14045,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-82,[0 0 0 ... 0 0 0],"[411.2550000000001, 410.02660443999997, 4.475900000000003, 5, 0, 57.260000000000005, 4, 4, 26, 0.49720674148610366, 0.1, 4]",411.2550000000001,410.02660443999997,4.475900000000003,5,0,57.260000000000005,4,4,26,0.49720674148610366,0.1,4,8.198917763972727,6.325316133456756
587,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C(C#N)C=C3)OC4=CC(OC)=CC=C41,8.240730567537,Inactive,357.39,4,4,0,5,2.636,81.05,0.216788,-1199.162256,7.7725,-0.21473,-0.08635,0.12838,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-83,[0 0 0 ... 0 0 0],"[357.3690000000001, 357.11134133999997, 3.5850800000000023, 6, 0, 81.05, 4, 4, 27, 0.5574791445544158, 0.09523809523809523, 4]",357.3690000000001,357.11134133999997,3.5850800000000023,6,0,81.05,4,4,27,0.5574791445544158,0.09523809523809523,4,8.155992361873402,6.982446843031894
588,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C([H])C=C3)OC4=CC([H])=CC=C41,8.145770397656566,Active,302.35,3,4,0,3,2.773,48.03,0.187521973,-992.3983472,6.8875,-0.2116,-0.07202,0.13958,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-84,[0 0 0 ... 0 0 0],"[302.333, 302.105527688, 3.7048000000000023, 4, 0, 48.03, 4, 3, 23, 0.5794649149385186, 0.05263157894736842, 4]",302.333,302.105527688,3.7048000000000023,4,0,48.03,4,3,23,0.5794649149385186,0.05263157894736842,4,8.200662233726964,6.299959626516137
589,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C([N+]([O-])=O)C=C3)OC4=CC([H])=CC=C41,8.133902522424899,Active,347.35,4,4,0,5,2.668,93.85,0.213089615,-1196.894835,6.9973,-0.21751,-0.1095,0.10801,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-85,[0 0 0 ... 0 0 0],"[347.33000000000004, 347.090605896, 3.613000000000002, 6, 0, 91.17, 4, 4, 26, 0.4152855260804782, 0.05263157894736842, 4]",347.33000000000004,347.090605896,3.613000000000002,6,0,91.17,4,4,26,0.4152855260804782,0.05263157894736842,4,8.187932403069855,6.487353998527601
590,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C(Br)C=C3)OC4=CC([H])=CC=C41,8.196778715372892,Active,381.24,3,4,0,3,3.522,48.03,0.188808973,-3563.501972,6.7105,-0.21528,-0.07812,0.13716,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-86,[0 0 0 ... 0 0 0],"[381.22900000000004, 380.016039756, 4.467300000000003, 4, 0, 48.03, 4, 3, 24, 0.5263116063097704, 0.05263157894736842, 4]",381.22900000000004,380.016039756,4.467300000000003,4,0,48.03,4,3,24,0.5263116063097704,0.05263157894736842,4,8.194723702312368,6.386696779375206
591,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C(C#N)C=C3)OC4=CC([H])=CC=C41,8.145017174164185,Active,327.36,3,4,0,4,2.652,71.82,0.201717237,-1084.638611,7.6207,-0.2202,-0.09322,0.12698,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-87,[0 0 0 ... 0 0 0],"[327.343, 327.100776656, 3.576480000000002, 5, 0, 71.82, 4, 3, 25, 0.5764378873832966, 0.05, 4]",327.343,327.100776656,3.576480000000002,5,0,71.82,4,3,25,0.5764378873832966,0.05,4,8.14151522445102,7.219128554096381
592,Non-Steroid,O=C1C(CN2C=CN=C2)=C(C3=CC=C(OC)C=C3)OC4=CC([H])=CC=C41,8.148930701478921,Active,332.38,4,4,0,4,2.757,57.26,0.205339976,-1106.923147,6.1855,-0.21077,-0.06754,0.14323,Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme,J Med Chem. 2006;49(15):4777-88,[0 0 0 ... 0 0 0],"[332.35900000000004, 332.116092372, 3.7134000000000027, 5, 0, 57.260000000000005, 4, 4, 25, 0.5714811038969209, 0.1, 4]",332.35900000000004,332.116092372,3.7134000000000027,5,0,57.260000000000005,4,4,25,0.5714811038969209,0.1,4,8.19938922078712,6.318453289330265
593,Non-Steroid,N1(CC=NC1)CC2=CC=CC=C2,8.468784292915547,Inactive,160.24,2,2,0,2,1.682,15.6,0.157562333,-497.7590684,1.7816,-0.216,-0.00419,0.21181,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-53,[0 0 0 ... 0 0 0],"[160.22, 160.100048384, 1.5305, 2, 0, 15.6, 1, 2, 12, 0.6402724233818677, 0.3, 2]",160.22,160.100048384,1.5305,2,0,15.6,1,2,12,0.6402724233818677,0.3,2,8.260479327619613,5.489346842294429
594,Non-Steroid,N1(C=CN=C1)CCC2=CC=CC=C2,8.45310230467106,Inactive,172.25,3,2,0,1,1.828,17.82,0.16741972,-535.8934832,3.8097,-0.21991,-0.00439,0.21552,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-54,[0 0 0 ... 0 0 0],"[172.23100000000002, 172.100048384, 2.1258, 2, 0, 17.82, 2, 3, 13, 0.6930891571049377, 0.18181818181818182, 2]",172.23100000000002,172.100048384,2.1258,2,0,17.82,2,3,13,0.6930891571049377,0.18181818181818182,2,8.236516146680547,5.800746054665815
595,Non-Steroid,N1(C=CN=C1)CCCC2=CC=CC=C2,8.351061449647467,Inactive,186.28,4,2,0,1,2.284,17.82,0.167846857,-575.2071824,4.1353,-0.21962,-0.00449,0.21513,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-55,[0 0 0 ... 0 0 0],"[186.25800000000004, 186.115698448, 2.5159000000000002, 2, 0, 17.82, 2, 4, 14, 0.717038059663501, 0.25, 2]",186.25800000000004,186.115698448,2.5159000000000002,2,0,17.82,2,4,14,0.717038059663501,0.25,2,8.252922047318068,5.585704450474994
596,Non-Steroid,C1(C(CC2N=CN=C2)CC3=CC=CC=C3)=CC=CC=C1,8.361831591903389,Inactive,262.38,5,3,0,2,4.105,24.72,0.164217263,-806.2302703,2.1814,-0.23149,-0.04784,0.18365,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-56,[0 1 0 ... 0 0 0],"[262.35600000000005, 262.146998576, 3.884300000000003, 2, 0, 24.72, 2, 5, 20, 0.7808414755826142, 0.2222222222222222, 3]",262.35600000000005,262.146998576,3.884300000000003,2,0,24.72,2,5,20,0.7808414755826142,0.2222222222222222,3,8.341045365732544,4.5598928152553855
597,Non-Steroid,N1(C=CN=C1)CCCCCC2=CC=CC=C2,8.366427528603348,Inactive,214.34,6,2,0,1,3.196,17.82,0.172684441,-653.8276797,4.6273,-0.21108,-0.00912,0.20196,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-57,[0 0 0 ... 0 0 0],"[214.312, 214.146998576, 3.296100000000002, 2, 0, 17.82, 2, 6, 16, 0.674576570260511, 0.35714285714285715, 2]",214.312,214.146998576,3.296100000000002,2,0,17.82,2,6,16,0.674576570260511,0.35714285714285715,2,8.251219293721288,5.607647506031406
598,Non-Steroid,C1(C(C2N=CN=C2)C3=CC=CC=C3)=CC=CC=C1,8.337047724304826,Inactive,234.32,3,3,0,2,3.26,24.72,0.162049094,-727.6025036,2.2572,-0.23573,-0.05316,0.18257,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-58,[0 1 0 ... 0 0 0],"[234.30200000000002, 234.115698448, 3.299800000000002, 2, 0, 24.72, 2, 3, 18, 0.7781544008280149, 0.125, 3]",234.30200000000002,234.115698448,3.299800000000002,2,0,24.72,2,3,18,0.7781544008280149,0.125,3,8.293969199136763,5.081954833236417
599,Non-Steroid,C1(C(CC2N=CN=C2)C3=CC=CC=C3)=CC=CC=C1,8.365542488168533,Inactive,248.35,4,3,0,2,3.649,24.72,0.163656,-766.9135751,1.9115,-0.23259,-0.0536,0.17899,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-59,[0 1 0 ... 0 0 0],"[248.32900000000004, 248.131348512, 3.6899000000000024, 2, 0, 24.72, 2, 4, 19, 0.7880571973854872, 0.17647058823529413, 3]",248.32900000000004,248.131348512,3.6899000000000024,2,0,24.72,2,4,19,0.7880571973854872,0.17647058823529413,3,8.28770557771542,5.155780531788472
600,Non-Steroid,C1(C(C2N=CN=C2)CCCCC3=CC=CC=C3)=CC=CC=C1,8.337860078141151,Inactive,290.44,7,3,0,2,5.085,24.72,0.166292341,-884.8502984,1.9084,-0.23473,-0.0529,0.18183,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-60,[0 1 0 ... 0 0 0],"[290.41, 290.178298704, 4.664500000000004, 2, 0, 24.72, 2, 7, 22, 0.6623178104365566, 0.3, 3]",290.41,290.178298704,4.664500000000004,2,0,24.72,2,7,22,0.6623178104365566,0.3,3,8.305003573271215,4.95446114375787
601,Non-Steroid,C1(C(CCC2N=CN=C2)C3=CC=CC=C3)=CC=CC=C1,8.316600916799707,Inactive,262.38,5,3,0,2,4.105,24.72,0.164988842,-806.2319322,1.8987,-0.23226,-0.05213,0.18013,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-61,[0 1 0 ... 0 0 0],"[262.35600000000005, 262.146998576, 4.080000000000003, 2, 0, 24.72, 2, 5, 20, 0.7753868744704835, 0.2222222222222222, 3]",262.35600000000005,262.146998576,4.080000000000003,2,0,24.72,2,5,20,0.7753868744704835,0.2222222222222222,3,8.292944658433385,5.0939577854625515
602,Non-Steroid,C1(C(CCCCC2N=CN=C2)C3=CC=CC=C3)=CC=CC=C1,8.238857977398489,Inactive,290.44,7,3,0,2,5.017,24.72,0.166216273,-884.8529667,2.3229,-0.23382,-0.04996,0.18386,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-62,[0 1 0 ... 0 0 0],"[290.41, 290.178298704, 4.860200000000004, 2, 0, 24.72, 2, 7, 22, 0.65054868687099, 0.3, 3]",290.41,290.178298704,4.860200000000004,2,0,24.72,2,7,22,0.65054868687099,0.3,3,8.297426752906214,5.041656433332856
603,Non-Steroid,C1(C(CCCCCC2N=CN=C2)C3=CC=CC=C3)=CC=CC=C1,8.315277406888146,Inactive,304.47,8,3,0,2,5.473,24.72,0.166819426,-924.1679782,2.1731,-0.22996,-0.05174,0.17822,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-63,[0 1 0 ... 0 0 0],"[304.43700000000007, 304.193948768, 5.250300000000005, 2, 0, 24.72, 2, 8, 23, 0.5950203288382472, 0.3333333333333333, 3]",304.43700000000007,304.193948768,5.250300000000005,2,0,24.72,2,8,23,0.5950203288382472,0.3333333333333333,3,8.302099106153065,4.9877065483384575
604,Non-Steroid,C1(C(C2N=CN=C2)CCC3=CC=CC=C3)=CC=CC=C1,8.27190707707259,Inactive,262.38,5,3,0,2,4.172,24.72,0.165595658,-806.2321214,2.1599,-0.23398,-0.05222,0.18176,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-64,[0 1 0 ... 0 0 0],"[262.35600000000005, 262.146998576, 3.884300000000003, 2, 0, 24.72, 2, 5, 20, 0.7808414755826142, 0.2222222222222222, 3]",262.35600000000005,262.146998576,3.884300000000003,2,0,24.72,2,5,20,0.7808414755826142,0.2222222222222222,3,8.28872299582564,5.143716264096362
605,Non-Steroid,C1(C(C2=CC=CC=C2)CCN3C=CN=C3)=CC=CC=C1,8.327997327298576,Inactive,262.38,5,3,0,1,3.568,17.82,0.161369395,-806.2498579,4.5696,-0.21756,-0.015,0.20256,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-65,[0 1 0 ... 0 0 0],"[262.356, 262.146998576, 4.105300000000002, 2, 0, 17.82, 3, 5, 20, 0.676436552326794, 0.16666666666666666, 3]",262.356,262.146998576,4.105300000000002,2,0,17.82,3,5,20,0.676436552326794,0.16666666666666666,3,8.211634535898646,6.1427871075153835
606,Non-Steroid,C1(C(CCC2=CC=CC=C2)CN3C=CN=C3)=CC=CC=C1,8.27904420247403,Inactive,276.41,6,3,0,1,4.092,17.82,0.162481049,-845.5656614,4.2619,-0.21551,-0.01118,0.20433,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-66,[0 1 0 ... 0 0 0],"[276.383, 276.16264864, 4.299700000000003, 2, 0, 17.82, 3, 6, 21, 0.6560847348150783, 0.21052631578947367, 3]",276.383,276.16264864,4.299700000000003,2,0,17.82,3,6,21,0.6560847348150783,0.21052631578947367,3,8.254486850144886,5.565614859393359
607,Non-Steroid,C1(C(CC2=CC=CC=C2)CCN3C=CN=C3)=CC=CC=C1,8.290311321753547,Inactive,276.41,6,3,0,1,4.024,17.82,0.163058585,-845.5662816,4.4756,-0.21554,-0.0101,0.20544,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-67,[0 1 0 ... 0 0 0],"[276.383, 276.16264864, 4.299700000000003, 2, 0, 17.82, 3, 6, 21, 0.6560847348150783, 0.21052631578947367, 3]",276.383,276.16264864,4.299700000000003,2,0,17.82,3,6,21,0.6560847348150783,0.21052631578947367,3,8.226027025598027,5.942551777145068
608,Non-Steroid,C1(C(C2=CC=CC=C2)CCCN3C=CN=C3)=CC=CC=C1,8.319131690587083,Inactive,276.41,6,3,0,1,4.024,17.82,0.163402366,-845.5617551,4.4413,-0.21451,-0.01375,0.20076,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-68,[0 1 0 ... 0 0 0],"[276.383, 276.16264864, 4.495400000000003, 2, 0, 17.82, 3, 6, 21, 0.6480891168613826, 0.21052631578947367, 3]",276.383,276.16264864,4.495400000000003,2,0,17.82,3,6,21,0.6480891168613826,0.21052631578947367,3,8.227825685482987,5.917991192967682
609,Non-Steroid,C1(C(CC2=CC=CC=C2)CCCN3C=CN=C3)=CC=CC=C1,8.273443760485597,Inactive,290.44,7,3,0,1,4.48,17.82,0.164763205,-884.8781576,4.5752,-0.21434,-0.01022,0.20412,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-69,[0 1 0 ... 0 0 0],"[290.40999999999997, 290.178298704, 4.6898000000000035, 2, 0, 17.82, 3, 7, 22, 0.6169944488731541, 0.25, 3]",290.40999999999997,290.178298704,4.6898000000000035,2,0,17.82,3,7,22,0.6169944488731541,0.25,3,8.261663535237156,5.474399215631836
610,Non-Steroid,CC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=CC=C3,8.288298899270062,Inactive,264.4,4,3,1,2,3.76,24.39,0.184688425,-807.4567643,2.5686,-0.21737,-0.00058,0.21679,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-70,[0 1 0 ... 0 0 0],"[264.372, 264.16264864, 3.517120000000002, 2, 1, 24.39, 2, 4, 20, 0.8974643688254975, 0.2777777777777778, 3]",264.372,264.16264864,3.517120000000002,2,1,24.39,2,4,20,0.8974643688254975,0.2777777777777778,3,8.293044894681614,5.092782222983459
611,Non-Steroid,N#CC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=CC=C3,8.199368224774929,Active,275.38,4,3,1,3,3.153,48.18,0.187964421,-860.3833734,7.1091,-0.2268,-0.04537,0.18143,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-71,[0 1 0 ... 0 0 0],"[275.35499999999996, 275.14224754400004, 3.0803800000000017, 3, 1, 48.18, 2, 4, 21, 0.93179738736454, 0.2222222222222222, 3]",275.35499999999996,275.14224754400004,3.0803800000000017,3,1,48.18,2,4,21,0.93179738736454,0.2222222222222222,3,8.226323969968002,5.938490007450847
612,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=CC=C3,8.301405507736664,Inactive,268.36,4,3,1,3,3.48,24.39,0.189277568,-867.3721983,3.7558,-0.22073,-0.00834,0.21239,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-72,[0 1 0 ... 0 0 0],"[268.33500000000004, 268.137576764, 3.347800000000001, 2, 1, 24.39, 2, 4, 20, 0.9032078717753079, 0.23529411764705882, 3]",268.33500000000004,268.137576764,3.347800000000001,2,1,24.39,2,4,20,0.9032078717753079,0.23529411764705882,3,8.283399530659173,5.207154567694196
613,Non-Steroid,CC1=CC=CC=C1C(CC2N=CNC2)C3=CC=CC=C3C,8.34857795014455,Inactive,278.43,4,3,1,2,4.246,24.39,0.189082907,-846.754601,2.8519,-0.21629,-0.0042,0.21209,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-73,[0 1 0 ... 0 0 0],"[278.39900000000006, 278.178298704, 3.825540000000003, 2, 1, 24.39, 2, 4, 21, 0.9029101780257889, 0.3157894736842105, 3]",278.39900000000006,278.178298704,3.825540000000003,2,1,24.39,2,4,21,0.9029101780257889,0.3157894736842105,3,8.296797804478409,5.04896308635025
614,Non-Steroid,CC1=CC(C(CC2N=CNC2)C3=CC=CC(C)=C3)=CC=C1,8.327997327298576,Inactive,278.43,4,3,1,2,4.246,24.39,0.196066186,-846.7746821,2.4133,-0.21704,0.00171,0.21875,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-74,[0 1 0 ... 0 0 0],"[278.399, 278.178298704, 3.825540000000003, 2, 1, 24.39, 2, 4, 21, 0.9029101780257889, 0.3157894736842105, 3]",278.399,278.178298704,3.825540000000003,2,1,24.39,2,4,21,0.9029101780257889,0.3157894736842105,3,8.292353357357246,5.100898039760603
615,Non-Steroid,CC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(C)C=C3,8.31391168372342,Inactive,278.43,4,3,1,2,4.246,24.39,0.195077605,-846.7746612,2.4382,-0.2166,0.00077,0.21737,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-75,[0 1 0 ... 0 0 0],"[278.399, 278.178298704, 3.825540000000003, 2, 1, 24.39, 2, 4, 21, 0.9029101780257889, 0.3157894736842105, 3]",278.399,278.178298704,3.825540000000003,2,1,24.39,2,4,21,0.9029101780257889,0.3157894736842105,3,8.292353357357246,5.100898039760603
616,Non-Steroid,CCC(C=C1)=CC=C1C(CCC2N=CNC2)C3=CC=CC=C3,8.294942268916857,Inactive,292.46,6,3,1,2,4.673,24.39,0.184328826,-886.0820627,2.7966,-0.21883,0.0015,0.22033,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-76,[0 1 0 ... 0 0 0],"[292.426, 292.193948768, 4.161200000000003, 2, 1, 24.39, 2, 6, 22, 0.8490926339228154, 0.35, 3]",292.426,292.193948768,4.161200000000003,2,1,24.39,2,6,22,0.8490926339228154,0.35,3,8.289283715603238,5.137079471622723
617,Non-Steroid,CC1=CC=CC=C1C(CC2N=CNC2)C3=CC=CC(C)=C3,8.295377547504238,Inactive,278.43,4,3,1,2,4.246,24.39,0.190713767,-846.7664619,3.518,-0.21594,0.00426,0.2202,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-77,[0 1 0 ... 0 0 0],"[278.39900000000006, 278.178298704, 3.825540000000003, 2, 1, 24.39, 2, 4, 21, 0.9029101780257889, 0.3157894736842105, 3]",278.39900000000006,278.178298704,3.825540000000003,2,1,24.39,2,4,21,0.9029101780257889,0.3157894736842105,3,8.293208688542322,5.090861845880084
618,Non-Steroid,CC1=CC=CC=C1C(CC2N=CNC2)C3=CC=C(C)C=C3,8.260044156835887,Inactive,278.43,4,3,1,2,4.246,24.39,0.190647,-846.7666149,3.2935,-0.21411,0.00454,0.21865,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-78,[0 1 0 ... 0 0 0],"[278.399, 278.178298704, 3.825540000000003, 2, 1, 24.39, 2, 4, 21, 0.9029101780257889, 0.3157894736842105, 3]",278.399,278.178298704,3.825540000000003,2,1,24.39,2,4,21,0.9029101780257889,0.3157894736842105,3,8.293208688542322,5.090861845880084
619,Non-Steroid,COC(CC1N=CNC1)OC,8.295377547504238,Inactive,158.23,4,1,1,4,-0.177,42.85,0.22546656,-535.0829119,2.3541,-0.22053,0.0271,0.24763,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-79,[0 1 0 ... 0 0 0],"[158.201, 158.105527688, -0.0045000000000001705, 4, 1, 42.849999999999994, 0, 4, 11, 0.5853234723434991, 0.8571428571428571, 1]",158.201,158.105527688,-0.0045000000000001705,4,1,42.849999999999994,0,4,11,0.5853234723434991,0.8571428571428571,1,8.291413531497861,5.111948483543261
620,Non-Steroid,FC(C(C=C1)=CC=C1C(CCC2N=CNC2)C3=CC=C(C(F)(F)F)C=C3)(F)F,8.406623233179769,Inactive,400.4,5,3,1,8,5.615,24.39,0.218012565,-1481.52764,4.1378,-0.22943,-0.02975,0.19968,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-80,[0 1 0 ... 0 0 0],"[400.366, 400.137417896, 5.636400000000003, 2, 1, 24.39, 2, 5, 28, 0.6460375094335403, 0.35, 3]",400.366,400.137417896,5.636400000000003,2,1,24.39,2,5,28,0.6460375094335403,0.35,3,8.32745693673399,4.704820549243392
621,Non-Steroid,FC1=CC(C(CC2N=CNC2)C3=CC=CC(F)=C3)=CC=C1,8.325943333410386,Inactive,286.35,4,3,1,4,3.685,24.39,0.206568027,-966.6066574,4.3516,-0.22307,-0.00938,0.21369,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-81,[0 1 0 ... 0 0 0],"[286.325, 286.128154952, 3.486900000000002, 2, 1, 24.39, 2, 4, 21, 0.9138842018419271, 0.23529411764705882, 3]",286.325,286.128154952,3.486900000000002,2,1,24.39,2,4,21,0.9138842018419271,0.23529411764705882,3,8.287146903703407,5.162417167009958
622,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(F)C=C3,8.275639738301319,Inactive,286.35,4,3,1,4,3.685,24.39,0.206017486,-966.6056429,4.057,-0.2228,-0.01134,0.21146,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-82,[0 1 0 ... 0 0 0],"[286.32500000000005, 286.128154952, 3.486900000000002, 2, 1, 24.39, 2, 4, 21, 0.913884201841927, 0.23529411764705882, 3]",286.32500000000005,286.128154952,3.486900000000002,2,1,24.39,2,4,21,0.913884201841927,0.23529411764705882,3,8.282544199474097,5.2174200226189855
623,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(C(F)(F)F)C=C3,8.277037465902554,Inactive,336.36,4,3,1,6,4.422,24.39,0.21308405,-1204.410768,4.9553,-0.22587,-0.02386,0.20201,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-83,[0 1 0 ... 0 0 0],"[336.332, 336.124961392, 4.366600000000003, 2, 1, 24.39, 2, 4, 24, 0.8241488816150252, 0.2777777777777778, 3]",336.332,336.124961392,4.366600000000003,2,1,24.39,2,4,24,0.8241488816150252,0.2777777777777778,3,8.281333201702036,5.231988711636031
624,Non-Steroid,CC1=CC(CCCCC(C2N=CNC2)C3=CC=C(F)C=C3)=CC=C1,8.265983373839362,Inactive,324.48,7,3,1,3,5.402,24.39,0.196632306,-1024.629115,2.6763,-0.22223,-0.00634,0.21589,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-84,[0 1 0 ... 0 0 0],"[324.44300000000004, 324.20017702, 4.6308200000000035, 2, 1, 24.39, 2, 7, 24, 0.7378063506916244, 0.38095238095238093, 3]",324.44300000000004,324.20017702,4.6308200000000035,2,1,24.39,2,7,24,0.7378063506916244,0.38095238095238093,3,8.27277889879125,5.336064877300156
625,Non-Steroid,FC(C(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(C(F)(F)F)C=C3)(F)F,8.347284794632522,Inactive,386.37,4,3,1,8,5.159,24.39,0.219088209,-1442.215478,5.7048,-0.22877,-0.03289,0.19588,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-85,[0 1 0 ... 0 0 0],"[386.33899999999994, 386.121767832, 5.246300000000002, 2, 1, 24.39, 2, 4, 27, 0.7138059900775803, 0.3157894736842105, 3]",386.33899999999994,386.121767832,5.246300000000002,2,1,24.39,2,4,27,0.7138059900775803,0.3157894736842105,3,8.29925344200058,5.02049522088288
626,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(C#N)C=C3,8.200588452924745,Active,293.37,4,3,1,4,3.358,48.18,0.204221632,-959.6169211,6.5378,-0.2287,-0.04584,0.18286,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-86,[0 1 0 ... 0 0 0],"[293.345, 293.132825732, 3.2194800000000017, 3, 1, 48.18, 2, 4, 22, 0.9405802826307018, 0.2222222222222222, 3]",293.345,293.132825732,3.2194800000000017,3,1,48.18,2,4,22,0.9405802826307018,0.2222222222222222,3,8.21393727579297,6.110302683051137
627,Non-Steroid,FC(C=C1)=CC=C1C(C2N=CNC2)CCCCC3=CC=C(C)C=C3,8.294942268916857,Inactive,324.48,7,3,1,3,5.402,24.39,0.197239469,-1024.61278,2.4528,-0.22051,-0.0098,0.21071,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-87,[0 1 0 ... 0 0 0],"[324.443, 324.20017702, 4.6308200000000035, 2, 1, 24.39, 2, 7, 24, 0.7378063506916245, 0.38095238095238093, 3]",324.443,324.20017702,4.6308200000000035,2,1,24.39,2,7,24,0.7378063506916245,0.38095238095238093,3,8.27277889879125,5.336064877300156
628,Non-Steroid,N#CC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(OC)C=C3,8.216769736411791,Active,305.41,5,3,1,4,3.137,57.41,0.204259048,-974.9058464,6.8438,-0.21439,-0.04388,0.17051,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-88,[0 1 0 ... 0 0 0],"[305.38100000000003, 305.152812228, 3.088980000000001, 4, 1, 57.41, 2, 5, 23, 0.9232274464962215, 0.2631578947368421, 3]",305.38100000000003,305.152812228,3.088980000000001,4,1,57.41,2,5,23,0.9232274464962215,0.2631578947368421,3,8.225468638782926,5.950197226950534
629,Non-Steroid,N#CC(C=C1)=CC=C1C(CC2N=CNC2)C3=CC=C(C#N)C=C3,8.217133282026225,Active,300.39,4,3,1,4,3.032,71.97,0.202248974,-952.6270608,7.7672,-0.23445,-0.05835,0.1761,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-89,[0 1 0 ... 0 0 0],"[300.365, 300.137496512, 2.9520600000000012, 4, 1, 71.97, 2, 4, 23, 0.9431979033839373, 0.21052631578947367, 3]",300.365,300.137496512,2.9520600000000012,4,1,71.97,2,4,23,0.9431979033839373,0.21052631578947367,3,8.220907817496418,6.013013549971114
630,Non-Steroid,CC1=CC=CC=C1C(CCC2N=CNC2)C3=CC=CC=C3,8.262130109193974,Inactive,278.43,5,3,1,2,4.216,24.39,0.179750349,-846.7639658,2.3206,-0.21812,0.00084,0.21896,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-90,[0 1 0 ... 0 0 0],"[278.399, 278.178298704, 3.9072200000000024, 2, 1, 24.39, 2, 5, 21, 0.880828945392758, 0.3157894736842105, 3]",278.399,278.178298704,3.9072200000000024,2,1,24.39,2,5,21,0.880828945392758,0.3157894736842105,3,8.289283715603238,5.137079471622723
631,Non-Steroid,FC(C=C1)=CC=C1C(CCN2C=CN=C2)C3=CC=CC=C3,8.275639738301319,Inactive,280.37,5,3,0,2,3.774,17.82,0.177531816,-905.4828789,4.5688,-0.21964,-0.02194,0.1977,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-91,[0 1 0 ... 0 0 0],"[280.346, 280.137576764, 4.244400000000002, 2, 0, 17.82, 3, 5, 21, 0.6830738825488032, 0.16666666666666666, 3]",280.346,280.137576764,4.244400000000002,2,0,17.82,3,5,21,0.6830738825488032,0.16666666666666666,3,8.201734017083924,6.2844312990010565
632,Non-Steroid,CC1=CC(C(CCC2N=CNC2)C3=CC=CC=C3)=CC=C1,8.25165224474116,Inactive,278.43,5,3,1,2,4.216,24.39,0.185983047,-846.7684248,2.7043,-0.22002,0.00216,0.22218,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-92,[0 1 0 ... 0 0 0],"[278.39900000000006, 278.178298704, 3.9072200000000024, 2, 1, 24.39, 2, 5, 21, 0.880828945392758, 0.3157894736842105, 3]",278.39900000000006,278.178298704,3.9072200000000024,2,1,24.39,2,5,21,0.880828945392758,0.3157894736842105,3,8.289283715603238,5.137079471622723
633,Non-Steroid,FC1=CC=CC=C1C(CCC2N=CNC2)C3=CC=CC=C3,8.319131690587083,Inactive,282.39,5,3,1,3,3.936,24.39,0.182679175,-906.6821784,3.3134,-0.21743,-0.00387,0.21356,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-93,[0 1 0 ... 0 0 0],"[282.362, 282.153226828, 3.7379000000000024, 2, 1, 24.39, 2, 5, 21, 0.8873658973426892, 0.2777777777777778, 3]",282.362,282.153226828,3.7379000000000024,2,1,24.39,2,5,21,0.8873658973426892,0.2777777777777778,3,8.284913693090669,5.189031497885949
634,Non-Steroid,FC(C=C1)=CC=C1C(CCC2N=CNC2)C3=CC=CC=C3,8.255484686147076,Inactive,282.39,5,3,1,3,3.936,24.39,0.1902479,-906.6843679,3.4921,-0.22308,-0.00548,0.2176,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-94,[0 1 0 ... 0 0 0],"[282.362, 282.153226828, 3.7379000000000024, 2, 1, 24.39, 2, 5, 21, 0.8873658973426892, 0.2777777777777778, 3]",282.362,282.153226828,3.7379000000000024,2,1,24.39,2,5,21,0.8873658973426892,0.2777777777777778,3,8.280310988861359,5.244317915274458
635,Non-Steroid,CC1=CC(C(C2=CC=CC(C)=C2)CCC3N=CNC3)=CC=C1,8.341717423968634,Inactive,292.46,5,3,1,2,4.703,24.39,0.195825522,-886.086308,2.8879,-0.21964,0.00427,0.22391,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-95,[0 1 0 ... 0 0 0],"[292.426, 292.193948768, 4.215640000000003, 2, 1, 24.39, 2, 5, 22, 0.8765745920308998, 0.35, 3]",292.426,292.193948768,4.215640000000003,2,1,24.39,2,5,22,0.8765745920308998,0.35,3,8.288428384418163,5.147206779555576
636,Non-Steroid,CC(C=C1)=CC=C1C(C2=CC=C(C)C=C2)CCC3N=CNC3,8.263131054648865,Inactive,292.46,5,3,1,2,4.703,24.39,0.195276891,-886.0863019,2.9022,-0.21537,0.0024,0.21777,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-96,[0 1 0 ... 0 0 0],"[292.426, 292.193948768, 4.215640000000003, 2, 1, 24.39, 2, 5, 22, 0.8765745920308998, 0.35, 3]",292.426,292.193948768,4.215640000000003,2,1,24.39,2,5,22,0.8765745920308998,0.35,3,8.288428384418163,5.147206779555576
638,Non-Steroid,NC(C=C1)=CC=C1C(C2=CC=C(N)C=C2)CCC3N=CNC3,8.33865813550478,Inactive,294.44,5,3,5,4,2.237,76.43,0.227787455,-918.1559213,2.1007,-0.18321,0.0078,0.19101,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-97,[0 1 0 ... 0 0 0],"[294.402, 294.184446704, 2.7632000000000003, 4, 3, 76.43, 2, 5, 22, 0.7421155754244461, 0.2777777777777778, 3]",294.402,294.184446704,2.7632000000000003,4,3,76.43,2,5,22,0.7421155754244461,0.2777777777777778,3,8.297018127235468,5.0464023369180655
639,Non-Steroid,O=[N+](C(C=C1)=CC=C1C(C2=CC=C([N+]([O-])=O)C=C2)CCC3N=CNC3)[O-],8.327997327298576,Inactive,354.4,7,3,1,6,3.519,116.03,0.225458455,-1216.456071,5.9458,-0.23577,-0.09259,0.14318,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-98,[0 1 0 ... 0 0 0],"[354.36600000000004, 354.132805056, 3.4152000000000022, 6, 1, 110.66999999999999, 2, 7, 26, 0.604829189525151, 0.2777777777777778, 3]",354.36600000000004,354.132805056,3.4152000000000022,6,1,110.66999999999999,2,7,26,0.604829189525151,0.2777777777777778,3,8.296728547152814,5.049768313167879
640,Non-Steroid,FC(C=C1)=CC=C1C(C2=CC=C(F)C=C2)CCC3N=CNC3,8.261101686010912,Inactive,300.38,5,3,1,4,4.141,24.39,0.2055997,-1005.917701,3.1351,-0.22493,-0.01314,0.21179,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-99,[0 1 0 ... 0 0 0],"[300.352, 300.143805016, 3.8770000000000033, 2, 1, 24.39, 2, 5, 22, 0.8901792486230532, 0.2777777777777778, 3]",300.352,300.143805016,3.8770000000000033,2,1,24.39,2,5,22,0.8901792486230532,0.2777777777777778,3,8.279614254831232,5.252738071249367
641,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)CCC3N=CNC3,8.236880613624288,Inactive,314.42,5,3,1,4,3.488,71.97,0.2024395,-991.9394045,5.8184,-0.23462,-0.05639,0.17823,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-100,[0 1 0 ... 0 0 0],"[314.392, 314.15314657600004, 3.3421600000000025, 4, 1, 71.97, 2, 5, 24, 0.9196435386848667, 0.25, 3]",314.392,314.15314657600004,3.3421600000000025,4,1,71.97,2,5,24,0.9196435386848667,0.25,3,8.22870553446246,5.906013910617917
642,Non-Steroid,FC(C=C1)=CC=C1C(N2N=CN=C2)CCC3=CC=C(F)C=C3,8.267771946364356,Inactive,299.35,5,3,0,4,4.18,30.71,0.203234,-1020.75473,2.1954,-0.24147,-0.02073,0.22074,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-101,[0 1 0 ... 0 0 0],"[299.324, 299.12340392000004, 3.778500000000003, 3, 0, 30.71, 3, 5, 22, 0.7175930743518354, 0.17647058823529413, 3]",299.324,299.12340392000004,3.778500000000003,3,0,30.71,3,5,22,0.7175930743518354,0.17647058823529413,3,8.234229128321564,5.831373671407864
643,Non-Steroid,FC(C=C1)=CC=C1C(C2N=CNC2)CCCCC3=CC=CC=C3C,8.263131054648865,Inactive,324.48,7,3,1,3,5.402,24.39,0.194818347,-1024.611845,2.4459,-0.22255,-0.00798,0.21457,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-102,[0 1 0 ... 0 0 0],"[324.443, 324.20017702, 4.630820000000004, 2, 1, 24.39, 2, 7, 24, 0.7378063506916244, 0.38095238095238093, 3]",324.443,324.20017702,4.630820000000004,2,1,24.39,2,7,24,0.7378063506916244,0.38095238095238093,3,8.270243895034653,5.367302898519129
644,Non-Steroid,FC(C=C1)=CC=C1C(C2N=CNC2)CCCC3=CC=CC=C3,8.214890214875727,Active,296.42,6,3,1,3,4.459,24.39,0.188159093,-945.995722,3.0727,-0.22174,-0.01369,0.20805,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-103,[0 1 0 ... 0 0 0],"[296.38899999999995, 296.168876892, 3.9323000000000023, 2, 1, 24.39, 2, 6, 22, 0.8578307030163128, 0.3157894736842105, 3]",296.38899999999995,296.168876892,3.9323000000000023,2,1,24.39,2,6,22,0.8578307030163128,0.3157894736842105,3,8.264162628884474,5.442987928236647
645,Non-Steroid,N#CC(C=C1)=CC=C1C(C2N=CNC2)CCCC3=CC=CC=C3,8.175367847062448,Active,303.44,6,3,1,3,4.133,48.18,0.187182841,-939.0063427,5.1212,-0.2291,-0.05184,0.17726,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-104,[0 1 0 ... 0 0 0],"[303.40899999999993, 303.17354767200004, 3.664880000000003, 3, 1, 48.18, 2, 6, 23, 0.8849236084112446, 0.3, 3]",303.40899999999993,303.17354767200004,3.664880000000003,3,1,48.18,2,6,23,0.8849236084112446,0.3,3,8.213224455654865,6.12033993515344
646,Non-Steroid,FC(C=C1)=CC=C1C(C2N=CNC2)CCCC3=CC=C(F)C=C3,8.207562120066182,Active,314.41,6,3,1,4,4.665,24.39,0.202663512,-1045.22921,4.357,-0.22329,-0.01596,0.20733,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-105,[0 1 0 ... 0 0 0],"[314.37899999999996, 314.15945508, 4.071400000000003, 2, 1, 24.39, 2, 6, 23, 0.8537243799071658, 0.3157894736842105, 3]",314.37899999999996,314.15945508,4.071400000000003,2,1,24.39,2,6,23,0.8537243799071658,0.3157894736842105,3,8.251889861917903,5.598995753153382
647,Non-Steroid,N#CC(C=C1)=CC=C1C(C2N=CN=C2)CCC3=CC=C(C#N)C=C3,8.224855234569844,Inactive,312.4,5,3,0,4,3.93,72.3,0.194546525,-990.7185505,4.0236,-0.25951,-0.07228,0.18723,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-106,[0 1 0 ... 0 0 0],"[312.37600000000003, 312.13749651200004, 3.6276600000000023, 4, 0, 72.3, 2, 5, 24, 0.8453519588695189, 0.2, 3]",312.37600000000003,312.13749651200004,3.6276600000000023,4,0,72.3,2,5,24,0.8453519588695189,0.2,3,8.211713007867786,6.141677277494899
648,Non-Steroid,FC(C=C1)=CC=C1CCCC(C2N=CNC2)C3=CC=C(C#N)C=C3,8.177944945826134,Active,321.43,6,3,1,4,4.338,48.18,0.200079523,-1038.238518,6.6762,-0.23068,-0.0405,0.19018,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-107,[0 1 0 ... 0 0 0],"[321.39900000000006, 321.16412586, 3.803980000000002, 3, 1, 48.18, 2, 6, 24, 0.8794107065470734, 0.3, 3]",321.39900000000006,321.16412586,3.803980000000002,3,1,48.18,2,6,24,0.8794107065470734,0.3,3,8.18968990351172,6.4611540598619355
649,Non-Steroid,FC(C=C1)=CC=C1C(C2N=CNC2)CCC3=CC=CC=C3,8.210778860453235,Active,282.39,5,3,1,3,4.003,24.39,0.1886589,-906.686332,3.1102,-0.22255,-0.0121,0.21045,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-108,[0 1 0 ... 0 0 0],"[282.36199999999997, 282.153226828, 3.542200000000002, 2, 1, 24.39, 2, 5, 21, 0.8909057342860629, 0.2777777777777778, 3]",282.36199999999997,282.153226828,3.542200000000002,2,1,24.39,2,5,21,0.8909057342860629,0.2777777777777778,3,8.27880655965664,5.262516134277228
650,Non-Steroid,FC(C=C1)=CC=C1C(C2N=CNC2)CCC3=CC=C(F)C=C3,8.247369502068667,Inactive,300.38,5,3,1,4,4.209,24.39,0.20423875,-1005.919851,4.3672,-0.22443,-0.01403,0.2104,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-109,[0 1 0 ... 0 0 0],"[300.352, 300.143805016, 3.681300000000002, 2, 1, 24.39, 2, 5, 22, 0.8947114313495698, 0.2777777777777778, 3]",300.352,300.143805016,3.681300000000002,2,1,24.39,2,5,22,0.8947114313495698,0.2777777777777778,3,8.270316522133015,5.3664053991045755
651,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)CC3=CC=CC=C3,8.271115053831668,Inactive,282.39,5,3,1,3,3.936,24.39,0.187733725,-906.6839826,3.6323,-0.21743,-0.00222,0.21521,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-110,[0 1 0 ... 0 0 0],"[282.362, 282.153226828, 3.542200000000002, 2, 1, 24.39, 2, 5, 21, 0.8909057342860629, 0.2777777777777778, 3]",282.362,282.153226828,3.542200000000002,2,1,24.39,2,5,21,0.8909057342860629,0.2777777777777778,3,8.279791326584851,5.250596846821562
653,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)CCC3=CC=CC=C3,8.247369502068667,Inactive,296.42,6,3,1,3,4.392,24.39,0.18622007,-945.9951655,3.9388,-0.21999,0.00053,0.22052,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-111,[0 1 0 ... 0 0 0],"[296.389, 296.168876892, 3.9323000000000023, 2, 1, 24.39, 2, 6, 22, 0.8578307030163128, 0.3157894736842105, 3]",296.389,296.168876892,3.9323000000000023,2,1,24.39,2,6,22,0.8578307030163128,0.3157894736842105,3,8.273530690005538,5.326835801889704
654,Non-Steroid,FC(C=C1)=CC=C1C(CC2N=CNC2)CCC3=CC=C(F)C=C3,8.230175562522609,Inactive,314.41,6,3,1,4,4.597,24.39,0.200572628,-1045.228495,4.3224,-0.22148,-0.00639,0.21509,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-112,[0 1 0 ... 0 0 0],"[314.379, 314.15945508, 4.071400000000003, 2, 1, 24.39, 2, 6, 23, 0.8537243799071658, 0.3157894736842105, 3]",314.379,314.15945508,4.071400000000003,2,1,24.39,2,6,23,0.8537243799071658,0.3157894736842105,3,8.261257923038967,5.479514455250347
655,Non-Steroid,FC(C=C1)=CC=C1CCC(CC2N=CNC2)C3=CC=C(C#N)C=C3,8.200588452924745,Active,321.43,6,3,1,4,4.271,48.18,0.200816,-1038.242943,2.883,-0.22458,-0.05292,0.17166,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-113,[0 1 0 ... 0 0 0],"[321.39900000000006, 321.16412586, 3.803980000000002, 3, 1, 48.18, 2, 6, 24, 0.8794107065470734, 0.3, 3]",321.39900000000006,321.16412586,3.803980000000002,3,1,48.18,2,6,24,0.8794107065470734,0.3,3,8.200959736721392,6.2956454684482885
656,Non-Steroid,FC(C=C1)=CC=C1C(CCN2C=CN=C2)C3=CC=C(F)C=C3,8.247369502068667,Inactive,298.36,5,3,0,3,3.979,17.82,0.193371289,-1004.715678,3.6652,-0.22162,-0.02861,0.19301,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-114,[0 1 0 ... 0 0 0],"[298.336, 298.128154952, 4.383500000000002, 2, 0, 17.82, 3, 5, 22, 0.6830979550861145, 0.16666666666666666, 3]",298.336,298.128154952,4.383500000000002,2,0,17.82,3,5,22,0.6830979550861145,0.16666666666666666,3,8.189954954615228,6.4572120030124
659,Non-Steroid,FC(C=C1)=CC=C1CCC(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.17255018319399,Active,306.37,5,3,0,4,3.853,54.5,0.2009835,-1013.771238,3.97,-0.24258,-0.06053,0.18205,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-115,[0 1 0 ... 0 0 0],"[306.34400000000005, 306.1280747, 3.5110800000000015, 4, 0, 54.5, 3, 5, 23, 0.7245432432965477, 0.16666666666666666, 3]",306.34400000000005,306.1280747,3.5110800000000015,4,0,54.5,3,5,23,0.7245432432965477,0.16666666666666666,3,8.151387041780284,7.056883668428155
660,Non-Steroid,FC(C=C1)=CC=C1CCCC(N2C=CN=C2)C3=CC=C(C#N)C=C3,8.130889194765137,Active,319.41,6,3,0,3,4.437,41.61,0.190399929,-1037.043422,3.7178,-0.23561,-0.05945,0.17616,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-116,[0 1 0 ... 0 0 0],"[319.3830000000001, 319.148475796, 4.506180000000003, 3, 0, 41.61, 3, 6, 24, 0.6707403459989785, 0.2, 3]",319.3830000000001,319.148475796,4.506180000000003,3,0,41.61,3,6,24,0.6707403459989785,0.2,3,8.14270976941762,7.1992993249577895
661,Non-Steroid,FC(C=C1)=CC=C1CCCC(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.159842524140021,Active,320.4,6,3,0,4,4.31,54.5,0.199587634,-1053.08046,3.5581,-0.2429,-0.06088,0.18202,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-117,[0 1 0 ... 0 0 0],"[320.3710000000001, 320.14372476400007, 3.9011800000000028, 4, 0, 54.5, 3, 6, 24, 0.6919029748506443, 0.21052631578947367, 3]",320.3710000000001,320.14372476400007,3.9011800000000028,4,0,54.5,3,6,24,0.6919029748506443,0.21052631578947367,3,8.14779431275696,7.115504329562445
662,Non-Steroid,FC(C=C1)=CC=C1CCC(N2C=CN=C2)C3=CC=C(C#N)C=C3,8.189195002006803,Active,305.38,5,3,0,3,3.981,41.61,0.191244179,-997.7305338,3.7181,-0.23617,-0.06004,0.17613,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-118,[0 1 0 ... 0 0 0],"[305.35600000000005, 305.132825732, 4.116080000000003, 3, 0, 41.61, 3, 5, 23, 0.7113674539818252, 0.15789473684210525, 3]",305.35600000000005,305.132825732,4.116080000000003,3,0,41.61,3,5,23,0.7113674539818252,0.15789473684210525,3,8.15141495107903,7.056430182707241
664,Non-Steroid,FC(C=C1)=CC=C1CC(C2N=CN=C2)C3=CC=C(C#N)C=C3,8.188325408687179,Active,291.35,4,3,0,4,3.801,48.51,0.196167333,-958.3930004,5.2151,-0.24822,-0.0684,0.17982,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-119,[0 1 0 ... 0 0 0],"[291.329, 291.117175668, 3.5049800000000024, 3, 0, 48.51, 2, 4, 22, 0.8500574480424743, 0.16666666666666666, 3]",291.329,291.117175668,3.5049800000000024,3,0,48.51,2,4,22,0.8500574480424743,0.16666666666666666,3,8.183358310717466,6.5560414286609126
665,Non-Steroid,FC(C=C1)=CC=C1CCC(C2N=CN=C2)C3=CC=C(C#N)C=C3,8.175367847062448,Active,305.38,5,3,0,4,4.257,48.51,0.194594897,-997.7048161,4.2985,-0.24639,-0.06883,0.17756,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-120,[0 1 0 ... 0 0 0],"[305.35600000000005, 305.132825732, 3.8950800000000028, 3, 0, 48.51, 2, 5, 23, 0.8262470560461953, 0.21052631578947367, 3]",305.35600000000005,305.132825732,3.8950800000000028,3,0,48.51,2,5,23,0.8262470560461953,0.21052631578947367,3,8.198804107864804,6.326971703402456
667,Non-Steroid,OC(C1=CC=C(F)C=C1)C(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.3588481891316,Inactive,308.34,4,3,1,5,2.565,74.73,0.21282725,-1049.664452,1.9076,-0.24734,-0.0685,0.17884,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-121,[0 1 0 ... 0 0 0],"[308.3160000000001, 308.10733925600005, 2.61188, 5, 1, 74.72999999999999, 3, 4, 23, 0.8036710345428694, 0.11764705882352941, 3]",308.3160000000001,308.10733925600005,2.61188,5,1,74.72999999999999,3,4,23,0.8036710345428694,0.11764705882352941,3,8.297020295325767,5.04637714426861
669,Non-Steroid,FC(C=C1)=CC=C1CC(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.136615867273427,Active,292.34,4,3,0,4,3.397,54.5,0.203405543,-974.4531703,4.436,-0.25577,-0.06059,0.19518,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-122,[0 1 0 ... 0 0 0],"[292.317, 292.112424636, 3.120980000000001, 4, 0, 54.5, 3, 4, 22, 0.7420800659491651, 0.11764705882352941, 3]",292.317,292.112424636,3.120980000000001,4,0,54.5,3,4,22,0.7420800659491651,0.11764705882352941,3,8.125389310875867,7.492222893077373
671,Non-Steroid,FC(C=C1)=CC=C1CCC(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.141351611412963,Active,306.37,5,3,0,4,3.853,54.5,0.2009835,-1013.771238,3.97,-0.24258,-0.06053,0.18205,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-123,[0 1 0 ... 0 0 0],"[306.34400000000005, 306.1280747, 3.5110800000000015, 4, 0, 54.5, 3, 5, 23, 0.7245432432965477, 0.16666666666666666, 3]",306.34400000000005,306.1280747,3.5110800000000015,4,0,54.5,3,5,23,0.7245432432965477,0.16666666666666666,3,8.151387041780284,7.056883668428155
672,Non-Steroid,OC(C1=CC=C(F)C=C1)C(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.321522495821112,Inactive,308.34,4,3,1,5,2.565,74.73,0.21282725,-1049.664452,1.9076,-0.24734,-0.0685,0.17884,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-124,[0 1 0 ... 0 0 0],"[308.3160000000001, 308.10733925600005, 2.61188, 5, 1, 74.72999999999999, 3, 4, 23, 0.8036710345428694, 0.11764705882352941, 3]",308.3160000000001,308.10733925600005,2.61188,5,1,74.72999999999999,3,4,23,0.8036710345428694,0.11764705882352941,3,8.297020295325767,5.04637714426861
674,Non-Steroid,OC(CC1=CC=C(F)C=C1)C(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.200588452924745,Active,322.37,5,3,1,5,2.887,74.73,0.216527846,-1088.969555,4.5957,-0.25106,-0.06094,0.19012,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-125,[0 1 0 ... 0 0 0],"[322.3430000000001, 322.12298932000004, 2.4818800000000003, 5, 1, 74.72999999999999, 3, 5, 24, 0.7829027399156618, 0.16666666666666666, 3]",322.3430000000001,322.12298932000004,2.4818800000000003,5,1,74.72999999999999,3,5,24,0.7829027399156618,0.16666666666666666,3,8.199842185849697,6.311866637443404
676,Non-Steroid,OC(CCC1=CC=C(F)C=C1)C(N2N=CN=C2)C3=CC=C(C#N)C=C3,8.266888205955082,Inactive,336.4,6,3,1,5,3.343,74.73,0.212716738,-1128.281226,5.656,-0.23982,-0.06119,0.17863,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-126,[0 1 0 ... 0 0 0],"[336.37000000000006, 336.13863938400004, 2.8719800000000015, 5, 1, 74.72999999999999, 3, 6, 25, 0.7509469521917651, 0.21052631578947367, 3]",336.37000000000006,336.13863938400004,2.8719800000000015,5,1,74.72999999999999,3,6,25,0.7509469521917651,0.21052631578947367,3,8.249941216128802,5.624174459763451
678,Non-Steroid,OC(CCC1=CC=C(F)C=C1)C(C2N=CN=C2)C3=CC=C(C#N)C=C3,8.200588452924745,Active,335.41,6,3,1,5,3.482,68.74,0.206307907,-1112.229929,1.2973,-0.22986,-0.07243,0.15743,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-127,[0 1 0 ... 0 0 0],"[335.38200000000006, 335.143390416, 3.255980000000002, 4, 1, 68.74000000000001, 2, 6, 25, 0.8801826444095163, 0.25, 3]",335.38200000000006,335.143390416,3.255980000000002,4,1,68.74000000000001,2,6,25,0.8801826444095163,0.25,3,8.2113321033722,6.147066290670526
680,Non-Steroid,OC(C1=CC=C(F)C=C1)CC(C2N=CN=C2)C3=CC=C(C#N)C=C3,8.210778860453235,Active,321.38,5,3,1,5,3.155,68.74,0.20528615,-1072.919908,6.6222,-0.24922,-0.05532,0.1939,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-128,[0 1 0 ... 0 0 0],"[321.3550000000001, 321.127740352, 3.3859800000000018, 4, 1, 68.74000000000001, 2, 5, 24, 0.9168871672211147, 0.21052631578947367, 3]",321.3550000000001,321.127740352,3.3859800000000018,4,1,68.74000000000001,2,5,24,0.9168871672211147,0.21052631578947367,3,8.190783970977968,6.44489771251844
681,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3C=CNC3,8.221848749616356,Inactive,286.36,3,3,1,4,2.08,62.85,0.187957528,-913.2773343,6.4624,-0.18338,-0.06866,0.11472,Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer,J Comput Chem. 2010;31(12):2342-129,[0 1 0 ... 0 0 0],"[286.338, 286.121846448, 2.8532600000000006, 4, 1, 62.85, 2, 3, 22, 0.9420510175593657, 0.1111111111111111, 3]",286.338,286.121846448,2.8532600000000006,4,1,62.85,2,3,22,0.9420510175593657,0.1111111111111111,3,8.157538427232625,6.957633894594927
682,Steroid,C[C@]12C(CCCC2)CCC3C1CC[C@]4(C3CCC4=O)C,8.177320912757096,Active,274.49,0,4,0,1,4.685,17.07,0.18730688,-817.3297464,3.0151,-0.22729,-0.00959,0.2177,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-20,[0 0 0 ... 0 0 0],"[274.44800000000004, 274.22966558, 4.988300000000005, 1, 0, 17.07, 0, 0, 20, 0.6080381293997492, 0.9473684210526315, 4]",274.44800000000004,274.22966558,4.988300000000005,1,0,17.07,0,0,20,0.6080381293997492,0.9473684210526315,4,8.256620828080175,5.538334366600337
683,Steroid,C[C@]12C(CCCC2)CCC3C1CC[C@]4(C3CCC4O)C,8.3445850552086,Inactive,276.51,0,4,1,1,4.725,20.23,0.182886038,-818.5236973,1.6089,-0.24763,0.06709,0.31472,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-21,[0 0 0 ... 0 0 0],"[276.464, 276.245315644, 4.780100000000005, 1, 1, 20.23, 0, 0, 20, 0.6748083233840423, 1.0, 4]",276.464,276.245315644,4.780100000000005,1,1,20.23,0,0,20,0.6748083233840423,1.0,4,8.328735387774962,4.690991135038572
684,Steroid,C[C@]12C([C@H]3[C@@H](CC2)O3)CCC4C1CC[C@]5(C4CCC5=O)C,8.165030765990325,Active,288.47,0,5,0,2,3.315,29.6,0.190060918,-891.3085094,3.0221,-0.23001,-0.0122,0.21781,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-22,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.975500000000004, 2, 0, 29.6, 0, 0, 21, 0.631095663260168, 0.9473684210526315, 5]",288.43100000000004,288.208930136,3.975500000000004,2,0,29.6,0,0,21,0.631095663260168,0.9473684210526315,5,8.219106706207508,6.038002573522727
685,Steroid,C[C@]12C([C@H]3[C@@H](CC2)O3)CCC4C1CC[C@]5(C4CCC5O)C,8.285076497666232,Inactive,290.49,0,5,1,2,3.355,32.76,0.185576627,-892.5026809,1.4143,-0.24957,0.06507,0.31464,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-23,[0 0 0 ... 0 0 0],"[290.447, 290.2245802, 3.767300000000003, 2, 1, 32.76, 0, 0, 21, 0.6889012491892766, 1.0, 5]",290.447,290.2245802,3.767300000000003,2,1,32.76,0,0,21,0.6889012491892766,1.0,5,8.294155977962186,5.079769685807918
686,Steroid,C[C@]12C(CCC3C1CC[C@]4(C3CCC4=O)C)=C(C(CC2)=O)O,8.13213489284645,Active,302.45,0,4,1,3,2.731,54.37,0.224320479,-965.3535282,2.6662,-0.22091,-0.05208,0.16883,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-24,[0 0 0 ... 0 0 0],"[302.414, 302.18819469199997, 3.9731000000000023, 3, 1, 54.370000000000005, 0, 0, 22, 0.7362676475612525, 0.7894736842105263, 4]",302.414,302.18819469199997,3.9731000000000023,3,1,54.370000000000005,0,0,22,0.7362676475612525,0.7894736842105263,4,8.19274263083604,6.415896792299018
687,Steroid,C[C@@]12C(CCC3C2CC[C@]4(C3CCC4=O)C)=CCCC1,8.141351611412963,Active,272.47,0,4,0,1,4.435,17.07,0.191305479,-816.1115547,2.678,-0.22518,-0.01067,0.21451,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-25,[0 0 0 ... 0 0 0],"[272.432, 272.214015516, 4.908400000000005, 1, 0, 17.07, 0, 0, 20, 0.5726737469300093, 0.8421052631578947, 4]",272.432,272.214015516,4.908400000000005,1,0,17.07,0,0,20,0.5726737469300093,0.8421052631578947,4,8.230631835892886,5.879875955574241
688,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CCCC[C@]4(CO)C3CC1,8.136094272509188,Active,288.47,1,4,1,2,3.344,37.3,0.196753776,-891.2985015,2.0829,-0.22242,-0.01098,0.21144,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-26,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.8808000000000034, 2, 1, 37.3, 0, 1, 21, 0.7434541175838038, 0.8421052631578947, 4]",288.43100000000004,288.208930136,3.8808000000000034,2,1,37.3,0,1,21,0.7434541175838038,0.8421052631578947,4,8.265116362283585,5.431047957236189
689,Steroid,C[C@@]12C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)O)=CCCC1,8.17255018319399,Active,288.47,0,4,1,2,3.333,37.3,0.200579163,-891.318726,2.3791,-0.22396,-0.01273,0.21123,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-27,[0 0 0 ... 0 0 0],"[288.4310000000001, 288.208930136, 3.8792000000000035, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.4310000000001,288.208930136,3.8792000000000035,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.203506176853445,6.258839620791174
690,Steroid,C[C@@]12C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)O)=CCCC1,8.136615867273427,Active,288.47,0,4,1,2,3.333,37.3,0.200234959,-891.3173328,2.8271,-0.22804,-0.01122,0.21682,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-28,[0 0 0 ... 0 0 0],"[288.4310000000001, 288.208930136, 3.8792000000000035, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.4310000000001,288.208930136,3.8792000000000035,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.203506176853445,6.258839620791174
691,Steroid,C[C@]12C(CCC3C1CC[C@]4(C3CCC4=O)C)=C(CCC2)OC(CCC)=O,8.234785438913192,Inactive,358.57,4,4,0,3,4.895,43.37,0.216257367,-1122.619428,2.2297,-0.22608,-0.01212,0.21396,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-29,[0 0 0 ... 0 0 0],"[358.52200000000016, 358.25079494799996, 5.579400000000006, 3, 0, 43.370000000000005, 0, 3, 26, 0.6186102341763323, 0.8260869565217391, 4]",358.52200000000016,358.25079494799996,5.579400000000006,3,0,43.370000000000005,0,3,26,0.6186102341763323,0.8260869565217391,4,8.22489035731549,5.958125443377402
692,Steroid,C[C@]12C(CCC3C1CC[C@]4(C3CCC4=O)C)=C(CCC2)OC(CCCCC)=O,8.240730567537,Inactive,386.63,6,4,0,3,5.808,43.37,0.212273106,-1201.241843,2.4296,-0.22524,-0.01194,0.2133,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-30,[0 0 0 ... 0 0 0],"[386.57600000000025, 386.28209507599996, 6.3596000000000075, 3, 0, 43.370000000000005, 0, 5, 28, 0.4077229386983286, 0.84, 4]",386.57600000000025,386.28209507599996,6.3596000000000075,3,0,43.370000000000005,0,5,28,0.4077229386983286,0.84,4,8.249813429444917,5.625829558730569
693,Steroid,C[C@]12C(CCC3C1CC[C@]4(C3CCC4=O)C)=C(CCC2)OC(C5=CC=CC=C5)=O,8.208041418102681,Active,392.58,3,5,0,3,5.437,43.37,0.201346541,-1235.715887,4.1366,-0.22471,-0.04639,0.17832,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-31,[0 0 0 ... 0 0 0],"[392.5390000000001, 392.23514488399996, 6.093100000000007, 3, 0, 43.370000000000005, 1, 2, 29, 0.5717904082980432, 0.6153846153846154, 5]",392.5390000000001,392.23514488399996,6.093100000000007,3,0,43.370000000000005,1,2,29,0.5717904082980432,0.6153846153846154,5,8.24551577443533,5.681777538442994
694,Steroid,C[C@]12C(CCC3C1CC[C@]4(C3CCC4=O)C)=C(CCC2)OC(C)=O,8.208979476566421,Active,330.51,2,4,0,3,3.772,43.37,0.219675093,-1043.991222,2.2841,-0.22618,-0.01225,0.21393,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-32,[0 0 0 ... 0 0 0],"[330.4680000000001, 330.21949481999997, 4.799200000000004, 3, 0, 43.370000000000005, 0, 1, 24, 0.6486817152106633, 0.8095238095238095, 4]",330.4680000000001,330.21949481999997,4.799200000000004,3,0,43.370000000000005,0,1,24,0.6486817152106633,0.8095238095238095,4,8.221744582394843,6.001439295952083
695,Steroid,C[C@@]12C(CCC2=O)C3CCC4=C(OC(C)=O)CCC[C@]4(C)C3CC1,8.264106016122115,Inactive,330.51,2,4,0,3,3.772,43.37,0.221304222,-1043.977686,2.6622,-0.22818,-0.01202,0.21616,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-33,[0 0 0 ... 0 0 0],"[330.46800000000013, 330.21949481999997, 4.799200000000004, 3, 0, 43.370000000000005, 0, 1, 24, 0.6486817152106632, 0.8095238095238095, 4]",330.46800000000013,330.21949481999997,4.799200000000004,3,0,43.370000000000005,0,1,24,0.6486817152106632,0.8095238095238095,4,8.221744582394843,6.001439295952083
696,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](O)C4=CCCC[C@]4(C)C3CC1,8.221848749616356,Inactive,288.47,0,4,1,2,3.333,37.3,0.201914571,-891.3069541,2.8898,-0.2294,-0.01094,0.21846,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-34,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.8792000000000035, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.43100000000004,288.208930136,3.8792000000000035,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.203506176853445,6.258839620791174
697,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](O)C4=CCCC[C@]4(C)C3CC1,8.21990802155277,Active,288.47,0,4,1,2,3.333,37.3,0.203051816,-891.3080281,4.14,-0.22652,-0.00778,0.21874,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-35,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.8792000000000035, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.43100000000004,288.208930136,3.8792000000000035,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.203506176853445,6.258839620791174
698,Steroid,C[C@@]12C(CCCC2)=CCC3C1CC[C@]4(C3CCC4=O)C,8.208979476566421,Active,272.47,0,4,0,1,4.435,17.07,0.191230188,-816.1119136,2.867,-0.2267,-0.01036,0.21634,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-36,[0 0 0 ... 0 0 0],"[272.432, 272.214015516, 4.908400000000005, 1, 0, 17.07, 0, 0, 20, 0.5726737469300093, 0.8421052631578947, 4]",272.432,272.214015516,4.908400000000005,1,0,17.07,0,0,20,0.5726737469300093,0.8421052631578947,4,8.234484085075898,5.827951312048022
699,Steroid,C[C@]12C(C3CC=C4CCCC[C@@]4(C3CC2)CO)CCC1=O,8.28725344223061,Inactive,288.47,1,4,1,2,3.344,37.3,0.200101184,-891.2978224,3.1377,-0.22357,-0.00756,0.21601,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-37,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.8808000000000025, 2, 1, 37.3, 0, 1, 21, 0.7434541175838038, 0.8421052631578947, 4]",288.43100000000004,288.208930136,3.8808000000000025,2,1,37.3,0,1,21,0.7434541175838038,0.8421052631578947,4,8.274362489800362,5.316643131644459
700,Steroid,C[C@@]12C([C@H](CCC2)O)=CCC3C1CC[C@]4(C3CCC4=O)C,8.183570305539794,Active,288.47,0,4,1,2,3.333,37.3,0.200560143,-891.3191616,3.4286,-0.22539,-0.00988,0.21551,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-38,[0 0 0 ... 0 0 0],"[288.431, 288.208930136, 3.8792000000000026, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.431,288.208930136,3.8792000000000026,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.222543415241438,5.990410511088821
701,Steroid,C[C@@]12C([C@H](CCC2)OC(C)=O)=CCC3C1CC[C@]4(C3CCC4=O)C,8.210778860453235,Active,330.51,2,4,0,3,3.712,43.37,0.213269667,-1043.990961,2.6955,-0.23006,-0.01256,0.2175,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-39,[0 0 0 ... 0 0 0],"[330.46800000000013, 330.21949481999997, 4.450000000000004, 3, 0, 43.370000000000005, 0, 1, 24, 0.5268094332325616, 0.8095238095238095, 4]",330.46800000000013,330.21949481999997,4.450000000000004,3,0,43.370000000000005,0,1,24,0.5268094332325616,0.8095238095238095,4,8.232884166959492,5.849460774865985
702,Steroid,C[C@]12C([C@H](CCC2)OC(C)=O)=CCC3C1CC[C@]4(C3CCC4=O)C,8.221848749616356,Inactive,330.51,2,4,0,3,3.712,43.37,0.215242074,-1043.985848,2.195,-0.22989,-0.01208,0.21781,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-40,[0 0 0 ... 0 0 0],"[330.46800000000013, 330.21949481999997, 4.450000000000004, 3, 0, 43.370000000000005, 0, 1, 24, 0.5268094332325616, 0.8095238095238095, 4]",330.46800000000013,330.21949481999997,4.450000000000004,3,0,43.370000000000005,0,1,24,0.5268094332325616,0.8095238095238095,4,8.232884166959492,5.849460774865985
703,Steroid,C[C@]12C(C3CC=C4[C@@H](CCC[C@@]4(C3CC2)CO)O)CCC1=O,8.304640283255823,Inactive,304.47,1,4,2,3,2.243,57.53,0.20759314,-966.5042961,3.9713,-0.2226,-0.00709,0.21551,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-41,[0 0 0 ... 0 0 0],"[304.43000000000006, 304.20384475599997, 2.851600000000002, 3, 2, 57.53, 0, 1, 22, 0.7324306903705828, 0.8421052631578947, 4]",304.43000000000006,304.20384475599997,2.851600000000002,3,2,57.53,0,1,22,0.7324306903705828,0.8421052631578947,4,8.231260991334434,5.871364040728836
704,Steroid,C[C@@]12C([C@@H](CCC2)O)=CCC3C1CC[C@]4(C3CCC4=O)C,8.217133282026225,Active,288.47,0,4,1,2,3.333,37.3,0.20021798,-891.3176408,4.0168,-0.22777,-0.01022,0.21755,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-42,[0 0 0 ... 0 0 0],"[288.431, 288.208930136, 3.8792000000000026, 2, 1, 37.3, 0, 0, 21, 0.6868426969908572, 0.8421052631578947, 4]",288.431,288.208930136,3.8792000000000026,2,1,37.3,0,0,21,0.6868426969908572,0.8421052631578947,4,8.222543415241438,5.990410511088821
706,Steroid,C[C@]12C(C3CC=C4[C@H](CCC[C@@]4(C3CC2)CO)O)CCC1=O,8.124438815300776,Active,304.47,1,4,2,3,2.243,57.53,0.21109592,-966.5140162,5.6376,-0.22696,-0.0084,0.21856,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-43,[0 0 0 ... 0 0 0],"[304.43000000000006, 304.20384475599997, 2.851600000000002, 3, 2, 57.53, 0, 1, 22, 0.7324306903705828, 0.8421052631578947, 4]",304.43000000000006,304.20384475599997,2.851600000000002,3,2,57.53,0,1,22,0.7324306903705828,0.8421052631578947,4,8.231260991334434,5.871364040728836
707,Steroid,C[C@]12C(C3CC=C4[C@H](CCC[C@@]4(C3CC2)CO)OC)CCC1=O,8.417492480871108,Inactive,318.5,2,4,1,3,2.651,46.53,0.202085057,-1005.821581,4.9221,-0.22807,-0.00955,0.21852,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-44,[0 0 0 ... 0 0 0],"[318.4570000000001, 318.21949481999997, 3.5057000000000027, 3, 1, 46.53, 0, 2, 23, 0.7926633173765353, 0.85, 4]",318.4570000000001,318.21949481999997,3.5057000000000027,3,1,46.53,0,2,23,0.7926633173765353,0.85,4,8.35295821424455,4.4365132790477295
708,Steroid,C[C@@]12C([C@H](CCC2)C)=CCC3C1CC[C@]4(C3CCC4=O)C,8.240730567537,Inactive,286.5,0,4,0,1,4.687,17.07,0.190517941,-855.4240667,2.8957,-0.22683,-0.01019,0.21664,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-45,[0 0 0 ... 0 0 0],"[286.459, 286.22966558, 5.154400000000005, 1, 0, 17.07, 0, 0, 21, 0.5624739524074177, 0.85, 4]",286.459,286.22966558,5.154400000000005,1,0,17.07,0,0,21,0.5624739524074177,0.85,4,8.20011143197499,6.307954731998623
709,Steroid,C[C@@]12C([C@H](CCC2)CC)=CCC3C1CC[C@]4(C3CCC4=O)C,8.27190707707259,Inactive,300.53,1,4,0,1,5.143,17.07,0.189551611,-894.7353984,2.8768,-0.22664,-0.01033,0.21631,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-46,[0 0 0 ... 0 0 0],"[300.48600000000005, 300.245315644, 5.5445000000000055, 1, 0, 17.07, 0, 1, 22, 0.5806337844702286, 0.8571428571428571, 4]",300.48600000000005,300.245315644,5.5445000000000055,1,0,17.07,0,1,22,0.5806337844702286,0.8571428571428571,4,8.239158067913039,5.765565788876849
710,Steroid,C[C@@]12C([C@H](CCC2)CCC)=CCC3C1CC[C@]4(C3CCC4=O)C,8.27904420247403,Inactive,314.56,2,4,0,1,5.599,17.07,0.188441386,-934.0490582,2.8209,-0.22656,-0.01037,0.21619,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-47,[0 0 0 ... 0 0 0],"[314.5130000000001, 314.26096570799996, 5.934600000000007, 1, 0, 17.07, 0, 2, 23, 0.5768556929192085, 0.8636363636363636, 4]",314.5130000000001,314.26096570799996,5.934600000000007,1,0,17.07,0,2,23,0.5768556929192085,0.8636363636363636,4,8.246369369371383,5.670621114304216
711,Steroid,C[C@]12C(C(CCC2)=O)CCC3C1CC[C@]4(C3CCC4=O)C,8.250280008800894,Inactive,288.47,0,4,0,2,3.333,34.14,0.208162592,-891.3296517,2.0316,-0.23256,-0.01393,0.21863,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-48,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 4.167300000000004, 2, 0, 34.14, 0, 0, 21, 0.6702343996322836, 0.8947368421052632, 4]",288.43100000000004,288.208930136,4.167300000000004,2,0,34.14,0,0,21,0.6702343996322836,0.8947368421052632,4,8.237559789468591,5.786823154743506
712,Steroid,C[C@]12C(C([C@@H](CC2)O)=O)CCC3C1CC[C@]4(C3CCC4=O)C,8.209438636714456,Active,304.47,0,4,1,3,2.653,54.37,0.21729046,-966.5571493,1.589,-0.23379,-0.02886,0.20493,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-49,[0 0 0 ... 0 0 0],"[304.43000000000006, 304.20384475599997, 3.1381000000000014, 3, 1, 54.37, 0, 0, 22, 0.7477804090828566, 0.8947368421052632, 4]",304.43000000000006,304.20384475599997,3.1381000000000014,3,1,54.37,0,0,22,0.7477804090828566,0.8947368421052632,4,8.23431366720597,5.830238658490685
713,Steroid,C[C@]12C(C3CCC4=C(C(CC[C@@]4(C3CC2)C)=O)O)CCC(O1)=O,8.241631067407221,Inactive,318.45,0,4,1,4,2.583,63.6,0.243261429,-1040.580704,2.7813,-0.22641,-0.05716,0.16925,Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors,Eur J Med Chem. 2010;45(12):5612-50,[0 0 0 ... 0 0 0],"[318.4130000000001, 318.18310931199994, 3.699600000000002, 4, 1, 63.6, 0, 0, 23, 0.6917443142294778, 0.7894736842105263, 4]",318.4130000000001,318.18310931199994,3.699600000000002,4,1,63.6,0,0,23,0.6917443142294778,0.7894736842105263,4,8.221339488883181,6.0070398237348535
714,Non-Steroid,ClC1=CC=C(C(CN2C3=CC=C2)/C(C3=O)=C/C4=CC=NC=C4)C=C1,8.165408749047506,Active,334.82,2,4,0,2,4.193,34.89,0.181982436,-1416.059277,5.7809,-0.22985,-0.08396,0.14589,MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase,J Steroid Biochem Mol Biol. 1999;70(1-3):59-71,[0 0 0 ... 0 0 0],"[334.80600000000004, 334.08729078000005, 4.600200000000004, 3, 0, 34.89, 3, 2, 24, 0.6418469149270338, 0.1, 4]",334.80600000000004,334.08729078000005,4.600200000000004,3,0,34.89,3,2,24,0.6418469149270338,0.1,4,8.1820388107147,6.575990684064482
715,Non-Steroid,ClC1=CC=C(C(CN2C3=CC=C2)/C(C3=O)=C/C4=CN=CC=C4)C=C1,8.157723034076605,Active,334.82,2,4,0,2,4.193,34.89,0.178964385,-1416.059009,6.174,-0.2239,-0.07527,0.14863,MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase,J Steroid Biochem Mol Biol. 1999;70(1-3):59-71,[0 0 0 ... 0 0 0],"[334.80600000000004, 334.08729078000005, 4.600200000000004, 3, 0, 34.89, 3, 2, 24, 0.6418469149270338, 0.1, 4]",334.80600000000004,334.08729078000005,4.600200000000004,3,0,34.89,3,2,24,0.6418469149270338,0.1,4,8.173785303356857,6.702158536264112
716,Non-Steroid,O=C1N(C)C2=C3C(OCO3)=CC=C2C(OC)=C1,8.267066608158085,Inactive,233.24,1,3,0,5,0.728,49.69,0.287175,-819.5316686,3.1572,-0.20769,-0.03637,0.17132,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-93,[0 0 0 ... 0 0 0],"[233.22299999999998, 233.068807832, 1.2757999999999998, 5, 0, 49.69, 2, 1, 17, 0.7440143696427856, 0.25, 3]",233.22299999999998,233.068807832,1.2757999999999998,5,0,49.69,2,1,17,0.7440143696427856,0.25,3,8.273952312704001,5.321666901202815
717,Non-Steroid,C[C@](C1OC(C[C@H]1O)=O)(OC2=CC(C)=C(C(O)=C23)C4=C(C5=C(C=C4)O[C@](C6OC(C[C@@H]6C)=O)(C)CC5=O)O)CC3=O,8.320343563272335,Inactive,566.6,3,6,3,11,2.818,165.89,0.290129845,-1988.769067,6.5103,-0.21582,-0.0709,0.14492,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-94,[0 0 0 ... 0 0 0],"[566.5590000000003, 566.1788117799999, 3.149020000000001, 11, 3, 165.89, 2, 3, 41, 0.46726422297575415, 0.4666666666666667, 6]",566.5590000000003,566.1788117799999,3.149020000000001,11,3,165.89,2,3,41,0.46726422297575415,0.4666666666666667,6,8.310860013974732,4.8880989191568425
718,Non-Steroid,C[C@](C1OC(C[C@H]1O)=O)(OC2=C(C(C)=CC(O)=C23)C4=C(C5=C(C=C4)O[C@](C6OC(C[C@@H]6C)=O)(C)CC5=O)O)CC3=O,8.336053247415254,Inactive,566.6,3,6,3,11,2.818,165.89,0.29198138,-1988.773139,7.4914,-0.22365,-0.08312,0.14053,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-95,[0 0 0 ... 0 0 0],"[566.5590000000003, 566.1788117799999, 3.149020000000001, 11, 3, 165.89, 2, 3, 41, 0.46726422297575415, 0.4666666666666667, 6]",566.5590000000003,566.1788117799999,3.149020000000001,11,3,165.89,2,3,41,0.46726422297575415,0.4666666666666667,6,8.310860013974732,4.8880989191568425
719,Non-Steroid,CC(O[C@H]1[C@@H](CCCCC)OC(C2=CC=C(OC)C=C21)=O)=O,8.236880613624288,Inactive,306.39,7,2,0,5,3.561,61.83,0.239178205,-1037.208413,3.0968,-0.23503,-0.04148,0.19355,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-96,[0 0 0 ... 0 0 0],"[306.35800000000006, 306.146723804, 3.418700000000002, 5, 0, 61.830000000000005, 1, 6, 22, 0.5950528697090063, 0.5294117647058824, 2]",306.35800000000006,306.146723804,3.418700000000002,5,0,61.830000000000005,1,6,22,0.5950528697090063,0.5294117647058824,2,8.241002103356625,5.741136816775485
720,Non-Steroid,OC(C=C1C)=CC2=C1OC(C=C(O)C=C3C)=C3C(O2)=O,8.27771792198676,Inactive,272.27,0,3,2,5,3.43,83.81,0.303659656,-954.9297855,5.2532,-0.22005,-0.04017,0.17988,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-97,[0 0 0 ... 0 0 0],"[272.25600000000003, 272.068473484, 3.0395400000000015, 5, 2, 75.99000000000001, 2, 0, 20, 0.5691340649903459, 0.13333333333333333, 3]",272.25600000000003,272.068473484,3.0395400000000015,5,2,75.99000000000001,2,0,20,0.5691340649903459,0.13333333333333333,3,8.276997241350855,5.284486084829731
721,Non-Steroid,O=C(CCCCCCC/C=C\C/C=C\C/C=C\CC)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,8.291757154858376,Inactive,442.66,20,0,5,7,3.615,127.45,0.231803425,-1466.322431,4.6835,-0.22476,-0.01874,0.20602,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-98,[0 1 0 ... 0 0 0],"[442.5930000000002, 442.29305368399986, 2.555000000000001, 7, 5, 127.45000000000002, 0, 19, 31, 0.11814347406632954, 0.7083333333333334, 0]",442.5930000000002,442.29305368399986,2.555000000000001,7,5,127.45000000000002,0,19,31,0.11814347406632954,0.7083333333333334,0,8.322842215493246,4.755079524296722
723,Non-Steroid,OC1=CC(O)=C(C([C@@H](C2=C3C(C([C@H](O)[C@@H](C4=CC=C(O)C=C4)O3)=O)=C(O)C=C2O)[C@H](C5=CC=C(O)C=C5)O6)=O)C6=C1,8.305664976159397,Inactive,558.52,3,6,7,11,3.715,194.21,0.293494857,-1983.881485,3.7394,-0.21492,-0.06216,0.15276,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-99,[0 0 0 ... 0 0 0],"[558.4950000000001, 558.1162115239998, 3.6977, 11, 7, 194.20999999999998, 4, 3, 41, 0.19375611795913392, 0.13333333333333333, 6]",558.4950000000001,558.1162115239998,3.6977,11,7,194.20999999999998,4,3,41,0.19375611795913392,0.13333333333333333,6,8.287939082939733,5.1530091907987865
724,Non-Steroid,OC1=C(C(/C=C/C2=CC=C(O)C=C2)=O)C=CC(O)=C1,8.265983373839362,Inactive,256.27,3,2,3,4,2.9,77.76,0.265174806,-879.6790363,2.717,-0.2138,-0.05863,0.15517,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-100,[0 0 0 ... 0 0 0],"[256.25699999999995, 256.073558864, 2.6995000000000005, 4, 3, 77.76, 2, 3, 19, 0.5825029725741742, 0.0, 2]",256.25699999999995,256.073558864,2.6995000000000005,4,3,77.76,2,3,19,0.5825029725741742,0.0,2,8.256713535525556,5.537152242363495
725,Non-Steroid,O=C1C2=C([H])C=C(O)C=C2O[C@H](C3=CC=C(O)C=C3)C1,8.189195002006803,Active,256.27,1,3,2,4,2.565,66.76,0.260550161,-879.7072141,1.3327,-0.2238,-0.04645,0.17735,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-101,[0 0 0 ... 0 0 0],"[256.257, 256.073558864, 2.8043000000000005, 4, 2, 66.76, 2, 1, 19, 0.8229096892671589, 0.13333333333333333, 3]",256.257,256.073558864,2.8043000000000005,4,2,66.76,2,1,19,0.8229096892671589,0.13333333333333333,3,8.22903687523301,5.901509692924229
726,Non-Steroid,O=C1C2=C(O)C=C(O)C=C2O[C@H](C3=CC=C([H])C=C3)C1,8.32530798304608,Inactive,256.27,1,3,2,4,2.565,66.76,0.258577516,-879.7225048,1.9177,-0.22059,-0.05293,0.16766,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-102,[0 0 0 ... 0 0 0],"[256.257, 256.073558864, 2.8043000000000005, 4, 2, 66.76, 2, 1, 19, 0.8229096892671589, 0.13333333333333333, 3]",256.257,256.073558864,2.8043000000000005,4,2,66.76,2,1,19,0.8229096892671589,0.13333333333333333,3,8.236082972544414,5.806534722973119
728,Non-Steroid,O=C1C2=C(O)C([H])=C(O)C([H])=C2OC(C3=CC([H])=C(OC)C([H])=C3)C1[H],8.303942893016451,Inactive,286.3,2,3,2,5,2.549,75.99,0.270201114,-994.2489208,2.9371,-0.22085,-0.05175,0.1691,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-103,[0 0 0 ... 0 0 0],"[286.283, 286.08412354800004, 2.812900000000001, 5, 2, 75.99000000000001, 2, 2, 21, 0.8874343900434254, 0.1875, 3]",286.283,286.08412354800004,2.812900000000001,5,2,75.99000000000001,2,2,21,0.8874343900434254,0.1875,3,8.244918351785728,5.6895988636399935
729,Non-Steroid,OC(C(O)=C1)=C(O)C=C1C2C(O)C(C3=C(O)C([H])=C(O)C([H])=C3O2)=O,8.301029995663981,Inactive,320.27,1,3,6,8,1.217,147.68,0.3452416,-1180.579445,4.265,-0.22082,-0.0565,0.16432,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-104,[0 0 0 ... 0 0 0],"[320.25300000000004, 320.05321734399996, 0.8918999999999997, 8, 6, 147.68, 2, 1, 23, 0.4244413087668663, 0.13333333333333333, 3]",320.25300000000004,320.05321734399996,0.8918999999999997,8,6,147.68,2,1,23,0.4244413087668663,0.13333333333333333,3,8.267378774516738,5.402829039611087
730,Non-Steroid,OC(C(O)=C1)=C([H])C=C1C2C(O)C(C3=C(O)C([H])=C(O)C(O)=C3O2)=O,8.304640283255823,Inactive,320.27,1,3,6,8,1.217,147.68,0.334328457,-1180.56271,2.8863,-0.1996,-0.05766,0.14194,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-105,[0 0 0 ... 0 0 0],"[320.25300000000004, 320.05321734399996, 0.8918999999999997, 8, 6, 147.68, 2, 1, 23, 0.33515044962189655, 0.13333333333333333, 3]",320.25300000000004,320.05321734399996,0.8918999999999997,8,6,147.68,2,1,23,0.33515044962189655,0.13333333333333333,3,8.274368166200729,5.316573641473499
734,Non-Steroid,OC1=CC(O)=C(C(C(C2=CC=C(OC)C=C2)=CO3)=O)C3=C1,8.309530136021838,Inactive,284.28,2,3,2,5,2.316,79.9,0.261442909,-993.0382233,3.7401,-0.20814,-0.05392,0.15422,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-106,[0 0 0 ... 0 0 0],"[284.26700000000005, 284.06847348400004, 2.8798000000000012, 5, 2, 79.9, 3, 2, 21, 0.7560099167404623, 0.0625, 3]",284.26700000000005,284.06847348400004,2.8798000000000012,5,2,79.9,3,2,21,0.7560099167404623,0.0625,3,8.23202164690017,5.86108949871301
735,Non-Steroid,CC1=CCC2=C1C([C@H](OC(C)=O)[C@H](C)C[C@@H](OC)/C=C(C)\C2)=O,8.175367847062448,Active,318.45,3,2,0,4,3.281,52.6,0.239549936,-1076.443807,0.625,-0.2232,-0.04449,0.17871,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-107,[0 0 0 ... 0 0 0],"[318.41300000000007, 318.18310931199994, 3.525000000000002, 4, 0, 52.6, 0, 2, 23, 0.5772133232397881, 0.5789473684210527, 2]",318.41300000000007,318.18310931199994,3.525000000000002,4,0,52.6,0,2,23,0.5772133232397881,0.5789473684210527,2,8.219038884107645,6.03894557880612
736,Non-Steroid,CC(C)C(C=C1)=CC2=C1[C@]3(C)C(CC2)[C@](C)(C(O)=O)CCC3,8.187430873131344,Active,300.48,2,3,1,2,5.364,37.3,0.2109406,-929.4699602,1.4133,-0.22102,-0.00083,0.22019,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-108,[0 1 0 ... 0 0 0],"[300.44200000000006, 300.208930136, 4.904900000000004, 1, 1, 37.3, 1, 2, 22, 0.8427040752295011, 0.65, 3]",300.44200000000006,300.208930136,4.904900000000004,1,1,37.3,1,2,22,0.8427040752295011,0.65,3,8.22177352928503,6.001039297282781
737,Non-Steroid,OC(C(C/C=C(C)/C)=C1O)=CC2=C1C(C3=C(CCC(C)C)C(O)=C(O)C=C3O2)=O,8.28725344223061,Inactive,398.49,5,3,4,6,5.858,111.13,0.272308182,-1343.460807,3.808,-0.20372,-0.05606,0.14766,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-109,[0 1 0 ... 0 0 0],"[398.4550000000001, 398.1729385519999, 4.865900000000004, 6, 4, 111.13, 3, 5, 29, 0.2772691855131097, 0.34782608695652173, 3]",398.4550000000001,398.1729385519999,4.865900000000004,6,4,111.13,3,5,29,0.2772691855131097,0.34782608695652173,3,8.268748541001035,5.385815340556448
738,Non-Steroid,OC(C(C/C=C(C)/C)=C1O)=CC2=C1C(C3=C(CCC(C)(O)C)C(OC)=C(O)C=C3O2)=O,8.277037465902554,Inactive,428.52,6,3,4,7,4.758,120.36,0.277174814,-1457.975442,3.4789,-0.20722,-0.0544,0.15282,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-110,[0 0 0 ... 0 0 0],"[428.48100000000017, 428.18350323599986, 4.283800000000004, 7, 4, 120.36000000000001, 3, 6, 31, 0.3414764404326362, 0.375, 3]",428.48100000000017,428.18350323599986,4.283800000000004,7,4,120.36000000000001,3,6,31,0.3414764404326362,0.375,3,8.276476857151518,5.290821903901048
739,Non-Steroid,OC(C(C/C=C(C)/C)=C1O)=CC2=C1C(C3=C(CCC(C)C)C(OC)=C(O)C=C3O2)=O,8.329380364034753,Inactive,412.52,6,3,3,6,6.109,100.13,0.26007631,-1382.759344,3.0312,-0.20887,-0.05634,0.15253,Natural compounds with aromatase inhibitory activity: an update,Planta Med. 2010;76(11):1087-111,[0 1 0 ... 0 0 0],"[412.48200000000014, 412.1885886159999, 5.168900000000004, 6, 3, 100.13, 3, 6, 30, 0.3814944822579883, 0.375, 3]",412.48200000000014,412.1885886159999,5.168900000000004,6,3,100.13,3,6,30,0.3814944822579883,0.375,3,8.276341268201021,5.292473983342871
742,Non-Steroid,O=C(C1=CC=CC(OC)=C1CC/2)C2=C\C3=CC=NC=C3,8.283941583716755,Inactive,265.33,2,3,0,3,3.096,39.19,0.195724514,-862.0251156,5.0576,-0.22698,-0.07595,0.15103,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-91,[0 0 0 ... 0 0 0],"[265.31199999999995, 265.11027872, 3.3027000000000015, 3, 0, 39.19, 2, 2, 20, 0.7819886294803063, 0.17647058823529413, 3]",265.31199999999995,265.11027872,3.3027000000000015,3,0,39.19,2,2,20,0.7819886294803063,0.17647058823529413,3,8.28234857899954,5.219770649028926
743,Non-Steroid,O=C(C1=CC=C(OC)C=C1CC/2)C2=C\C3=CC=NC=C3,8.29665616631788,Inactive,265.33,2,3,0,3,3.096,39.19,0.204739257,-862.0281075,4.7077,-0.23055,-0.07305,0.1575,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-92,[0 0 0 ... 0 0 0],"[265.31199999999995, 265.11027872, 3.3027000000000015, 3, 0, 39.19, 2, 2, 20, 0.7819886294803063, 0.17647058823529413, 3]",265.31199999999995,265.11027872,3.3027000000000015,3,0,39.19,2,2,20,0.7819886294803063,0.17647058823529413,3,8.28234857899954,5.219770649028926
744,Non-Steroid,O=C(C1=CC(OC)=CC=C1CC/2)C2=C\C3=CC=NC=C3,8.311041502206791,Inactive,265.33,2,3,0,3,3.096,39.19,0.202723057,-862.0262956,2.7923,-0.22474,-0.07889,0.14585,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-93,[0 0 0 ... 0 0 0],"[265.31199999999995, 265.11027872, 3.3027000000000015, 3, 0, 39.19, 2, 2, 20, 0.7819886294803063, 0.17647058823529413, 3]",265.31199999999995,265.11027872,3.3027000000000015,3,0,39.19,2,2,20,0.7819886294803063,0.17647058823529413,3,8.28234857899954,5.219770649028926
745,Non-Steroid,O=C(C1=CC=CC(O)=C1CC/2)C2=C\C3=CC=NC=C3,8.210338153624491,Active,251.3,1,3,1,3,2.845,50.19,0.208318125,-822.7187177,4.7331,-0.23075,-0.0776,0.15315,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-94,[0 0 0 ... 0 0 0],"[251.28499999999997, 251.094628656, 2.9997000000000007, 3, 1, 50.19, 2, 1, 19, 0.7925275768859943, 0.125, 3]",251.28499999999997,251.094628656,2.9997000000000007,3,1,50.19,2,1,19,0.7925275768859943,0.125,3,8.247675997056195,5.65358600105643
746,Non-Steroid,O=C(C1=CC=C(O)C=C1CC/2)C2=C\C3=CC=NC=C3,8.295377547504238,Inactive,251.3,1,3,1,3,2.845,50.19,0.216879656,-822.7217323,4.0482,-0.23475,-0.07442,0.16033,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-95,[0 0 0 ... 0 0 0],"[251.28499999999997, 251.094628656, 2.9997000000000007, 3, 1, 50.19, 2, 1, 19, 0.7925275768859943, 0.125, 3]",251.28499999999997,251.094628656,2.9997000000000007,3,1,50.19,2,1,19,0.7925275768859943,0.125,3,8.28405305731167,5.199324730360331
747,Non-Steroid,O=C(C1=CC(O)=CC=C1CC/2)C2=C\C3=CC=NC=C3,8.257834491622507,Inactive,251.3,1,3,1,3,2.845,50.19,0.215533875,-822.7195628,2.3595,-0.22867,-0.08096,0.14771,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-96,[0 0 0 ... 0 0 0],"[251.28499999999997, 251.094628656, 2.9997000000000007, 3, 1, 50.19, 2, 1, 19, 0.7925275768859943, 0.125, 3]",251.28499999999997,251.094628656,2.9997000000000007,3,1,50.19,2,1,19,0.7925275768859943,0.125,3,8.28405305731167,5.199324730360331
748,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=CC=CC=C31,8.270306313551282,Inactive,237.32,2,3,0,2,3.152,29.96,0.183772788,-748.7229294,5.4438,-0.24108,-0.05777,0.18331,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-97,[0 0 0 ... 0 0 0],"[237.302, 237.1153641, 3.0694000000000017, 2, 0, 29.96, 2, 2, 18, 0.8030904438701663, 0.25, 3]",237.302,237.1153641,3.0694000000000017,2,0,29.96,2,2,18,0.8030904438701663,0.25,3,8.272565429509322,5.33868836430991
749,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=C(OC)C=CC=C31,8.247369502068667,Inactive,267.35,3,3,0,3,3.135,39.19,0.196131405,-863.2455692,6.5671,-0.22705,-0.05349,0.17356,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-98,[0 0 0 ... 0 0 0],"[267.328, 267.125928784, 3.078000000000001, 3, 0, 39.19, 2, 3, 20, 0.8575496994202955, 0.29411764705882354, 3]",267.328,267.125928784,3.078000000000001,3,0,39.19,2,3,20,0.8575496994202955,0.29411764705882354,3,8.263418252027765,5.452325160532161
750,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=CC(OC)=CC=C31,8.261101686010912,Inactive,267.35,3,3,0,3,3.135,39.19,0.204456784,-863.2480073,5.6214,-0.23038,-0.04821,0.18217,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-99,[0 0 0 ... 0 0 0],"[267.328, 267.125928784, 3.078000000000001, 3, 0, 39.19, 2, 3, 20, 0.8575496994202955, 0.29411764705882354, 3]",267.328,267.125928784,3.078000000000001,3,0,39.19,2,3,20,0.8575496994202955,0.29411764705882354,3,8.267205852781974,5.404980696219339
751,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=CC=C(OC)C=C31,8.29222780397738,Inactive,267.35,3,3,0,3,3.135,39.19,0.203071405,-863.246346,4.1896,-0.22465,-0.05682,0.16783,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-100,[0 0 0 ... 0 0 0],"[267.328, 267.125928784, 3.078000000000002, 3, 0, 39.19, 2, 3, 20, 0.8575496994202955, 0.29411764705882354, 3]",267.328,267.125928784,3.078000000000002,3,0,39.19,2,3,20,0.8575496994202955,0.29411764705882354,3,8.267205852781974,5.404980696219339
752,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=C(O)C=CC=C31,8.173991966846375,Active,253.32,2,3,1,3,2.884,50.19,0.209591353,-823.9411363,4.7609,-0.23089,-0.05826,0.17263,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-101,[0 0 0 ... 0 0 0],"[253.301, 253.11027872, 2.7750000000000012, 3, 1, 50.19, 2, 2, 19, 0.8949216632838944, 0.25, 3]",253.301,253.11027872,2.7750000000000012,3,1,50.19,2,2,19,0.8949216632838944,0.25,3,8.225418196913289,5.95088836284128
753,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=CC(O)=CC=C31,8.283361688565918,Inactive,253.32,2,3,1,3,2.884,50.19,0.215901765,-823.9416688,5.0342,-0.23469,-0.04952,0.18517,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-102,[0 0 0 ... 0 0 0],"[253.301, 253.11027872, 2.7750000000000012, 3, 1, 50.19, 2, 2, 19, 0.8949216632838944, 0.25, 3]",253.301,253.11027872,2.7750000000000012,3,1,50.19,2,2,19,0.8949216632838944,0.25,3,8.260921060637108,5.483766313218444
754,Non-Steroid,O=C1C(CC2=CC=NC=C2)CCC3=CC=C(O)C=C31,8.27492151621313,Inactive,253.32,2,3,1,3,2.884,50.19,0.215243294,-823.9396032,4.2097,-0.22867,-0.05927,0.1694,New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives,J Med Chem. 1991;34(9):2685-103,[0 0 0 ... 0 0 0],"[253.301, 253.11027872, 2.7750000000000012, 3, 1, 50.19, 2, 2, 19, 0.8949216632838944, 0.25, 3]",253.301,253.11027872,2.7750000000000012,3,1,50.19,2,2,19,0.8949216632838944,0.25,3,8.260921060637108,5.483766313218444
755,Non-Steroid,[H]C1=CC=C(C(/C(C(C2=CC=CC=C2)O3)=C/C4=CC=NC=C4)=O)C3=C1,8.214890214875727,Active,313.37,2,4,0,3,3.861,39.19,0.173541051,-1014.441981,2.6103,-0.23058,-0.08691,0.14367,New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives,Bioorg Med Chem Lett. 2002;12(7):1059-61,[0 0 0 ... 0 0 0],"[313.35600000000005, 313.11027872, 4.481600000000003, 3, 0, 39.19, 3, 2, 24, 0.6547401349672944, 0.047619047619047616, 4]",313.35600000000005,313.11027872,4.481600000000003,3,0,39.19,3,2,24,0.6547401349672944,0.047619047619047616,4,8.23301870522087,5.8476489756583385
756,Non-Steroid,[H]C1=CC=C(C(/C(C(C2=CC=CC=C2)O3)=C\C4=CC=NC=C4)=O)C3=C1,8.261101686010912,Inactive,313.37,2,4,0,3,3.861,39.19,0.174359026,-1014.44569,4.3977,-0.23555,-0.08346,0.15209,New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives,Bioorg Med Chem Lett. 2002;12(7):1059-62,[0 0 0 ... 0 0 0],"[313.35600000000005, 313.11027872, 4.481600000000003, 3, 0, 39.19, 3, 2, 24, 0.6547401349672944, 0.047619047619047616, 4]",313.35600000000005,313.11027872,4.481600000000003,3,0,39.19,3,2,24,0.6547401349672944,0.047619047619047616,4,8.23301870522087,5.8476489756583385
757,Non-Steroid,O=C1C2=CC=C(OC)C=C2OC(C3=CC=CC=C3)/C1=C\C4=CC=NC=C4,8.207075694091682,Active,343.4,3,4,0,4,3.845,48.42,0.194750488,-1128.974749,3.904,-0.22816,-0.08183,0.14633,New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives,Bioorg Med Chem Lett. 2002;12(7):1059-63,[0 0 0 ... 0 0 0],"[343.38200000000006, 343.120843404, 4.490200000000003, 4, 0, 48.42, 3, 3, 26, 0.6575434172134831, 0.09090909090909091, 4]",343.38200000000006,343.120843404,4.490200000000003,4,0,48.42,3,3,26,0.6575434172134831,0.09090909090909091,4,8.239514399730256,5.76083717263374
758,Non-Steroid,O=C1C2=CC=C(OC)C=C2OC(C3=CC=CC=C3)/C1=C/C4=CC=NC=C4,8.236880613624288,Inactive,343.4,3,4,0,4,3.845,48.42,0.193365512,-1128.970702,4.5632,-0.23045,-0.07742,0.15303,New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives,Bioorg Med Chem Lett. 2002;12(7):1059-64,[0 0 0 ... 0 0 0],"[343.38200000000006, 343.120843404, 4.490200000000003, 4, 0, 48.42, 3, 3, 26, 0.6575434172134831, 0.09090909090909091, 4]",343.38200000000006,343.120843404,4.490200000000003,4,0,48.42,3,3,26,0.6575434172134831,0.09090909090909091,4,8.239514399730256,5.76083717263374
759,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=CC=C2[N+]([O-])=O)OC4=CC=CC=C41,8.35675069901751,Inactive,321.31,3,4,0,5,2.535,93.85,0.215689486,-1119.475715,4.6812,-0.23158,-0.09281,0.13877,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-51,[0 0 0 ... 0 0 0],"[321.2920000000001, 321.07495583200006, 3.0992000000000015, 6, 0, 91.17, 4, 3, 24, 0.32834513050861935, 0.058823529411764705, 4]",321.2920000000001,321.07495583200006,3.0992000000000015,6,0,91.17,4,3,24,0.32834513050861935,0.058823529411764705,4,8.222048983930849,5.997234298335486
760,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=CC([N+]([O-])=O)=C2)OC4=CC=CC=C41,8.368990323267674,Inactive,321.31,3,4,0,5,2.535,93.85,0.225160771,-1119.492874,4.8579,-0.23234,-0.09986,0.13248,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-52,[0 0 0 ... 0 0 0],"[321.2920000000001, 321.07495583200006, 3.0992000000000015, 6, 0, 91.17, 4, 3, 24, 0.32834513050861935, 0.058823529411764705, 4]",321.2920000000001,321.07495583200006,3.0992000000000015,6,0,91.17,4,3,24,0.32834513050861935,0.058823529411764705,4,8.313725209922403,4.855956527209549
761,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=C([N+]([O-])=O)C=C2)OC4=CC=CC=C41,8.56523213264831,Inactive,321.31,3,4,0,5,2.535,93.85,0.217523029,-1119.483389,3.8955,-0.22811,-0.11199,0.11612,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-53,[0 0 0 ... 0 0 0],"[321.2920000000001, 321.07495583200006, 3.0992000000000015, 6, 0, 91.17, 4, 3, 24, 0.32834513050861935, 0.058823529411764705, 4]",321.2920000000001,321.07495583200006,3.0992000000000015,6,0,91.17,4,3,24,0.32834513050861935,0.058823529411764705,4,8.500112348667935,3.1614597088756207
762,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=CC=C2[N+]([O-])=O)SC4=CC=CC=C41,8.320343563272335,Inactive,337.38,3,4,0,4,3.094,108.95,0.202612571,-1442.436879,3.8907,-0.23141,-0.09473,0.13668,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-54,[0 0 0 ... 0 0 0],"[337.36000000000007, 337.05211221200005, 3.567700000000002, 6, 0, 78.03, 4, 3, 24, 0.32517591050967704, 0.058823529411764705, 4]",337.36000000000007,337.05211221200005,3.567700000000002,6,0,78.03,4,3,24,0.32517591050967704,0.058823529411764705,4,8.292452527396588,5.0997333956556075
763,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=CC=C2[N+]([O-])=O)OC4=NC=CC=C41,8.398409449517013,Inactive,322.3,3,4,0,6,1.924,106.74,0.227317647,-1135.517773,5.284,-0.23696,-0.1007,0.13626,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-55,[0 0 0 ... 0 0 0],"[322.2800000000001, 322.0702048, 2.4942, 7, 0, 104.06, 4, 3, 24, 0.3259106567899511, 0.0625, 4]",322.2800000000001,322.0702048,2.4942,7,0,104.06,4,3,24,0.3259106567899511,0.0625,4,8.332023433471893,4.655609723097051
764,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=CC=C2[H])OC4=CC=CC=C41,8.321522495821112,Inactive,276.31,2,4,0,3,2.641,48.03,0.196691879,-914.9944986,2.8794,-0.22262,-0.07261,0.15001,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-56,[0 0 0 ... 0 0 0],"[276.2950000000001, 276.089877624, 3.1910000000000016, 4, 0, 48.03, 4, 2, 21, 0.528192006706474, 0.058823529411764705, 4]",276.2950000000001,276.089877624,3.1910000000000016,4,0,48.03,4,2,21,0.528192006706474,0.058823529411764705,4,8.31898722702726,4.797475582158523
765,Non-Steroid,O=C1C2=C(C(CN3C=NC=C3)=CC=C2[H])SC4=CC=CC=C41,8.267596836355661,Inactive,292.38,2,4,0,2,3.199,63.13,0.178261939,-1237.956783,2.787,-0.22255,-0.07547,0.14708,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-57,[0 0 0 ... 0 0 0],"[292.36300000000006, 292.067034004, 3.659500000000002, 4, 0, 34.89, 4, 2, 21, 0.5284559753511798, 0.058823529411764705, 4]",292.36300000000006,292.067034004,3.659500000000002,4,0,34.89,4,2,21,0.5284559753511798,0.058823529411764705,4,8.376870393281326,4.198842715676826
766,Non-Steroid,O=C1C2=C(C=C(CN3C=NC=C3)C=C2[H])OC4=CC=CC=C41,8.467381229551243,Inactive,276.31,2,4,0,3,2.641,48.03,0.20259097,-914.9953396,0.7708,-0.2292,-0.07076,0.15844,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-58,[0 0 0 ... 0 0 0],"[276.295, 276.089877624, 3.1910000000000016, 4, 0, 48.03, 4, 2, 21, 0.528192006706474, 0.058823529411764705, 4]",276.295,276.089877624,3.1910000000000016,4,0,48.03,4,2,21,0.528192006706474,0.058823529411764705,4,8.366931218669896,4.296044599258788
767,Non-Steroid,O=C1C2=C(C=CC(CN3C=NC=C3)=C2[H])OC4=CC=CC=C41,8.677290248366324,Inactive,276.31,2,4,0,3,2.641,48.03,0.203579152,-914.9957766,4.2494,-0.22494,-0.07328,0.15166,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-59,[0 0 0 ... 0 0 0],"[276.295, 276.089877624, 3.1910000000000016, 4, 0, 48.03, 4, 2, 21, 0.528192006706474, 0.058823529411764705, 4]",276.295,276.089877624,3.1910000000000016,4,0,48.03,4,2,21,0.528192006706474,0.058823529411764705,4,8.363342102733808,4.33169527376667
768,Non-Steroid,O=C1C2=C(C=CC=C2CCN3C=NC=C3)OC4=CC=CC=C41,8.417492480871108,Inactive,290.34,3,4,0,3,2.962,48.03,0.195931278,-954.3046417,6.7553,-0.21618,-0.07104,0.14514,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-60,[0 0 0 ... 0 0 0],"[290.322, 290.105527688, 3.3854000000000024, 4, 0, 48.03, 4, 3, 22, 0.5433699042716724, 0.1111111111111111, 4]",290.322,290.105527688,3.3854000000000024,4,0,48.03,4,3,22,0.5433699042716724,0.1111111111111111,4,8.358682257704718,4.378423260023431
769,Non-Steroid,O=[N+](C1=CC(OC2=CC=CC=C2)=C(CN3C=NC=C3)C=C1)[O-],8.306168049518838,Inactive,295.32,5,3,0,4,2.961,72.87,0.212082857,-1007.343178,5.2453,-0.23161,-0.09163,0.13998,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-61,[0 0 0 ... 0 0 0],"[295.298, 295.095691276, 3.6319000000000017, 5, 0, 70.19, 3, 5, 22, 0.532046496255504, 0.0625, 3]",295.298,295.095691276,3.6319000000000017,5,0,70.19,3,5,22,0.532046496255504,0.0625,3,8.204180558594132,6.249128302967174
770,Non-Steroid,O=[N+](C1=CC(SC2=CC=CC=C2)=C(CN3C=NC=C3)C=C1)[O-],8.279626646970101,Inactive,311.39,5,3,0,3,3.519,88.94,0.189724829,-1330.313064,4.3125,-0.23395,-0.09797,0.13598,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-62,[0 0 0 ... 0 0 0],"[311.36600000000004, 311.072847656, 3.990800000000003, 5, 0, 60.959999999999994, 3, 5, 22, 0.5277767652322426, 0.0625, 3]",311.36600000000004,311.072847656,3.990800000000003,5,0,60.959999999999994,3,5,22,0.5277767652322426,0.0625,3,8.24813397386952,5.647627264100385
771,Non-Steroid,[H]C1=CC(OC2=CC=CC=C2)=C(CN3C=NC=C3)C=C1,8.467267633290824,Inactive,250.32,4,3,0,2,3.067,27.05,0.182307848,-802.8425771,4.9793,-0.22076,-0.01619,0.20457,"Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation",J Med Chem. 2010;53(14):5347-63,[0 0 0 ... 0 0 0],"[250.301, 250.110613068, 3.723700000000002, 3, 0, 27.05, 3, 4, 19, 0.7052101715022018, 0.0625, 3]",250.301,250.110613068,3.723700000000002,3,0,27.05,3,4,19,0.7052101715022018,0.0625,3,8.351901761443049,4.447318556104333
773,Non-Steroid,O=C(C1=CC([H])=CC=C1CC/2)C2=C\C3C=NC=N3,8.181442462950777,Active,224.28,1,3,0,3,2.502,41.79,0.191116103,-725.4026425,4.6317,-0.24918,-0.07377,0.17541,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-304,[0 0 0 ... 0 0 0],"[224.263, 224.094963004, 2.2232000000000003, 3, 0, 41.79, 1, 1, 17, 0.6742501560883769, 0.21428571428571427, 3]",224.263,224.094963004,2.2232000000000003,3,0,41.79,1,1,17,0.6742501560883769,0.21428571428571427,3,8.239474827283416,5.7613621178467
774,Non-Steroid,O=C(C1=CC([H])=CC=C1CC/2)C2=C/C3C=NC=N3,8.169440130484347,Active,224.28,1,3,0,3,2.502,41.79,0.191116103,-725.4026425,4.6317,-0.24918,-0.07377,0.17541,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-305,[0 0 0 ... 0 0 0],"[224.263, 224.094963004, 2.2232000000000003, 3, 0, 41.79, 1, 1, 17, 0.6742501560883769, 0.21428571428571427, 3]",224.263,224.094963004,2.2232000000000003,3,0,41.79,1,1,17,0.6742501560883769,0.21428571428571427,3,8.239474827283416,5.7613621178467
775,Non-Steroid,O=C(C1=CC(OC)=CC=C1CC/2)C2=C\C3C=NC=N3,8.131519193744829,Active,254.31,2,3,0,4,2.485,51.02,0.215153212,-839.926113,0.9321,-0.22065,-0.0698,0.15085,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-306,[0 0 0 ... 0 0 0],"[254.289, 254.105527688, 2.2318, 4, 0, 51.019999999999996, 1, 2, 19, 0.7598232080355627, 0.26666666666666666, 3]",254.289,254.105527688,2.2318,4,0,51.019999999999996,1,2,19,0.7598232080355627,0.26666666666666666,3,8.290646906759626,5.120980159666642
776,Non-Steroid,COC1=CC=C(CCC2C3C2C4=CC=NC=C4)C3=C1,8.123615938154465,Active,251.35,2,4,0,2,3.136,22.12,0.185128167,-787.9877738,3.3918,-0.20783,-0.02,0.18783,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-307,[0 0 0 ... 0 0 0],"[251.32900000000004, 251.131014164, 3.5336000000000025, 2, 0, 22.12, 2, 2, 19, 0.8142066276314464, 0.35294117647058826, 4]",251.32900000000004,251.131014164,3.5336000000000025,2,0,22.12,2,2,19,0.8142066276314464,0.35294117647058826,4,8.143590676307884,7.184711331924287
777,Non-Steroid,C12=NC=CC=C1C(CCN3C=CN=C3)=CCC2,8.200588452924745,Active,225.32,3,3,0,2,1.713,30.71,0.187048688,-706.7630007,2.8193,-0.22287,-0.04047,0.1824,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-308,[0 0 0 ... 0 0 0],"[225.295, 225.12659748, 2.6980000000000013, 3, 0, 30.71, 2, 3, 17, 0.8037123748764268, 0.2857142857142857, 3]",225.295,225.12659748,2.6980000000000013,3,0,30.71,2,3,17,0.8037123748764268,0.2857142857142857,3,8.220761208965191,6.015043757436415
780,Non-Steroid,CCN1C2=C(C=CC=C2)C(C(N3C=CN=C3)C4=CC=CC=C4)=C1,8.154901959985743,Active,301.42,4,4,0,1,3.967,22.75,0.167743762,-937.8251833,6.2203,-0.20432,-0.01387,0.19045,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-309,[0 1 0 ... 0 0 0],"[301.39300000000003, 301.15789760800004, 4.495400000000004, 3, 0, 22.75, 4, 4, 23, 0.5441385220462859, 0.15, 4]",301.39300000000003,301.15789760800004,4.495400000000004,3,0,22.75,4,4,23,0.5441385220462859,0.15,4,8.16922195343806,6.772952760978618
781,Non-Steroid,CCN1C2=C(C=CC=C2)C(C(N3C=CN=C3)C4=CC=C(F)C=C4)=C1,8.130889194765137,Active,319.41,4,4,0,2,4.173,22.75,0.182736214,-1037.057654,4.0698,-0.20396,-0.01778,0.18618,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-310,[0 1 0 ... 0 0 0],"[319.38300000000004, 319.148475796, 4.634500000000004, 3, 0, 22.75, 4, 4, 24, 0.5373788912163184, 0.15, 4]",319.38300000000004,319.148475796,4.634500000000004,3,0,22.75,4,4,24,0.5373788912163184,0.15,4,8.15423016509034,7.010836433470514
782,Non-Steroid,FC(C=C1)=CC=C1C(C2=CC(C=CC=C3)=C3O2)N4N=CN=C4,8.17255018319399,Active,293.32,3,4,0,4,3.792,43.85,0.208894559,-994.3246088,3.5071,-0.23209,-0.037,0.19509,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-311,[0 1 0 ... 0 0 0],"[293.301, 293.096440224, 3.8011000000000035, 4, 0, 43.85, 4, 3, 22, 0.5768043931380165, 0.058823529411764705, 4]",293.301,293.096440224,3.8011000000000035,4,0,43.85,4,3,22,0.5768043931380165,0.058823529411764705,4,8.145218509203856,7.157831832858252
783,Non-Steroid,BrC(C=C1)=CC=C1CN(C2=CC=C([N+]([O-])=O)C=C2)N3N=CN=C3,7.977865433736294,Active,374.22,5,3,0,5,3.827,79.77,0.211328114,-3574.586085,4.6676,-0.24881,-0.086,0.16281,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-312,[0 0 0 ... 0 0 0],"[374.19800000000004, 373.01743672400005, 3.418700000000002, 6, 0, 77.08999999999999, 3, 5, 23, 0.5052881708491825, 0.06666666666666667, 3]",374.19800000000004,373.01743672400005,3.418700000000002,6,0,77.08999999999999,3,5,23,0.5052881708491825,0.06666666666666667,3,8.130792297797182,7.39959077353863
784,Non-Steroid,BrC(C=C1)=CC=C1CN(C2=CC=C(C#N)C=C2)N3N=CN=C3,8.003452484532211,Active,354.23,4,3,0,4,3.812,57.74,0.198834882,-3462.327315,5.4889,-0.23538,-0.0445,0.19088,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-313,[0 0 0 ... 0 0 0],"[354.211, 353.02760748400004, 3.3821800000000026, 5, 0, 57.74, 3, 4, 22, 0.720803730982883, 0.0625, 3]",354.211,353.02760748400004,3.3821800000000026,5,0,57.74,3,4,22,0.720803730982883,0.0625,3,8.018862571068702,9.574970154474707
787,Non-Steroid,FC1=CC=C(CCCC(C2N=CNC2)C3=CC=C(C#N)C=C3)C=C1,8.17255018319399,Active,321.43,6,3,1,4,4.338,48.18,0.200117432,-1038.238531,6.6692,-0.23069,-0.04053,0.19016,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-314,[0 1 0 ... 0 0 0],"[321.39900000000006, 321.16412586, 3.803980000000002, 3, 1, 48.18, 2, 6, 24, 0.8794107065470734, 0.3, 3]",321.39900000000006,321.16412586,3.803980000000002,3,1,48.18,2,6,24,0.8794107065470734,0.3,3,8.18968990351172,6.4611540598619355
788,Non-Steroid,O=[N+](C1=CC=C(CCN2C=CN=C2)C=C1)[O-],8.16775429731547,Active,217.25,4,2,0,3,1.722,63.64,0.208039815,-740.3947718,1.6459,-0.23062,-0.09548,0.13514,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-315,[0 0 0 ... 0 0 0],"[217.22800000000004, 217.085126592, 2.034, 4, 0, 60.959999999999994, 2, 4, 16, 0.5811523175537564, 0.18181818181818182, 2]",217.22800000000004,217.085126592,2.034,4,0,60.959999999999994,2,4,16,0.5811523175537564,0.18181818181818182,2,8.196287844490998,6.3637360131211755
789,Non-Steroid,FC(C=C1)=CC=C1CCCN2C=CN=C2,8.186509862130398,Active,204.27,4,2,0,2,2.49,17.82,0.189681571,-674.4402047,3.6627,-0.22148,-0.01559,0.20589,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-316,[0 0 0 ... 0 0 0],"[204.24800000000002, 204.106276636, 2.6550000000000002, 2, 0, 17.82, 2, 4, 15, 0.7482426433218491, 0.25, 2]",204.24800000000002,204.106276636,2.6550000000000002,2,0,17.82,2,4,15,0.7482426433218491,0.25,2,8.222986748074396,5.984298550826281
790,Non-Steroid,CC1=C(C(OCC)=O)C(C2=CC=CC(N3C=NC=C3)=C2)C(C(OCC)=O)=C(C)N1,8.073467333970294,Active,395.5,8,3,1,6,2.239,82.45,0.252007519,-1318.551139,9.3438,-0.21218,-0.04959,0.16259,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-317,[0 0 0 ... 0 0 0],"[395.45900000000023, 395.18450628, 3.2333000000000016, 7, 1, 82.45000000000002, 2, 6, 29, 0.7564506820088096, 0.3181818181818182, 3]",395.45900000000023,395.18450628,3.2333000000000016,7,1,82.45000000000002,2,6,29,0.7564506820088096,0.3181818181818182,3,8.120037724444572,7.585116850028889
791,Non-Steroid,CC1=C(C(OCC)=O)C(C2=CC=CC(N3C=NC=C3)=C2)C(C#N)=C(C)N1,8.047759499536678,Active,348.44,5,3,1,5,1.914,79.94,0.250883348,-1143.599844,7.0019,-0.21837,-0.05342,0.16495,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-318,[0 0 0 ... 0 0 0],"[348.4060000000001, 348.15862588000005, 3.193780000000001, 6, 1, 79.94, 2, 4, 26, 0.8584668401905148, 0.25, 3]",348.4060000000001,348.15862588000005,3.193780000000001,6,1,79.94,2,4,26,0.8584668401905148,0.25,3,8.047306634153374,8.96795387431283
792,Non-Steroid,CC1=C(C#N)C(C2=CC=CC(N3C=NC=C3)=C2)C(C#N)=C(C)N1,8.05825371954857,Active,301.38,2,3,1,4,1.589,77.43,0.247954816,-968.6651555,6.4064,-0.22683,-0.06579,0.16104,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-319,[0 0 0 ... 0 0 0],"[301.353, 301.13274548000004, 3.1542600000000007, 5, 1, 77.43, 2, 2, 23, 0.9239272476810251, 0.16666666666666666, 3]",301.353,301.13274548000004,3.1542600000000007,5,1,77.43,2,2,23,0.9239272476810251,0.16666666666666666,3,8.08761716474473,8.17302514859209
793,Non-Steroid,O=C(C(C=CC=C1)=C1O2)C3=C2C(CN4C=NC=C4)=CC=C3C#N,8.132736947129581,Active,301.32,2,4,0,4,2.52,71.82,0.207112088,-1007.229108,7.032,-0.23748,-0.0929,0.14458,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-320,[0 0 0 ... 0 0 0],"[301.305, 301.08512659200005, 3.062680000000001, 5, 0, 71.82, 4, 2, 23, 0.533385875082084, 0.05555555555555555, 4]",301.305,301.08512659200005,3.062680000000001,5,0,71.82,4,2,23,0.533385875082084,0.05555555555555555,4,8.137941934223006,7.278771162153465
794,Non-Steroid,O=C(C(C=CC=C1)=C1O2)C3=C2C(CN4C=NC=C4)=CC=C3[N+]([O-])=O,8.130889194765137,Active,321.31,3,4,0,5,2.535,93.85,0.215336943,-1119.476756,6.6374,-0.23741,-0.09181,0.1456,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-321,[0 0 0 ... 0 0 0],"[321.29200000000003, 321.074955832, 3.0992000000000015, 6, 0, 91.16999999999999, 4, 3, 24, 0.32834513050861935, 0.058823529411764705, 4]",321.29200000000003,321.074955832,3.0992000000000015,6,0,91.16999999999999,4,3,24,0.32834513050861935,0.058823529411764705,4,8.222048983930849,5.997234298335486
795,Non-Steroid,BrC(C(OC1=C2C=CC=C1)=C3C2=O)=CC=C3CN4C=NC=C4,8.13213489284645,Active,355.2,2,4,0,3,3.389,48.03,0.192979152,-3486.091915,5.6113,-0.21295,-0.08605,0.1269,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-322,[0 0 0 ... 0 0 0],"[355.1910000000001, 354.00038969200006, 3.9535000000000036, 4, 0, 48.03, 4, 2, 22, 0.5117248787124429, 0.058823529411764705, 4]",355.1910000000001,354.00038969200006,3.9535000000000036,4,0,48.03,4,2,22,0.5117248787124429,0.058823529411764705,4,8.192653830550954,6.417208786208021
797,Non-Steroid,OC1=CC(O)=CC(O)=C1C(/C=C/C2=CC=C(O)C=C2)=O,8.2529747500705,Inactive,272.27,3,2,4,5,2.632,97.99,0.299295281,-954.9155943,5.974,-0.21333,-0.07551,0.13782,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-323,[0 0 0 ... 0 0 0],"[272.25600000000003, 272.068473484, 2.4051, 5, 4, 97.99000000000001, 2, 3, 20, 0.5078021958672847, 0.0, 2]",272.25600000000003,272.068473484,2.4051,5,4,97.99000000000001,2,3,20,0.5078021958672847,0.0,2,8.251560788179912,5.603239833513126
798,Non-Steroid,OC1=CC(O)=CC(O)=C1C(/C=C/C2=CC=C(O)C(O)=C2)=O,8.255484686147076,Inactive,288.27,3,2,5,6,2.365,118.22,0.325735242,-1030.13299,4.9995,-0.21371,-0.07656,0.13715,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-324,[0 0 0 ... 0 0 0],"[288.255, 288.063388104, 2.1107000000000005, 6, 5, 118.22, 2, 3, 21, 0.3351830044490491, 0.0, 2]",288.255,288.063388104,2.1107000000000005,6,5,118.22,2,3,21,0.3351830044490491,0.0,2,8.280631969121515,5.240443353903206
799,Non-Steroid,CC1=CCC2C1[C@@H](OC(C3=C)=O)[C@H]3CC[C@@]2(O)C,8.287779590057651,Inactive,248.35,0,3,1,3,2.208,46.53,0.245006368,-809.2714432,4.8179,-0.23676,-0.04153,0.19523,Nonsteroidal aromatase inhibitors: recent advances,Med Res Rev. 2002;22(3):282-325,[0 0 0 ... 0 0 0],"[248.32199999999995, 248.1412445, 2.2114000000000003, 3, 1, 46.53, 0, 0, 18, 0.40598593548882295, 0.6666666666666666, 3]",248.32199999999995,248.1412445,2.2114000000000003,3,1,46.53,0,0,18,0.40598593548882295,0.6666666666666666,3,8.128642474516862,7.436310675033074
800,Non-Steroid,COC(C=C1)=CC2=C1CCC3C2C3C4=CC=NC=C4,8.05256035125915,Active,251.35,2,4,0,2,3.136,22.12,0.186469667,-787.9859796,3.2728,-0.21108,-0.02067,0.19041,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-64,[0 0 0 ... 0 0 0],"[251.329, 251.131014164, 3.5336000000000016, 2, 0, 22.12, 2, 2, 19, 0.8142066276314464, 0.35294117647058826, 4]",251.329,251.131014164,3.5336000000000016,2,0,22.12,2,2,19,0.8142066276314464,0.35294117647058826,4,8.143590676307884,7.184711331924287
801,Non-Steroid,O=C1C(C(C2CCC([N+]([O-])=O)CC2)N3C=CN=C3)=COC4=CC=CC=C14,8.063573116859333,Active,353.41,4,4,0,5,2.655,93.85,0.202448378,-1200.515583,6.4619,-0.22947,-0.07273,0.15674,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-65,[0 1 0 ... 0 0 0],"[353.3780000000001, 353.137556088, 3.4144000000000023, 6, 0, 91.17, 3, 4, 26, 0.5293228172699422, 0.3684210526315789, 4]",353.3780000000001,353.137556088,3.4144000000000023,6,0,91.17,3,4,26,0.5293228172699422,0.3684210526315789,4,8.199711407738766,6.313767601710077
804,Non-Steroid,O=C(C1=CC=CC(CN2C=CN=C2)=C1)C3=CC=C(C4=CC=CC=C4)C=C3,8.082193994905241,Active,338.43,5,4,0,2,4.429,34.89,0.166853568,-1072.016952,6.7898,-0.21918,-0.07077,0.14841,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-66,[0 0 0 ... 0 0 0],"[338.41, 338.14191319599996, 4.829400000000004, 3, 0, 34.89, 4, 5, 26, 0.4885866696427487, 0.043478260869565216, 4]",338.41,338.14191319599996,4.829400000000004,3,0,34.89,4,5,26,0.4885866696427487,0.043478260869565216,4,8.112611198403686,7.715939284593831
805,Non-Steroid,CN(C1=C(S2)C=C(C(C3=CC=CC=C3)N4C=CN=C4)C=C1)C2=O,8.103140107579122,Active,321.43,3,4,0,3,3.393,68.06,0.201237895,-1332.635181,6.6791,-0.22122,-0.02893,0.19229,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-67,[0 1 0 ... 0 0 0],"[321.4050000000001, 321.0935831, 3.4342000000000015, 5, 0, 39.82, 4, 3, 23, 0.5797907533457093, 0.1111111111111111, 4]",321.4050000000001,321.0935831,3.4342000000000015,5,0,39.82,4,3,23,0.5797907533457093,0.1111111111111111,4,8.140641634643348,7.233664553308804
806,Non-Steroid,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(C(C)(C#N)C)=C1,8.106576223853285,Active,293.41,4,2,0,4,2.966,78.29,0.231930927,-932.9726684,4.8637,-0.2655,-0.03676,0.22874,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-68,[0 0 0 ... 0 0 0],"[293.374, 293.164045608, 2.9287600000000014, 5, 0, 78.28999999999999, 2, 4, 22, 0.8678513137549794, 0.4117647058823529, 2]",293.374,293.164045608,2.9287600000000014,5,0,78.28999999999999,2,4,22,0.8678513137549794,0.4117647058823529,2,8.12565809874806,7.487587338911528
807,Non-Steroid,O=C1C=C(C2=CC=CC=C2)OC3C4=CC(O)=CC=C4CC=C31,8.11356737242492,Active,290.33,1,4,1,3,3.206,46.53,0.212683611,-958.1000702,4.5327,-0.22368,-0.06367,0.16001,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-69,[0 0 0 ... 0 0 0],"[290.31800000000004, 290.094294308, 3.5562000000000022, 3, 1, 46.53, 2, 1, 22, 0.8732422863181868, 0.10526315789473684, 4]",290.31800000000004,290.094294308,3.5562000000000022,3,1,46.53,2,1,22,0.8732422863181868,0.10526315789473684,4,8.157149498939251,6.963867528285148
808,Non-Steroid,CCN(C(C)=C1C(N2C=NC=C2)C3=CC=C(F)C=C3)C4=C1C=CC=C4,8.125237053311967,Active,333.44,4,4,0,2,4.318,22.75,0.196870644,-1076.373536,4.3368,-0.20127,-0.01942,0.18185,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-70,[0 1 0 ... 0 0 0],"[333.41, 333.16412586, 4.942920000000004, 3, 0, 22.75, 4, 4, 25, 0.5183751867903048, 0.19047619047619047, 4]",333.41,333.16412586,4.942920000000004,3,0,22.75,4,4,25,0.5183751867903048,0.19047619047619047,4,8.156559245361743,6.973338618599606
809,Non-Steroid,O=C(C1=CC=CN1C/2C3=CC=C(OC(F)(F)F)C=C3)C2=C/C4=CN=CC=C4,8.130889194765137,Active,370.35,3,4,0,6,5.588,44.12,0.22290875,-1329.405666,4.6754,-0.22727,-0.08246,0.14481,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-71,[0 0 0 ... 0 0 0],"[370.33000000000004, 370.0929123160001, 4.651000000000003, 4, 0, 44.120000000000005, 3, 3, 27, 0.6305692578054622, 0.1, 4]",370.33000000000004,370.0929123160001,4.651000000000003,4,0,44.120000000000005,3,3,27,0.6305692578054622,0.1,4,8.197336398954175,6.348390031786784
811,Non-Steroid,FC(C=C1)=CC=C1N(C=C2N3C=NC=C3)C4=C2C=CC=C4,8.14606611932293,Active,277.32,2,4,0,2,3.781,22.75,0.198889788,-919.1172992,4.1755,-0.20811,-0.03167,0.17644,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-72,[0 0 0 ... 0 0 0],"[277.302, 277.101525604, 3.955300000000002, 3, 0, 22.75, 4, 2, 21, 0.5436272159366246, 0.0, 4]",277.302,277.101525604,3.955300000000002,3,0,22.75,4,2,21,0.5436272159366246,0.0,4,8.159259234616506,6.930120168923269
812,Non-Steroid,C12=CC=CC=C1C(C=CC=C3)=C3C2(C4=CC=CC=C4)N5C=NC=C5,8.146863676068275,Active,308.4,2,5,0,1,4.247,17.82,0.147179925,-957.4773088,4.2304,-0.21672,-0.04305,0.17367,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-73,[0 0 0 ... 0 0 0],"[308.384, 308.131348512, 4.703700000000004, 2, 0, 17.82, 4, 2, 24, 0.4618779869723752, 0.045454545454545456, 5]",308.384,308.131348512,4.703700000000004,2,0,17.82,4,2,24,0.4618779869723752,0.045454545454545456,5,8.187052802173895,6.500506514060608
813,Non-Steroid,O=C1C(C2=CC=CC=C2)=C(SCC3=CC=NC=C3)OC4=C1C=CC(OCC(C=C5)=CC=C5C6=CC=CC=C6)=C4,8.150544893577656,Active,527.67,8,6,0,4,7.608,77.63,0.178490563,-1989.280897,4.2725,-0.22343,-0.06128,0.16215,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-74,[0 0 0 ... 0 0 0],"[527.6450000000003, 527.15551466, 8.393300000000004, 5, 0, 52.33, 6, 8, 39, 0.18608303484290456, 0.058823529411764705, 6]",527.6450000000003,527.15551466,8.393300000000004,5,0,52.33,6,8,39,0.18608303484290456,0.058823529411764705,6,8.1948908022199,6.384239895394346
814,Non-Steroid,BrC1=CC2=C(N(CC)C=C2C(C3=CC=CC=C3)N4C=CN=C4)C=C1,8.155435860490243,Active,380.31,4,4,0,1,4.715,22.75,0.170623095,-3508.929748,3.6155,-0.2094,-0.02406,0.18534,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-75,[0 1 0 ... 0 0 0],"[380.28900000000004, 379.06840967600004, 5.257900000000005, 3, 0, 22.75, 4, 4, 24, 0.47373940884065985, 0.15, 4]",380.28900000000004,379.06840967600004,5.257900000000005,3,0,22.75,4,4,24,0.47373940884065985,0.15,4,8.16922195343806,6.772952760978618
815,Non-Steroid,O=C1C2=CC=CN2CC(C3=CC=C(Cl)C=C3)/C1=C/C4=CC=CN=C4,8.157477670724482,Active,334.82,2,4,0,2,4.193,34.89,0.175124359,-1416.060254,2.1239,-0.22491,-0.07432,0.15059,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-76,[0 0 0 ... 0 0 0],"[334.80600000000004, 334.08729078000005, 4.600200000000004, 3, 0, 34.89, 3, 2, 24, 0.6418469149270338, 0.1, 4]",334.80600000000004,334.08729078000005,4.600200000000004,3,0,34.89,3,2,24,0.6418469149270338,0.1,4,8.173785303356857,6.702158536264112
816,Non-Steroid,FC1=CC=C(C=CC(CN2C=CN=C2)=C3)C3=C1,8.16775429731547,Active,226.27,2,3,0,2,2.621,17.82,0.191332643,-749.4547153,3.5562,-0.22169,-0.05097,0.17072,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-77,[0 0 0 ... 0 0 0],"[226.25400000000002, 226.090626572, 3.223700000000001, 2, 0, 17.82, 3, 2, 17, 0.6556403853041365, 0.07142857142857142, 3]",226.25400000000002,226.090626572,3.223700000000001,2,0,17.82,3,2,17,0.6556403853041365,0.07142857142857142,3,8.182553496045328,6.568202049079681
817,Non-Steroid,O=[N+](C1=CC=C(CCC2=NC=CN2)C=C1)[O-],8.16775429731547,Active,217.25,4,2,1,3,2.028,74.5,0.243871556,-740.4038592,6.1784,-0.22614,-0.08535,0.14079,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-78,[0 0 0 ... 0 0 0],"[217.228, 217.085126592, 2.1030999999999995, 3, 1, 71.82, 2, 4, 16, 0.6292484162355377, 0.18181818181818182, 2]",217.228,217.085126592,2.1030999999999995,3,1,71.82,2,4,16,0.6292484162355377,0.18181818181818182,2,8.214020078221733,6.109137806003756
818,Non-Steroid,C12=NC=CC=C1C(CN3C=CN=C3)CCC2,8.16775429731547,Active,213.31,2,3,0,2,1.574,30.71,0.182790548,-668.671367,2.4242,-0.22341,-0.03063,0.19278,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-79,[0 0 0 ... 0 0 0],"[213.284, 213.12659748, 2.3982, 3, 0, 30.71, 2, 2, 16, 0.7665586541326073, 0.38461538461538464, 3]",213.284,213.12659748,2.3982,3,0,30.71,2,2,16,0.7665586541326073,0.38461538461538464,3,8.205799184332635,6.225881003474486
820,Non-Steroid,ClC1=CC=C(C(N2C=NC=C2)C3=CC=C(NC=C4)C4=C3)C=C1,8.080868016801505,Active,307.8,3,4,1,1,4.077,33.61,0.180135444,-1318.789871,6.6023,-0.21501,-0.02548,0.18953,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-80,[0 1 0 ... 0 0 0],"[307.78400000000005, 307.08762512799996, 4.655500000000002, 2, 1, 33.61, 4, 3, 22, 0.5867612802233076, 0.05555555555555555, 4]",307.78400000000005,307.08762512799996,4.655500000000002,2,1,33.61,4,3,22,0.5867612802233076,0.05555555555555555,4,8.106472131549507,7.825784211047262
822,Non-Steroid,N#CC(C=C1)=CC=C1C(N2C=NC=N2)C3=CC=C(C#N)C=C3,8.100217669031371,Active,285.33,3,3,0,4,2.749,78.29,0.200397939,-928.1464256,3.8997,-0.269,-0.0728,0.1962,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-81,[0 1 0 ... 0 0 0],"[285.31, 285.101445352, 2.659160000000001, 5, 0, 78.28999999999999, 3, 3, 22, 0.7407442417149674, 0.058823529411764705, 3]",285.31,285.101445352,2.659160000000001,5,0,78.28999999999999,3,3,22,0.7407442417149674,0.058823529411764705,3,8.100519941747148,7.933778259590931
823,Non-Steroid,O=C1C=C(C2=CC=CC=C2)OC3=C1C=CC4=C3C=CC=C4,8.145396312780894,Active,272.31,1,4,0,2,4.045,30.21,0.18521197,-881.7161811,4.6164,-0.22056,-0.06299,0.15757,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-82,[0 0 0 ... 0 0 0],"[272.303, 272.083729624, 4.613200000000003, 2, 0, 30.21, 4, 1, 21, 0.47344241954632516, 0.0, 4]",272.303,272.083729624,4.613200000000003,2,0,30.21,4,1,21,0.47344241954632516,0.0,4,8.205040768184501,6.236762868606127
824,Non-Steroid,O=C(C1=CC=CN1CC/2C3=CC=C(Cl)C=C3)C2=C/C4=CC=NC=C4,8.173991966846375,Active,334.82,2,4,0,2,4.193,34.89,0.177664795,-1416.059429,4.0716,-0.22823,-0.07925,0.14898,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-83,[0 0 0 ... 0 0 0],"[334.80600000000004, 334.08729078000005, 4.600200000000004, 3, 0, 34.89, 3, 2, 24, 0.6418469149270338, 0.1, 4]",334.80600000000004,334.08729078000005,4.600200000000004,3,0,34.89,3,2,24,0.6418469149270338,0.1,4,8.1820388107147,6.575990684064482
825,Non-Steroid,O=C1C(CC2=CC=CC=C2)CCC3=C1C=CC=C3O,8.173991966846375,Active,252.33,2,3,1,2,4.035,37.3,0.202986686,-807.9051362,3.092,-0.22662,-0.05363,0.17299,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-84,[0 0 0 ... 0 0 0],"[252.31299999999996, 252.115029752, 3.380000000000002, 2, 1, 37.3, 2, 2, 19, 0.889250799710634, 0.23529411764705882, 3]",252.31299999999996,252.115029752,3.380000000000002,2,1,37.3,2,2,19,0.889250799710634,0.23529411764705882,3,8.22747513797871,5.922769919389828
826,Non-Steroid,O=C1C(C2=CC=CC=C2)=C(SCC3=CN=CC=C3)OC4=C1C=CC(OC5=CC=CC=C5)=C4,8.175367847062448,Active,437.54,6,5,0,4,6.083,77.63,0.189733235,-1718.911954,3.6478,-0.22294,-0.0603,0.16264,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-85,[0 0 0 ... 0 0 0],"[437.52000000000015, 437.108564468, 6.939600000000004, 5, 0, 52.33, 5, 6, 32, 0.26936610926031385, 0.037037037037037035, 5]",437.52000000000015,437.108564468,6.939600000000004,5,0,52.33,5,6,32,0.26936610926031385,0.037037037037037035,5,8.240539002051767,5.74726202929131
827,Non-Steroid,FC1=CC=C(CCCN2C=CN=C2)C=C1,8.186509862130398,Active,204.27,4,2,0,2,2.49,17.82,0.189666571,-674.4402163,3.6656,-0.22148,-0.0156,0.20588,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-86,[0 0 0 ... 0 0 0],"[204.24800000000005, 204.106276636, 2.655000000000001, 2, 0, 17.82, 2, 4, 15, 0.7482426433218492, 0.25, 2]",204.24800000000005,204.106276636,2.655000000000001,2,0,17.82,2,4,15,0.7482426433218492,0.25,2,8.222986748074396,5.984298550826281
828,Non-Steroid,OC(C=C1)=CC=C1C2CC(C3=C(O)C=C(O)C(C/C=C/C(C)C)=C3O2)=O,8.206080550578456,Active,354.43,4,3,3,5,4.416,86.99,0.245774625,-1189.596523,2.7205,-0.21349,-0.05147,0.16202,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-87,[0 1 0 ... 0 0 0],"[354.4020000000001, 354.1467238039999, 4.264600000000002, 5, 3, 86.99000000000001, 2, 4, 26, 0.7140897658189941, 0.2857142857142857, 3]",354.4020000000001,354.1467238039999,4.264600000000002,5,3,86.99000000000001,2,4,26,0.7140897658189941,0.2857142857142857,3,8.23679089650318,5.797077461141831
829,Non-Steroid,O=C(C1=CC=CN12)/C(C2C3=CC=C(OC(F)(F)F)C=C3)=C\C4=CN=CC=C4,8.20851380214497,Active,370.35,3,4,0,6,5.588,44.12,0.2259118,-1329.408769,2.9098,-0.22722,-0.08238,0.14484,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-88,[0 0 0 ... 0 0 0],"[370.33, 370.0929123160001, 4.651000000000003, 4, 0, 44.120000000000005, 3, 3, 27, 0.6305692578054625, 0.1, 4]",370.33,370.0929123160001,4.651000000000003,4,0,44.120000000000005,3,3,27,0.6305692578054625,0.1,4,8.197336398954175,6.348390031786784
830,Non-Steroid,O=C1CC(C2=CC=CC=C2)OC3=CC=CC=C31,8.218549277342257,Active,224.27,1,3,0,2,3.1,26.3,0.188714552,-729.2749817,2.5203,-0.23258,-0.05643,0.17615,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-89,[0 0 0 ... 0 0 0],"[224.259, 224.083729624, 3.3931000000000022, 2, 0, 26.3, 2, 1, 17, 0.7417295882600524, 0.13333333333333333, 3]",224.259,224.083729624,3.3931000000000022,2,0,26.3,2,1,17,0.7417295882600524,0.13333333333333333,3,8.24579269317357,5.678155827324565
831,Non-Steroid,O=C(OC1)C(C2=CC=C(OC)C(OC)=C2)=C1C3=CC=C(OC)C(OC)=C3,8.045757490560675,Active,356.4,6,3,0,6,3.28,63.22,0.22930837,-1225.46247,6.8383,-0.19534,-0.05664,0.1387,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-90,[0 0 0 ... 0 0 0],"[356.3740000000001, 356.12598835999995, 3.188600000000002, 6, 0, 63.22000000000001, 2, 6, 26, 0.7409689148035102, 0.25, 3]",356.3740000000001,356.12598835999995,3.188600000000002,6,0,63.22000000000001,2,6,26,0.7409689148035102,0.25,3,8.122591546902402,7.540644264347605
832,Non-Steroid,O=C1C2=C(O)C=C(O)C=C2OC(C3=CC=CC=C3)=C1,8.045757490560675,Active,254.25,1,3,2,4,2.602,70.67,0.262495276,-878.4963985,3.6683,-0.22142,-0.05624,0.16518,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-91,[0 0 0 ... 0 0 0],"[254.24099999999999, 254.0579088, 2.871200000000001, 4, 2, 70.67, 3, 1, 19, 0.700091545915688, 0.0, 3]",254.24099999999999,254.0579088,2.871200000000001,4,2,70.67,3,1,19,0.700091545915688,0.0,3,8.232963304721121,5.848394974866322
833,Non-Steroid,ClC(C=CC=C1)=C1C(C2=CC=CC=C2)(N3C=NC=C3)C4=CC=CC=C4,8.05825371954857,Active,344.86,4,4,0,1,5.223,17.82,0.145854167,-1418.244626,4.8683,-0.21664,-0.03033,0.18631,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-92,[0 0 0 ... 0 0 0],"[344.8450000000001, 344.108026224, 5.376700000000004, 2, 0, 17.82, 4, 4, 25, 0.45454498474207145, 0.045454545454545456, 4]",344.8450000000001,344.108026224,5.376700000000004,2,0,17.82,4,4,25,0.45454498474207145,0.045454545454545456,4,8.167178168124348,6.804901322046322
834,Non-Steroid,CC1=CCC2C1[C@@H](OC([C@H]3C)=O)[C@H]3CC[C@@]2(O)C,8.060532166698685,Active,250.37,0,3,1,3,2.193,46.53,0.237613125,-810.5162814,4.4252,-0.2367,0.01624,0.25294,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-93,[0 0 0 ... 0 0 0],"[250.33799999999997, 250.156894564, 2.2913000000000006, 3, 1, 46.53, 0, 0, 18, 0.5297982507265288, 0.8, 3]",250.33799999999997,250.156894564,2.2913000000000006,3,1,46.53,0,0,18,0.5297982507265288,0.8,3,8.116935894693716,7.639485401126099
835,Non-Steroid,O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=CC=C31,8.060532166698685,Active,254.25,1,3,2,4,2.602,70.67,0.271647069,-878.5062468,4.6645,-0.22032,-0.05763,0.16269,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-94,[0 0 0 ... 0 0 0],"[254.24099999999999, 254.0579088, 2.871200000000001, 4, 2, 70.67, 3, 1, 19, 0.700091545915688, 0.0, 3]",254.24099999999999,254.0579088,2.871200000000001,4,2,70.67,3,1,19,0.700091545915688,0.0,3,8.12515885140313,7.496199715296361
836,Non-Steroid,OC(C=C1)=CC=C1C(O2)CC(C3=C2C=C(O)C=C3O)=O,8.068664094596956,Active,272.27,1,3,3,5,2.298,86.99,0.289186156,-954.9423732,2.5818,-0.22177,-0.05261,0.16916,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-95,[0 0 0 ... 0 0 0],"[272.256, 272.068473484, 2.5099000000000014, 5, 3, 86.99000000000001, 2, 1, 20, 0.7421139126791213, 0.13333333333333333, 3]",272.256,272.068473484,2.5099000000000014,5,3,86.99000000000001,2,1,20,0.7421139126791213,0.13333333333333333,3,8.23094129546908,5.875687701123882
837,Non-Steroid,O=C1C(CC2=CCNC=C2)=C(N)C3=CC(OC)=CC=C31,8.07283852040884,Active,268.34,3,3,3,4,0.73,64.35,0.237863917,-879.2391211,7.2312,-0.18164,-0.05748,0.12416,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-96,[0 1 0 ... 0 0 0],"[268.316, 268.121177752, 1.9947, 4, 2, 64.35000000000001, 1, 3, 20, 0.8796768288005626, 0.1875, 3]",268.316,268.121177752,1.9947,4,2,64.35000000000001,1,3,20,0.8796768288005626,0.1875,3,8.130383382587745,7.406561228554626
838,Non-Steroid,NC1=CC=C(C2(CCC(NC2=O)=O)CC)C=C1,8.081760085090155,Active,232.31,2,2,3,4,1.285,72.19,0.279952909,-765.0074962,3.6333,-0.20598,-0.02537,0.18061,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-97,[0 0 0 ... 0 0 0],"[232.283, 232.121177752, 1.3531999999999997, 3, 2, 72.19, 1, 2, 17, 0.5969362176118972, 0.38461538461538464, 2]",232.283,232.121177752,1.3531999999999997,3,2,72.19,1,2,17,0.5969362176118972,0.38461538461538464,2,8.30792185803158,4.921280755977949
839,Non-Steroid,O=C1OC[C@H](CC2=CC=C(C(O)=C2)O)[C@H]1CC3=CC=C(C(O)=C3)O,8.085030516809448,Active,330.36,4,3,4,6,2.966,107.22,0.278898929,-1148.070695,4.2745,-0.20099,-0.003,0.19799,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-98,[0 0 0 ... 0 0 0],"[330.336, 330.11033829599995, 2.0834000000000006, 6, 4, 107.22000000000001, 2, 4, 24, 0.5049766312692308, 0.2777777777777778, 3]",330.336,330.11033829599995,2.0834000000000006,6,4,107.22000000000001,2,4,24,0.5049766312692308,0.2777777777777778,3,8.115219181707413,7.6697431159710545
840,Non-Steroid,O=C1OC[C@H](CC2=CC=CC(O)=C2)[C@H]1CC3=CC=CC=C3,8.085030516809448,Active,282.36,4,3,1,3,3.768,46.53,0.212623333,-922.4349068,3.0022,-0.22653,-0.01005,0.21648,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-99,[0 0 0 ... 0 0 0],"[282.339, 282.125594436, 2.9666000000000015, 3, 1, 46.53, 2, 4, 21, 0.8769615133064369, 0.2777777777777778, 3]",282.339,282.125594436,2.9666000000000015,3,1,46.53,2,4,21,0.8769615133064369,0.2777777777777778,3,8.111372710011489,7.737974424999881
841,Non-Steroid,O=C1C(C2=CC=C(OC)C(OC)=C2)=C(C3=CC=C(OC)C=C3)CO1,8.088248591468904,Active,326.37,5,3,0,5,3.296,53.99,0.221680452,-1110.947874,6.3256,-0.19327,-0.05665,0.13662,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-100,[0 0 0 ... 0 0 0],"[326.34800000000007, 326.115423676, 3.1800000000000015, 5, 0, 53.99000000000001, 2, 5, 24, 0.7900147460442926, 0.21052631578947367, 3]",326.34800000000007,326.115423676,3.1800000000000015,5,0,53.99000000000001,2,5,24,0.7900147460442926,0.21052631578947367,3,8.117855898398092,7.623319145214749
842,Non-Steroid,OC1=C(C2=CC=C(O)C(O)=C2)OC3=CC(O)=CC(O)=C3C1=O,8.101229924222892,Active,302.25,1,3,5,7,1.504,131.36,0.341602625,-1104.149006,5.1271,-0.19401,-0.05647,0.13754,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-101,[0 0 0 ... 0 0 0],"[302.23800000000006, 302.04265266, 1.988, 7, 5, 131.36, 3, 1, 22, 0.43419044029909815, 0.0, 3]",302.23800000000006,302.04265266,1.988,7,5,131.36,3,1,22,0.43419044029909815,0.0,3,8.24844942810248,5.64352654183138
843,Non-Steroid,O=C1C=C(C2=CC=CC=C2)OC3=CC=CC=C31,8.091680687335494,Active,222.25,1,3,0,2,3.137,30.21,0.197196333,-728.0713143,4.1955,-0.23326,-0.0658,0.16746,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-102,[0 0 0 ... 0 0 0],"[222.243, 222.06807956, 3.4600000000000017, 2, 0, 30.21, 3, 1, 17, 0.6307722261623976, 0.0, 3]",222.243,222.06807956,3.4600000000000017,2,0,30.21,3,1,17,0.6307722261623976,0.0,3,8.228216784678706,5.912664208982578
845,Non-Steroid,ClC(C=C1)=CC=C1C(C2=CC(C=CC=C3)=C3O2)N4C=CN=C4,8.093906563813192,Active,308.78,3,4,0,2,4.378,30.96,0.177679486,-1338.648134,4.5831,-0.22169,-0.04231,0.17938,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-103,[0 1 0 ... 0 0 0],"[308.768, 308.07164071600005, 4.920400000000003, 3, 0, 30.96, 4, 3, 22, 0.5376058386893484, 0.05555555555555555, 4]",308.768,308.07164071600005,4.920400000000003,3,0,30.96,4,3,22,0.5376058386893484,0.05555555555555555,4,8.113005836865458,7.708931082844058
846,Non-Steroid,CC(C(C)CC1=CC=C(O)C(O)=C1)CC2=CC=C(O)C(O)=C2,8.09916292325829,Active,302.4,5,2,4,4,4.607,80.92,0.256371545,-1000.027585,2.008,-0.19802,0.00648,0.2045,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-104,[0 1 0 ... 0 0 0],"[302.37, 302.151809184, 3.5664000000000033, 4, 4, 80.92, 2, 5, 22, 0.636536149264244, 0.3333333333333333, 2]",302.37,302.151809184,3.5664000000000033,4,4,80.92,2,5,22,0.636536149264244,0.3333333333333333,2,8.17884428544507,6.624539813596595
847,Non-Steroid,[H][C@]12C(C(C=C2C)=C)C(C)C[C@@H]3[C@@H]1OC(C3=C)=O,8.106576223853285,Active,230.33,0,3,0,2,3.024,26.3,0.222412914,-732.8484184,3.8343,-0.2156,-0.0449,0.1707,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-105,[0 0 0 ... 0 0 0],"[230.30699999999996, 230.130679816, 2.8725000000000014, 2, 0, 26.3, 0, 0, 17, 0.4722479598540797, 0.5333333333333333, 3]",230.30699999999996,230.130679816,2.8725000000000014,2,0,26.3,0,0,17,0.4722479598540797,0.5333333333333333,3,8.137172009760764,7.291686533330349
848,Non-Steroid,O=CC1=CC(C(O)=O)=CC(O)=C1C(C2=C(C)C=CC=C2O)=O,8.109888096847953,Active,300.28,4,2,3,6,2.549,111.9,0.280343118,-1068.264766,5.2742,-0.24836,-0.10566,0.1427,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-106,[0 0 0 ... 0 0 0],"[300.266, 300.06338810399996, 2.1479200000000005, 5, 3, 111.9, 2, 4, 22, 0.5888917032489174, 0.0625, 2]",300.266,300.06338810399996,2.1479200000000005,5,3,111.9,2,4,22,0.5888917032489174,0.0625,2,8.147046495516678,7.127767162492451
849,Non-Steroid,C[C@]12[C@@H](CC3=C(CC[C@H]4C(C32)OC(C4=C)=O)C)O1,8.139085075961884,Active,246.33,0,4,0,3,2.14,38.83,0.229267194,-808.0529452,5.2212,-0.23485,-0.04848,0.18637,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-107,[0 0 0 ... 0 0 0],"[246.30599999999998, 246.125594436, 2.3719, 3, 0, 38.83, 0, 0, 18, 0.28494521165902875, 0.6666666666666666, 4]",246.30599999999998,246.125594436,2.3719,3,0,38.83,0,0,18,0.28494521165902875,0.6666666666666666,4,8.157625213850299,6.956243664672152
850,Non-Steroid,ClC1=C([C@@]2(CN3C=CN=C3)OC[C@H](CCC4=CC=C(N5CCN(CC5)OC)C=C4)O2)C=CC(Cl)=C1,8.141351611412963,Active,517.5,8,5,0,6,4.925,51.99,0.183565462,-2373.811326,3.7769,-0.18939,-0.03668,0.15271,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-108,[0 0 0 ... 0 0 0],"[517.4570000000002, 516.16949618, 4.774500000000005, 7, 0, 51.99000000000001, 3, 8, 35, 0.42918071428859, 0.4230769230769231, 5]",517.4570000000002,516.16949618,4.774500000000005,7,0,51.99000000000001,3,8,35,0.42918071428859,0.4230769230769231,5,8.14634208059479,7.1393376057128295
851,Non-Steroid,CC1=CCC2C1[C@@H](OC(C3=C)=O)[C@H]3CCC2,8.145396312780894,Active,218.32,0,3,0,2,3.172,26.3,0.212769971,-694.7611235,4.6236,-0.23177,-0.04382,0.18795,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-109,[0 0 0 ... 0 0 0],"[218.29599999999994, 218.130679816, 2.850500000000001, 2, 0, 26.3, 0, 0, 16, 0.35485200877307094, 0.6428571428571429, 3]",218.29599999999994,218.130679816,2.850500000000001,2,0,26.3,0,0,16,0.35485200877307094,0.6428571428571429,3,8.148478492616494,7.104303514761869
852,Non-Steroid,O=C1C(C2=CC=C(OC)C=C2)=COC3=C1C(O)=CC(O)=C3,8.097377140044248,Active,284.28,2,3,2,5,2.316,79.9,0.255619545,-993.0148371,3.0512,-0.20073,-0.03904,0.16169,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-110,[0 0 0 ... 0 0 0],"[284.267, 284.068473484, 2.8798000000000012, 5, 2, 79.9, 3, 2, 21, 0.7560099167404621, 0.0625, 3]",284.267,284.068473484,2.8798000000000012,5,2,79.9,3,2,21,0.7560099167404621,0.0625,3,8.23202164690017,5.86108949871301
853,Non-Steroid,O=C1C(C2=CC=C(OC)C(OC)=C2)=C(C3=CC(OC)=C(OC)C(OC)=C3)CO1,8.104396290777379,Active,386.43,7,3,0,7,3.264,72.45,0.23762494,-1339.977198,5.1382,-0.20663,-0.06424,0.14239,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-111,[0 0 0 ... 0 0 0],"[386.40000000000015, 386.1365530439999, 3.1972000000000023, 7, 0, 72.45000000000002, 2, 7, 28, 0.6768098315410567, 0.2857142857142857, 3]",386.40000000000015,386.1365530439999,3.1972000000000023,7,0,72.45000000000002,2,7,28,0.6768098315410567,0.2857142857142857,3,8.126174994121145,7.478680946776278
854,Non-Steroid,CC1=C(C(C2=C(OC)C=C(C(N(C)C)=O)C=C2C=O)=O)C(O)=CC=C1,8.109888096847953,Active,341.39,5,2,1,6,2.61,83.91,0.240489409,-1166.317412,6.839,-0.21494,-0.08338,0.13156,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-112,[0 0 0 ... 0 0 0],"[341.36300000000006, 341.126322708, 2.4545200000000005, 5, 1, 83.91, 2, 5, 25, 0.6669906903207934, 0.21052631578947367, 2]",341.36300000000006,341.126322708,2.4545200000000005,5,1,83.91,2,5,25,0.6669906903207934,0.21052631578947367,2,8.137867939789004,7.280011413778515
855,Non-Steroid,O=C1CC(C2=CC=CC=C2)OC3=CC(O)=CC=C31,8.124030554412473,Active,240.27,1,3,1,3,2.833,46.53,0.2255407,-804.4938832,3.899,-0.228,-0.04742,0.18058,Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19),Bioorg Med Chem Lett. 2010;20(10):3050-113,[0 0 0 ... 0 0 0],"[240.25799999999998, 240.078644244, 3.098700000000002, 3, 1, 46.53, 2, 1, 18, 0.8326826582212098, 0.13333333333333333, 3]",240.25799999999998,240.078644244,3.098700000000002,3,1,46.53,2,1,18,0.8326826582212098,0.13333333333333333,3,8.227036713902432,5.928752026389567
856,Steroid,O=C1C(C)(C)C[C@@]2(C)C(CCC3C2CC[C@@]4(C)C3CCC4=O)=C1,8.151773307812324,Active,314.51,0,4,0,2,4.173,34.14,0.209058151,-968.7623337,3.3317,-0.22942,-0.04444,0.18498,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-13,[0 0 0 ... 0 0 0],"[314.46900000000005, 314.2245802, 4.723500000000005, 2, 0, 34.14, 0, 0, 23, 0.6478847894702293, 0.8095238095238095, 4]",314.46900000000005,314.2245802,4.723500000000005,2,0,34.14,0,0,23,0.6478847894702293,0.8095238095238095,4,8.219267041605937,6.035773839552572
857,Steroid,O=C1C(C)(C)C[C@@]2(CO)C(CCC3C2CC[C@@]4(C)C3CCC4=O)=C1,8.27634489188231,Inactive,330.51,1,4,1,3,3.082,54.37,0.213656944,-1043.963464,4.3795,-0.22377,-0.03932,0.18445,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-14,[0 0 0 ... 0 0 0],"[330.4680000000001, 330.21949481999997, 3.6959000000000026, 3, 1, 54.37, 0, 1, 24, 0.7974584246182259, 0.8095238095238095, 4]",330.4680000000001,330.21949481999997,3.6959000000000026,3,1,54.37,0,1,24,0.7974584246182259,0.8095238095238095,4,8.269484602669587,5.376694951376871
858,Steroid,O=C1C(C)(C)C[C@@]2(C=O)C(CCC3C2CC[C@@]4(C)C3CCC4=O)=C1,8.206080550578456,Active,328.49,1,4,0,3,3.339,51.21,0.212066788,-1042.763942,4.6304,-0.23621,-0.05792,0.17829,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-15,[0 0 0 ... 0 0 0],"[328.45200000000006, 328.20384475599997, 3.9025000000000034, 3, 0, 51.21, 0, 1, 24, 0.6859407932132536, 0.7619047619047619, 4]",328.45200000000006,328.20384475599997,3.9025000000000034,3,0,51.21,0,1,24,0.6859407932132536,0.7619047619047619,4,8.233447086395431,5.8418837914578665
859,Steroid,O=C1[C@H](C[C@]2(C(CCC3C2CC[C@]4(C3CCC4=O)C)=C1)C)C,8.180320533680066,Active,300.48,0,4,0,2,3.756,34.14,0.21029588,-929.4482112,3.4851,-0.22905,-0.04519,0.18386,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-16,[0 0 0 ... 0 0 0],"[300.442, 300.208930136, 4.333400000000004, 2, 0, 34.14, 0, 0, 22, 0.666890035800204, 0.8, 4]",300.442,300.208930136,4.333400000000004,2,0,34.14,0,0,22,0.666890035800204,0.8,4,8.2288994386105,5.903377577377774
861,Steroid,O=C1[C@@H](C[C@]2(C(CCC3C2CC[C@]4(C3CCC4=O)C)=C1)CO)C,8.304640283255823,Inactive,316.48,1,4,1,3,2.666,54.37,0.214513824,-1004.649529,4.5104,-0.22317,-0.03939,0.18378,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-17,[0 0 0 ... 0 0 0],"[316.44100000000003, 316.20384475599997, 3.3058000000000023, 3, 1, 54.370000000000005, 0, 1, 23, 0.8072829092630206, 0.8, 4]",316.44100000000003,316.20384475599997,3.3058000000000023,3,1,54.370000000000005,0,1,23,0.8072829092630206,0.8,4,8.288537635604403,5.145912110281902
862,Steroid,O=C1[C@@H](C[C@]2(C(CCC3C2CC[C@]4(C3CCC4=O)C)=C1)C=O)C,8.307962630817833,Inactive,314.46,1,4,0,3,2.922,51.21,0.213542429,-1003.44929,4.8111,-0.23583,-0.05844,0.17739,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-18,[0 0 0 ... 0 0 0],"[314.425, 314.18819469199997, 3.512400000000002, 3, 0, 51.21, 0, 1, 23, 0.6959321447973222, 0.75, 4]",314.425,314.18819469199997,3.512400000000002,3,0,51.21,0,1,23,0.6959321447973222,0.75,4,8.278111520820838,5.270944934619809
863,Steroid,O=C(C=C(CCC1C2CC[C@@]3(C)C1CCC3=O)[C@]2(C)C4)C4=C,8.203450829472398,Active,298.46,0,4,0,2,3.771,34.14,0.211158,-928.2180131,3.4339,-0.23586,-0.06002,0.17584,Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs,Steroids. 2003;68(6):503-19,[0 0 0 ... 0 0 0],"[298.42600000000004, 298.193280072, 4.253500000000003, 2, 0, 34.14, 0, 0, 22, 0.6263821986857138, 0.7, 4]",298.42600000000004,298.193280072,4.253500000000003,2,0,34.14,0,0,22,0.6263821986857138,0.7,4,8.218119312313874,6.051745942614155
864,Steroid,O=C1[C@H](C2=CC=CC=C2)CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.477345310785735,Inactive,362.55,1,5,0,2,4.789,34.14,0.198107351,-1121.181595,3.5626,-0.23275,-0.04869,0.18406,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-7,[0 0 0 ... 0 0 0],"[362.5130000000001, 362.2245802, 5.481100000000006, 2, 0, 34.14, 1, 1, 27, 0.662640068845324, 0.6, 5]",362.5130000000001,362.2245802,5.481100000000006,2,0,34.14,1,1,27,0.662640068845324,0.6,5,8.418661957176285,3.8136254996749015
865,Steroid,O=C1[C@H](CC2=CC=CC=C2)CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.408976657920725,Inactive,376.58,2,5,0,2,5.245,34.14,0.1968062,-1160.495296,3.5688,-0.22334,-0.04536,0.17798,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-8,[0 0 0 ... 0 0 0],"[376.54000000000013, 376.240230264, 5.556200000000006, 2, 0, 34.14, 1, 2, 28, 0.6773809714641035, 0.6153846153846154, 5]",376.54000000000013,376.240230264,5.556200000000006,2,0,34.14,1,2,28,0.6773809714641035,0.6153846153846154,5,8.341183962576284,4.5584378441568445
866,Steroid,O=C1[C@H](CCC2=CC=CC=C2)CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.366602624750838,Inactive,390.61,3,5,0,2,5.701,34.14,0.196645063,-1199.811964,3.7328,-0.23078,-0.04728,0.1835,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-9,[0 0 0 ... 0 0 0],"[390.56700000000023, 390.255880328, 5.946300000000006, 2, 0, 34.14, 1, 3, 29, 0.6392785529005046, 0.6296296296296297, 5]",390.56700000000023,390.255880328,5.946300000000006,2,0,34.14,1,3,29,0.6392785529005046,0.6296296296296297,5,8.328193469488863,4.696848268149208
867,Steroid,O=C1[C@H](CCCC2=CC=CC=C2)CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.437273411571608,Inactive,404.64,4,5,0,2,6.157,34.14,0.196191015,-1239.118203,3.3589,-0.22894,-0.04603,0.18291,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-10,[0 0 0 ... 0 0 0],"[404.5940000000002, 404.271530392, 6.3364000000000065, 2, 0, 34.14, 1, 4, 30, 0.5869089668597727, 0.6428571428571429, 5]",404.5940000000002,404.271530392,6.3364000000000065,2,0,34.14,1,4,30,0.5869089668597727,0.6428571428571429,5,8.375392890297043,4.213151825703454
868,Steroid,O=C1[C@H](CC2=CC=C(C)C=C2)CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.355446374759403,Inactive,390.61,2,5,0,2,5.731,34.14,0.203368159,-1199.813298,3.2004,-0.21872,-0.04453,0.17419,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-11,[0 0 0 ... 0 0 0],"[390.56700000000023, 390.255880328, 5.864620000000006, 2, 0, 34.14, 1, 2, 29, 0.6332191166496236, 0.6296296296296297, 5]",390.56700000000023,390.255880328,5.864620000000006,2,0,34.14,1,2,29,0.6332191166496236,0.6296296296296297,5,8.317939754579067,4.809060552109189
869,Steroid,O=C1[C@H](CC2=CC=C(C(F)(F)F)C=C2)CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.363350242972254,Inactive,444.58,2,5,0,5,6.187,34.14,0.21169,-1497.533897,6.6319,-0.23325,-0.05211,0.18114,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-12,[0 0 0 ... 0 0 0],"[444.5370000000003, 444.227614892, 6.5750000000000055, 2, 0, 34.14, 1, 2, 32, 0.5166479476197902, 0.6296296296296297, 5]",444.5370000000003,444.227614892,6.5750000000000055,2,0,34.14,1,2,32,0.5166479476197902,0.6296296296296297,5,8.36478697656028,4.317307908376403
870,Steroid,O=C1C(C2=CC=CC=C2)=CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.391101204616666,Inactive,360.53,1,5,0,2,4.749,34.14,0.191560382,-1119.965053,3.5534,-0.22734,-0.05698,0.17036,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-13,[0 0 0 ... 0 0 0],"[360.49700000000007, 360.208930136, 5.390800000000005, 2, 0, 34.14, 1, 1, 27, 0.672643507595721, 0.52, 5]",360.49700000000007,360.208930136,5.390800000000005,2,0,34.14,1,1,27,0.672643507595721,0.52,5,8.330846704002271,4.6682412945395155
871,Steroid,O=C1C(CC2=CC=CC=C2)=CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.252582996382213,Inactive,374.56,2,5,0,2,5.205,34.14,0.198091397,-1159.279119,3.8359,-0.22958,-0.05659,0.17299,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-14,[0 0 0 ... 0 0 0],"[374.52400000000017, 374.2245802, 5.4763000000000055, 2, 0, 34.14, 1, 2, 28, 0.6871189590262342, 0.5384615384615384, 5]",374.52400000000017,374.2245802,5.4763000000000055,2,0,34.14,1,2,28,0.6871189590262342,0.5384615384615384,5,8.262700178693667,5.461347627945027
872,Steroid,O=C1C(CCC2=CC=CC=C2)=CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.165030765990325,Active,388.59,3,5,0,2,5.662,34.14,0.197103344,-1198.590109,3.0945,-0.23078,-0.05074,0.18004,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-15,[0 0 0 ... 0 0 0],"[388.5510000000002, 388.240230264, 5.866400000000006, 2, 0, 34.14, 1, 3, 29, 0.6491384726402469, 0.5555555555555556, 5]",388.5510000000002,388.240230264,5.866400000000006,2,0,34.14,1,3,29,0.6491384726402469,0.5555555555555556,5,8.250731293756441,5.6139521448043235
873,Steroid,O=C1C(CCCC2=CC=CC=C2)=CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.350083819940103,Inactive,402.62,4,5,0,2,6.118,34.14,0.194874094,-1237.907146,3.6391,-0.23075,-0.05431,0.17644,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-16,[0 0 0 ... 0 0 0],"[402.57800000000026, 402.255880328, 6.256500000000006, 2, 0, 34.14, 1, 4, 30, 0.5957976878677892, 0.5714285714285714, 5]",402.57800000000026,402.255880328,6.256500000000006,2,0,34.14,1,4,30,0.5957976878677892,0.5714285714285714,5,8.299145103344575,5.021747784696372
874,Steroid,O=C1C(CC2=CC=C(C)C=C2)=CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.284285484387013,Inactive,388.59,2,5,0,2,5.692,34.14,0.201807246,-1198.488513,3.8047,-0.20298,-0.07423,0.12875,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-17,[0 0 0 ... 0 0 0],"[388.5510000000002, 388.240230264, 5.784720000000006, 2, 0, 34.14, 1, 2, 29, 0.6429617339871532, 0.5555555555555556, 5]",388.5510000000002,388.240230264,5.784720000000006,2,0,34.14,1,2,29,0.6429617339871532,0.5555555555555556,5,8.246787855069694,5.665159541668216
875,Steroid,O=C1C(CC2=CC=C(C(F)(F)F)C=C2)=CC3(C)C(CCC4C3CCC5(C)C4CCC5=O)=C1,8.349984924673622,Inactive,442.56,2,5,0,5,6.148,34.14,0.213303393,-1496.317831,6.1603,-0.24085,-0.06282,0.17803,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-18,[0 0 0 ... 0 0 0],"[442.5210000000003, 442.211964828, 6.495100000000005, 2, 0, 34.14, 1, 2, 32, 0.5242542795481383, 0.5555555555555556, 5]",442.5210000000003,442.211964828,6.495100000000005,2,0,34.14,1,2,32,0.5242542795481383,0.5555555555555556,5,8.327904634894917,4.6999730222905285
876,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(C)=O)=C1)C,8.191667585060895,Active,344.49,2,4,0,4,2.571,60.44,0.231088283,-1118.002789,4.1074,-0.23961,-0.0641,0.17551,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-19,[0 0 0 ... 0 0 0],"[344.451, 344.19875937599994, 3.629000000000003, 4, 0, 60.440000000000005, 0, 1, 25, 0.6816293019238052, 0.7619047619047619, 4]",344.451,344.19875937599994,3.629000000000003,4,0,60.440000000000005,0,1,25,0.6816293019238052,0.7619047619047619,4,8.22462747040255,5.961733104597193
877,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CC)=O)=C1)C,8.175367847062448,Active,358.52,3,4,0,4,3.238,60.44,0.227976018,-1157.328929,4.2133,-0.23613,-0.05604,0.18009,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-20,[0 0 0 ... 0 0 0],"[358.47800000000007, 358.21440943999994, 4.0191000000000034, 4, 0, 60.440000000000005, 0, 2, 26, 0.6996485817471967, 0.7727272727272727, 4]",358.47800000000007,358.21440943999994,4.0191000000000034,4,0,60.440000000000005,0,2,26,0.6996485817471967,0.7727272727272727,4,8.22521460907512,5.953678664263455
878,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCC)=O)=C1)C,8.173991966846375,Active,372.55,4,4,0,4,3.694,60.44,0.225250017,-1196.642783,4.2171,-0.23569,-0.0555,0.18019,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-21,[0 0 0 ... 0 0 0],"[372.5050000000001, 372.23005950399994, 4.409200000000004, 4, 0, 60.440000000000005, 0, 3, 27, 0.688646342014585, 0.782608695652174, 4]",372.5050000000001,372.23005950399994,4.409200000000004,4,0,60.440000000000005,0,3,27,0.688646342014585,0.782608695652174,4,8.22521460907512,5.953678664263455
879,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCC)=O)=C1)C,8.164064012810684,Active,386.58,5,4,0,4,4.15,60.44,0.221667565,-1235.955372,4.6283,-0.23545,-0.05539,0.18006,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-22,[0 0 0 ... 0 0 0],"[386.53200000000015, 386.24570956799994, 4.799300000000005, 4, 0, 60.440000000000005, 0, 4, 28, 0.6513035132428572, 0.7916666666666666, 4]",386.53200000000015,386.24570956799994,4.799300000000005,4,0,60.440000000000005,0,4,28,0.6513035132428572,0.7916666666666666,4,8.217192676265135,6.06467208597458
880,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCCC)=O)=C1)C,8.151471137195424,Active,400.61,6,4,0,4,4.606,60.44,0.219315815,-1275.269017,4.6311,-0.23533,-0.05519,0.18014,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-23,[0 0 0 ... 0 0 0],"[400.5590000000002, 400.26135963199994, 5.189400000000005, 4, 0, 60.440000000000005, 0, 5, 29, 0.4706064983580446, 0.8, 4]",400.5590000000002,400.26135963199994,5.189400000000005,4,0,60.440000000000005,0,5,29,0.4706064983580446,0.8,4,8.21865073807831,6.044345234147822
881,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCCCC)=O)=C1)C,8.153522080814703,Active,414.64,7,4,0,4,5.063,60.44,0.217847559,-1314.583992,4.1905,-0.23573,-0.0556,0.18013,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-24,[0 0 0 ... 0 0 0],"[414.58600000000024, 414.27700969599994, 5.579500000000007, 4, 0, 60.440000000000005, 0, 6, 30, 0.4204182979858331, 0.8076923076923077, 4]",414.58600000000024,414.27700969599994,5.579500000000007,4,0,60.440000000000005,0,6,30,0.4204182979858331,0.8076923076923077,4,8.220732026589847,6.01544795129464
882,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCCCCC)=O)=C1)C,8.165966789804358,Active,428.67,8,4,0,4,5.519,60.44,0.214994958,-1353.89653,4.6692,-0.23529,-0.0552,0.18009,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-25,[0 0 0 ... 0 0 0],"[428.6130000000003, 428.29265975999994, 5.969600000000007, 4, 0, 60.440000000000005, 0, 7, 31, 0.3701521425059433, 0.8148148148148148, 4]",428.6130000000003,428.29265975999994,5.969600000000007,4,0,60.440000000000005,0,7,31,0.3701521425059433,0.8148148148148148,4,8.226964971676123,5.929731493136044
883,Steroid,O=C1CC[C@]2(C([C@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(C5=CC=CC=C5)=O)=C1)C,8.154901959985743,Active,406.56,3,5,0,4,4.235,60.44,0.211938017,-1309.754266,3.1142,-0.23911,-0.05945,0.17966,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-26,[0 0 0 ... 0 0 0],"[406.52200000000005, 406.21440943999994, 4.922900000000005, 4, 0, 60.440000000000005, 1, 2, 30, 0.654050042282383, 0.5769230769230769, 5]",406.52200000000005,406.21440943999994,4.922900000000005,4,0,60.440000000000005,1,2,30,0.654050042282383,0.5769230769230769,5,8.240501571929812,5.747757384397338
884,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(C)=O)=C1)C,8.236880613624288,Inactive,344.49,2,4,0,4,2.571,60.44,0.231088283,-1118.002789,4.1074,-0.23961,-0.0641,0.17551,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-27,[0 0 0 ... 0 0 0],"[344.451, 344.19875937599994, 3.629000000000003, 4, 0, 60.440000000000005, 0, 1, 25, 0.6816293019238052, 0.7619047619047619, 4]",344.451,344.19875937599994,3.629000000000003,4,0,60.440000000000005,0,1,25,0.6816293019238052,0.7619047619047619,4,8.22462747040255,5.961733104597193
885,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CC)=O)=C1)C,8.247369502068667,Inactive,358.52,3,4,0,4,3.238,60.44,0.227976018,-1157.328929,4.2133,-0.23613,-0.05604,0.18009,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-28,[0 0 0 ... 0 0 0],"[358.47800000000007, 358.21440943999994, 4.0191000000000034, 4, 0, 60.440000000000005, 0, 2, 26, 0.6996485817471967, 0.7727272727272727, 4]",358.47800000000007,358.21440943999994,4.0191000000000034,4,0,60.440000000000005,0,2,26,0.6996485817471967,0.7727272727272727,4,8.22521460907512,5.953678664263455
886,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCC)=O)=C1)C,8.254251150912134,Inactive,372.55,4,4,0,4,3.694,60.44,0.225250017,-1196.642783,4.2171,-0.23569,-0.0555,0.18019,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-29,[0 0 0 ... 0 0 0],"[372.5050000000001, 372.23005950399994, 4.409200000000004, 4, 0, 60.440000000000005, 0, 3, 27, 0.688646342014585, 0.782608695652174, 4]",372.5050000000001,372.23005950399994,4.409200000000004,4,0,60.440000000000005,0,3,27,0.688646342014585,0.782608695652174,4,8.22521460907512,5.953678664263455
887,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCC)=O)=C1)C,8.234785438913192,Inactive,386.58,5,4,0,4,4.15,60.44,0.221667581,-1235.955372,4.6283,-0.23545,-0.05539,0.18006,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-30,[0 0 0 ... 0 0 0],"[386.53200000000015, 386.24570956799994, 4.799300000000005, 4, 0, 60.440000000000005, 0, 4, 28, 0.6513035132428572, 0.7916666666666666, 4]",386.53200000000015,386.24570956799994,4.799300000000005,4,0,60.440000000000005,0,4,28,0.6513035132428572,0.7916666666666666,4,8.217192676265135,6.06467208597458
888,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCCC)=O)=C1)C,8.202336155501285,Active,400.61,6,4,0,4,4.606,60.44,0.219315815,-1275.269017,4.6311,-0.23533,-0.05519,0.18014,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-31,[0 0 0 ... 0 0 0],"[400.5590000000002, 400.26135963199994, 5.189400000000005, 4, 0, 60.440000000000005, 0, 5, 29, 0.4706064983580446, 0.8, 4]",400.5590000000002,400.26135963199994,5.189400000000005,4,0,60.440000000000005,0,5,29,0.4706064983580446,0.8,4,8.21865073807831,6.044345234147822
889,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCCCC)=O)=C1)C,8.234785438913192,Inactive,414.64,7,4,0,4,5.063,60.44,0.217859559,-1314.584021,4.1929,-0.23573,-0.05558,0.18015,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-32,[0 0 0 ... 0 0 0],"[414.58600000000024, 414.27700969599994, 5.579500000000007, 4, 0, 60.440000000000005, 0, 6, 30, 0.4204182979858331, 0.8076923076923077, 4]",414.58600000000024,414.27700969599994,5.579500000000007,4,0,60.440000000000005,0,6,30,0.4204182979858331,0.8076923076923077,4,8.220732026589847,6.01544795129464
890,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(CCCCCCC)=O)=C1)C,8.234785438913192,Inactive,428.67,8,4,0,4,5.519,60.44,0.214995268,-1353.89653,4.6695,-0.23529,-0.05521,0.18008,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-33,[0 0 0 ... 0 0 0],"[428.6130000000003, 428.29265975999994, 5.969600000000007, 4, 0, 60.440000000000005, 0, 7, 31, 0.3701521425059433, 0.8148148148148148, 4]",428.6130000000003,428.29265975999994,5.969600000000007,4,0,60.440000000000005,0,7,31,0.3701521425059433,0.8148148148148148,4,8.226964971676123,5.929731493136044
891,Steroid,O=C1CC[C@]2(C([C@@H](CC3C2CC[C@]4(C3CCC4=O)C)OC(C5=CC=CC=C5)=O)=C1)C,8.333643771468738,Inactive,406.56,3,5,0,4,4.235,60.44,0.211938017,-1309.754266,3.1142,-0.23911,-0.05945,0.17966,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-34,[0 0 0 ... 0 0 0],"[406.52200000000005, 406.21440943999994, 4.922900000000005, 4, 0, 60.440000000000005, 1, 2, 30, 0.654050042282383, 0.5769230769230769, 5]",406.52200000000005,406.21440943999994,4.922900000000005,4,0,60.440000000000005,1,2,30,0.654050042282383,0.5769230769230769,5,8.240501571929812,5.747757384397338
892,Steroid,C[C@@]12C([C@@H](OC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.169440130484347,Active,302.5,1,4,0,2,3.742,26.3,0.192813269,-930.6311915,4.3851,-0.23013,-0.0475,0.18263,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-35,[0 0 0 ... 0 0 0],"[302.458, 302.2245802, 4.533300000000004, 2, 0, 26.3, 0, 1, 22, 0.7109119657273894, 0.85, 4]",302.458,302.2245802,4.533300000000004,2,0,26.3,0,1,22,0.7109119657273894,0.85,4,8.212392402782873,6.132076966105932
893,Steroid,C[C@@]12C([C@@H](OCC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.200588452924745,Active,316.53,2,4,0,2,4.091,26.3,0.1925012,-969.9504191,4.3691,-0.22967,-0.04699,0.18268,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-36,[0 0 0 ... 0 0 0],"[316.48500000000007, 316.240230264, 4.923400000000005, 2, 0, 26.3, 0, 2, 23, 0.7222718923311353, 0.8571428571428571, 4]",316.48500000000007,316.240230264,4.923400000000005,2,0,26.3,0,2,23,0.7222718923311353,0.8571428571428571,4,8.217735194391658,6.057100863026479
894,Steroid,C[C@@]12C([C@@H](OCCC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.203450829472398,Active,330.56,3,4,0,2,4.614,26.3,0.191714276,-1009.264014,4.3738,-0.22952,-0.04688,0.18264,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-37,[0 0 0 ... 0 0 0],"[330.5120000000001, 330.255880328, 5.313500000000006, 2, 0, 26.3, 0, 3, 24, 0.7003891363895687, 0.8636363636363636, 4]",330.5120000000001,330.255880328,5.313500000000006,2,0,26.3,0,3,24,0.7003891363895687,0.8636363636363636,4,8.217735194391658,6.057100863026479
895,Steroid,C[C@@]12C([C@@H](OCCCC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.195400560806002,Active,344.59,4,4,0,2,5.071,26.3,0.190545,-1048.5776,4.3771,-0.2294,-0.04678,0.18262,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-38,[0 0 0 ... 0 0 0],"[344.53900000000016, 344.271530392, 5.703600000000006, 2, 0, 26.3, 0, 4, 25, 0.6111408072627859, 0.8695652173913043, 4]",344.53900000000016,344.271530392,5.703600000000006,2,0,26.3,0,4,25,0.6111408072627859,0.8695652173913043,4,8.223272083828991,5.980368099017119
896,Steroid,C[C@@]12C([C@@H](OCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.150544893577656,Active,378.6,3,5,0,2,5.325,26.3,0.182602726,-1161.684307,4.2883,-0.23151,-0.04939,0.18212,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-39,[0 0 0 ... 0 0 0],"[378.5560000000002, 378.255880328, 6.103700000000007, 2, 0, 26.3, 1, 3, 28, 0.6347011498907502, 0.6538461538461539, 5]",378.5560000000002,378.255880328,6.103700000000007,2,0,26.3,1,3,28,0.6347011498907502,0.6538461538461539,5,8.237068449679054,5.793373791650764
897,Steroid,C[C@@]12C([C@H](OC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.202898295733574,Active,302.5,1,4,0,2,3.742,26.3,0.192813269,-930.6311915,4.3851,-0.23013,-0.0475,0.18263,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-40,[0 0 0 ... 0 0 0],"[302.458, 302.2245802, 4.533300000000004, 2, 0, 26.3, 0, 1, 22, 0.7109119657273894, 0.85, 4]",302.458,302.2245802,4.533300000000004,2,0,26.3,0,1,22,0.7109119657273894,0.85,4,8.212392402782873,6.132076966105932
898,Steroid,C[C@@]12C([C@H](OCC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.232556780695596,Inactive,316.53,2,4,0,2,4.091,26.3,0.1925012,-969.9504191,4.3691,-0.22967,-0.04699,0.18268,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-41,[0 0 0 ... 0 0 0],"[316.48500000000007, 316.240230264, 4.923400000000005, 2, 0, 26.3, 0, 2, 23, 0.7222718923311353, 0.8571428571428571, 4]",316.48500000000007,316.240230264,4.923400000000005,2,0,26.3,0,2,23,0.7222718923311353,0.8571428571428571,4,8.217735194391658,6.057100863026479
899,Steroid,C[C@@]12C([C@H](OCCC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.230175562522609,Inactive,330.56,3,4,0,2,4.614,26.3,0.191714276,-1009.264014,4.3738,-0.22952,-0.04688,0.18264,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-42,[0 0 0 ... 0 0 0],"[330.5120000000001, 330.255880328, 5.313500000000006, 2, 0, 26.3, 0, 3, 24, 0.7003891363895687, 0.8636363636363636, 4]",330.5120000000001,330.255880328,5.313500000000006,2,0,26.3,0,3,24,0.7003891363895687,0.8636363636363636,4,8.217735194391658,6.057100863026479
900,Steroid,C[C@@]12C([C@H](OCCCC)CC3C2CC[C@@]4(C)C3CCC4)=CC(CC1)=O,8.214107698183895,Active,344.59,4,4,0,2,5.071,26.3,0.190545,-1048.5776,4.3771,-0.2294,-0.04678,0.18262,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-43,[0 0 0 ... 0 0 0],"[344.53900000000016, 344.271530392, 5.703600000000006, 2, 0, 26.3, 0, 4, 25, 0.6111408072627859, 0.8695652173913043, 4]",344.53900000000016,344.271530392,5.703600000000006,2,0,26.3,0,4,25,0.6111408072627859,0.8695652173913043,4,8.223272083828991,5.980368099017119
901,Steroid,C[C@@]12C([C@H](OCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5)=CC(CC1)=O,8.25165224474116,Inactive,378.6,3,5,0,2,5.325,26.3,0.182602726,-1161.684307,4.2883,-0.23151,-0.04939,0.18212,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-44,[0 0 0 ... 0 0 0],"[378.5560000000002, 378.255880328, 6.103700000000007, 2, 0, 26.3, 1, 3, 28, 0.6347011498907502, 0.6538461538461539, 5]",378.5560000000002,378.255880328,6.103700000000007,2,0,26.3,1,3,28,0.6347011498907502,0.6538461538461539,5,8.237068449679054,5.793373791650764
902,Steroid,C[C@@]12C([C@@H](OC(C)=O)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.224855234569844,Inactive,342.47,2,4,0,4,2.548,60.44,0.228684118,-1116.765484,1.1965,-0.23773,-0.0703,0.16743,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-45,[0 0 0 ... 0 0 0],"[342.43500000000006, 342.18310931199994, 3.405000000000002, 4, 0, 60.440000000000005, 0, 1, 25, 0.685313644647627, 0.6666666666666666, 4]",342.43500000000006,342.18310931199994,3.405000000000002,4,0,60.440000000000005,0,1,25,0.685313644647627,0.6666666666666666,4,8.226501477836512,5.936063282380092
903,Steroid,C[C@@]12C([C@@H](OC(CCCCC)=O)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.175367847062448,Active,398.59,6,4,0,4,4.583,60.44,0.217885825,-1274.036742,3.479,-0.23777,-0.06371,0.17406,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-46,[0 0 0 ... 0 0 0],"[398.5430000000002, 398.24570956799994, 4.965400000000005, 4, 0, 60.440000000000005, 0, 5, 29, 0.4847327483424668, 0.72, 4]",398.5430000000002,398.24570956799994,4.965400000000005,4,0,60.440000000000005,0,5,29,0.4847327483424668,0.72,4,8.223356933276412,5.979199810255067
904,Steroid,C[C@@]12C([C@@H](OC(C3=CC=CC=C3)=O)CC4C2CC[C@@]5(C)C4CCC5=O)=CC(C=C1)=O,8.202336155501285,Active,404.54,3,5,0,4,4.212,60.44,0.207737155,-1308.518435,6.3614,-0.23697,-0.06368,0.17329,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-47,[0 0 0 ... 0 0 0],"[404.5060000000002, 404.19875937599994, 4.6989000000000045, 4, 0, 60.440000000000005, 1, 2, 30, 0.6706309672215583, 0.5, 5]",404.5060000000002,404.19875937599994,4.6989000000000045,4,0,60.440000000000005,1,2,30,0.6706309672215583,0.5,5,8.230437684196694,5.8825051464796605
905,Steroid,C[C@@]12C([C@H](OC(C)=O)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.275639738301319,Inactive,342.47,2,4,0,4,2.548,60.44,0.228684118,-1116.765484,1.1965,-0.23773,-0.0703,0.16743,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-48,[0 0 0 ... 0 0 0],"[342.43500000000006, 342.18310931199994, 3.405000000000002, 4, 0, 60.440000000000005, 0, 1, 25, 0.685313644647627, 0.6666666666666666, 4]",342.43500000000006,342.18310931199994,3.405000000000002,4,0,60.440000000000005,0,1,25,0.685313644647627,0.6666666666666666,4,8.226501477836512,5.936063282380092
906,Steroid,C[C@@]12C([C@H](OC(CCCCC)=O)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.240730567537,Inactive,398.59,6,4,0,4,4.583,60.44,0.217885825,-1274.036742,3.479,-0.23777,-0.06371,0.17406,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-49,[0 0 0 ... 0 0 0],"[398.5430000000002, 398.24570956799994, 4.965400000000005, 4, 0, 60.440000000000005, 0, 5, 29, 0.4847327483424668, 0.72, 4]",398.5430000000002,398.24570956799994,4.965400000000005,4,0,60.440000000000005,0,5,29,0.4847327483424668,0.72,4,8.223356933276412,5.979199810255067
907,Steroid,C[C@@]12C([C@H](OC(C3=CC=CC=C3)=O)CC4C2CC[C@@]5(C)C4CCC5=O)=CC(C=C1)=O,8.319131690587083,Inactive,404.54,3,5,0,4,4.212,60.44,0.207737155,-1308.518435,6.3614,-0.23697,-0.06368,0.17329,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-50,[0 0 0 ... 0 0 0],"[404.5060000000002, 404.19875937599994, 4.6989000000000045, 4, 0, 60.440000000000005, 1, 2, 30, 0.6706309672215583, 0.5, 5]",404.5060000000002,404.19875937599994,4.6989000000000045,4,0,60.440000000000005,1,2,30,0.6706309672215583,0.5,5,8.230437684196694,5.8825051464796605
908,Steroid,C[C@@]12C([C@@H](OC)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.207075694091682,Active,314.46,1,4,0,3,2.577,43.37,0.20505598,-1003.416893,4.1243,-0.23669,-0.06212,0.17457,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-51,[0 0 0 ... 0 0 0],"[314.42499999999995, 314.18819469199997, 3.4883000000000024, 3, 0, 43.370000000000005, 0, 1, 23, 0.7439226974951417, 0.7, 4]",314.42499999999995,314.18819469199997,3.4883000000000024,3,0,43.370000000000005,0,1,23,0.7439226974951417,0.7,4,8.226501477836512,5.936063282380092
909,Steroid,C[C@@]12C([C@@H](OCC)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.203994092123821,Active,328.49,2,4,0,3,2.926,43.37,0.204764712,-1042.73465,3.1325,-0.23547,-0.0603,0.17517,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-52,[0 0 0 ... 0 0 0],"[328.452, 328.20384475599997, 3.8784000000000036, 3, 0, 43.370000000000005, 0, 2, 24, 0.772466440537957, 0.7142857142857143, 4]",328.452,328.20384475599997,3.8784000000000036,3,0,43.370000000000005,0,2,24,0.772466440537957,0.7142857142857143,4,8.23673842101629,5.797777960121525
910,Steroid,C[C@@]12C([C@@H](OCCCC)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.198099696659426,Active,356.55,4,4,0,3,3.906,43.37,0.200700879,-1121.363255,4.2892,-0.23595,-0.06139,0.17456,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-53,[0 0 0 ... 0 0 0],"[356.5060000000001, 356.23514488399996, 4.658600000000004, 3, 0, 43.370000000000005, 0, 4, 26, 0.6882438453555331, 0.7391304347826086, 4]",356.5060000000001,356.23514488399996,4.658600000000004,3,0,43.370000000000005,0,4,26,0.6882438453555331,0.7391304347826086,4,8.230903300839609,5.876201763245443
911,Steroid,C[C@@]12C([C@@H](OCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5=O)=CC(C=C1)=O,8.165966789804358,Active,390.56,3,5,0,3,4.161,43.37,0.192877949,-1234.46864,2.8924,-0.23572,-0.06136,0.17436,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-54,[0 0 0 ... 0 0 0],"[390.52300000000014, 390.21949481999997, 5.058700000000004, 3, 0, 43.370000000000005, 1, 3, 29, 0.7245687066318108, 0.5384615384615384, 5]",390.52300000000014,390.21949481999997,5.058700000000004,3,0,43.370000000000005,1,3,29,0.7245687066318108,0.5384615384615384,5,8.230573955881576,5.880659640332694
912,Steroid,C[C@@]12C([C@H](OC)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.196778715372892,Active,314.46,1,4,0,3,2.577,43.37,0.20505598,-1003.416893,4.1243,-0.23669,-0.06212,0.17457,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-55,[0 0 0 ... 0 0 0],"[314.42499999999995, 314.18819469199997, 3.4883000000000024, 3, 0, 43.370000000000005, 0, 1, 23, 0.7439226974951417, 0.7, 4]",314.42499999999995,314.18819469199997,3.4883000000000024,3,0,43.370000000000005,0,1,23,0.7439226974951417,0.7,4,8.226501477836512,5.936063282380092
913,Steroid,C[C@@]12C([C@H](OCC)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.234785438913192,Inactive,328.49,2,4,0,3,2.926,43.37,0.204764712,-1042.73465,3.1325,-0.23547,-0.0603,0.17517,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-56,[0 0 0 ... 0 0 0],"[328.452, 328.20384475599997, 3.8784000000000036, 3, 0, 43.370000000000005, 0, 2, 24, 0.772466440537957, 0.7142857142857143, 4]",328.452,328.20384475599997,3.8784000000000036,3,0,43.370000000000005,0,2,24,0.772466440537957,0.7142857142857143,4,8.23673842101629,5.797777960121525
914,Steroid,C[C@@]12C([C@H](OCCCC)CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.208979476566421,Active,356.55,4,4,0,3,3.906,43.37,0.200700879,-1121.363255,4.2892,-0.23595,-0.06139,0.17456,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-57,[0 0 0 ... 0 0 0],"[356.5060000000001, 356.23514488399996, 4.658600000000004, 3, 0, 43.370000000000005, 0, 4, 26, 0.6882438453555331, 0.7391304347826086, 4]",356.5060000000001,356.23514488399996,4.658600000000004,3,0,43.370000000000005,0,4,26,0.6882438453555331,0.7391304347826086,4,8.230903300839609,5.876201763245443
915,Steroid,C[C@@]12C([C@H](OCC3=CC=CC=C3)CC4C2CC[C@@]5(C)C4CCC5=O)=CC(C=C1)=O,8.242509347913112,Inactive,390.56,3,5,0,3,4.161,43.37,0.192877949,-1234.46864,2.8924,-0.23572,-0.06136,0.17436,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-58,[0 0 0 ... 0 0 0],"[390.52300000000014, 390.21949481999997, 5.058700000000004, 3, 0, 43.370000000000005, 1, 3, 29, 0.7245687066318108, 0.5384615384615384, 5]",390.52300000000014,390.21949481999997,5.058700000000004,3,0,43.370000000000005,1,3,29,0.7245687066318108,0.5384615384615384,5,8.230573955881576,5.880659640332694
916,Steroid,C[C@@]12C(C(OC)=CC3C2CC[C@@]4(C)C3CCC4=O)=CC(CC1)=O,8.210778860453235,Active,314.46,1,4,0,3,2.351,43.37,0.215557265,-1003.429333,3.4215,-0.22207,-0.06077,0.1613,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-59,[0 0 0 ... 0 0 0],"[314.425, 314.18819469199997, 3.837500000000003, 3, 0, 43.370000000000005, 0, 1, 23, 0.7383952728970892, 0.7, 4]",314.425,314.18819469199997,3.837500000000003,3,0,43.370000000000005,0,1,23,0.7383952728970892,0.7,4,8.239872359312647,5.756090860295577
917,Steroid,C[C@@]12C(C(OCC)=CC3C2CC[C@@]4(C)C3CCC4=O)=CC(CC1)=O,8.21289825085174,Active,328.49,2,4,0,3,2.699,43.37,0.214584173,-1042.745936,3.5576,-0.21968,-0.06065,0.15903,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-60,[0 0 0 ... 0 0 1],"[328.45200000000006, 328.20384475599997, 4.227600000000004, 3, 0, 43.370000000000005, 0, 2, 24, 0.761763346112997, 0.7142857142857143, 4]",328.45200000000006,328.20384475599997,4.227600000000004,3,0,43.370000000000005,0,2,24,0.761763346112997,0.7142857142857143,4,8.25419094744491,5.569408233943866
918,Steroid,C[C@@]12C(C(OC)=CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.214890214875727,Active,312.44,1,4,0,3,2.327,43.37,0.209874319,-1002.202267,4.5341,-0.22353,-0.0662,0.15733,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-61,[0 0 0 ... 0 0 0],"[312.40899999999993, 312.17254462799997, 3.613500000000003, 3, 0, 43.370000000000005, 0, 1, 23, 0.7426089964175349, 0.6, 4]",312.40899999999993,312.17254462799997,3.613500000000003,3,0,43.370000000000005,0,1,23,0.7426089964175349,0.6,4,8.233666001189102,5.838939815489688
919,Steroid,C[C@@]12C(C(OCC)=CC3C2CC[C@@]4(C)C3CCC4=O)=CC(C=C1)=O,8.22023931623131,Active,326.47,2,4,0,3,2.676,43.37,0.20916446,-1041.51906,4.7067,-0.22105,-0.0658,0.15525,"Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids",Steroids. 2010;75(4-5):330-62,[0 0 0 ... 0 0 1],"[326.436, 326.18819469199997, 4.003600000000003, 3, 0, 43.370000000000005, 0, 2, 24, 0.7700482256315118, 0.6190476190476191, 4]",326.436,326.18819469199997,4.003600000000003,3,0,43.370000000000005,0,2,24,0.7700482256315118,0.6190476190476191,4,8.245425953073287,5.68295277275369
920,Non-Steroid,C12=CC=CC=C1C3C(C3C4=CC=CC=C4)CC2,8.171802462536942,Active,220.33,1,4,0,0,4.303,0.0,0.154671303,-657.4294248,0.5444,-0.22543,3e-05,0.22546,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-11,[0 0 0 ... 0 0 0],"[220.31499999999997, 220.125200512, 4.130000000000003, 0, 0, 0.0, 2, 1, 17, 0.6775460478302358, 0.29411764705882354, 4]",220.31499999999997,220.125200512,4.130000000000003,0,0,0.0,2,1,17,0.6775460478302358,0.29411764705882354,4,8.249761718877883,5.626499454777257
921,Non-Steroid,COC1=C(CCC2C3C2C4=CC=CC=C4)C3=CC=C1,8.2616194307367,Inactive,250.36,2,4,0,1,4.287,9.23,0.171138865,-771.9472753,1.1576,-0.2092,0.0008,0.21,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-12,[0 0 0 ... 0 0 0],"[250.341, 250.135765196, 4.138600000000003, 1, 0, 9.23, 2, 2, 19, 0.7780730703959071, 0.3333333333333333, 4]",250.341,250.135765196,4.138600000000003,1,0,9.23,2,2,19,0.7780730703959071,0.3333333333333333,4,8.2629312534387,5.4584425856465035
922,Non-Steroid,COC1=CC=C2C(CCC3C2C3C4=CC=CC=C4)=C1,8.145017174164185,Active,250.36,2,4,0,1,4.287,9.23,0.18153227,-771.9478534,1.0702,-0.2034,0.00095,0.20435,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-13,[0 0 0 ... 0 0 0],"[250.34100000000004, 250.135765196, 4.138600000000003, 1, 0, 9.23, 2, 2, 19, 0.7780730703959071, 0.3333333333333333, 4]",250.34100000000004,250.135765196,4.138600000000003,1,0,9.23,2,2,19,0.7780730703959071,0.3333333333333333,4,8.250816513842388,5.612850646701549
923,Non-Steroid,COC1=CC=C(CCC2C3C2C4=CC=CC=C4)C3=C1,8.141783518873298,Active,250.36,2,4,0,1,4.287,9.23,0.177007838,-771.9473467,1.2925,-0.20474,-0.00382,0.20092,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-14,[0 0 0 ... 0 0 0],"[250.34100000000004, 250.135765196, 4.138600000000003, 1, 0, 9.23, 2, 2, 19, 0.7780730703959071, 0.3333333333333333, 4]",250.34100000000004,250.135765196,4.138600000000003,1,0,9.23,2,2,19,0.7780730703959071,0.3333333333333333,4,8.159241922504634,6.9303964271119884
924,Non-Steroid,CC1(C2=CC=CC=C2)C3CCC4=CC=C(OC)C=C4C31,8.191667585060895,Active,264.39,2,4,0,1,4.493,9.23,0.17780455,-811.2629023,1.3247,-0.20375,-0.00189,0.20186,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-15,[0 0 0 ... 0 0 0],"[264.36799999999994, 264.15141526, 4.312700000000003, 1, 0, 9.23, 2, 2, 20, 0.7849338867023348, 0.3684210526315789, 4]",264.36799999999994,264.15141526,4.312700000000003,1,0,9.23,2,2,20,0.7849338867023348,0.3684210526315789,4,8.252226062192848,5.594663081260627
925,Non-Steroid,BrC1=C2C(CCC3C2C3C4=CC=CC=C4)=C(OC)C=C1,8.270306313551282,Inactive,329.25,2,4,0,1,5.035,9.23,0.170095919,-3343.056175,2.5907,-0.21232,-0.00817,0.20415,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-16,[0 0 0 ... 0 0 0],"[329.2370000000001, 328.046277264, 4.901100000000004, 1, 0, 9.23, 2, 2, 20, 0.7612871927107037, 0.3333333333333333, 4]",329.2370000000001,328.046277264,4.901100000000004,1,0,9.23,2,2,20,0.7612871927107037,0.3333333333333333,4,8.257905101513073,5.521980879196786
926,Non-Steroid,BrC1=C(OC)C=C2C(CCC3C2C3C4=CC=CC=C4)=C1,8.232556780695596,Inactive,329.25,2,4,0,1,5.035,9.23,0.175803162,-3343.047939,2.5457,-0.22306,-0.01552,0.20754,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-17,[0 0 0 ... 0 0 0],"[329.23699999999997, 328.046277264, 4.901100000000004, 1, 0, 9.23, 2, 2, 20, 0.7612871927107038, 0.3333333333333333, 4]",329.23699999999997,328.046277264,4.901100000000004,1,0,9.23,2,2,20,0.7612871927107038,0.3333333333333333,4,8.227718126723012,5.919457043099431
927,Non-Steroid,OC1=C(CCC2C3C2C4=CC=CC=C4)C3=CC=C1,8.275639738301319,Inactive,236.33,1,4,1,1,4.036,20.23,0.184644412,-732.6399961,1.8884,-0.21245,-0.0062,0.20625,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-18,[0 0 0 ... 0 0 0],"[236.31400000000002, 236.120115132, 3.835600000000002, 1, 1, 20.23, 2, 1, 18, 0.7973331544632757, 0.29411764705882354, 4]",236.31400000000002,236.120115132,3.835600000000002,1,1,20.23,2,1,18,0.7973331544632757,0.29411764705882354,4,8.24150980977128,5.734429135668425
928,Non-Steroid,OC1=CC=C2C(CCC3C2C3C4=CC=CC=C4)=C1,8.188325408687179,Active,236.33,1,4,1,1,4.036,20.23,0.188695588,-732.6414793,1.6767,-0.20548,-0.00025,0.20523,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-19,[0 0 0 ... 0 0 0],"[236.31400000000005, 236.120115132, 3.835600000000003, 1, 1, 20.23, 2, 1, 18, 0.7973331544632757, 0.29411764705882354, 4]",236.31400000000005,236.120115132,3.835600000000003,1,1,20.23,2,1,18,0.7973331544632757,0.29411764705882354,4,8.240111734697717,5.752919079705212
929,Non-Steroid,OC1=CC=C(CCC2C3C2C4=CC=CC=C4)C3=C1,8.14384797082895,Active,236.33,1,4,1,1,4.036,20.23,0.190566559,-732.6409136,1.4311,-0.20872,-0.00634,0.20238,Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom,J Med Chem. 1995;38(12):2103-20,[0 0 0 ... 0 0 0],"[236.31400000000002, 236.120115132, 3.835600000000003, 1, 1, 20.23, 2, 1, 18, 0.7973331544632757, 0.29411764705882354, 4]",236.31400000000002,236.120115132,3.835600000000003,1,1,20.23,2,1,18,0.7973331544632757,0.29411764705882354,4,8.172917748199684,6.715560280669364
930,Steroid,C=C1CCC2C3CCC4=CC(CC[C@]4(CCSC)C3=CC[C@@]21C)=O,8.096910013008056,Active,342.59,3,4,0,1,4.625,42.37,0.209434278,-1329.774269,5.1942,-0.22089,-0.05033,0.17056,"RU54115, a tight-binding aromatase inhibitor potentially useful for the treatment of breast cancer",J Steroid Biochem Mol Biol. 1992;41(3-8):773-7,[0 0 0 ... 0 0 0],"[342.5480000000001, 342.20173658, 5.727800000000006, 2, 0, 17.07, 0, 3, 24, 0.6094430749172104, 0.6818181818181818, 4]",342.5480000000001,342.20173658,5.727800000000006,2,0,17.07,0,3,24,0.6094430749172104,0.6818181818181818,4,8.216057063403978,6.080551016369437
931,Non-Steroid,N#CC(C=C1)=CC=C1C2N3C(CCC2)=CN=C3,8.080868016801505,Active,223.3,1,3,0,2,2.271,41.61,0.203010333,-705.5639175,5.4907,-0.21999,-0.05828,0.16171,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-8,[0 0 0 ... 0 0 0],"[223.27899999999994, 223.110947416, 2.680480000000001, 3, 0, 41.61, 2, 1, 17, 0.7454496699795193, 0.2857142857142857, 3]",223.27899999999994,223.110947416,2.680480000000001,3,0,41.61,2,1,17,0.7454496699795193,0.2857142857142857,3,8.139930196375243,7.245524071451922
932,Non-Steroid,N#CC1=CC=C2C(CCC=C2N3C=NC=C3)=C1,8.069413690221253,Active,221.28,1,3,0,2,2.152,41.61,0.201047679,-704.342881,4.2328,-0.23453,-0.07501,0.15952,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-9,[0 0 0 ... 0 0 0],"[221.26300000000003, 221.095297352, 2.59018, 3, 0, 41.61, 2, 1, 17, 0.742299440459972, 0.14285714285714285, 3]",221.26300000000003,221.095297352,2.59018,3,0,41.61,2,1,17,0.742299440459972,0.14285714285714285,3,8.09796774161973,7.98053962651847
933,Non-Steroid,N#CC1=CC=C(CN2C=NC=C2)C3=C1C=CC=C3,8.060532166698685,Active,233.29,2,3,0,2,2.294,41.61,0.177902724,-742.4625335,4.8986,-0.23204,-0.07775,0.15429,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-10,[0 0 0 ... 0 0 0],"[233.274, 233.095297352, 2.9562800000000014, 3, 0, 41.61, 3, 2, 18, 0.6824704654183068, 0.06666666666666667, 3]",233.274,233.095297352,2.9562800000000014,3,0,41.61,3,2,18,0.6824704654183068,0.06666666666666667,3,8.102445588597616,7.898678032768031
934,Non-Steroid,CC1=C(C)OC2=C1C(CN3C=NC=C3)=CC=C2C#N,8.07283852040884,Active,251.31,2,3,0,3,2.321,54.75,0.217870031,-818.8847541,6.1534,-0.23088,-0.05936,0.17152,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-11,[0 0 0 ... 1 0 0],"[251.28900000000002, 251.105862036, 3.166120000000002, 4, 0, 54.75, 3, 2, 19, 0.7025533426052624, 0.2, 3]",251.28900000000002,251.105862036,3.166120000000002,4,0,54.75,3,2,19,0.7025533426052624,0.2,3,8.112104902757508,7.724939685515423
935,Non-Steroid,N#CC1=CC(CN2C=NC=C2)=CC=C1,8.221848749616356,Inactive,183.23,2,2,0,2,1.386,41.61,0.18810387,-588.8196298,6.7508,-0.2313,-0.06034,0.17096,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-12,[0 0 0 ... 0 0 0],"[183.21400000000003, 183.079647288, 1.80308, 3, 0, 41.61, 2, 2, 14, 0.7119802256009079, 0.09090909090909091, 2]",183.21400000000003,183.079647288,1.80308,3,0,41.61,2,2,14,0.7119802256009079,0.09090909090909091,2,8.1685963544003,6.782716196093128
937,Non-Steroid,BrC1=CC=C(CN2C=NC=C2)C=C1,8.150544893577656,Active,237.11,2,2,0,1,2.255,17.82,0.168615227,-3067.682355,3.1802,-0.2266,-0.02774,0.19886,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-13,[0 0 0 ... 0 0 0],"[237.1, 235.994910388, 2.6939, 2, 0, 17.82, 2, 2, 13, 0.7846419207807221, 0.1, 2]",237.1,235.994910388,2.6939,2,0,17.82,2,2,13,0.7846419207807221,0.1,2,8.174527982901129,6.690707084166544
938,Non-Steroid,O=C(C1=CC=C(CN2C=NC=C2)C=C1)C3=CC=CC=C3,8.096910013008056,Active,262.33,4,3,0,2,2.911,34.89,0.1740925,-840.9610427,5.3063,-0.2259,-0.06989,0.15601,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-14,[0 0 0 ... 0 0 0],"[262.312, 262.110613068, 3.1624000000000017, 3, 0, 34.89, 3, 4, 20, 0.6768584607856077, 0.058823529411764705, 3]",262.312,262.110613068,3.1624000000000017,3,0,34.89,3,4,20,0.6768584607856077,0.058823529411764705,3,8.122218697208986,7.547120824005187
939,Non-Steroid,O=[N+](C1=CC=C(CN2C=NC=C2)C=C1)[O-],8.083039022569398,Active,203.22,3,2,0,3,1.401,63.64,0.211069125,-701.0784661,4.0087,-0.2351,-0.09599,0.13911,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-15,[0 0 0 ... 0 0 0],"[203.201, 203.069476528, 1.8396, 4, 0, 60.959999999999994, 2, 3, 15, 0.5644437319980604, 0.1, 2]",203.201,203.069476528,1.8396,4,0,60.959999999999994,2,3,15,0.5644437319980604,0.1,2,8.151203655157715,7.059864160669521
940,Non-Steroid,N#CC1=CC=C(CN2C=NC=C2)C=C1,8.096910013008056,Active,183.23,2,2,0,2,1.386,41.61,0.189870348,-588.8203888,3.9687,-0.23368,-0.06184,0.17184,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-16,[0 0 0 ... 0 0 0],"[183.214, 183.079647288, 1.80308, 3, 0, 41.61, 2, 2, 14, 0.7119802256009078, 0.09090909090909091, 2]",183.214,183.079647288,1.80308,3,0,41.61,2,2,14,0.7119802256009078,0.09090909090909091,2,8.110129170625589,7.76016274607665
942,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3C=CN=N3,8.101229924222892,Active,285.33,3,3,0,4,2.966,78.29,0.177979091,-928.1191448,1.7682,-0.27185,-0.07745,0.1944,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-17,[0 1 0 ... 0 0 0],"[285.31, 285.10144535200004, 2.659160000000001, 5, 0, 78.29, 3, 3, 22, 0.7407442417149674, 0.058823529411764705, 3]",285.31,285.10144535200004,2.659160000000001,5,0,78.29,3,3,22,0.7407442417149674,0.058823529411764705,3,8.103558089187992,7.878470456868981
944,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3N=CN=N3,8.045757490560675,Active,286.32,3,3,0,5,2.839,91.18,0.188702406,-944.1544323,1.8455,-0.27386,-0.07706,0.1968,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-18,[0 1 0 ... 0 0 0],"[286.298, 286.09669432000004, 2.0541599999999995, 6, 0, 91.18, 3, 3, 22, 0.7344845416409409, 0.0625, 3]",286.298,286.09669432000004,2.0541599999999995,6,0,91.18,3,3,22,0.7344845416409409,0.0625,3,8.08776932978689,8.170162043203646
945,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=C(C#N)C=C2)N3C=CN=C3,8.07283852040884,Active,284.34,3,3,0,3,2.877,65.4,0.187846382,-912.1083485,4.1416,-0.23975,-0.07509,0.16466,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-19,[0 1 0 ... 0 0 0],"[284.322, 284.106196384, 3.2641600000000013, 4, 0, 65.4, 3, 3, 22, 0.7410656625437521, 0.05555555555555555, 3]",284.322,284.106196384,3.2641600000000013,4,0,65.4,3,3,22,0.7410656625437521,0.05555555555555555,3,8.09391258928613,8.055405565205463
947,Non-Steroid,N#CC(C=C1)=CC=C1C(C2=CC=CN=C2)C3=CC=C(C#N)C=C3,8.10201142300244,Active,295.36,3,3,0,3,3.696,60.47,0.182160444,-934.1827864,5.802,-0.25988,-0.06558,0.1943,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-20,[0 1 0 ... 0 0 0],"[295.34499999999997, 295.11094741600004, 4.005160000000003, 3, 0, 60.47, 3, 3, 23, 0.7332579260688172, 0.05, 3]",295.34499999999997,295.11094741600004,4.005160000000003,3,0,60.47,3,3,23,0.7332579260688172,0.05,3,8.142222738047499,7.207377372282562
950,Non-Steroid,N#CC(C=C1)=CC=C1C(N2C=NC=N2)C3=CC=CC=C3,8.152950965762567,Active,260.32,3,3,0,3,2.871,54.5,0.18367475,-835.9048662,5.0583,-0.25532,-0.05978,0.19554,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-21,[0 1 0 ... 0 0 0],"[260.3, 260.106196384, 2.7874800000000013, 4, 0, 54.5, 3, 3, 20, 0.7272499946884873, 0.0625, 3]",260.3,260.106196384,2.7874800000000013,4,0,54.5,3,3,20,0.7272499946884873,0.0625,3,8.112147659825672,7.724179188829688
951,Non-Steroid,BrC(C=C1)=CC=C1C(N2C=NC=N2)C3=CC=C(C#N)C=C3,8.088581255774772,Active,339.21,3,3,0,3,3.619,54.5,0.185398563,-3407.008891,3.8537,-0.25445,-0.06092,0.19353,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-22,[0 1 0 ... 0 0 0],"[339.1960000000001, 338.01670845200005, 3.5499800000000015, 4, 0, 54.5, 3, 3, 21, 0.7332667054157728, 0.0625, 3]",339.1960000000001,338.01670845200005,3.5499800000000015,4,0,54.5,3,3,21,0.7332667054157728,0.0625,3,8.101040807107477,7.924268690976646
952,Non-Steroid,CC(C1=CC=C(C#N)C=C1)(N2C=NC=N2)C3=CC=C(C#N)C=C3,8.094433061735891,Active,299.36,3,3,0,4,2.954,78.29,0.204311778,-967.4550761,4.7085,-0.26921,-0.06795,0.20126,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-23,[0 0 0 ... 0 0 0],"[299.33700000000005, 299.11709541600004, 2.833260000000001, 5, 0, 78.28999999999999, 3, 3, 23, 0.7446411969072746, 0.1111111111111111, 3]",299.33700000000005,299.11709541600004,2.833260000000001,5,0,78.28999999999999,3,3,23,0.7446411969072746,0.1111111111111111,3,8.124247662374586,7.511943929627179
953,Non-Steroid,CCC(C1=CC=C(C#N)C=C1)(N2C=NC=N2)C3=CC=C(C#N)C=C3,8.110993858666538,Active,313.39,4,3,0,4,3.478,78.29,0.201486641,-1006.764989,3.5282,-0.27314,-0.07406,0.19908,Structure-activity relationships and binding model of novel aromatase inhibitors,J Steroid Biochem Mol Biol. 1993;44(4-6):421-24,[0 0 0 ... 0 0 0],"[313.3640000000001, 313.13274548000004, 3.2233600000000022, 5, 0, 78.28999999999999, 3, 4, 24, 0.7405366065080138, 0.15789473684210525, 3]",313.3640000000001,313.13274548000004,3.2233600000000022,5,0,78.28999999999999,3,4,24,0.7405366065080138,0.15789473684210525,3,8.12882966233141,7.433106197747597
958,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(F)C(O)=C4,8.306665147054971,Inactive,288.39,0,4,1,3,3.979,37.3,0.223637667,-948.840168,2.5261,-0.2136,-0.01771,0.19589,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-8,[0 0 0 ... 0 0 0],"[288.36199999999997, 288.152558132, 3.9565000000000037, 2, 1, 37.3, 1, 0, 21, 0.7843776757956696, 0.6111111111111112, 4]",288.36199999999997,288.152558132,3.9565000000000037,2,1,37.3,1,0,21,0.7843776757956696,0.6111111111111112,4,8.28388951115163,5.201283055317488
959,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(Cl)C(O)=C4,8.248853964209266,Inactive,304.84,0,4,1,2,4.438,37.3,0.211743929,-1309.205706,2.8305,-0.21792,-0.01887,0.19905,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-9,[0 0 0 ... 0 0 0],"[304.817, 304.123007592, 4.470800000000005, 2, 1, 37.3, 1, 0, 21, 0.7675194667753027, 0.6111111111111112, 4]",304.817,304.123007592,4.470800000000005,2,1,37.3,1,0,21,0.7675194667753027,0.6111111111111112,4,8.257483032025553,5.527350029924599
960,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(Br)C(O)=C4,8.250280008800894,Inactive,349.29,0,4,1,2,4.522,37.3,0.212674071,-3420.715324,2.7685,-0.21672,-0.0188,0.19792,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-10,[0 0 0 ... 0 0 0],"[349.268, 348.072492012, 4.579900000000005, 2, 1, 37.3, 1, 0, 21, 0.7444197942139213, 0.6111111111111112, 4]",349.268,348.072492012,4.579900000000005,2,1,37.3,1,0,21,0.7444197942139213,0.6111111111111112,4,8.275867428590372,5.29825152019906
961,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(C)C(O)=C4,8.270306313551282,Inactive,284.43,0,4,1,2,4.259,37.3,0.218598578,-888.9310195,2.4878,-0.20591,-0.01488,0.19103,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-11,[0 0 0 ... 0 0 0],"[284.39899999999994, 284.177630008, 4.1258200000000045, 2, 1, 37.3, 1, 0, 21, 0.7776094640559809, 0.631578947368421, 4]",284.39899999999994,284.177630008,4.1258200000000045,2,1,37.3,1,0,21,0.7776094640559809,0.631578947368421,4,8.283068938566714,5.211119848300094
962,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(C=O)C(O)=C4,8.304640283255823,Inactive,298.41,1,4,1,3,3.533,54.37,0.21765725,-962.9330426,3.6448,-0.22603,-0.05135,0.17468,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-12,[0 0 0 ... 0 0 0],"[298.382, 298.15689456399997, 3.629900000000003, 3, 1, 54.370000000000005, 1, 1, 22, 0.8054793980335272, 0.5789473684210527, 4]",298.382,298.15689456399997,3.629900000000003,3,1,54.370000000000005,1,1,22,0.8054793980335272,0.5789473684210527,4,8.313938621541714,4.853570904070749
963,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(OC)C(O)=C4,8.321522495821112,Inactive,300.43,1,4,1,3,3.757,46.53,0.223365435,-964.1273423,3.5232,-0.20587,-0.01553,0.19034,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-13,[0 0 0 ... 0 0 0],"[300.39799999999997, 300.17254462799997, 3.826000000000003, 3, 1, 46.53, 1, 1, 22, 0.857197242338642, 0.631578947368421, 4]",300.39799999999997,300.17254462799997,3.826000000000003,3,1,46.53,1,1,22,0.857197242338642,0.631578947368421,4,8.30494305954286,4.955151536606344
964,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C([N+]([O-])=O)C(O)=C4,8.316600916799707,Inactive,315.4,1,4,1,4,3.668,83.12,0.23470675,-1054.106396,5.4041,-0.23905,-0.07514,0.16391,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-14,[0 0 0 ... 0 0 0],"[315.369, 315.147058152, 3.7256000000000036, 4, 1, 80.44, 1, 1, 23, 0.6322960662623553, 0.6111111111111112, 4]",315.369,315.147058152,3.7256000000000036,4,1,80.44,1,1,23,0.6322960662623553,0.6111111111111112,4,8.29789986617248,5.036167126251739
965,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=C(N)C(O)=C4,8.345954603462316,Inactive,285.42,0,4,3,3,3.027,63.32,0.237076341,-904.9644707,2.5276,-0.18334,-0.01322,0.17012,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-15,[0 0 0 ... 0 0 0],"[285.38699999999994, 285.17287897600005, 3.3996000000000013, 3, 2, 63.32000000000001, 1, 0, 21, 0.5670028196686884, 0.6111111111111112, 4]",285.38699999999994,285.17287897600005,3.3996000000000013,3,2,63.32000000000001,1,0,21,0.5670028196686884,0.6111111111111112,4,8.306765065395084,4.934406619093294
966,Steroid,O=C1CCC2C(C3CC[C@@]21C)CCC4=C3C=CC(O)=C4F,8.33865813550478,Inactive,288.39,0,4,1,3,3.979,37.3,0.216551,-948.8459067,1.9541,-0.21627,-0.01757,0.1987,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-16,[0 0 0 ... 0 0 0],"[288.36199999999997, 288.152558132, 3.956500000000004, 2, 1, 37.3, 1, 0, 21, 0.7843776757956696, 0.6111111111111112, 4]",288.36199999999997,288.152558132,3.956500000000004,2,1,37.3,1,0,21,0.7843776757956696,0.6111111111111112,4,8.286158603479794,5.174178374787743
970,Steroid,[H][C@]1(O)CCC2C(C3CC[C@@]21C)CCC4=C3C=C(F)C(O)=C4,8.38578751912434,Inactive,290.41,0,4,2,3,4.018,40.46,0.217769682,-950.0379284,2.9595,-0.21181,0.00074,0.21255,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-17,[0 0 0 ... 0 0 0],"[290.37799999999993, 290.168208196, 3.748300000000003, 2, 2, 40.46, 1, 0, 21, 0.7637350464032309, 0.6666666666666666, 4]",290.37799999999993,290.168208196,3.748300000000003,2,2,40.46,1,0,21,0.7637350464032309,0.6666666666666666,4,8.361480837247857,4.350299554112984
972,Steroid,[H][C@]1(O)CCC2C(C3CC[C@@]21C)CCC4=C3C=C(Br)C(O)=C4,8.39300015307213,Inactive,351.31,0,4,2,2,4.561,40.46,0.207323409,-3421.913081,3.3584,-0.21511,-0.00844,0.20667,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-18,[0 0 0 ... 0 0 0],"[351.284, 350.088142076, 4.371700000000004, 2, 2, 40.46, 1, 0, 21, 0.7286368767329344, 0.6666666666666666, 4]",351.284,350.088142076,4.371700000000004,2,2,40.46,1,0,21,0.7286368767329344,0.6666666666666666,4,8.345388851446234,4.514515501023812
974,Steroid,[H][C@]1(O)CCC2C(C3CC[C@@]21C)CCC4=C3C=C(C=O)C(O)=C4,8.398409449517013,Inactive,300.43,1,4,2,3,3.572,57.53,0.212291413,-964.130854,4.4691,-0.22438,-0.04948,0.1749,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-19,[0 0 0 ... 0 0 0],"[300.39799999999997, 300.17254462799997, 3.421700000000002, 3, 2, 57.53, 1, 1, 22, 0.7813224481409089, 0.631578947368421, 4]",300.39799999999997,300.17254462799997,3.421700000000002,3,2,57.53,1,1,22,0.7813224481409089,0.631578947368421,4,8.383294202073701,4.137193159338176
975,Steroid,[H][C@]1(O)CCC2C(C3CC[C@@]21C)CCC4=C3C=C(OC)C(O)=C4,8.431919190487823,Inactive,302.45,1,4,2,3,3.796,49.69,0.2177795,-965.3251057,2.7119,-0.20443,0.00672,0.21115,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-20,[0 0 0 ... 0 0 0],"[302.414, 302.18819469199997, 3.6178000000000026, 3, 2, 49.69, 1, 1, 22, 0.832809135520442, 0.6842105263157895, 4]",302.414,302.18819469199997,3.6178000000000026,3,2,49.69,1,1,22,0.832809135520442,0.6842105263157895,4,8.376208363365919,4.205248229414509
976,Steroid,[H][C@]1(O)CCC2C(C3CC[C@@]21C)CCC4=C3C=CC(O)=C4F,8.391953738650031,Inactive,290.41,0,4,2,3,4.018,40.46,0.211152545,-950.0434423,0.8883,-0.21458,0.00088,0.21546,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-21,[0 0 0 ... 0 0 0],"[290.37799999999993, 290.168208196, 3.7483000000000035, 2, 2, 40.46, 1, 0, 21, 0.7637350464032309, 0.6666666666666666, 4]",290.37799999999993,290.168208196,3.7483000000000035,2,2,40.46,1,0,21,0.7637350464032309,0.6666666666666666,4,8.363749929576022,4.327629478601063
979,Steroid,[H][C@]1(O)CCC2C(C3CC[C@@]21C)CCC4=C3C=CC(O)=C4C=O,8.342159150956787,Inactive,300.43,1,4,2,3,3.572,57.53,0.204860391,-964.1265452,1.6436,-0.22572,-0.06375,0.16197,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-22,[0 0 0 ... 0 0 0],"[300.39799999999997, 300.17254462799997, 3.421700000000002, 3, 2, 57.53, 1, 1, 22, 0.7813224481409089, 0.631578947368421, 4]",300.39799999999997,300.17254462799997,3.421700000000002,3,2,57.53,1,1,22,0.7813224481409089,0.631578947368421,4,8.378993754338643,4.178363755780001
981,Steroid,OC1=CC([C@@H](C)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.311041502206791,Inactive,284.43,0,4,1,2,4.025,37.3,0.211438533,-888.9253923,3.1431,-0.20976,-0.01395,0.19581,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-23,[0 0 0 ... 0 0 0],"[284.39899999999994, 284.177630008, 4.378400000000003, 2, 1, 37.3, 1, 0, 21, 0.7673972756720072, 0.631578947368421, 4]",284.39899999999994,284.177630008,4.378400000000003,2,1,37.3,1,0,21,0.7673972756720072,0.631578947368421,4,8.283068938566714,5.211119848300094
982,Steroid,OC1=CC([C@@H](CCCC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.351061449647467,Inactive,326.52,3,4,1,2,5.394,37.3,0.204782,-1006.86463,3.0717,-0.20928,-0.01367,0.19561,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-24,[0 0 0 ... 0 0 0],"[326.4800000000001, 326.2245802, 5.5487000000000055, 2, 1, 37.3, 1, 3, 24, 0.7905301729294211, 0.6818181818181818, 4]",326.4800000000001,326.2245802,5.5487000000000055,2,1,37.3,1,3,24,0.7905301729294211,0.6818181818181818,4,8.303936725341726,4.966646778809588
983,Steroid,OC1=CC([C@@H](C2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CCC5=O)=C4C=C1,8.232556780695596,Inactive,346.5,1,5,1,2,5.057,37.3,0.198004212,-1080.659991,3.0856,-0.21023,-0.0142,0.19603,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-25,[0 0 0 ... 0 0 0],"[346.4700000000001, 346.193280072, 5.406800000000005, 2, 1, 37.3, 2, 1, 26, 0.7497557551210702, 0.4583333333333333, 5]",346.4700000000001,346.193280072,5.406800000000005,2,1,37.3,2,1,26,0.7497557551210702,0.4583333333333333,5,8.278795776691224,5.262646797309592
984,Steroid,OC1=CC([C@@H](CC2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CCC5=O)=C4C=C1,8.263131054648865,Inactive,360.53,2,5,1,2,5.513,37.3,0.198014745,-1119.973761,3.1629,-0.21062,-0.01222,0.1984,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-26,[0 0 0 ... 0 0 0],"[360.4970000000001, 360.208930136, 5.601200000000006, 2, 1, 37.3, 2, 2, 27, 0.7565787054918557, 0.48, 5]",360.4970000000001,360.208930136,5.601200000000006,2,1,37.3,2,2,27,0.7565787054918557,0.48,5,8.284071292118846,5.1991064298810405
985,Steroid,OC1=CC([C@@H](OC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.373747117584882,Inactive,300.43,1,4,1,3,3.08,46.53,0.209665174,-964.1267007,3.0108,-0.21139,-0.01475,0.19664,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-27,[0 0 0 ... 0 0 0],"[300.39799999999997, 300.17254462799997, 3.9624000000000024, 3, 1, 46.53, 1, 1, 22, 0.8535520389972096, 0.631578947368421, 4]",300.39799999999997,300.17254462799997,3.9624000000000024,3,1,46.53,1,1,22,0.8535520389972096,0.631578947368421,4,8.324827379915124,4.7333936092431435
986,Steroid,OC1=CC([C@@H](OCC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.38396916656781,Inactive,314.46,2,4,1,3,3.429,46.53,0.208474469,-1003.446081,2.927,-0.21101,-0.01455,0.19646,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-28,[0 0 0 ... 0 0 0],"[314.425, 314.18819469199997, 4.352500000000004, 3, 1, 46.53, 1, 2, 23, 0.8823490529255328, 0.65, 4]",314.425,314.18819469199997,4.352500000000004,3,1,46.53,1,2,23,0.8823490529255328,0.65,4,8.361859111904486,4.346512051217052
987,Steroid,OC1=CC([C@@H](OCCCC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.423710367439275,Inactive,342.52,4,4,1,3,4.409,46.53,0.203994364,-1082.073914,2.0763,-0.20928,-0.01535,0.19393,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-29,[0 0 0 ... 0 0 0],"[342.4790000000001, 342.21949481999997, 5.132700000000004, 3, 1, 46.53, 1, 4, 25, 0.7713722649772833, 0.6818181818181818, 4]",342.4790000000001,342.21949481999997,5.132700000000004,3,1,46.53,1,4,25,0.7713722649772833,0.6818181818181818,4,8.383241478168333,4.137695450366075
988,Steroid,OC1=CC([C@H](C)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.261101686010912,Inactive,284.43,0,4,1,2,4.025,37.3,0.211438533,-888.9253923,3.1431,-0.20976,-0.01395,0.19581,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-30,[0 0 0 ... 0 0 0],"[284.39899999999994, 284.177630008, 4.378400000000003, 2, 1, 37.3, 1, 0, 21, 0.7673972756720072, 0.631578947368421, 4]",284.39899999999994,284.177630008,4.378400000000003,2,1,37.3,1,0,21,0.7673972756720072,0.631578947368421,4,8.283068938566714,5.211119848300094
989,Steroid,OC1=CC([C@H](CCCC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.297073626361334,Inactive,326.52,3,4,1,2,5.394,37.3,0.204782,-1006.86463,3.0717,-0.20928,-0.01367,0.19561,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-31,[0 0 0 ... 0 0 0],"[326.4800000000001, 326.2245802, 5.5487000000000055, 2, 1, 37.3, 1, 3, 24, 0.7905301729294211, 0.6818181818181818, 4]",326.4800000000001,326.2245802,5.5487000000000055,2,1,37.3,1,3,24,0.7905301729294211,0.6818181818181818,4,8.303936725341726,4.966646778809588
990,Steroid,OC1=CC([C@H](C2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CCC5=O)=C4C=C1,8.307962630817833,Inactive,346.5,1,5,1,2,5.057,37.3,0.198004212,-1080.659991,3.0856,-0.21023,-0.0142,0.19603,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-32,[0 0 0 ... 0 0 0],"[346.4700000000001, 346.193280072, 5.406800000000005, 2, 1, 37.3, 2, 1, 26, 0.7497557551210702, 0.4583333333333333, 5]",346.4700000000001,346.193280072,5.406800000000005,2,1,37.3,2,1,26,0.7497557551210702,0.4583333333333333,5,8.278795776691224,5.262646797309592
992,Steroid,OC1=CC([C@H](CCCC2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CCC5=O)=C4C=C1,8.3445850552086,Inactive,388.59,4,5,1,2,6.426,37.3,0.194809328,-1198.600761,3.2602,-0.2101,-0.01349,0.19661,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-33,[0 0 0 ... 0 0 0],"[388.5510000000002, 388.240230264, 6.381400000000006, 2, 1, 37.3, 2, 4, 29, 0.6595212241115465, 0.5185185185185185, 5]",388.5510000000002,388.240230264,6.381400000000006,2,1,37.3,2,4,29,0.6595212241115465,0.5185185185185185,5,8.36782539753968,4.287208474071038
993,Steroid,OC1=CC([C@H](OC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.365542488168533,Inactive,300.43,1,4,1,3,3.08,46.53,0.209665174,-964.1267007,3.0108,-0.21139,-0.01475,0.19664,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-34,[0 0 0 ... 0 0 0],"[300.39799999999997, 300.17254462799997, 3.9624000000000024, 3, 1, 46.53, 1, 1, 22, 0.8535520389972096, 0.631578947368421, 4]",300.39799999999997,300.17254462799997,3.9624000000000024,3,1,46.53,1,1,22,0.8535520389972096,0.631578947368421,4,8.324827379915124,4.7333936092431435
994,Steroid,OC1=CC([C@H](OCC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.389795583381096,Inactive,314.46,2,4,1,3,3.429,46.53,0.208474469,-1003.446081,2.927,-0.21101,-0.01455,0.19646,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-35,[0 0 0 ... 0 0 0],"[314.425, 314.18819469199997, 4.352500000000004, 3, 1, 46.53, 1, 2, 23, 0.8823490529255328, 0.65, 4]",314.425,314.18819469199997,4.352500000000004,3,1,46.53,1,2,23,0.8823490529255328,0.65,4,8.361859111904486,4.346512051217052
995,Steroid,OC1=CC([C@H](OCCCC)CC2C3CC[C@@]4(C)C2CCC4=O)=C3C=C1,8.424875599965826,Inactive,342.52,4,4,1,3,4.409,46.53,0.203994364,-1082.073914,2.0763,-0.20928,-0.01535,0.19393,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-36,[0 0 0 ... 0 0 0],"[342.4790000000001, 342.21949481999997, 5.132700000000004, 3, 1, 46.53, 1, 4, 25, 0.7713722649772833, 0.6818181818181818, 4]",342.4790000000001,342.21949481999997,5.132700000000004,3,1,46.53,1,4,25,0.7713722649772833,0.6818181818181818,4,8.383241478168333,4.137695450366075
996,Steroid,OC1=CC([C@@H](C)CC2C3CC[C@@]4(C)C2CC[C@@H]4O)=C3C=C1,8.325943333410386,Inactive,286.45,0,4,2,2,4.065,40.46,0.208221277,-890.1204866,2.3964,-0.20671,0.00568,0.21239,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-37,[0 0 0 ... 0 0 0],"[286.41499999999996, 286.193280072, 4.170200000000003, 2, 2, 40.46, 1, 0, 21, 0.7511867425258723, 0.6842105263157895, 4]",286.41499999999996,286.193280072,4.170200000000003,2,2,40.46,1,0,21,0.7511867425258723,0.6842105263157895,4,8.34672961880085,4.500599640952007
997,Steroid,OC1=CC([C@@H](CCCC)CC2C3CC[C@@]4(C)C2CC[C@@H]4O)=C3C=C1,8.341717423968634,Inactive,328.54,3,4,2,2,5.433,40.46,0.202248089,-1008.059585,2.2818,-0.20633,0.00579,0.21212,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-38,[0 0 0 ... 0 0 0],"[328.49600000000004, 328.240230264, 5.340500000000007, 2, 2, 40.46, 1, 3, 24, 0.7859346624575486, 0.7272727272727273, 4]",328.49600000000004,328.240230264,5.340500000000007,2,2,40.46,1,3,24,0.7859346624575486,0.7272727272727273,4,8.353272073549894,4.433308223480432
998,Steroid,OC1=CC([C@@H](C2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CC[C@@H]5O)=C4C=C1,8.410116241145602,Inactive,348.52,1,5,2,2,5.097,40.46,0.196009963,-1081.855003,2.4599,-0.20721,-0.00017,0.20704,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-39,[0 0 0 ... 0 0 0],"[348.48600000000005, 348.208930136, 5.198600000000005, 2, 2, 40.46, 2, 1, 26, 0.7435828308824817, 0.5, 5]",348.48600000000005,348.208930136,5.198600000000005,2,2,40.46,2,1,26,0.7435828308824817,0.5,5,8.355093529964558,4.414753606710616
1000,Steroid,OC1=CC([C@@H](OC)CC2C3CC[C@@]4(C)C2CC[C@@H]4O)=C3C=C1,8.397466364364174,Inactive,302.45,1,4,2,3,3.119,49.69,0.206161417,-965.3224377,2.304,-0.20643,0.00498,0.21141,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-40,[0 0 0 ... 0 0 0],"[302.414, 302.18819469199997, 3.7542000000000026, 3, 2, 49.69, 1, 1, 22, 0.830306766426083, 0.6842105263157895, 4]",302.414,302.18819469199997,3.7542000000000026,3,2,49.69,1,1,22,0.830306766426083,0.6842105263157895,4,8.383962810427192,4.130828736527256
1003,Steroid,OC1=CC([C@H](C)CC2C3CC[C@@]4(C)C2CC[C@@H]4O)=C3C=C1,8.375236407071363,Inactive,286.45,0,4,2,2,4.065,40.46,0.208221277,-890.1204866,2.3964,-0.20671,0.00568,0.21239,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-41,[0 0 0 ... 0 0 0],"[286.41499999999996, 286.193280072, 4.170200000000003, 2, 2, 40.46, 1, 0, 21, 0.7511867425258723, 0.6842105263157895, 4]",286.41499999999996,286.193280072,4.170200000000003,2,2,40.46,1,0,21,0.7511867425258723,0.6842105263157895,4,8.34672961880085,4.500599640952007
1004,Steroid,OC1=CC([C@H](CCCC)CC2C3CC[C@@]4(C)C2CC[C@@H]4O)=C3C=C1,8.360857563980318,Inactive,328.54,3,4,2,2,5.433,40.46,0.202248089,-1008.059585,2.2818,-0.20633,0.00579,0.21212,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-42,[0 0 0 ... 0 0 0],"[328.49600000000004, 328.240230264, 5.340500000000007, 2, 2, 40.46, 1, 3, 24, 0.7859346624575486, 0.7272727272727273, 4]",328.49600000000004,328.240230264,5.340500000000007,2,2,40.46,1,3,24,0.7859346624575486,0.7272727272727273,4,8.353272073549894,4.433308223480432
1005,Steroid,OC1=CC([C@H](C2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CC[C@@H]5O)=C4C=C1,8.410116241145602,Inactive,348.52,1,5,2,2,5.097,40.46,0.196009963,-1081.855003,2.4599,-0.20721,-0.00017,0.20704,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-43,[0 0 0 ... 0 0 0],"[348.48600000000005, 348.208930136, 5.198600000000005, 2, 2, 40.46, 2, 1, 26, 0.7435828308824817, 0.5, 5]",348.48600000000005,348.208930136,5.198600000000005,2,2,40.46,2,1,26,0.7435828308824817,0.5,5,8.355093529964558,4.414753606710616
1007,Steroid,OC1=CC([C@H](CCCC2=CC=CC=C2)CC3C4CC[C@@]5(C)C3CC[C@@H]5O)=C4C=C1,8.341717423968634,Inactive,390.61,4,5,2,2,6.465,40.46,0.192858111,-1199.79578,2.5476,-0.20714,0.00485,0.21199,"Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors",J Steroid Biochem Mol Biol. 2005;96(1):51-44,[0 0 0 ... 0 0 0],"[390.5670000000002, 390.255880328, 6.173200000000007, 2, 2, 40.46, 2, 4, 29, 0.6549069626209924, 0.5555555555555556, 5]",390.5670000000002,390.255880328,6.173200000000007,2,2,40.46,2,4,29,0.6549069626209924,0.5555555555555556,5,8.358391442975794,4.381356146445534
1011,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](F)C1)=O,8.220892309744627,Active,304.44,0,4,0,3,3.553,34.14,0.21143634,-989.3596677,3.8327,-0.23737,-0.05949,0.17788,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-9,[0 0 0 ... 0 0 0],"[304.40500000000003, 304.18385826, 4.035400000000004, 2, 0, 34.14, 0, 0, 22, 0.676732710828458, 0.7894736842105263, 4]",304.40500000000003,304.18385826,4.035400000000004,2,0,34.14,0,0,22,0.676732710828458,0.7894736842105263,4,8.23491189329462,5.82221322885249
1012,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](Cl)C1)=O,8.232556780695596,Inactive,320.89,0,4,0,2,3.817,34.14,0.211773936,-1349.72331,4.2896,-0.2384,-0.06408,0.17432,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-10,[0 0 0 ... 0 0 0],"[320.86, 320.15430771999996, 4.304700000000004, 2, 0, 34.14, 0, 0, 22, 0.6233796302566226, 0.7894736842105263, 4]",320.86,320.15430771999996,4.304700000000004,2,0,34.14,0,0,22,0.6233796302566226,0.7894736842105263,4,8.20932598675346,6.175526835220077
1013,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](Br)C1)=O,8.247369502068667,Inactive,365.34,0,4,0,2,3.962,34.14,0.211083319,-3461.235725,4.1724,-0.23813,-0.0658,0.17233,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-11,[0 0 0 ... 0 0 0],"[365.31100000000004, 364.10379214, 4.460800000000004, 2, 0, 34.14, 0, 0, 22, 0.5941791443893196, 0.7894736842105263, 4]",365.31100000000004,364.10379214,4.460800000000004,2,0,34.14,0,0,22,0.5941791443893196,0.7894736842105263,4,8.237210423518185,5.79148020762893
1014,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](C)C1)=O,8.198099696659426,Active,300.48,0,4,0,2,3.756,34.14,0.21030616,-929.4431335,3.7326,-0.2301,-0.04626,0.18384,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-12,[0 0 0 ... 0 0 0],"[300.44200000000006, 300.208930136, 4.333400000000004, 2, 0, 34.14, 0, 0, 22, 0.666890035800204, 0.8, 4]",300.44200000000006,300.208930136,4.333400000000004,2,0,34.14,0,0,22,0.666890035800204,0.8,4,8.2288994386105,5.903377577377774
1015,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](CC)C1)=O,8.199368224774929,Active,314.51,1,4,0,2,4.213,34.14,0.208216566,-968.7565913,3.728,-0.22957,-0.04641,0.18316,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-13,[0 0 0 ... 0 0 0],"[314.4690000000001, 314.2245802, 4.723500000000005, 2, 0, 34.14, 0, 1, 23, 0.7013194281770768, 0.8095238095238095, 4]",314.4690000000001,314.2245802,4.723500000000005,2,0,34.14,0,1,23,0.7013194281770768,0.8095238095238095,4,8.243713475078065,5.70540561141314
1016,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](O)C1)=O,8.317375877694138,Inactive,302.45,0,4,1,3,2.613,54.37,0.218847479,-965.3401504,2.8872,-0.23419,-0.0554,0.17879,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-14,[0 0 0 ... 0 0 0],"[302.41400000000004, 302.18819469199997, 3.058200000000001, 3, 1, 54.37, 0, 0, 22, 0.7479907013785353, 0.7894736842105263, 4]",302.41400000000004,302.18819469199997,3.058200000000001,3,1,54.37,0,0,22,0.7479907013785353,0.7894736842105263,4,8.243456676019287,5.708780224971731
1017,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](OC)C1)=O,8.307318902488246,Inactive,316.48,1,4,0,3,3.022,43.37,0.208510961,-1004.64704,2.7925,-0.22529,-0.05177,0.17352,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-15,[0 0 0 ... 0 0 0],"[316.4410000000001, 316.20384475599997, 3.7123000000000026, 3, 0, 43.370000000000005, 0, 1, 23, 0.7404194205822723, 0.8, 4]",316.4410000000001,316.20384475599997,3.7123000000000026,3,0,43.370000000000005,0,1,23,0.7404194205822723,0.8,4,8.252350572393825,5.593059347369734
1018,Steroid,C[C@@]12C(CCC3C2CC[C@@]4(C)C3CCC4=O)=CC([C@H](OCC)C1)=O,8.282773156087034,Inactive,330.51,2,4,0,3,3.371,43.37,0.207320759,-1043.966254,2.8175,-0.22424,-0.05124,0.173,Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions,J Steroid Biochem Mol Biol. 2005;97(4):353-16,[0 0 0 ... 0 0 0],"[330.46800000000013, 330.21949481999997, 4.102400000000004, 3, 0, 43.370000000000005, 0, 2, 24, 0.76531924221874, 0.8095238095238095, 4]",330.46800000000013,330.21949481999997,4.102400000000004,3,0,43.370000000000005,0,2,24,0.76531924221874,0.8095238095238095,4,8.26430972068041,5.441144747314643
1021,Steroid,O=C1CCC2C3CC=C4[C@@H](C)CCC[C@]4(C)C3CC[C@@]21C,8.240730567537,Inactive,286.5,0,4,0,1,4.687,17.07,0.19087351,-855.4294852,2.9381,-0.22711,-0.0104,0.21671,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-42,[0 0 0 ... 0 0 0],"[286.459, 286.22966558, 5.154400000000005, 1, 0, 17.07, 0, 0, 21, 0.5624739524074177, 0.85, 4]",286.459,286.22966558,5.154400000000005,1,0,17.07,0,0,21,0.5624739524074177,0.85,4,8.20011143197499,6.307954731998623
1022,Steroid,O=C1CCC2C3CC=C4[C@@H](CC)CCC[C@]4(C)C3CC[C@@]21C,8.27190707707259,Inactive,300.53,1,4,0,1,5.143,17.07,0.189988722,-894.7401327,2.9179,-0.22695,-0.01042,0.21653,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-43,[0 0 0 ... 0 0 0],"[300.48600000000005, 300.245315644, 5.5445000000000055, 1, 0, 17.07, 0, 1, 22, 0.5806337844702286, 0.8571428571428571, 4]",300.48600000000005,300.245315644,5.5445000000000055,1,0,17.07,0,1,22,0.5806337844702286,0.8571428571428571,4,8.239158067913039,5.765565788876849
1023,Steroid,O=C1CCC2C3CC=C4[C@@H](CCC)CCC[C@]4(C)C3CC[C@@]21C,8.27904420247403,Inactive,314.56,2,4,0,1,5.599,17.07,0.18883614,-934.049737,2.6175,-0.2276,-0.01471,0.21289,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-44,[0 0 0 ... 0 0 0],"[314.51300000000003, 314.260965708, 5.934600000000007, 1, 0, 17.07, 0, 2, 23, 0.5768556929192085, 0.8636363636363636, 4]",314.51300000000003,314.260965708,5.934600000000007,1,0,17.07,0,2,23,0.5768556929192085,0.8636363636363636,4,8.246369369371383,5.670621114304216
1026,Steroid,O=C1CCC2C3CCC4=C(OC(C)=O)CCC[C@]4(C)C3CC[C@@]21C,8.208979476566421,Active,330.51,2,4,0,3,3.772,43.37,0.219589296,-1043.99364,2.2815,-0.22775,-0.01188,0.21587,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-45,[0 0 0 ... 0 0 0],"[330.4680000000001, 330.21949481999997, 4.799200000000004, 3, 0, 43.370000000000005, 0, 1, 24, 0.6486817152106633, 0.8095238095238095, 4]",330.4680000000001,330.21949481999997,4.799200000000004,3,0,43.370000000000005,0,1,24,0.6486817152106633,0.8095238095238095,4,8.221744582394843,6.001439295952083
1027,Steroid,O=C1CCC2C3CCC4=C(OC(C)=O)CCC[C@]4(CO)C3CC[C@@]21C,8.264106016122115,Inactive,346.51,3,4,1,4,2.681,63.6,0.223803982,-1119.202104,3.9932,-0.23065,-0.01318,0.21747,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-46,[0 0 0 ... 0 0 0],"[346.4670000000001, 346.21440944, 3.771600000000003, 4, 1, 63.60000000000001, 0, 2, 25, 0.773158595000806, 0.8095238095238095, 4]",346.4670000000001,346.21440944,3.771600000000003,4,1,63.60000000000001,0,2,25,0.773158595000806,0.8095238095238095,4,8.264183964594427,5.442720535571022
1028,Steroid,O=C1CCC2C3CCC4=C(OC(CCC)=O)CCC[C@]4(C)C3CC[C@@]21C,8.234785438913192,Inactive,358.57,4,4,0,3,4.895,43.37,0.215532917,-1122.62049,2.4512,-0.22726,-0.01169,0.21557,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-47,[0 0 0 ... 0 0 0],"[358.52200000000016, 358.25079494799996, 5.579400000000006, 3, 0, 43.370000000000005, 0, 3, 26, 0.6186102341763323, 0.8260869565217391, 4]",358.52200000000016,358.25079494799996,5.579400000000006,3,0,43.370000000000005,0,3,26,0.6186102341763323,0.8260869565217391,4,8.22489035731549,5.958125443377402
1029,Steroid,O=C1CCC2C3CCC4=C(OC(CCCCC)=O)CCC[C@]4(C)C3CC[C@@]21C,8.240730567537,Inactive,386.63,6,4,0,3,5.808,43.37,0.211392955,-1201.248132,2.4934,-0.22704,-0.01168,0.21536,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-48,[0 0 0 ... 0 0 0],"[386.57600000000025, 386.28209507599996, 6.3596000000000075, 3, 0, 43.370000000000005, 0, 5, 28, 0.4077229386983286, 0.84, 4]",386.57600000000025,386.28209507599996,6.3596000000000075,3,0,43.370000000000005,0,5,28,0.4077229386983286,0.84,4,8.249813429444917,5.625829558730569
1030,Steroid,O=C1CCC2C3CCC4=C(OC(C5=CC=CC=C5)=O)CCC[C@]4(C)C3CC[C@@]21C,8.208041418102681,Active,392.58,3,5,0,3,5.437,43.37,0.202679492,-1235.722894,2.2876,-0.22524,-0.04674,0.1785,Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids,Steroids. 2003 Aug;68(6):533-49,[0 0 0 ... 0 0 0],"[392.5390000000003, 392.23514488399996, 6.093100000000006, 3, 0, 43.370000000000005, 1, 2, 29, 0.5717904082980431, 0.6153846153846154, 5]",392.5390000000003,392.23514488399996,6.093100000000006,3,0,43.370000000000005,1,2,29,0.5717904082980431,0.6153846153846154,5,8.24551577443533,5.681777538442994
1033,Non-Steroid,FC1=CC(CN(C2=CC=C(C#N)C=C2)C3=CN=CN=C3)=CC(F)=C1,7.982123261809046,Active,322.34,4,3,0,6,3.681,52.81,0.221268889,-1111.784738,3.7871,-0.2316,-0.06575,0.16585,"Studies on aromatase inhibitors. IV. Synthesis and biological evaluation of N,N-disubstituted-5-aminopyrimidine derivatives",Chem Pharm Bull. 1997;45(8):1293-9,[0 0 0 ... 0 0 0],"[322.31800000000004, 322.103002824, 3.964780000000002, 4, 0, 52.81, 3, 4, 24, 0.7292660205001944, 0.05555555555555555, 3]",322.31800000000004,322.103002824,3.964780000000002,4,0,52.81,3,4,24,0.7292660205001944,0.05555555555555555,3,8.041378621866219,9.091203476825745
1034,Non-Steroid,BrC(C=C1)=CC=C1CN(C2=CC=C(C#N)C=C2)N3C=NN=C3,8.004976905321396,Active,354.23,4,3,0,4,3.415,57.74,0.200624353,-3462.310164,5.0826,-0.24256,-0.05357,0.18899,"Studies on aromatase inhibitors. IV. Synthesis and biological evaluation of N,N-disubstituted-5-aminopyrimidine derivatives",Chem Pharm Bull. 1997;45(8):1293-10,[0 0 0 ... 0 0 0],"[354.211, 353.02760748400004, 3.3821800000000026, 5, 0, 57.74, 3, 4, 22, 0.720803730982883, 0.0625, 3]",354.211,353.02760748400004,3.3821800000000026,5,0,57.74,3,4,22,0.720803730982883,0.0625,3,8.032662804654699,9.27549712927465
1035,Non-Steroid,C12=CC=CC=C1C=C(C(C3=CC=CC=C3)N4C=CN=C4)O2,8.13291499495892,Active,274.34,3,4,0,2,3.714,30.96,0.183124771,-879.0536537,4.0902,-0.22188,-0.02984,0.19204,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-6,[0 1 0 ... 0 0 0],"[274.32300000000004, 274.11061306799996, 4.267000000000004, 3, 0, 30.96, 4, 3, 21, 0.5584110169379468, 0.05555555555555555, 4]",274.32300000000004,274.11061306799996,4.267000000000004,3,0,30.96,4,3,21,0.5584110169379468,0.05555555555555555,4,8.153509401027247,7.022481422408135
1036,Non-Steroid,ClC(C=C1)=CC=C1C(N2C=CN=C2)C3=CC4=CC=CC=C4O3,8.090791263035992,Active,308.78,3,4,0,2,4.378,30.96,0.179111657,-1338.648956,3.3893,-0.2241,-0.0329,0.1912,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-7,[0 1 0 ... 0 0 0],"[308.76800000000003, 308.071640716, 4.9204000000000025, 3, 0, 30.96, 4, 3, 22, 0.5376058386893485, 0.05555555555555555, 4]",308.76800000000003,308.071640716,4.9204000000000025,3,0,30.96,4,3,22,0.5376058386893485,0.05555555555555555,4,8.113005836865458,7.708931082844058
1037,Non-Steroid,FC(C=C1)=CC=C1C(N2C=CN=C2)C3=CC4=CC=CC=C4O3,8.089552916288797,Active,292.33,3,4,0,3,3.919,30.96,0.199813686,-978.2866721,3.2547,-0.2224,-0.0279,0.1945,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-8,[0 1 0 ... 0 0 0],"[292.31300000000005, 292.101191256, 4.406100000000002, 3, 0, 30.96, 4, 3, 22, 0.5598994535029161, 0.05555555555555555, 4]",292.31300000000005,292.101191256,4.406100000000002,3,0,30.96,4,3,22,0.5598994535029161,0.05555555555555555,4,8.130762579668366,7.4000971339114106
1039,Non-Steroid,CC1=CC=CC=C1C(N2C=CN=C2)C3=CC4=CC=CC=C4O3,8.091387772434338,Active,288.37,3,4,0,2,4.2,30.96,0.192650342,-918.3658578,3.6516,-0.21827,-0.02497,0.1933,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-9,[0 1 0 ... 0 0 0],"[288.3500000000001, 288.12626313199996, 4.575420000000003, 3, 0, 30.96, 4, 3, 22, 0.552421658203298, 0.10526315789473684, 4]",288.3500000000001,288.12626313199996,4.575420000000003,3,0,30.96,4,3,22,0.552421658203298,0.10526315789473684,4,8.146180885881066,7.141987966535639
1040,Non-Steroid,CC(C=C1)=CC=C1C(N2C=CN=C2)C3=CC4=CC=CC=C4O3,8.093906563813192,Active,288.37,3,4,0,2,4.2,30.96,0.190483263,-918.3669426,4.099,-0.22018,-0.03505,0.18513,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-10,[0 1 0 ... 0 0 0],"[288.3500000000001, 288.12626313199996, 4.575420000000003, 3, 0, 30.96, 4, 3, 22, 0.552421658203298, 0.10526315789473684, 4]",288.3500000000001,288.12626313199996,4.575420000000003,3,0,30.96,4,3,22,0.552421658203298,0.10526315789473684,4,8.140698625633295,7.232715366356471
1041,Non-Steroid,BrC1=C2C(OC(C(C3=CC=CC=C3Cl)N4C=CN=C4)=C2)=CC=C1,8.101427581489343,Active,387.67,3,4,0,2,5.127,30.96,0.176634971,-3909.743784,3.5673,-0.22204,-0.03889,0.18315,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-11,[0 1 0 ... 0 0 0],"[387.66400000000004, 385.98215278400005, 5.6829000000000045, 3, 0, 30.96, 4, 3, 23, 0.4524341346837917, 0.05555555555555555, 4]",387.66400000000004,385.98215278400005,5.6829000000000045,3,0,30.96,4,3,23,0.4524341346837917,0.05555555555555555,4,8.118488097113229,7.612230018704606
1042,Non-Steroid,ClC1=CC=CC=C1C(N2C=CN=C2)C3=CC4=CC=CC=C4O3,8.112947571546975,Active,308.78,3,4,0,2,4.378,30.96,0.181638686,-1338.641997,3.6895,-0.21833,-0.03086,0.18747,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-12,[0 1 0 ... 0 0 0],"[308.76800000000003, 308.071640716, 4.9204000000000025, 3, 0, 30.96, 4, 3, 22, 0.5376058386893485, 0.05555555555555555, 4]",308.76800000000003,308.071640716,4.9204000000000025,3,0,30.96,4,3,22,0.5376058386893485,0.05555555555555555,4,8.118488097113229,7.612230018704606
1043,Non-Steroid,COC1=CC=CC=C1C(N2C=CN=C2)C3=CC4=CC=CC=C4O3,8.113197271666715,Active,304.37,4,4,0,3,3.697,40.19,0.199808949,-993.5739843,3.8385,-0.21232,-0.01879,0.19353,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-13,[0 1 0 ... 0 0 0],"[304.34900000000005, 304.12117775199994, 4.275600000000003, 4, 0, 40.19, 4, 4, 23, 0.564888331180431, 0.10526315789473684, 4]",304.34900000000005,304.12117775199994,4.275600000000003,4,0,40.19,4,4,23,0.564888331180431,0.10526315789473684,4,8.146180885881066,7.141987966535639
1044,Non-Steroid,ClC1=CC=C(Cl)C=C1C(N2C=CN=C2)C3=CC4=C(Cl)C=CC=C4O3,8.122766797756467,Active,377.66,3,4,0,2,5.707,30.96,0.173839057,-2257.831238,4.493,-0.22736,-0.0454,0.18196,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-14,[0 1 0 ... 0 0 0],"[377.6580000000002, 375.993696012, 6.227200000000003, 3, 0, 30.96, 4, 3, 24, 0.4236933496428428, 0.05555555555555555, 4]",377.6580000000002,375.993696012,6.227200000000003,3,0,30.96,4,3,24,0.4236933496428428,0.05555555555555555,4,8.149240472450428,7.091849776338896
1045,Non-Steroid,ClC1=C2C(OC(C(C3=CC=CC=C3)N4C=CN=C4)=C2)=CC=C1,8.125935624352545,Active,308.78,3,4,0,2,4.378,30.96,0.179391143,-1338.649201,3.9206,-0.22509,-0.04041,0.18468,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-15,[0 1 0 ... 0 0 0],"[308.76800000000003, 308.07164071600005, 4.920400000000004, 3, 0, 30.96, 4, 3, 22, 0.5376058386893483, 0.05555555555555555, 4]",308.76800000000003,308.07164071600005,4.920400000000004,3,0,30.96,4,3,22,0.5376058386893483,0.05555555555555555,4,8.120774544314688,7.5722589236272
1046,Non-Steroid,ClC1=C2C(OC(C(C3=CC=CC=C3)N4C=CN=C4)=C2)=CC(Cl)=C1,8.129111081483499,Active,343.22,3,4,0,2,5.043,30.96,0.175084029,-1798.242357,3.4534,-0.22837,-0.05042,0.17795,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-16,[0 1 0 ... 0 0 0],"[343.2130000000001, 342.032668364, 5.573800000000004, 3, 0, 30.96, 4, 3, 23, 0.48658188794233165, 0.05555555555555555, 4]",343.2130000000001,342.032668364,5.573800000000004,3,0,30.96,4,3,23,0.48658188794233165,0.05555555555555555,4,8.120774544314688,7.5722589236272
1047,Non-Steroid,CC1=C(C(C2=CC=CC=C2)N3C=CN=C3)OC4=CC=CC=C41,8.136146880327441,Active,288.37,3,4,0,2,4.2,30.96,0.182935368,-918.3705344,3.5026,-0.21635,-0.02426,0.19209,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-17,[0 1 0 ... 0 0 0],"[288.35, 288.12626313199996, 4.575420000000003, 3, 0, 30.96, 4, 3, 22, 0.552421658203298, 0.10526315789473684, 4]",288.35,288.12626313199996,4.575420000000003,3,0,30.96,4,3,22,0.552421658203298,0.10526315789473684,4,8.14603718954712,7.144351448765189
1048,Non-Steroid,ClC1=C2C(OC(C(C3=CC=CC=C3Cl)N4C=CN=C4)=C2)=CC=C1,8.144321527641413,Active,343.22,3,4,0,2,5.043,30.96,0.177950943,-1798.234133,3.4827,-0.2223,-0.03886,0.18344,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-18,[0 1 0 ... 0 0 0],"[343.213, 342.032668364, 5.573800000000004, 3, 0, 30.96, 4, 3, 23, 0.4865818879423317, 0.05555555555555555, 4]",343.213,342.032668364,5.573800000000004,3,0,30.96,4,3,23,0.4865818879423317,0.05555555555555555,4,8.118488097113229,7.612230018704606
1049,Non-Steroid,BrC1=C2C(OC(C(C3=CC=CC=C3)N4C=CN=C4)=C2)=CC=C1,8.14668438760424,Active,353.23,3,4,0,2,4.462,30.96,0.178118143,-3450.158858,3.9049,-0.22482,-0.04058,0.18424,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-19,[0 1 0 ... 0 0 0],"[353.21900000000005, 352.0211251360001, 5.029500000000004, 3, 0, 30.96, 4, 3, 22, 0.517273196029932, 0.05555555555555555, 4]",353.21900000000005,352.0211251360001,5.029500000000004,3,0,30.96,4,3,22,0.517273196029932,0.05555555555555555,4,8.14636045085585,7.139035624620918
1050,Non-Steroid,CC1=C2C(OC(C(C3=CC=CC=C3Cl)N4C=CN=C4)=C2)=CC=C1,8.152602740004308,Active,322.81,3,4,0,2,4.864,30.96,0.187452474,-1377.956809,5.1414,-0.21439,-0.03345,0.18094,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-20,[0 1 0 ... 0 0 0],"[322.795, 322.08729078000005, 5.228820000000003, 3, 0, 30.96, 4, 3, 23, 0.5169085037689121, 0.10526315789473684, 4]",322.795,322.08729078000005,5.228820000000003,3,0,30.96,4,3,23,0.5169085037689121,0.10526315789473684,4,8.129741533978194,7.417515559934792
1051,Non-Steroid,C12=CC=CC=C1C=C(C(C3=CC=C(C4=CC=CC=C4)C=C3)N5C=CN=C5)O2,8.179392383683968,Active,350.44,4,5,0,2,5.232,30.96,0.174608578,-1110.111083,4.1474,-0.22124,-0.03342,0.18782,Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo,J Steroid Biochem Mol Biol. 1993;44(4-6):675-21,[0 1 0 ... 0 0 0],"[350.42100000000005, 350.141913196, 5.9340000000000055, 3, 0, 30.96, 5, 4, 27, 0.4018524341973117, 0.041666666666666664, 5]",350.42100000000005,350.141913196,5.9340000000000055,3,0,30.96,5,4,27,0.4018524341973117,0.041666666666666664,5,8.153738588515058,7.018776470259836
1055,Non-Steroid,FC1=CC=C(C(C2=CC=C(NC=C3)C3=C2)N4C=CN=C4)C=C1,8.120328258966454,Active,291.35,3,4,1,2,3.618,33.61,0.199062083,-958.4266027,5.7561,-0.21071,-0.02126,0.18945,Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors,Bioorg Med Chem Lett. 2006;16(5):1134-7,[0 1 0 ... 0 0 0],"[291.329, 291.117175668, 4.141200000000003, 2, 1, 33.61, 4, 3, 22, 0.6044165911763298, 0.05555555555555555, 4]",291.329,291.117175668,4.141200000000003,2,1,33.61,4,3,22,0.6044165911763298,0.05555555555555555,4,8.128617686635126,7.436735123553121
1056,Non-Steroid,ClC1=CC=C(C(C2=CC=C(NC=C3)C3=C2)N4C=CN=C4)C=C1,8.107053870214415,Active,307.8,3,4,1,1,4.077,33.61,0.17898025,-1318.790188,6.5672,-0.21434,-0.0238,0.19054,Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors,Bioorg Med Chem Lett. 2006;16(5):1134-8,[0 1 0 ... 0 0 0],"[307.78400000000005, 307.087625128, 4.6555000000000035, 2, 1, 33.61, 4, 3, 22, 0.5867612802233075, 0.05555555555555555, 4]",307.78400000000005,307.087625128,4.6555000000000035,2,1,33.61,4,3,22,0.5867612802233075,0.05555555555555555,4,8.106472131549507,7.825784211047262
1057,Non-Steroid,ClC1=CC=CC(C(C2=CC=C(NC=C3)C3=C2)N4C=CN=C4)=C1,8.123364031734539,Active,307.8,3,4,1,1,4.077,33.61,0.179072611,-1318.789017,4.9861,-0.21135,-0.02513,0.18622,Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors,Bioorg Med Chem Lett. 2006;16(5):1134-9,[0 1 0 ... 0 0 0],"[307.78400000000005, 307.087625128, 4.6555000000000035, 2, 1, 33.61, 4, 3, 22, 0.5867612802233075, 0.05555555555555555, 4]",307.78400000000005,307.087625128,4.6555000000000035,2,1,33.61,4,3,22,0.5867612802233075,0.05555555555555555,4,8.111954391797278,7.727617337741295
1058,Non-Steroid,CN(C=C1)C(C1=C2)=CC=C2C(N3C=CN=C3)C4=CC=CC=C4,8.123024400628166,Active,287.39,3,4,0,1,3.618,22.75,0.175974949,-898.5057289,5.563,-0.20394,-0.01641,0.18753,Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors,Bioorg Med Chem Lett. 2006;16(5):1134-10,[0 1 0 ... 0 0 0],"[287.36600000000004, 287.14224754400004, 4.012500000000003, 3, 0, 22.75, 4, 3, 22, 0.5579639195188316, 0.10526315789473684, 4]",287.36600000000004,287.14224754400004,4.012500000000003,3,0,22.75,4,3,22,0.5579639195188316,0.10526315789473684,4,8.144987099949423,7.161646824689465
1059,Non-Steroid,N#CC1=CC=C(C(C2=CC=C(NC=C3)C3=C2)N4C=CN=C4)C=C1,8.112695442895172,Active,298.37,3,4,1,2,3.291,57.4,0.197092243,-951.4360735,7.7462,-0.21726,-0.0578,0.15946,Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors,Bioorg Med Chem Lett. 2006;16(5):1134-11,[0 1 0 ... 0 0 0],"[298.349, 298.121846448, 3.8737800000000018, 3, 1, 57.4, 4, 3, 23, 0.6238457241297181, 0.05263157894736842, 4]",298.349,298.121846448,3.8737800000000018,3,1,57.4,4,3,23,0.6238457241297181,0.05263157894736842,4,8.096562948281774,8.006395723738695
1060,Non-Steroid,COC1=CC=C(C(N2C=NC=N2)CC(C3=CC=CC=C3)O4)C4=C1,8.232556780695596,Inactive,307.38,3,4,0,4,2.869,49.17,0.199200975,-1010.831778,3.1341,-0.21433,-0.00545,0.20888,Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors,Bioorg Med Chem Lett. 2004;14(20):5215-8,[0 0 0 ... 0 0 0],"[307.35300000000007, 307.132076784, 3.3999000000000024, 5, 0, 49.17, 3, 3, 23, 0.743897237770763, 0.2222222222222222, 4]",307.35300000000007,307.132076784,3.3999000000000024,5,0,49.17,3,3,23,0.743897237770763,0.2222222222222222,4,8.216862562886462,6.069283681457728
1061,Non-Steroid,COC1=CC=C(C(N2C=NN=C2)CC(C3=CC=CC=C3)O4)C4=C1,8.346757287690961,Inactive,307.38,3,4,0,4,2.472,49.17,0.200735625,-1010.81805,6.6805,-0.22519,-0.01374,0.21145,Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors,Bioorg Med Chem Lett. 2004;14(20):5215-9,[0 0 0 ... 0 0 0],"[307.35300000000007, 307.132076784, 3.3999000000000024, 5, 0, 49.17, 3, 3, 23, 0.743897237770763, 0.2222222222222222, 4]",307.35300000000007,307.132076784,3.3999000000000024,5,0,49.17,3,3,23,0.743897237770763,0.2222222222222222,4,8.284546773684076,5.193417371884376
1062,Non-Steroid,OC1=CC=C(C(N2C=NC=N2)CC(C3=CC=CC=C3)O4)C4=C1,8.196097104799357,Active,293.35,2,4,1,4,2.617,60.17,0.20905873,-971.5265989,3.5832,-0.22611,-0.01331,0.2128,Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors,Bioorg Med Chem Lett. 2004;14(20):5215-10,[0 0 0 ... 0 0 0],"[293.3260000000001, 293.11642672, 3.0969000000000015, 5, 1, 60.17, 3, 2, 22, 0.7884365062731474, 0.17647058823529413, 4]",293.3260000000001,293.11642672,3.0969000000000015,5,1,60.17,3,2,22,0.7884365062731474,0.17647058823529413,4,8.195647033341992,6.373132777740455
1063,Non-Steroid,COC1=CC=C(C(N2C=NC=C2)CC(C3=CC=CC=C3)O4)C4=C1,8.152368208780741,Active,306.39,3,4,0,3,2.996,36.28,0.188726244,-994.7934514,4.4578,-0.21792,-0.00869,0.20923,Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors,Bioorg Med Chem Lett. 2004;14(20):5215-11,[0 0 0 ... 0 0 0],"[306.36500000000007, 306.136827816, 4.004900000000003, 4, 0, 36.28, 3, 3, 23, 0.7334481782007923, 0.21052631578947367, 4]",306.36500000000007,306.136827816,4.004900000000003,4,0,36.28,3,3,23,0.7334481782007923,0.21052631578947367,4,8.195760648635266,6.371465727675417
1064,Non-Steroid,OC1=CC=C(C(N2C=NC=C2)CC(C3=CC=CC=C3)O4)C4=C1,8.131519193744829,Active,292.36,2,4,1,3,2.745,47.28,0.198564658,-955.4867737,4.2736,-0.22013,-0.01014,0.20999,Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors,Bioorg Med Chem Lett. 2004;14(20):5215-12,[0 0 0 ... 0 0 0],"[292.3380000000001, 292.121177752, 3.701900000000002, 4, 1, 47.28, 3, 2, 22, 0.783086957690208, 0.16666666666666666, 4]",292.3380000000001,292.121177752,3.701900000000002,4,1,47.28,3,2,22,0.783086957690208,0.16666666666666666,4,8.163308275218728,6.865809113279304
1065,Steroid,C=C1CCC2C3CCC4=CC(CC[C@]4(C5=NC5)C3CC[C@@]21C)=O,8.27904420247403,Inactive,309.49,1,5,0,2,3.755,29.43,0.20923504,-946.3820926,2.3698,-0.23946,-0.05963,0.17983,"Synthesis of 10 beta-(1'-azirinyl)estr-4-en-3,17-dione as an aromatase inhibitor",Steroids. 1996;61(3):138-43,[0 0 0 ... 0 0 0],"[309.45300000000003, 309.20926448399996, 4.509200000000004, 2, 0, 29.43, 0, 1, 23, 0.6553073391012987, 0.7142857142857143, 5]",309.45300000000003,309.20926448399996,4.509200000000004,2,0,29.43,0,1,23,0.6553073391012987,0.7142857142857143,5,8.253279906498845,5.581103718985383
1066,Steroid,O=C1CCC2C(CCC3C2CCC4(C)C3CCC4=C)=C1F,8.199368224774929,Active,288.44,0,4,0,2,4.195,17.07,0.197028717,-914.1259872,4.9901,-0.24218,-0.04896,0.19322,"Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors",Steroids. 1987;49(4-5):371-82,[0 0 0 ... 0 0 0],"[288.40599999999995, 288.18894364000005, 4.981600000000006, 1, 0, 17.07, 0, 0, 21, 0.5743800925752773, 0.7368421052631579, 4]",288.40599999999995,288.18894364000005,4.981600000000006,1,0,17.07,0,0,21,0.5743800925752773,0.7368421052631579,4,8.209536361604192,6.172536097421484
1067,Steroid,O=C1CCC2(C)C(CCC3C2CCC4(C)C3CCC4=C)=C1F,8.195400560806002,Active,302.47,0,4,0,2,4.401,17.07,0.199522898,-953.4338497,4.9732,-0.24164,-0.04919,0.19245,"Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors",Steroids. 1987;49(4-5):371-82,[0 0 0 ... 0 0 0],"[302.43300000000005, 302.20459370400005, 5.371700000000006, 1, 0, 17.07, 0, 0, 22, 0.5496047672546004, 0.75, 4]",302.43300000000005,302.20459370400005,5.371700000000006,1,0,17.07,0,0,22,0.5496047672546004,0.75,4,8.183380387224691,6.555708173638311
1073,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C\C3=CC(OCCCN4C=CN=C4)=CC(OC)=C3,8.203450829472398,Active,374.47,7,4,0,4,3.578,53.35,0.20659654,-1224.845751,2.3163,-0.22177,-0.07614,0.14563,Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy,Med Chem Res. 2011;20(6):661-669,[0 0 0 ... 0 0 0],"[374.44000000000005, 374.163042564, 4.183200000000003, 5, 0, 53.35000000000001, 3, 7, 28, 0.45976822928129435, 0.21739130434782608, 4]",374.44000000000005,374.163042564,4.183200000000003,5,0,53.35000000000001,3,7,28,0.45976822928129435,0.21739130434782608,4,8.222022292879629,5.997602890186192
1074,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C\C3=CC(OC)=CC(OCCCN4C=NC=C4)=C3,8.231147748790823,Inactive,374.47,7,4,0,4,3.578,53.35,0.20668086,-1224.845844,5.1039,-0.22251,-0.07655,0.14596,Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy,Med Chem Res. 2011;20(6):661-670,[0 0 0 ... 0 0 0],"[374.4400000000001, 374.163042564, 4.183200000000003, 5, 0, 53.35, 3, 7, 28, 0.45976822928129435, 0.21739130434782608, 4]",374.4400000000001,374.163042564,4.183200000000003,5,0,53.35,3,7,28,0.45976822928129435,0.21739130434782608,4,8.222022292879629,5.997602890186192
1076,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C\C3=CC=CC(OCCCN4C=NC=C4)=C3,8.210778860453235,Active,344.44,6,4,0,3,3.594,44.12,0.191712,-1110.322723,5.2462,-0.22433,-0.0788,0.14553,Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy,Med Chem Res. 2011;20(6):661-671,[0 0 0 ... 0 0 0],"[344.41400000000004, 344.15247788000005, 4.174600000000003, 4, 0, 44.120000000000005, 3, 6, 26, 0.4977538504492994, 0.18181818181818182, 4]",344.41400000000004,344.15247788000005,4.174600000000003,4,0,44.120000000000005,3,6,26,0.4977538504492994,0.18181818181818182,4,8.216311020388014,6.076996407552462
1079,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=CN=CC=C3,8.297895981578064,Inactive,235.3,1,3,0,2,3.112,29.96,0.177944742,-747.5026514,4.7927,-0.23789,-0.07635,0.16154,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17,J Med Chem. 1996;39(4):834-41,[0 0 0 ... 0 0 0],"[235.286, 235.099714036, 3.294100000000002, 2, 0, 29.96, 2, 1, 18, 0.7097881601750337, 0.125, 3]",235.286,235.099714036,3.294100000000002,2,0,29.96,2,1,18,0.7097881601750337,0.125,3,8.287154318765312,5.162329025627372
1080,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=CC=NC=C3,8.272683091399138,Inactive,235.3,1,3,0,2,3.112,29.96,0.182234387,-747.5029348,3.5439,-0.24771,-0.07967,0.16804,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 18,J Med Chem. 1996;39(4):834-42,[0 0 0 ... 0 0 0],"[235.286, 235.099714036, 3.294100000000002, 2, 0, 29.96, 2, 1, 18, 0.7097881601750337, 0.125, 3]",235.286,235.099714036,3.294100000000002,2,0,29.96,2,1,18,0.7097881601750337,0.125,3,8.282240034386147,5.221075406100313
1081,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=NC=CN=C3,8.354556468133227,Inactive,236.29,1,3,0,3,2.39,42.85,0.188851233,-763.5355689,3.1528,-0.24612,-0.08167,0.16445,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 19,J Med Chem. 1996;39(4):834-43,[0 0 0 ... 0 0 0],"[236.274, 236.094963004, 2.6891000000000007, 3, 0, 42.85, 2, 1, 18, 0.7148225357307709, 0.13333333333333333, 3]",236.274,236.094963004,2.6891000000000007,3,0,42.85,2,1,18,0.7148225357307709,0.13333333333333333,3,8.292678162464865,5.09708454820636
1083,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=CC=NN=C3,8.399336034003701,Inactive,236.29,1,3,0,3,2.645,42.85,0.180967767,-763.5062026,3.8751,-0.23535,-0.08866,0.14669,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 20,J Med Chem. 1996;39(4):834-44,[0 0 0 ... 0 0 0],"[236.274, 236.094963004, 2.6891000000000007, 3, 0, 42.85, 2, 1, 18, 0.7148225357307709, 0.13333333333333333, 3]",236.274,236.094963004,2.6891000000000007,3,0,42.85,2,1,18,0.7148225357307709,0.13333333333333333,3,8.343425202650522,4.534973956682644
1086,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=CN=CS3,8.224855234569844,Inactive,241.33,1,3,0,2,3.01,58.2,0.18923425,-1068.26959,2.4354,-0.23194,-0.08296,0.14898,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 21,J Med Chem. 1996;39(4):834-45,[0 0 0 ... 0 0 0],"[241.315, 241.056134972, 3.3556000000000017, 3, 0, 29.96, 2, 1, 17, 0.7165273485109248, 0.14285714285714285, 3]",241.315,241.056134972,3.3556000000000017,3,0,29.96,2,1,17,0.7165273485109248,0.14285714285714285,3,8.265847711529153,5.42190980222322
1087,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=NNC=C3,8.323788725452971,Inactive,224.28,1,3,1,2,3.136,45.75,0.208097414,-725.4221993,5.1867,-0.22399,-0.06489,0.1591,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 22,J Med Chem. 1996;39(4):834-46,[0 0 0 ... 0 1 0],"[224.263, 224.094963004, 2.6222000000000003, 2, 1, 45.75, 2, 1, 17, 0.7566832489821942, 0.14285714285714285, 3]",224.263,224.094963004,2.6222000000000003,2,1,45.75,2,1,17,0.7566832489821942,0.14285714285714285,3,8.295850247901402,5.059991089946492
1088,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C\C3=CNC=N3,8.181442462950777,Active,224.28,1,3,1,2,2.579,45.75,0.214178172,-725.443638,4.9494,-0.21051,-0.05884,0.15167,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 23,J Med Chem. 1996;39(4):834-47,[0 0 0 ... 0 0 0],"[224.263, 224.094963004, 2.6222000000000003, 2, 1, 45.75, 2, 1, 17, 0.7566832489821942, 0.14285714285714285, 3]",224.263,224.094963004,2.6222000000000003,2,1,45.75,2,1,17,0.7566832489821942,0.14285714285714285,3,8.211971789646862,6.138018744378038
1089,Non-Steroid,O=C(C1=CC=CC=C1CC/2)C2=C/C3=CNC=N3,8.169440130484347,Active,224.28,1,3,1,2,2.579,45.75,0.214178172,-725.443638,4.9494,-0.21051,-0.05884,0.15167,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 24,J Med Chem. 1996;39(4):834-48,[0 0 0 ... 0 0 0],"[224.263, 224.094963004, 2.6222000000000003, 2, 1, 45.75, 2, 1, 17, 0.7566832489821942, 0.14285714285714285, 3]",224.263,224.094963004,2.6222000000000003,2,1,45.75,2,1,17,0.7566832489821942,0.14285714285714285,3,8.211971789646862,6.138018744378038
1093,Non-Steroid,O=C1C(C(O)C2=NC=NC=C2)CCC3=CC=CC=C31,8.340213419967302,Inactive,254.31,2,3,1,4,1.985,63.08,0.215838364,-839.9734205,4.3576,-0.24114,-0.05509,0.18605,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 25,J Med Chem. 1996;39(4):834-49,[0 1 0 ... 0 0 0],"[254.28900000000002, 254.105527688, 1.9553, 4, 1, 63.08, 2, 2, 19, 0.8893888341029894, 0.26666666666666666, 3]",254.28900000000002,254.105527688,1.9553,4,1,63.08,2,2,19,0.8893888341029894,0.26666666666666666,3,8.296973781530355,5.046917650156
1096,Non-Steroid,C12=CC=CC=C1C3C(C3C4=CN=CC=C4)CC2,8.311041502206791,Inactive,221.32,1,4,0,1,3.152,12.89,0.161064625,-673.4680585,2.3306,-0.22366,-0.01826,0.2054,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 26,J Med Chem. 1996;39(4):834-50,[0 0 0 ... 0 0 0],"[221.30299999999997, 221.12044948, 3.525000000000002, 1, 0, 12.89, 2, 1, 17, 0.7175928060293889, 0.3125, 4]",221.30299999999997,221.12044948,3.525000000000002,1,0,12.89,2,1,17,0.7175928060293889,0.3125,4,8.276369137057316,5.292134373997787
1097,Non-Steroid,C12=CC=CC=C1C3C(C3C4=CC=NC=C4)CC2,8.191667585060895,Active,221.32,1,4,0,1,3.152,12.89,0.165368844,-673.4697572,3.0614,-0.22896,-0.02388,0.20508,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 27,J Med Chem. 1996;39(4):834-51,[0 0 0 ... 0 0 0],"[221.30299999999997, 221.12044948, 3.525000000000002, 1, 0, 12.89, 2, 1, 17, 0.7175928060293889, 0.3125, 4]",221.30299999999997,221.12044948,3.525000000000002,1,0,12.89,2,1,17,0.7175928060293889,0.3125,4,8.24016772616419,5.752177431754867
1099,Non-Steroid,C12=CC=CC=C1C3C(C3C4=NNC=C4)CC2,8.367296796294871,Inactive,210.3,1,4,1,1,2.965,28.68,0.188054433,-651.3836312,2.2982,-0.21333,0.0032,0.21653,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 28,J Med Chem. 1996;39(4):834-52,[0 0 0 ... 0 0 0],"[210.27999999999997, 210.115698448, 2.8531000000000013, 1, 1, 28.68, 2, 1, 16, 0.769961232169761, 0.35714285714285715, 4]",210.27999999999997,210.115698448,2.8531000000000013,1,1,28.68,2,1,16,0.769961232169761,0.35714285714285715,4,8.30530236239903,4.951053709228922
1100,Non-Steroid,C12=CC=CC=C1C3C(C3C4=CNC=N4)CC2,8.206080550578456,Active,210.3,1,4,1,1,2.408,28.68,0.191865933,-651.4025712,3.6224,-0.20115,0.00754,0.20869,Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 29,J Med Chem. 1996;39(4):834-53,[0 0 0 ... 0 0 0],"[210.27999999999997, 210.115698448, 2.8531000000000004, 1, 1, 28.68, 2, 1, 16, 0.7699612321697609, 0.35714285714285715, 4]",210.27999999999997,210.115698448,2.8531000000000004,1,1,28.68,2,1,16,0.7699612321697609,0.35714285714285715,4,8.243578547063173,5.707178460672595
1101,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4CCCC[C@]4(CO)C3CC1)=O,8.371427172403497,Inactive,302.45,1,4,1,3,2.414,54.37,0.215961708,-965.3411226,4.8998,-0.22851,-0.05255,0.17596,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-200,[0 0 0 ... 0 0 0],"[302.41400000000004, 302.18819469199997, 3.059800000000002, 3, 1, 54.37, 0, 1, 22, 0.8096758652820699, 0.7894736842105263, 4]",302.41400000000004,302.18819469199997,3.059800000000002,3,1,54.37,0,1,22,0.8096758652820699,0.7894736842105263,4,8.36010723755672,4.364080594859905
1102,Steroid,C[C@]12C(C3C(C=C4CCCC[C@@]4(C3CC2)CO)=O)CC[C@@H]1O,8.41409955849521,Inactive,304.47,1,4,2,3,2.453,57.53,0.2133168,-966.5236839,5.8687,-0.23661,-0.04967,0.18694,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-201,[0 0 0 ... 0 0 0],"[304.43, 304.20384475599997, 2.8516000000000017, 3, 2, 57.53, 0, 1, 22, 0.7829628292426379, 0.8421052631578947, 4]",304.43,304.20384475599997,2.8516000000000017,3,2,57.53,0,1,22,0.7829628292426379,0.8421052631578947,4,8.41506604666181,3.845332985208046
1103,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4CCCC[C@]4(C=O)C3CC1)=O,8.374502344442321,Inactive,300.43,1,4,0,3,2.67,51.21,0.214614891,-964.1408435,2.989,-0.23657,-0.06608,0.17049,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-202,[0 0 0 ... 0 0 0],"[300.398, 300.17254462799997, 3.2664000000000017, 3, 0, 51.21, 0, 1, 22, 0.6983751686488978, 0.7368421052631579, 4]",300.398,300.17254462799997,3.2664000000000017,3,0,51.21,0,1,22,0.6983751686488978,0.7368421052631579,4,8.336942631624826,4.6031737544945175
1104,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4CCCCC4C3CC1)=O,8.341721427399731,Inactive,272.42,0,4,0,2,3.298,34.14,0.209085409,-850.8325227,3.3737,-0.23178,-0.04773,0.18405,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-203,[0 0 0 ... 0 0 0],"[272.388, 272.177630008, 3.697300000000003, 2, 0, 34.14, 0, 0, 20, 0.6735797738387025, 0.7777777777777778, 4]",272.388,272.177630008,3.697300000000003,2,0,34.14,0,0,20,0.6735797738387025,0.7777777777777778,4,8.267159729812835,5.405554746792066
1105,Steroid,C[C@]12C(C3C(C=C4CCCC[C@@]4(C3CC2)C)=O)CC[C@@H]1O,8.358843298230587,Inactive,288.47,0,4,1,2,3.544,37.3,0.209748714,-891.3195851,4.36,-0.22898,-0.04783,0.18115,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-204,[0 0 0 ... 0 0 0],"[288.431, 288.208930136, 3.879200000000003, 2, 1, 37.3, 0, 0, 21, 0.7342296115534325, 0.8421052631578947, 4]",288.431,288.208930136,3.879200000000003,2,1,37.3,0,0,21,0.7342296115534325,0.8421052631578947,4,8.350538948182821,4.461296132116403
1106,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4C=CCC[C@]4(CO)C3CC1)=O,8.374502344442321,Inactive,300.43,1,4,1,3,1.969,54.37,0.209459065,-964.0230314,4.9446,-0.20016,-0.06437,0.13579,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-205,[0 0 0 ... 0 0 0],"[300.3980000000001, 300.17254462799997, 2.8358000000000008, 3, 1, 54.37, 0, 1, 22, 0.8099073792843556, 0.6842105263157895, 4]",300.3980000000001,300.17254462799997,2.8358000000000008,3,1,54.37,0,1,22,0.8099073792843556,0.6842105263157895,4,8.332707055599306,4.648287101359841
1107,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4C=CCC[C@]4(C=O)C3CC1)=O,8.304640923932988,Inactive,298.41,1,4,0,3,2.226,51.21,0.210125955,-962.8152824,3.7699,-0.21678,-0.07877,0.13801,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-206,[0 0 0 ... 0 0 0],"[298.38200000000006, 298.15689456399997, 3.0424000000000015, 3, 0, 51.21, 0, 1, 22, 0.6991428557280496, 0.631578947368421, 4]",298.38200000000006,298.15689456399997,3.0424000000000015,3,0,51.21,0,1,22,0.6991428557280496,0.631578947368421,4,8.311591237960359,4.879875725032697
1108,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4C=CCCC4C3CC1)=O,8.348576599240948,Inactive,270.4,0,4,0,2,2.854,34.14,0.202150786,-849.5132755,3.366,-0.20783,-0.07069,0.13714,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-207,[0 0 0 ... 0 0 0],"[270.37199999999996, 270.161979944, 3.473300000000002, 2, 0, 34.14, 0, 0, 20, 0.6751233897915203, 0.6666666666666666, 4]",270.37199999999996,270.161979944,3.473300000000002,2,0,34.14,0,0,20,0.6751233897915203,0.6666666666666666,4,8.284607661997654,5.192689303090732
1109,Steroid,C[C@@]12C(CCC2=O)C3CC=C4CCCC[C@]4(CO)C3CC1,8.287249311398284,Inactive,288.47,1,4,1,2,3.344,37.3,0.195373,-891.3201749,2.7547,-0.22864,-0.01176,0.21688,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-208,[0 0 0 ... 0 0 0],"[288.43100000000004, 288.208930136, 3.8808000000000034, 2, 1, 37.3, 0, 1, 21, 0.7434541175838038, 0.8421052631578947, 4]",288.43100000000004,288.208930136,3.8808000000000034,2,1,37.3,0,1,21,0.7434541175838038,0.8421052631578947,4,8.274362489800362,5.316643131644459
1110,Steroid,C[C@]12C(C3CC=C4CCCC[C@@]4(C3CC2)CO)CC[C@@H]1O,8.375965553561977,Inactive,290.49,1,4,2,2,3.384,40.46,0.194555784,-892.4986186,2.865,-0.22692,0.01911,0.24603,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-209,[0 0 0 ... 0 0 0],"[290.447, 290.2245802, 3.6726000000000023, 2, 2, 40.46, 0, 1, 21, 0.7233694765673034, 0.8947368421052632, 4]",290.447,290.2245802,3.6726000000000023,2,2,40.46,0,1,21,0.7233694765673034,0.8947368421052632,4,8.346226827006934,4.505813096452711
1111,Steroid,C[C@]12C(C3CC=C4CCCC[C@@]4(C3CC2)C=O)CCC1=O,8.297069967575434,Inactive,286.45,1,4,0,2,3.601,34.14,0.204656213,-890.0197444,3.8941,-0.23073,-0.01846,0.21227,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-210,[0 0 0 ... 0 0 0],"[286.415, 286.193280072, 4.087400000000003, 2, 0, 34.14, 0, 1, 21, 0.5372727077269144, 0.7894736842105263, 4]",286.415,286.193280072,4.087400000000003,2,0,34.14,0,1,21,0.5372727077269144,0.7894736842105263,4,8.26615839383294,5.41803250439254
1112,Steroid,C[C@]12C(C3CC=C4CCCC[C@@]4(C3CC2)C)CCC1=O,8.235114327475388,Inactive,272.47,0,4,0,1,4.435,17.07,0.199388917,-816.0147501,1.9103,-0.226,0.03068,0.25668,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-211,[0 0 0 ... 0 0 0],"[272.43199999999996, 272.214015516, 4.908400000000004, 1, 0, 17.07, 0, 0, 20, 0.5726737469300093, 0.8421052631578947, 4]",272.43199999999996,272.214015516,4.908400000000004,1,0,17.07,0,0,20,0.5726737469300093,0.8421052631578947,4,8.234484085075898,5.827951312048022
1113,Steroid,C[C@]12C(C3CC=C4CCCC[C@@]4(C3CC2)C)C[C@H](C1=O)Br,8.370631181636492,Inactive,351.36,0,4,0,1,5.104,17.07,0.193347083,-3387.197187,3.8472,-0.2313,-0.05211,0.17919,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-212,[0 0 0 ... 0 0 0],"[351.328, 350.124527584, 5.281800000000005, 1, 0, 17.07, 0, 0, 21, 0.4285161032875225, 0.8421052631578947, 4]",351.328,350.124527584,5.281800000000005,1,0,17.07,0,0,21,0.4285161032875225,0.8421052631578947,4,8.254877746883606,5.560607653474146
1114,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4CCCC[C@]4(C)C3CC1)=O,8.24073264613087,Inactive,286.45,0,4,0,2,3.504,34.14,0.210938915,-890.1399533,3.5176,-0.23126,-0.04814,0.18312,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-213,[0 0 0 ... 0 0 0],"[286.415, 286.193280072, 4.087400000000003, 2, 0, 34.14, 0, 0, 21, 0.6719379087230692, 0.7894736842105263, 4]",286.415,286.193280072,4.087400000000003,2,0,34.14,0,0,21,0.6719379087230692,0.7894736842105263,4,8.282523793407496,5.217665177752688
1115,Steroid,C[C@@]12C(CCC2=O)C3C(C=C4C=CCC[C@]4(C)C3CC1)=O,8.24073264613087,Inactive,284.43,0,4,0,2,3.06,34.14,0.210706556,-888.8996197,2.907,-0.23146,-0.06505,0.16641,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-214,[0 0 0 ... 0 0 0],"[284.399, 284.177630008, 3.863400000000003, 2, 0, 34.14, 0, 0, 21, 0.6765587980075699, 0.6842105263157895, 4]",284.399,284.177630008,3.863400000000003,2,0,34.14,0,0,21,0.6765587980075699,0.6842105263157895,4,8.26574845923744,5.4231490499975035
1116,Steroid,C[C@]12C(C3C(C=C4C=CCC[C@@]4(C3CC2)C)=O)CC[C@@H]1O,8.358843298230587,Inactive,286.45,0,4,1,2,3.099,37.3,0.20003517,-890.0141106,4.9585,-0.20159,-0.06375,0.13784,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-215,[0 0 0 ... 0 0 0],"[286.4149999999999, 286.193280072, 3.655200000000003, 2, 1, 37.3, 0, 0, 21, 0.7376993306573582, 0.7368421052631579, 4]",286.4149999999999,286.193280072,3.655200000000003,2,1,37.3,0,0,21,0.7376993306573582,0.7368421052631579,4,8.355689706149185,4.408697427360114
1117,Steroid,C[C@@]12C(CC[C@@H]2O)C3CC=C4CCCC[C@]4(C)C3CC1,8.344583014272276,Inactive,274.49,0,4,1,1,4.475,20.23,0.18734682,-817.2518893,1.2801,-0.21917,0.02551,0.24468,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-216,[0 0 0 ... 0 0 0],"[274.44800000000004, 274.22966558, 4.700200000000005, 1, 1, 20.23, 0, 0, 20, 0.6347734214058449, 0.8947368421052632, 4]",274.44800000000004,274.22966558,4.700200000000005,1,1,20.23,0,0,20,0.6347734214058449,0.8947368421052632,4,8.321805642042591,4.7664424964991605
1118,Steroid,C[C@@]12C(CCC2=O)C3CC=C4C=CCC[C@]4(C)C3CC1,8.257157083272556,Inactive,270.45,0,4,0,1,3.991,17.07,0.190589848,-814.8739299,2.4099,-0.20702,-0.01384,0.19318,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-217,[0 0 0 ... 0 0 0],"[270.41600000000005, 270.198365452, 4.684400000000005, 1, 0, 17.07, 0, 0, 20, 0.624123398652106, 0.7368421052631579, 4]",270.41600000000005,270.198365452,4.684400000000005,1,0,17.07,0,0,20,0.624123398652106,0.7368421052631579,4,8.247939497818102,5.65015682467989
1119,Steroid,C[C@]12C(C3CC=C4C=CCC[C@@]4(C3CC2)C)CC[C@@H]1O,8.323791242133096,Inactive,272.47,0,4,1,1,4.03,20.23,0.183294438,-815.9966508,1.0244,-0.17502,-0.04529,0.12973,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-218,[0 0 0 ... 0 0 0],"[272.4319999999999, 272.214015516, 4.476200000000005, 1, 1, 20.23, 0, 0, 20, 0.6892564605705604, 0.7894736842105263, 4]",272.4319999999999,272.214015516,4.476200000000005,1,1,20.23,0,0,20,0.6892564605705604,0.7894736842105263,4,8.308802663895204,4.9113098711621985
1120,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CC(CCC4C3CC1)=O,8.227619608798658,Inactive,272.42,0,4,0,2,3.088,34.14,0.209324545,-850.825172,3.6052,-0.23218,-0.04586,0.18632,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-219,[0 0 0 ... 0 0 0],"[272.388, 272.177630008, 3.697300000000003, 2, 0, 34.14, 0, 0, 20, 0.6735797738387025, 0.7777777777777778, 4]",272.388,272.177630008,3.697300000000003,2,0,34.14,0,0,20,0.6735797738387025,0.7777777777777778,4,8.239995323291858,5.7544613400610505
1121,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CCCC[C@]4(C)C3CC1,8.297448842950477,Inactive,272.47,0,4,0,1,4.435,17.07,0.1913,-816.1141173,2.7907,-0.22608,-0.01045,0.21563,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-220,[0 0 0 ... 0 0 0],"[272.432, 272.214015516, 4.908400000000005, 1, 0, 17.07, 0, 0, 20, 0.5726737469300093, 0.8421052631578947, 4]",272.432,272.214015516,4.908400000000005,1,0,17.07,0,0,20,0.5726737469300093,0.8421052631578947,4,8.230631835892886,5.879875955574241
1123,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CC(CC[C@]4(CO)C3CC1)=O,8.27344393508696,Inactive,302.45,1,4,1,3,2.203,54.37,0.215325063,-965.3343318,5.1164,-0.22483,-0.03942,0.18541,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-221,[0 0 0 ... 0 0 0],"[302.41400000000004, 302.18819469199997, 3.059800000000002, 3, 1, 54.37, 0, 1, 22, 0.8096758652820699, 0.7894736842105263, 4]",302.41400000000004,302.18819469199997,3.059800000000002,3,1,54.37,0,1,22,0.8096758652820699,0.7894736842105263,4,8.290499139702414,5.122722850280051
1124,Steroid,C[C@@]12C(CCC2=O)C3CC(C4=CC(CC[C@]4(C)C3CC1)=O)=O,8.245559921624436,Inactive,300.43,0,4,0,3,2.152,51.21,0.222720609,-964.1411238,3.4313,-0.23934,-0.08746,0.15188,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-222,[0 0 0 ... 0 0 0],"[300.398, 300.17254462799997, 3.2664000000000017, 3, 0, 51.21, 0, 0, 22, 0.6896763188469792, 0.7368421052631579, 4]",300.398,300.17254462799997,3.2664000000000017,3,0,51.21,0,0,22,0.6896763188469792,0.7368421052631579,4,8.249974108561842,5.623748514271963
1125,Steroid,C[C@@]12C(CCC2=O)C3[C@H]4[C@H](C(F)4F)C5=CC(CC[C@]5(C)C3CC1)=O,8.226264737519069,Inactive,334.44,0,5,0,4,2.611,34.14,0.229369563,-1126.658418,2.218,-0.23727,-0.05753,0.17974,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-223,[0 0 0 ... 0 0 0],"[334.4060000000001, 334.174436448, 4.188500000000004, 2, 0, 34.14, 0, 0, 24, 0.6655786521653276, 0.8, 5]",334.4060000000001,334.174436448,4.188500000000004,2,0,34.14,0,0,24,0.6655786521653276,0.8,5,8.2288994386105,5.903377577377774
1126,Steroid,C[C@@]12C(CCC2=O)C3[C@H]4[C@H](C4)C5=CCCC[C@]5(C)C3CC1,8.285997341877867,Inactive,284.48,0,5,0,1,4.111,17.07,0.191611857,-854.1748297,2.6916,-0.21554,-0.0124,0.20314,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-224,[0 0 0 ... 0 0 0],"[284.44300000000004, 284.214015516, 4.764300000000005, 1, 0, 17.07, 0, 0, 21, 0.5858725268385402, 0.85, 5]",284.44300000000004,284.214015516,4.764300000000005,1,0,17.07,0,0,21,0.5858725268385402,0.85,5,8.233156629642046,5.845792158275653
1127,Steroid,C[C@@]12C(CC[C@]2(C)O)C3[C@H]4[C@H](C4)C5=CCCC[C@]5(C)C3CC1,8.254253976944467,Inactive,300.53,0,5,1,1,4.356,20.23,0.194184833,-894.6781071,1.5124,-0.21291,0.02959,0.2425,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-225,[0 0 0 ... 0 0 0],"[300.48600000000005, 300.245315644, 4.9462000000000055, 1, 1, 20.23, 0, 0, 22, 0.6278038316434098, 0.9047619047619048, 5]",300.48600000000005,300.245315644,4.9462000000000055,1,1,20.23,0,0,22,0.6278038316434098,0.9047619047619048,5,8.24332777391232,5.7104748884945815
1128,Steroid,C[C@@]12C(CC[C@]2(C)O)C3CCC4=CCCC[C@]4(C)C3CC1,8.28931579774639,Inactive,288.52,0,4,1,1,4.68,20.23,0.197379792,-856.6208632,1.3875,-0.22419,0.03144,0.25563,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-226,[0 0 0 ... 0 0 0],"[288.475, 288.245315644, 5.090300000000005, 1, 1, 20.23, 0, 0, 21, 0.615505184239922, 0.9, 4]",288.475,288.245315644,5.090300000000005,1,1,20.23,0,0,21,0.615505184239922,0.9,4,8.25659649286388,5.538644709803953
1129,Steroid,C[C@@]12C(CC[C@]2(C)O)C3CCC4=CCCC[C@]4(CO)C3CC1,8.248851820114231,Inactive,304.52,1,4,2,2,3.589,40.46,0.201272963,-931.821645,1.9131,-0.21882,0.03706,0.25588,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-227,[0 0 0 ... 0 0 0],"[304.474, 304.240230264, 4.062700000000003, 2, 2, 40.46, 0, 1, 22, 0.7171471979361801, 0.9, 4]",304.474,304.240230264,4.062700000000003,2,2,40.46,0,1,22,0.7171471979361801,0.9,4,8.27740683618015,5.27950449310222
1130,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CCCC[C@]4(CC(OC)=O)C3CC1,8.267775165324235,Inactive,330.51,3,4,0,3,3.839,43.37,0.210283389,-1043.982452,3.5416,-0.22877,-0.01284,0.21593,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-228,[0 0 0 ... 0 0 0],"[330.4680000000001, 330.21949481999997, 4.451600000000004, 3, 0, 43.370000000000005, 0, 2, 24, 0.5547237312995008, 0.8095238095238095, 4]",330.4680000000001,330.21949481999997,4.451600000000004,3,0,43.370000000000005,0,2,24,0.5547237312995008,0.8095238095238095,4,8.24637174211678,5.670590133244231
1132,Steroid,C[C@@]12C(C[C@@](Br)([H])C2=O)C3CCC4=CCCC[C@]4(C)C3CC1,8.281573052751924,Inactive,351.36,0,4,0,1,5.104,17.07,0.190411146,-3387.217126,3.8221,-0.2301,-0.05218,0.17792,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-229,[0 0 0 ... 0 0 0],"[351.32800000000015, 350.124527584, 5.281800000000005, 1, 0, 17.07, 0, 0, 21, 0.4285161032875224, 0.8421052631578947, 4]",351.32800000000015,350.124527584,5.281800000000005,1,0,17.07,0,0,21,0.4285161032875224,0.8421052631578947,4,8.235011654627987,5.820875967908513
1133,Steroid,C[C@@]12C(CCC2=O)C3CCC4=CCCC[C@]4(C(F)(F)F)C3CC1,8.227619608798658,Inactive,326.44,0,4,0,4,4.891,17.07,0.212632417,-1113.838682,2.9116,-0.23014,-0.01228,0.21786,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-230,[0 0 0 ... 0 0 0],"[326.40200000000004, 326.18575008000005, 5.4508000000000045, 1, 0, 17.07, 0, 0, 23, 0.5409206856692456, 0.8421052631578947, 4]",326.40200000000004,326.18575008000005,5.4508000000000045,1,0,17.07,0,0,23,0.5409206856692456,0.8421052631578947,4,8.229832198780697,5.890712147158969
1134,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](C)C4=CC(CC[C@]4(C)C3CC1)=O,8.232302531647651,Inactive,300.48,0,4,0,2,3.546,34.14,0.20939158,-929.4419205,3.5102,-0.2318,-0.04788,0.18392,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-231,[0 0 0 ... 0 0 0],"[300.44200000000006, 300.208930136, 4.333400000000004, 2, 0, 34.14, 0, 0, 22, 0.666890035800204, 0.8, 4]",300.44200000000006,300.208930136,4.333400000000004,2,0,34.14,0,0,22,0.666890035800204,0.8,4,8.2288994386105,5.903377577377774
1135,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](C)C4=CC(CC[C@]4(C)C3CC1)=O,8.256168944872346,Inactive,300.48,0,4,0,2,3.546,34.14,0.20939158,-929.4419205,3.5102,-0.2318,-0.04788,0.18392,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-232,[0 0 0 ... 0 0 0],"[300.44200000000006, 300.208930136, 4.333400000000004, 2, 0, 34.14, 0, 0, 22, 0.666890035800204, 0.8, 4]",300.44200000000006,300.208930136,4.333400000000004,2,0,34.14,0,0,22,0.666890035800204,0.8,4,8.2288994386105,5.903377577377774
1136,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](CC)C4=CC(CC[C@]4(C)C3CC1)=O,8.28852177875019,Inactive,314.51,1,4,0,2,4.002,34.14,0.207613717,-968.7543641,3.6305,-0.23128,-0.04732,0.18396,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-233,[0 0 0 ... 0 0 0],"[314.46900000000005, 314.2245802, 4.723500000000005, 2, 0, 34.14, 0, 1, 23, 0.7013194281770768, 0.8095238095238095, 4]",314.46900000000005,314.2245802,4.723500000000005,2,0,34.14,0,1,23,0.7013194281770768,0.8095238095238095,4,8.237425670630651,5.788610517656393
1137,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](CC)C4=CC(CC[C@]4(C)C3CC1)=O,8.266401539038661,Inactive,314.51,1,4,0,2,4.002,34.14,0.207613717,-968.7543641,3.6305,-0.23128,-0.04732,0.18396,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-234,[0 0 0 ... 0 0 0],"[314.46900000000005, 314.2245802, 4.723500000000005, 2, 0, 34.14, 0, 1, 23, 0.7013194281770768, 0.8095238095238095, 4]",314.46900000000005,314.2245802,4.723500000000005,2,0,34.14,0,1,23,0.7013194281770768,0.8095238095238095,4,8.237425670630651,5.788610517656393
1138,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](CCC)C4=CC(CC[C@]4(C)C3CC1)=O,8.269201579857413,Inactive,328.54,2,4,0,2,4.458,34.14,0.205638929,-1008.067979,3.6885,-0.231,-0.04692,0.18408,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-235,[0 0 0 ... 0 0 0],"[328.4960000000001, 328.240230264, 5.113600000000005, 2, 0, 34.14, 0, 2, 24, 0.7053206907275269, 0.8181818181818182, 4]",328.4960000000001,328.240230264,5.113600000000005,2,0,34.14,0,2,24,0.7053206907275269,0.8181818181818182,4,8.234321081983476,5.830139118765405
1139,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](CCC)C4=CC(CC[C@]4(C)C3CC1)=O,8.252502740068316,Inactive,328.54,2,4,0,2,4.458,34.14,0.205638929,-1008.067979,3.6885,-0.231,-0.04692,0.18408,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-236,[0 0 0 ... 0 0 0],"[328.4960000000001, 328.240230264, 5.113600000000005, 2, 0, 34.14, 0, 2, 24, 0.7053206907275269, 0.8181818181818182, 4]",328.4960000000001,328.240230264,5.113600000000005,2,0,34.14,0,2,24,0.7053206907275269,0.8181818181818182,4,8.234321081983476,5.830139118765405
1141,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](CCCC)C4=CC(CC[C@]4(C)C3CC1)=O,8.22932468646102,Inactive,342.57,3,4,0,2,4.914,34.14,0.203800983,-1047.381708,3.73,-0.23089,-0.0468,0.18409,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-237,[0 0 0 ... 0 0 0],"[342.52300000000014, 342.255880328, 5.503700000000006, 2, 0, 34.14, 0, 3, 25, 0.6780525315473497, 0.8260869565217391, 4]",342.52300000000014,342.255880328,5.503700000000006,2,0,34.14,0,3,25,0.6780525315473497,0.8260869565217391,4,8.23985797142081,5.756281558975912
1142,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](C(C)C)C4=CC(CC[C@]4(C)C3CC1)=O,8.22485576772565,Inactive,328.54,1,4,0,2,4.254,34.14,0.206262482,-1008.065391,3.642,-0.23168,-0.04775,0.18393,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-238,[0 1 0 ... 0 0 0],"[328.49600000000015, 328.240230264, 4.969500000000005, 2, 0, 34.14, 0, 1, 24, 0.6808260974452236, 0.8181818181818182, 4]",328.49600000000015,328.240230264,4.969500000000005,2,0,34.14,0,1,24,0.6808260974452236,0.8181818181818182,4,8.231021611149082,5.874601189000123
1143,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](C(C)C)C4=CC(CC[C@]4(C)C3CC1)=O,8.23255470073023,Inactive,328.54,1,4,0,2,4.254,34.14,0.206262482,-1008.065391,3.642,-0.23168,-0.04775,0.18393,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-239,[0 1 0 ... 0 0 0],"[328.49600000000015, 328.240230264, 4.969500000000005, 2, 0, 34.14, 0, 1, 24, 0.6808260974452236, 0.8181818181818182, 4]",328.49600000000015,328.240230264,4.969500000000005,2,0,34.14,0,1,24,0.6808260974452236,0.8181818181818182,4,8.231021611149082,5.874601189000123
1144,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](C4=CC=CC=C4)C5=CC(CC[C@]5(C)C3CC1)=O,8.238854294957692,Inactive,362.55,1,5,0,2,4.578,34.14,0.199224386,-1121.17505,3.6704,-0.23345,-0.05009,0.18336,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-240,[0 0 0 ... 0 0 0],"[362.51300000000026, 362.2245802, 5.481100000000006, 2, 0, 34.14, 1, 1, 27, 0.6626400688453239, 0.6, 5]",362.51300000000026,362.2245802,5.481100000000006,2,0,34.14,1,1,27,0.6626400688453239,0.6,5,8.262931210238088,5.458443128614643
1145,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](C4=CC=CC=C4)C5=CC(CC[C@]5(C)C3CC1)=O,8.22485576772565,Inactive,362.55,1,5,0,2,4.578,34.14,0.199224386,-1121.17505,3.6704,-0.23345,-0.05009,0.18336,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-241,[0 0 0 ... 0 0 0],"[362.51300000000026, 362.2245802, 5.481100000000006, 2, 0, 34.14, 1, 1, 27, 0.6626400688453239, 0.6, 5]",362.51300000000026,362.2245802,5.481100000000006,2,0,34.14,1,1,27,0.6626400688453239,0.6,5,8.262931210238088,5.458443128614643
1146,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](CC4=CC=CC=C4)C5=CC(CC[C@]5(C)C3CC1)=O,8.267775165324235,Inactive,376.58,2,5,0,2,5.034,34.14,0.197458,-1160.49101,3.4937,-0.23237,-0.04979,0.18258,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-242,[0 0 0 ... 0 0 0],"[376.5400000000003, 376.240230264, 5.556200000000006, 2, 0, 34.14, 1, 2, 28, 0.6773809714641033, 0.6153846153846154, 5]",376.5400000000003,376.240230264,5.556200000000006,2,0,34.14,1,2,28,0.6773809714641033,0.6153846153846154,5,8.269566138999018,5.375685602102443
1147,Steroid,C[C@@]12C(CCC2=O)C3C[C@H](CC4=CC=CC=C4)C5=CC(CC[C@]5(C)C3CC1)=O,8.235114327475388,Inactive,376.58,2,5,0,2,5.034,34.14,0.197458,-1160.49101,3.4937,-0.23237,-0.04979,0.18258,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-243,[0 0 0 ... 0 0 0],"[376.5400000000003, 376.240230264, 5.556200000000006, 2, 0, 34.14, 1, 2, 28, 0.6773809714641033, 0.6153846153846154, 5]",376.5400000000003,376.240230264,5.556200000000006,2,0,34.14,1,2,28,0.6773809714641033,0.6153846153846154,5,8.269566138999018,5.375685602102443
1148,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](C=C)C4=CC(CC[C@]4(C)C3CC1)=O,8.259234787672476,Inactive,312.49,1,4,0,2,3.611,34.14,0.204767039,-967.5179111,3.4241,-0.23205,-0.05068,0.18137,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-244,[0 0 0 ... 0 0 0],"[312.4530000000001, 312.208930136, 4.499500000000004, 2, 0, 34.14, 0, 1, 23, 0.6680759732740659, 0.7142857142857143, 4]",312.4530000000001,312.208930136,4.499500000000004,2,0,34.14,0,1,23,0.6680759732740659,0.7142857142857143,4,8.258724571620204,5.511571279416488
1149,Steroid,C[C@@]12C(CCC2=O)C3C[C@@H](C#C)C4=CC(CC[C@]4(C)C3CC1)=O,8.24251287003224,Inactive,310.47,0,4,0,2,4.187,34.14,0.222018388,-966.2651952,3.2285,-0.23529,-0.05312,0.18217,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-245,[0 0 0 ... 0 0 0],"[310.43700000000007, 310.193280072, 3.9467000000000034, 2, 0, 34.14, 0, 0, 23, 0.6349592193321884, 0.7142857142857143, 4]",310.43700000000007,310.193280072,3.9467000000000034,2,0,34.14,0,0,23,0.6349592193321884,0.7142857142857143,4,8.243760841362416,5.70478338585131
1150,Steroid,C[C@@]12C(CCC2=O)C3C/C(C4=CC(CC[C@]4(C)C3CC1)=O)=C\C,8.252502740068316,Inactive,312.49,0,4,0,2,3.752,34.14,0.209572137,-967.5349116,4.0566,-0.22881,-0.0545,0.17431,Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors,J Comput Aided Mol Des. 1996;10(3):186-246,[0 0 0 ... 0 0 0],"[312.45300000000003, 312.208930136, 4.643600000000005, 2, 0, 34.14, 0, 0, 23, 0.6525583414720545, 0.7142857142857143, 4]",312.45300000000003,312.208930136,4.643600000000005,2,0,34.14,0,0,23,0.6525583414720545,0.7142857142857143,4,8.245693267206958,5.679455914670792
1151,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=CC(OC)=CC(OC)=C2,8.2055713513207,Active,255.34,4,2,2,3,3.037,44.48,0.231562861,-825.1095782,2.4043,-0.17925,-0.03558,0.14367,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-66,[0 0 0 ... 0 0 0],"[255.31699999999998, 255.125928784, 3.456400000000002, 3, 1, 44.480000000000004, 2, 4, 19, 0.6718586136474659, 0.125, 2]",255.31699999999998,255.125928784,3.456400000000002,3,1,44.480000000000004,2,4,19,0.6718586136474659,0.125,2,8.251432450597214,5.60489588153318
1152,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=C(OC)C=C(OC)C=C2,8.213306316744077,Active,255.34,4,2,2,3,3.037,44.48,0.223421056,-825.1085398,1.2046,-0.16828,-0.02742,0.14086,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-67,[0 0 0 ... 0 0 0],"[255.31699999999998, 255.125928784, 3.456400000000002, 3, 1, 44.480000000000004, 2, 4, 19, 0.6718586136474659, 0.125, 2]",255.31699999999998,255.125928784,3.456400000000002,3,1,44.480000000000004,2,4,19,0.6718586136474659,0.125,2,8.251432450597214,5.60489588153318
1153,Non-Steroid,NC1=CC(/C=C/C2=C(OC)C=C(OC)C=C2)=CC=C1,8.305121605323157,Inactive,255.34,4,2,2,3,3.037,44.48,0.223610333,-825.1079711,2.019,-0.17912,-0.03389,0.14523,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-68,[0 0 0 ... 0 0 0],"[255.317, 255.125928784, 3.456400000000002, 3, 1, 44.480000000000004, 2, 4, 19, 0.6718586136474659, 0.125, 2]",255.317,255.125928784,3.456400000000002,3,1,44.480000000000004,2,4,19,0.6718586136474659,0.125,2,8.28784136765433,5.154168736764262
1154,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=C(OC)C=CC(OC)=C2,8.241093508927335,Inactive,255.34,4,2,2,3,3.037,44.48,0.223175833,-825.1058633,2.2572,-0.17239,-0.03486,0.13753,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-69,[0 0 0 ... 0 0 0],"[255.31699999999998, 255.125928784, 3.456400000000002, 3, 1, 44.480000000000004, 2, 4, 19, 0.6718586136474659, 0.125, 2]",255.31699999999998,255.125928784,3.456400000000002,3,1,44.480000000000004,2,4,19,0.6718586136474659,0.125,2,8.251432450597214,5.60489588153318
1155,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=C(OC)C(OC)=CC=C2,8.22121413571156,Active,255.34,4,2,2,3,3.037,44.48,0.217540556,-825.1011201,2.2881,-0.17757,-0.03364,0.14393,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-70,[0 0 0 ... 0 0 0],"[255.31699999999998, 255.125928784, 3.456400000000002, 3, 1, 44.480000000000004, 2, 4, 19, 0.6718586136474659, 0.125, 2]",255.31699999999998,255.125928784,3.456400000000002,3,1,44.480000000000004,2,4,19,0.6718586136474659,0.125,2,8.251432450597214,5.60489588153318
1156,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=CC(OC)=C(OC)C=C2,8.31530428145397,Inactive,255.34,4,2,2,3,3.037,44.48,0.224165944,-825.1015018,1.9611,-0.17352,-0.03259,0.14093,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-71,[0 0 0 ... 0 0 0],"[255.31699999999998, 255.125928784, 3.456400000000002, 3, 1, 44.480000000000004, 2, 4, 19, 0.6718586136474659, 0.125, 2]",255.31699999999998,255.125928784,3.456400000000002,3,1,44.480000000000004,2,4,19,0.6718586136474659,0.125,2,8.279875612989628,5.249577927614246
1161,Non-Steroid,NC1=CC(/C=C/C2=CC(OC)=C(C(OC)=C2)OC)=CC=C1,8.32017592801067,Inactive,285.37,5,2,2,4,3.02,53.71,0.2337046,-939.6172756,2.8416,-0.18965,-0.04329,0.14636,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-72,[0 0 0 ... 0 0 0],"[285.34299999999996, 285.136493468, 3.4650000000000025, 4, 1, 53.71000000000001, 2, 5, 21, 0.6748778495132262, 0.17647058823529413, 2]",285.34299999999996,285.136493468,3.4650000000000025,4,1,53.71000000000001,2,5,21,0.6748778495132262,0.17647058823529413,2,8.2861368893422,5.174437083186394
1163,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=CC(OC)=C(OC)C(OC)=C2,8.218549277342257,Active,285.37,5,2,2,4,3.02,53.71,0.233605875,-939.6166677,1.7176,-0.17938,-0.03811,0.14127,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-73,[0 0 0 ... 0 0 0],"[285.343, 285.136493468, 3.4650000000000025, 4, 1, 53.71000000000001, 2, 5, 21, 0.6748778495132263, 0.17647058823529413, 2]",285.343,285.136493468,3.4650000000000025,4,1,53.71000000000001,2,5,21,0.6748778495132263,0.17647058823529413,2,8.249727972285084,5.626936675536794
1164,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=C(OC)C(OC)=C(OC)C=C2,8.263816172079146,Inactive,285.37,5,2,2,4,3.02,53.71,0.226043,-939.614823,2.0964,-0.17193,-0.02992,0.14201,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-74,[0 0 0 ... 0 0 0],"[285.34299999999996, 285.136493468, 3.4650000000000025, 4, 1, 53.71000000000001, 2, 5, 21, 0.6748778495132262, 0.17647058823529413, 2]",285.34299999999996,285.136493468,3.4650000000000025,4,1,53.71000000000001,2,5,21,0.6748778495132262,0.17647058823529413,2,8.249727972285084,5.626936675536794
1165,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=C(OC)C(OC)=CC(OC)=C2,8.248561903039745,Inactive,285.37,5,2,2,4,3.02,53.71,0.233489525,-939.6233558,1.8127,-0.17656,-0.03376,0.1428,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-75,[0 0 0 ... 0 0 0],"[285.343, 285.136493468, 3.4650000000000025, 4, 1, 53.71000000000001, 2, 5, 21, 0.6748778495132263, 0.17647058823529413, 2]",285.343,285.136493468,3.4650000000000025,4,1,53.71000000000001,2,5,21,0.6748778495132263,0.17647058823529413,2,8.249727972285084,5.626936675536794
1166,Non-Steroid,NC1=CC(/C=C/C2=CC3=C(COCO3)C=C2)=CC=C1,8.331581480574526,Inactive,253.32,2,3,2,3,2.658,44.48,0.213358441,-823.9109391,2.4172,-0.19373,-0.04659,0.14714,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-76,[0 0 0 ... 0 0 0],"[253.30099999999996, 253.11027872, 3.3057000000000025, 3, 1, 44.480000000000004, 2, 2, 19, 0.6593586500007307, 0.125, 3]",253.30099999999996,253.11027872,3.3057000000000025,3,1,44.480000000000004,2,2,19,0.6593586500007307,0.125,3,8.294153484130097,5.079798855252946
1167,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=CC3=C(COCO3)C=C2,8.29489848384007,Inactive,253.32,2,3,2,3,2.658,44.48,0.213630882,-823.912045,2.782,-0.18161,-0.04005,0.14156,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-77,[0 0 0 ... 0 0 0],"[253.30099999999996, 253.11027872, 3.3057000000000016, 3, 1, 44.480000000000004, 2, 2, 19, 0.6593586500007307, 0.125, 3]",253.30099999999996,253.11027872,3.3057000000000016,3,1,44.480000000000004,2,2,19,0.6593586500007307,0.125,3,8.286187729465395,5.173831379838981
1168,Non-Steroid,O=[N+](C1=CC=C(/C=C/C2=CC=CC([N+]([O-])=O)=C2)C=C1)[O-],8.294191433023146,Inactive,270.26,4,2,0,4,3.605,91.64,0.221241867,-949.712995,4.7756,-0.24134,-0.10541,0.13593,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-78,[0 0 0 ... 0 0 0],"[270.244, 270.0640568, 3.6734000000000027, 4, 0, 86.27999999999999, 2, 4, 20, 0.48145243168898105, 0.0, 2]",270.244,270.0640568,3.6734000000000027,4,0,86.27999999999999,2,4,20,0.48145243168898105,0.0,2,8.269028876494376,5.382339938331164
1170,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=CC(OC)=CC=C2,8.258734184660513,Inactive,225.31,3,2,2,2,3.053,35.25,0.213632375,-710.5866097,1.5901,-0.17983,-0.03588,0.14395,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-79,[0 0 0 ... 0 0 0],"[225.291, 225.1153641, 3.4478000000000018, 2, 1, 35.25, 2, 3, 17, 0.6410985982688429, 0.06666666666666667, 2]",225.291,225.1153641,3.4478000000000018,2,1,35.25,2,3,17,0.6410985982688429,0.06666666666666667,2,8.282709855737085,5.21543028173487
1179,Non-Steroid,NC(C=C1)=CC=C1CCC2=CC(OC)=CC(OC)=C2,8.254996223089913,Inactive,257.36,5,2,2,3,3.481,44.48,0.232136342,-826.3286749,1.9326,-0.19331,0.00845,0.20176,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-80,[0 0 0 ... 0 0 0],"[257.33299999999997, 257.141578848, 3.071200000000002, 3, 1, 44.480000000000004, 2, 5, 19, 0.8371481603782874, 0.25, 2]",257.33299999999997,257.141578848,3.071200000000002,3,1,44.480000000000004,2,5,19,0.8371481603782874,0.25,2,8.25545552212755,5.553214869499402
1180,Non-Steroid,NC(C=C1)=CC=C1CCC2=CC(OC)=C(OC)C=C2,8.209438636714456,Active,257.36,5,2,2,3,3.481,44.48,0.225570763,-826.3201953,2.7038,-0.19247,0.00851,0.20098,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-81,[0 0 0 ... 0 0 0],"[257.33299999999997, 257.141578848, 3.071200000000002, 3, 1, 44.480000000000004, 2, 5, 19, 0.8371481603782874, 0.25, 2]",257.33299999999997,257.141578848,3.071200000000002,3,1,44.480000000000004,2,5,19,0.8371481603782874,0.25,2,8.25545552212755,5.553214869499402
1181,Non-Steroid,NC(C=C1)=CC=C1CCC2=CC(OC)=C(OC)C(OC)=C2,8.25536317638113,Inactive,287.39,6,2,2,4,3.465,53.71,0.234001857,-940.8354134,2.3401,-0.19423,0.00419,0.19842,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-82,[0 0 0 ... 0 0 0],"[287.35900000000004, 287.152143532, 3.0798000000000014, 4, 1, 53.71000000000001, 2, 6, 21, 0.8295545316497802, 0.29411764705882354, 2]",287.35900000000004,287.152143532,3.0798000000000014,4,1,53.71000000000001,2,6,21,0.8295545316497802,0.29411764705882354,2,8.25545552212755,5.553214869499402
1182,Non-Steroid,NC1=CC=CC(CCC2=CC=C(N)C=C2)=C1,8.260151268958486,Inactive,212.32,3,2,4,2,2.768,52.04,0.2442685,-652.626932,2.0208,-0.18184,0.01302,0.19486,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-83,[0 0 0 ... 0 0 0],"[212.29600000000002, 212.131348512, 2.6362000000000005, 2, 2, 52.04, 2, 3, 16, 0.7683462943337546, 0.14285714285714285, 2]",212.29600000000002,212.131348512,2.6362000000000005,2,2,52.04,2,3,16,0.7683462943337546,0.14285714285714285,2,8.252042984582586,5.597022018592245
1183,Non-Steroid,NC1=CC=CC(/C=C/C2=CC=C(N)C=C2)=C1,8.290163840748214,Inactive,210.3,2,2,4,2,2.323,52.04,0.230988767,-651.4169496,3.0205,-0.17738,-0.03462,0.14276,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-84,[0 0 0 ... 0 0 0],"[210.28, 210.115698448, 3.0214000000000008, 2, 2, 52.04, 2, 2, 16, 0.5909919693682338, 0.0, 2]",210.28,210.115698448,3.0214000000000008,2,2,52.04,2,2,16,0.5909919693682338,0.0,2,8.285577747989004,5.181103308880441
1184,Non-Steroid,NC1=CC(N)=CC(/C=C/C2=CC=C(N)C=C2)=C1,8.29498600684205,Inactive,225.32,2,2,6,3,1.576,78.06,0.265182031,-706.7701218,1.3951,-0.17465,-0.03018,0.14447,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-85,[0 0 0 ... 0 0 0],"[225.29500000000002, 225.12659748, 2.603600000000001, 3, 3, 78.06, 2, 2, 17, 0.5426998204572783, 0.0, 2]",225.29500000000002,225.12659748,2.603600000000001,3,3,78.06,2,2,17,0.5426998204572783,0.0,2,8.250871584528667,5.612138954628823
1187,Non-Steroid,NC(C=C1)=CC=C1/C=C/C2=CC(OC(C)=O)=CC(OC(C)=O)=C2,8.25714509686316,Inactive,311.36,6,2,2,5,2.605,78.62,0.276235475,-1051.81725,3.0525,-0.18494,-0.04338,0.14156,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-86,[0 0 0 ... 0 0 0],"[311.33700000000005, 311.115758024, 3.2898000000000014, 5, 1, 78.62, 2, 4, 23, 0.40553286949951683, 0.1111111111111111, 2]",311.33700000000005,311.115758024,3.2898000000000014,5,1,78.62,2,4,23,0.40553286949951683,0.1111111111111111,2,8.254742030098388,5.562345611829497
1189,Non-Steroid,OC1=CC(O)=CC(/C=C/C2=CC=C(N)C=C2)=C1,8.275639738301319,Inactive,227.28,2,2,4,3,2.535,66.48,0.2649962,-746.4967064,4.9863,-0.18324,-0.04055,0.14269,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-87,[0 0 0 ... 0 0 0],"[227.26299999999998, 227.094628656, 2.8503999999999996, 3, 3, 66.48, 2, 2, 17, 0.5455928166364253, 0.0, 2]",227.26299999999998,227.094628656,2.8503999999999996,3,3,66.48,2,2,17,0.5455928166364253,0.0,2,8.250871584528667,5.612138954628823
1191,Non-Steroid,O=C(C1=CC=C(C=C1)[N+]([O-])=O)CN2C=CN=C2,8.17255018319399,Active,231.23,4,2,0,4,1.287,80.71,0.226310538,-814.3998955,3.5068,-0.23938,-0.11724,0.12214,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-88,[0 0 0 ... 0 0 0],"[231.21099999999998, 231.064391148, 1.6741999999999997, 5, 0, 78.03, 2, 4, 17, 0.4552299986396691, 0.09090909090909091, 2]",231.21099999999998,231.064391148,1.6741999999999997,5,0,78.03,2,4,17,0.4552299986396691,0.09090909090909091,2,8.232106898686439,5.859939082737327
1192,Non-Steroid,O=C(CN1C=CN=C1)C2=CC=C(N)C=C2,8.241452782259797,Inactive,201.25,3,2,2,3,0.646,60.91,0.234127077,-665.2608839,5.0956,-0.22096,-0.05544,0.16552,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-89,[0 0 0 ... 0 0 0],"[201.22899999999998, 201.090211972, 1.3481999999999998, 4, 1, 60.91, 2, 3, 15, 0.60191412883291, 0.09090909090909091, 2]",201.22899999999998,201.090211972,1.3481999999999998,4,1,60.91,2,3,15,0.60191412883291,0.09090909090909091,2,8.228500645014497,5.908800879985704
1193,Non-Steroid,O=[N+](C1=CC=C(/C(CN2C=CN=C2)=C/C3=CC(OC)=CC(OC)=C3)C=C1)[O-],8.145396312780894,Active,365.42,7,3,0,5,3.315,82.1,0.217611283,-1238.576224,8.9417,-0.22429,-0.09166,0.13263,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-90,[0 0 0 ... 0 0 0],"[365.3890000000001, 365.137556088, 4.049300000000003, 6, 0, 79.42, 3, 7, 27, 0.35845907483977585, 0.15, 3]",365.3890000000001,365.137556088,4.049300000000003,6,0,79.42,3,7,27,0.35845907483977585,0.15,3,8.15276381457725,7.03454780637424
1194,Non-Steroid,NC1=CC=C(/C(CN2C=CN=C2)=C/C3=CC(OC)=CC(OC)=C3)C=C1,8.128211284276421,Active,335.44,6,3,2,4,2.674,62.3,0.220496,-1089.428998,3.0046,-0.19462,-0.03257,0.16205,"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer",Bioorg Med Chem. 2010;18(14):5352-91,[0 0 0 ... 0 0 0],"[335.4070000000001, 335.163376912, 3.7233000000000027, 5, 1, 62.30000000000001, 3, 6, 25, 0.5507065678430975, 0.15, 3]",335.4070000000001,335.163376912,3.7233000000000027,5,1,62.30000000000001,3,6,25,0.5507065678430975,0.15,3,8.149029505929645,7.095295609486387
1196,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC(C)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.158446883079538,Active,346.41,5,4,0,4,3.59,57.26,0.222290977,-1146.244777,9.2209,-0.22717,-0.06698,0.16019,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-25,[0 0 0 ... 0 0 0],"[346.3860000000001, 346.131742436, 3.925220000000002, 5, 0, 57.26, 4, 5, 26, 0.5139462579185174, 0.14285714285714285, 4]",346.3860000000001,346.131742436,3.925220000000002,5,0,57.26,4,5,26,0.5139462579185174,0.14285714285714285,4,8.187860676339753,6.488425518281974
1197,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC(F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.158207605048831,Active,350.37,5,4,0,5,3.309,57.26,0.228122293,-1206.159502,7.3041,-0.22994,-0.0703,0.15964,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-26,[0 0 0 ... 0 0 0],"[350.3490000000001, 350.10667056000005, 3.7559000000000022, 5, 0, 57.26, 4, 5, 26, 0.5144365012273265, 0.1, 4]",350.3490000000001,350.10667056000005,3.7559000000000022,5,0,57.26,4,5,26,0.5144365012273265,0.1,4,8.179935090822582,6.607922019060686
1198,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC(Cl)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.16202940890224,Active,366.82,5,4,0,4,3.768,57.26,0.210447902,-1566.521948,6.8026,-0.23058,-0.07116,0.15942,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-27,[0 0 0 ... 0 0 0],"[366.80400000000014, 366.0771200200001, 4.2702000000000035, 5, 0, 57.26, 4, 5, 26, 0.49481529887150366, 0.1, 4]",366.80400000000014,366.0771200200001,4.2702000000000035,5,0,57.26,4,5,26,0.49481529887150366,0.1,4,8.160194728166884,6.91520838544794
1199,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC(C(F)(F)F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.17855642693857,Active,400.38,5,4,0,7,4.046,57.26,0.231918932,-1443.963502,6.2668,-0.23105,-0.07184,0.15921,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-28,[0 0 0 ... 0 0 0],"[400.3560000000001, 400.10347700000005, 4.635600000000004, 5, 0, 57.26, 4, 5, 29, 0.4583564917896464, 0.14285714285714285, 4]",400.3560000000001,400.10347700000005,4.635600000000004,5,0,57.26,4,5,29,0.4583564917896464,0.14285714285714285,4,8.200774543549237,6.2983306491829305
1200,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC(OC(F)(F)F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.174961631942278,Active,416.38,6,4,0,8,5.224,66.49,0.250998178,-1519.181296,6.7497,-0.23065,-0.07128,0.15937,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-29,[0 0 0 ... 0 0 0],"[416.35500000000013, 416.0983916200001, 4.515400000000003, 6, 0, 66.49000000000001, 4, 6, 30, 0.4327460753784311, 0.14285714285714285, 4]",416.35500000000013,416.0983916200001,4.515400000000003,6,0,66.49000000000001,4,6,30,0.4327460753784311,0.14285714285714285,4,8.189318738152927,6.466678379734438
1201,Non-Steroid,O=C1OC2=CC(OCC3=CC=CC([N+]([O-])=O)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.164259922582582,Active,377.38,6,4,0,6,2.998,103.08,0.234685395,-1311.426998,5.0522,-0.23325,-0.0982,0.13505,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-30,[0 0 0 ... 0 0 0],"[377.3560000000001, 377.1011705800001, 3.525000000000002, 7, 0, 100.39999999999999, 4, 6, 28, 0.2894521777235716, 0.1, 4]",377.3560000000001,377.1011705800001,3.525000000000002,7,0,100.39999999999999,4,6,28,0.2894521777235716,0.1,4,8.185336440542264,6.526247794586194
1202,Non-Steroid,O=C1OC2=CC(OCC3=CC=C(F)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.182204076717053,Active,350.37,5,4,0,5,3.309,57.26,0.228022512,-1206.159628,8.2206,-0.22884,-0.06888,0.15996,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-31,[0 0 0 ... 0 0 0],"[350.3490000000001, 350.10667056000005, 3.7559000000000022, 5, 0, 57.26, 4, 5, 26, 0.5144365012273265, 0.1, 4]",350.3490000000001,350.10667056000005,3.7559000000000022,5,0,57.26,4,5,26,0.5144365012273265,0.1,4,8.179935090822582,6.607922019060686
1203,Non-Steroid,O=C1OC2=CC(OCC3=CC=C(Cl)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.17072325090617,Active,366.82,5,4,0,4,3.768,57.26,0.210495683,-1566.521993,7.726,-0.23048,-0.07094,0.15954,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-32,[0 0 0 ... 0 0 0],"[366.80400000000014, 366.0771200200001, 4.2702000000000035, 5, 0, 57.26, 4, 5, 26, 0.49481529887150366, 0.1, 4]",366.80400000000014,366.0771200200001,4.2702000000000035,5,0,57.26,4,5,26,0.49481529887150366,0.1,4,8.160194728166884,6.91520838544794
1204,Non-Steroid,O=C1OC2=CC(OCC3=CC=C(OC)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.161390386151801,Active,362.41,6,4,0,5,3.087,66.49,0.226493044,-1221.44997,9.769,-0.22551,-0.06527,0.16024,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-33,[0 0 0 ... 0 0 0],"[362.3850000000001, 362.12665705600006, 3.6254000000000026, 6, 0, 66.49000000000001, 4, 6, 27, 0.49018005154684025, 0.14285714285714285, 4]",362.3850000000001,362.12665705600006,3.6254000000000026,6,0,66.49000000000001,4,6,27,0.49018005154684025,0.14285714285714285,4,8.189238213352779,6.467877511393441
1205,Non-Steroid,O=C1OC2=CC(OCC3=CC=C(C=C3)OC(F)(F)F)=CC=C2C(CN4C=CN=C4)=C1,8.199430350958513,Active,416.38,6,4,0,8,5.224,66.49,0.251120644,-1519.181315,8.1065,-0.2296,-0.06979,0.15981,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-34,[0 0 0 ... 0 0 0],"[416.35500000000013, 416.0983916200001, 4.515400000000003, 6, 0, 66.49000000000001, 4, 6, 30, 0.4327460753784311, 0.14285714285714285, 4]",416.35500000000013,416.0983916200001,4.515400000000003,6,0,66.49000000000001,4,6,30,0.4327460753784311,0.14285714285714285,4,8.189318738152927,6.466678379734438
1207,Non-Steroid,O=C1OC2=CC(OCC3=CC=C(F)C(F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.168609169475847,Active,368.36,5,4,0,6,3.515,57.26,0.235336268,-1305.385299,6.7162,-0.23114,-0.07186,0.15928,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-35,[0 0 0 ... 0 0 0],"[368.3390000000001, 368.097248748, 3.895000000000003, 5, 0, 57.26, 4, 5, 27, 0.5015981715102613, 0.1, 4]",368.3390000000001,368.097248748,3.895000000000003,5,0,57.26,4,5,27,0.5015981715102613,0.1,4,8.178557553809556,6.628914937823814
1209,Non-Steroid,O=C1OC2=CC(OC3=CC=CC(F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.14613956610659,Active,336.34,4,4,0,5,3.302,57.26,0.241288421,-1166.847634,6.8817,-0.23161,-0.0741,0.15751,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-36,[0 0 0 ... 0 0 0],"[336.322, 336.09102049600006, 3.9692000000000034, 5, 0, 57.26, 4, 4, 25, 0.5292253569068397, 0.05263157894736842, 4]",336.322,336.09102049600006,3.9692000000000034,5,0,57.26,4,4,25,0.5292253569068397,0.05263157894736842,4,8.17206185930017,6.728808068041568
1210,Non-Steroid,O=C1OC2=CC(OC3=CC=CC(Cl)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.14613956610659,Active,352.79,4,4,0,4,3.761,57.26,0.221982105,-1527.209821,6.4823,-0.23251,-0.07519,0.15732,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-37,[0 0 0 ... 0 0 0],"[352.7770000000001, 352.0614699560001, 4.483500000000004, 5, 0, 57.26, 4, 4, 25, 0.507887648519021, 0.05263157894736842, 4]",352.7770000000001,352.0614699560001,4.483500000000004,5,0,57.26,4,4,25,0.507887648519021,0.05263157894736842,4,8.153699033657498,7.019415758481034
1211,Non-Steroid,O=C1OC2=CC(OC3=CC=CC(OC)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.184779851839721,Active,348.38,5,4,0,5,3.08,66.49,0.238547024,-1182.138094,9.7673,-0.22597,-0.06866,0.15731,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-38,[0 0 0 ... 0 0 0],"[348.35800000000006, 348.11100699200006, 3.838700000000002, 6, 0, 66.49000000000001, 4, 5, 26, 0.5127596093759133, 0.1, 4]",348.35800000000006,348.11100699200006,3.838700000000002,6,0,66.49000000000001,4,5,26,0.5127596093759133,0.1,4,8.185780634708046,6.519576194278145
1212,Non-Steroid,O=C1OC2=CC(OC3=CC=C(C)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.210338153624491,Active,332.38,4,4,0,4,3.583,57.26,0.233571659,-1106.933216,8.996,-0.22774,-0.06849,0.15925,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-39,[0 0 0 ... 0 0 0],"[332.359, 332.116092372, 4.138520000000003, 5, 0, 57.26, 4, 4, 25, 0.5271090427641821, 0.1, 4]",332.359,332.116092372,4.138520000000003,5,0,57.26,4,4,25,0.5271090427641821,0.1,4,8.185780634708046,6.519576194278145
1213,Non-Steroid,O=C1OC2=CC(OC3=CC=C(Cl)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.157966333655635,Active,352.79,4,4,0,4,3.761,57.26,0.222162132,-1527.209723,6.2118,-0.2321,-0.07492,0.15718,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-40,[0 0 0 ... 0 0 0],"[352.7770000000001, 352.0614699560001, 4.483500000000004, 5, 0, 57.26, 4, 4, 25, 0.507887648519021, 0.05263157894736842, 4]",352.7770000000001,352.0614699560001,4.483500000000004,5,0,57.26,4,4,25,0.507887648519021,0.05263157894736842,4,8.153699033657498,7.019415758481034
1214,Non-Steroid,O=C1OC2=CC(OC3=CC=C(C#N)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.168440153137393,Active,343.36,4,4,0,5,2.976,81.05,0.237783333,-1159.857322,4.0419,-0.23671,-0.08279,0.15392,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-41,[0 0 0 ... 0 0 0],"[343.34200000000004, 343.0956912760001, 3.701780000000002, 6, 0, 81.05, 4, 4, 26, 0.5277770591309622, 0.05, 4]",343.34200000000004,343.0956912760001,3.701780000000002,6,0,81.05,4,4,26,0.5277770591309622,0.05,4,8.143358854472666,7.1885474791646695
1215,Non-Steroid,O=C1OC2=CC(OC3=CC=C(C(C)=O)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.185172735792515,Active,360.39,5,4,0,5,2.837,74.33,0.243596814,-1220.262206,4.9895,-0.23397,-0.07852,0.15545,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-42,[0 0 0 ... 0 0 0],"[360.3690000000001, 360.11100699200006, 4.032700000000003, 6, 0, 74.33, 4, 5, 27, 0.39669422097569174, 0.09523809523809523, 4]",360.3690000000001,360.11100699200006,4.032700000000003,6,0,74.33,4,5,27,0.39669422097569174,0.09523809523809523,4,8.187596991814239,6.492366201324078
1216,Non-Steroid,O=C1OC2=CC(OC3=CC=C(N(C)C)C=C3)=CC=C2C(CN4C=CN=C4)=C1,8.149260975310048,Active,361.43,5,4,0,5,3.259,60.5,0.235568261,-1201.582267,11.3036,-0.20115,-0.0638,0.13735,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-43,[0 0 0 ... 0 0 0],"[361.40100000000007, 361.1426414680001, 3.8961000000000023, 6, 0, 60.5, 4, 5, 27, 0.5047235327493789, 0.14285714285714285, 4]",361.40100000000007,361.1426414680001,3.8961000000000023,6,0,60.5,4,5,27,0.5047235327493789,0.14285714285714285,4,8.164253761506151,6.850878075626187
1217,Non-Steroid,O=C1OC2=CC(OC3=CC(F)=CC(F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.145396312780894,Active,354.33,4,4,0,6,3.508,57.26,0.257886237,-1266.079182,6.2268,-0.23384,-0.07762,0.15622,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-44,[0 0 0 ... 0 0 0],"[354.31200000000007, 354.081598684, 4.1083000000000025, 5, 0, 57.26, 4, 4, 26, 0.517712469909678, 0.05263157894736842, 4]",354.31200000000007,354.081598684,4.1083000000000025,5,0,57.26,4,4,26,0.517712469909678,0.05263157894736842,4,8.169957848399541,6.761485975991743
1218,Non-Steroid,O=C1OC2=CC(OC3=CC=C(F)C(F)=C3)=CC=C2C(CN4C=CN=C4)=C1,8.135020338940803,Active,354.33,4,4,0,6,3.508,57.26,0.248865316,-1266.072262,5.7046,-0.23274,-0.07544,0.1573,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-45,[0 0 0 ... 0 0 0],"[354.31200000000007, 354.081598684, 4.1083000000000025, 5, 0, 57.26, 4, 4, 26, 0.517712469909678, 0.05263157894736842, 4]",354.31200000000007,354.081598684,4.1083000000000025,5,0,57.26,4,4,26,0.517712469909678,0.05263157894736842,4,8.17206185930017,6.728808068041568
1219,Non-Steroid,O=C1OC2=CC(NC3=CC=CC=C3)=CC=C2C(CN4C=CN=C4)=C1,8.156218581674961,Active,317.37,4,4,1,4,3.087,60.06,0.235173641,-1047.756826,8.4656,-0.20731,-0.0658,0.14151,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-46,[0 0 0 ... 0 0 0],"[317.348, 317.11642672000005, 3.7814000000000023, 5, 1, 60.06, 4, 4, 24, 0.5819082865445969, 0.05263157894736842, 4]",317.348,317.11642672000005,3.7814000000000023,5,1,60.06,4,4,24,0.5819082865445969,0.05263157894736842,4,8.187802067040407,6.4893012092027025
1220,Non-Steroid,O=C1OC2=CC(O)=CC=C2C(CN3C=CN=C3)=C1,8.265522713257612,Inactive,242.25,2,3,1,4,1.269,68.26,0.257976,-836.5678052,8.2647,-0.23003,-0.06939,0.16064,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-47,[0 0 0 ... 0 0 0],"[242.23399999999998, 242.06914218, 1.7433999999999998, 5, 1, 68.25999999999999, 3, 2, 18, 0.6948863346140922, 0.07692307692307693, 3]",242.23399999999998,242.06914218,1.7433999999999998,5,1,68.25999999999999,3,2,18,0.6948863346140922,0.07692307692307693,3,8.233737940341669,5.837972698448211
1222,Non-Steroid,O=C1OC2=CC(OC)=CC=C2C([C@@H](N3C=CN=C3)C4=CC=CC=C4)=C1,8.197774542765988,Active,332.38,4,4,0,4,3.132,57.26,0.213995268,-1106.921067,9.3461,-0.22391,-0.06716,0.15675,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-48,[0 1 0 ... 0 0 0],"[332.35900000000004, 332.116092372, 3.6358000000000024, 5, 0, 57.26, 4, 4, 25, 0.535494538613217, 0.1, 4]",332.35900000000004,332.116092372,3.6358000000000024,5,0,57.26,4,4,25,0.535494538613217,0.1,4,8.177112011175442,6.6510159422598845
1223,Non-Steroid,O=C1OC2=CC(OC3=CC=CC=C3)=CC=C2C([C@@H](N4C=CN=C4)C5=CC=CC=C5)=C1,8.144243156054184,Active,394.45,5,5,0,4,4.709,57.26,0.205839771,-1298.66187,9.1283,-0.22468,-0.06913,0.15555,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-49,[0 1 0 ... 0 0 0],"[394.43000000000006, 394.131742436, 5.419500000000005, 5, 0, 57.26, 5, 5, 30, 0.373611889635257, 0.04, 5]",394.43000000000006,394.131742436,5.419500000000005,5,0,57.26,5,5,30,0.373611889635257,0.04,5,8.175435818077187,6.6767356536993185
1224,Non-Steroid,O=C1OC2=CC(OC3=CC=C(F)C(F)=C3)=CC=C2C([C@@H](N4C=CN=C4)C5=CC=CC=C5)=C1,8.187157423223255,Active,430.43,5,5,0,6,5.12,57.26,0.224686604,-1497.119033,6.5823,-0.22808,-0.07465,0.15343,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-50,[0 1 0 ... 0 0 0],"[430.4100000000001, 430.112898812, 5.697700000000005, 5, 0, 57.26, 5, 5, 32, 0.3358950741834266, 0.04, 5]",430.4100000000001,430.112898812,5.697700000000005,5,0,57.26,5,5,32,0.3358950741834266,0.04,5,8.203499731644667,6.258932506676384
1225,Non-Steroid,O=C1OC2=CC(OC3=CC=CC=C3)=CC=C2C([C@@H](N4C=CN=C4)C5=CC=C(Cl)C=C5)=C1,8.20244936873287,Active,428.89,5,5,0,4,5.373,57.26,0.2030165,-1758.256701,8.385,-0.22862,-0.07298,0.15564,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-51,[0 1 0 ... 0 0 0],"[428.8750000000001, 428.09277008400005, 6.072900000000004, 5, 0, 57.26, 5, 5, 31, 0.31851121947092687, 0.04, 5]",428.8750000000001,428.09277008400005,6.072900000000004,5,0,57.26,5,5,31,0.31851121947092687,0.04,5,8.176117608101302,6.666262206138542
1226,Non-Steroid,O=C1OC2=CC(OC3=CC=CC=C3)=CC=C2C([C@@H](N4C=CN=C4)C5=CC=C(C#N)C=C5)=C1,8.267859199729095,Inactive,419.46,5,5,0,5,4.588,81.05,0.215957551,-1390.902514,7.9803,-0.23373,-0.07918,0.15455,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-52,[0 1 0 ... 0 0 0],"[419.4400000000001, 419.1269914040001, 5.291180000000004, 6, 0, 81.05, 5, 5, 32, 0.3616043516726277, 0.038461538461538464, 5]",419.4400000000001,419.1269914040001,5.291180000000004,6,0,81.05,5,5,32,0.3616043516726277,0.038461538461538464,5,8.203770117323854,6.2550369954796485
1227,Non-Steroid,O=C1OC2=CC(OC)=CC=C2C=C1CN3C=NC=C3,8.25572651032918,Inactive,256.28,3,3,0,4,1.52,57.26,0.233668548,-875.8779376,9.4632,-0.21483,-0.07232,0.14251,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-53,[0 0 0 ... 0 0 0],"[256.26099999999997, 256.084792244, 2.0463999999999998, 5, 0, 57.26, 3, 3, 19, 0.6728349870006699, 0.14285714285714285, 3]",256.26099999999997,256.084792244,2.0463999999999998,5,0,57.26,3,3,19,0.6728349870006699,0.14285714285714285,3,8.223357312767625,5.979194585567913
1228,Non-Steroid,O=C1OC2=CC(OC3=CC=CC=C3)=CC=C2C=C1[C@@H](C4=CC=CC=C4)N5C=NC=C5,8.186789042358557,Active,394.45,5,5,0,4,4.709,57.26,0.200457354,-1298.665821,9.1828,-0.21804,-0.07216,0.14588,"Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase",J Med Chem. 2011;54(6):1613-54,[0 1 0 ... 0 0 0],"[394.43000000000006, 394.131742436, 5.419500000000005, 5, 0, 57.26, 5, 5, 30, 0.373611889635257, 0.04, 5]",394.43000000000006,394.131742436,5.419500000000005,5,0,57.26,5,5,30,0.373611889635257,0.04,5,8.175435818077187,6.6767356536993185
1229,Non-Steroid,O=C1C2=C(C(C=CC=C3)=C3C=C2)OC(C4=CC=CC=C4)C1,8.270306313551282,Inactive,274.33,1,4,0,2,4.008,26.3,0.180968314,-882.9169512,2.9939,-0.21024,-0.0589,0.15134,Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors,Eur J Med Chem. 2011;46(6):2541-5,[0 0 0 ... 0 0 0],"[274.319, 274.099379688, 4.546300000000003, 2, 0, 26.3, 3, 1, 21, 0.6505700325551026, 0.10526315789473684, 4]",274.319,274.099379688,4.546300000000003,2,0,26.3,3,1,21,0.6505700325551026,0.10526315789473684,4,8.255008657424915,5.558931757310366
1230,Non-Steroid,O=C1C2=C(C(C=CC=C3)=C3C=C2)OC(C4=CC=C(C#N)C=C4)C1,8.235638582322549,Inactive,299.34,1,4,0,3,3.887,50.09,0.195384611,-975.1589994,5.3856,-0.22148,-0.0693,0.15218,Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors,Eur J Med Chem. 2011;46(6):2541-6,[0 0 0 ... 0 0 0],"[299.329, 299.09462865600005, 4.417980000000003, 3, 0, 50.09, 3, 1, 23, 0.6681013050882435, 0.1, 4]",299.329,299.09462865600005,4.417980000000003,3,0,50.09,3,1,23,0.6681013050882435,0.1,4,8.164813513755812,6.842053823082017
1231,Non-Steroid,O=C1C2=C(C(C=CC=C3)=C3C=C2)OC(C4=CC=C(O)C=C4)C1,8.207562120066182,Active,290.33,1,4,1,3,3.741,46.53,0.210783278,-958.133909,1.9374,-0.20912,-0.05787,0.15125,Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors,Eur J Med Chem. 2011;46(6):2541-7,[0 0 0 ... 0 0 0],"[290.31800000000004, 290.094294308, 4.251900000000002, 3, 1, 46.53, 3, 1, 22, 0.7283781141596471, 0.10526315789473684, 4]",290.31800000000004,290.094294308,4.251900000000002,3,1,46.53,3,1,22,0.7283781141596471,0.10526315789473684,4,8.230839046312362,5.877071220525321
1232,Non-Steroid,C1(C(C=CC=C2)=C2C=C3)=C3[C@H](N4C=CN=C4)C[C@@H](C5=CC=CC=C5)O1,8.128211284276421,Active,326.42,2,5,0,2,3.921,27.05,0.165286209,-1033.910911,4.1771,-0.2057,-0.03658,0.16912,Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors,Eur J Med Chem. 2011;46(6):2541-8,[0 0 0 ... 0 0 0],"[326.39900000000006, 326.14191319599996, 5.149500000000004, 3, 0, 27.05, 4, 2, 25, 0.5092295095480726, 0.13636363636363635, 5]",326.39900000000006,326.14191319599996,5.149500000000004,3,0,27.05,4,2,25,0.5092295095480726,0.13636363636363635,5,8.191339710421163,6.4366558550593025
1233,Non-Steroid,N#CC1=CC=C(C2CC(N3C=CN=C3)C4=C(C(C=CC=C5)=C5C=C4)O2)C=C1,8.148258361091031,Active,351.43,2,5,0,3,3.799,50.84,0.178056886,-1126.153311,2.7446,-0.21476,-0.06116,0.1536,Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors,Eur J Med Chem. 2011;46(6):2541-9,[0 0 0 ... 0 0 0],"[351.40900000000005, 351.137162164, 5.021180000000005, 4, 0, 50.84, 4, 2, 27, 0.5093256819812613, 0.13043478260869565, 5]",351.40900000000005,351.137162164,5.021180000000005,4,0,50.84,4,2,27,0.5093256819812613,0.13043478260869565,5,8.11999152827597,7.585923726442116
1234,Non-Steroid,OC1=CC=C(C2CC(N3C=CN=C3)C4=C(C(C=CC=C5)=C5C=C4)O2)C=C1,8.125237053311967,Active,342.42,2,5,1,3,3.653,47.28,0.189898432,-1109.127215,4.7422,-0.20557,-0.03658,0.16899,Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors,Eur J Med Chem. 2011;46(6):2541-10,[0 0 0 ... 0 0 0],"[342.3980000000001, 342.13682781599994, 4.855100000000005, 4, 1, 47.28, 4, 2, 26, 0.5660517834746116, 0.13636363636363635, 5]",342.3980000000001,342.13682781599994,4.855100000000005,4,1,47.28,4,2,26,0.5660517834746116,0.13636363636363635,5,8.160936777375706,6.903402931398548
1235,Non-Steroid,O=C1C2=C(O)C=C(O)C(C(N3CCSCC3)C=O)=C2OC(C4=CC=CC=C4)=C1,8.28156906720413,Inactive,397.48,4,4,2,6,2.853,116.28,0.239243191,-1640.691904,3.5131,-0.21954,-0.0652,0.15434,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-4,[0 1 0 ... 0 0 0],"[397.45200000000006, 397.098393708, 3.160000000000001, 7, 2, 90.98, 3, 4, 28, 0.6536102444976662, 0.23809523809523808, 4]",397.45200000000006,397.098393708,3.160000000000001,7,2,90.98,3,4,28,0.6536102444976662,0.23809523809523808,4,8.28521751144957,5.185402688895794
1236,Non-Steroid,O=C1C2=C(O)C=C(O)C(C(N3CCNCC3)C=O)=C2OC(C4=CC=CC=C4)=C1,8.381237784857943,Inactive,380.43,4,4,3,7,1.842,103.01,0.237920771,-1297.848104,4.8882,-0.21862,-0.05437,0.16425,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-5,[0 1 0 ... 0 0 0],"[380.40000000000003, 380.13722174, 2.0163999999999995, 7, 3, 103.01, 3, 4, 28, 0.5951242468869254, 0.23809523809523808, 4]",380.40000000000003,380.13722174,2.0163999999999995,7,3,103.01,3,4,28,0.5951242468869254,0.23809523809523808,4,8.339674699962872,4.574306911021592
1237,Non-Steroid,O=C1C2=C(O)C=C(O)C(C(N3CCOCC3)COC(C=O)=O)=C2OC(C4=CC=CC=C4)=C1,8.426121840766676,Inactive,439.45,7,4,2,9,2.029,126.51,0.236948132,-1545.580415,5.8245,-0.22453,-0.09321,0.13132,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-6,[0 1 0 ... 0 0 0],"[439.4200000000001, 439.12671663199995, 1.9865999999999997, 9, 2, 126.51, 3, 6, 32, 0.336717288877567, 0.2608695652173913, 4]",439.4200000000001,439.12671663199995,1.9865999999999997,9,2,126.51,3,6,32,0.336717288877567,0.2608695652173913,4,8.410528657054964,3.885718570749399
1238,Non-Steroid,O=C1C2=C(O)C=C(O)C(C(N3CCOCC3)OC4=CC=C(C=O)C=C4)=C2OC(C5=CC=CC=C5)=C1,8.318212526592417,Inactive,473.51,6,5,2,8,3.954,109.44,0.225861414,-1623.997479,5.0009,-0.22614,-0.06279,0.16335,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-7,[0 1 0 ... 0 0 0],"[473.4810000000001, 473.147452076, 4.093500000000003, 8, 2, 109.44000000000001, 4, 6, 35, 0.4031625445284793, 0.18518518518518517, 5]",473.4810000000001,473.147452076,4.093500000000003,8,2,109.44000000000001,4,6,35,0.4031625445284793,0.18518518518518517,5,8.3740824059552,4.225884218890624
1239,Non-Steroid,O=C1C2=C(O)C(C(OC3=CC=C(C=O)C=C3)N4CCOCC4)=C(O)C=C2OC(C5=CC=CC=C5)=C1,8.433145169073368,Inactive,473.51,6,5,2,8,3.954,109.44,0.222952293,-1623.976691,7.9943,-0.21496,-0.06431,0.15065,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-8,[0 1 0 ... 0 0 0],"[473.4810000000003, 473.147452076, 4.093500000000003, 8, 2, 109.44000000000001, 4, 6, 35, 0.40316254452847927, 0.18518518518518517, 5]",473.4810000000003,473.147452076,4.093500000000003,8,2,109.44000000000001,4,6,35,0.40316254452847927,0.18518518518518517,5,8.392027640500551,4.054827278392773
1246,Non-Steroid,O=C(OCC)C1C2=C3C(C(C=C(C4=CC=CC=C4)O3)=O)=C(O)C=C2OC(NC5CCCCC5)=C1C(OCC)=O,8.422703684021588,Inactive,533.62,9,5,2,9,4.992,124.3,0.250006829,-1818.415805,5.5201,-0.2164,-0.05863,0.15777,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-9,[0 0 1 ... 0 0 0],"[533.5770000000005, 533.204966952, 4.901700000000004, 9, 2, 124.30000000000001, 3, 7, 39, 0.40803694046325645, 0.36666666666666664, 5]",533.5770000000005,533.204966952,4.901700000000004,9,2,124.30000000000001,3,7,39,0.40803694046325645,0.36666666666666664,5,8.373549392297498,4.231073869906177
1247,Non-Steroid,O=C(OC)C1C2=C3C(C(C=C(C4=CC=CC=C4)O3)=O)=C(O)C=C2OC(NC(C)C)=C1C(OC)=O,8.42862455903899,Inactive,465.49,7,4,2,9,3.162,124.3,0.271143211,-1623.039777,5.3926,-0.2189,-0.0597,0.1592,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-10,[0 1 0 ... 0 0 0],"[465.45800000000025, 465.14236669599995, 3.1972000000000014, 9, 2, 124.30000000000001, 3, 5, 34, 0.546667654720686, 0.24, 4]",465.45800000000025,465.14236669599995,3.1972000000000014,9,2,124.30000000000001,3,5,34,0.546667654720686,0.24,4,8.37728284607671,4.194856935556638
1248,Non-Steroid,O=C(OCC)C1C2=C3C(C(C=C(C4=CC=CC=C4)O3)=O)=C(O)C=C2OC(NC(C)C)=C1C(OCC)=O,8.387202923557439,Inactive,493.55,9,4,2,9,3.86,124.3,0.263798587,-1701.678482,5.1927,-0.21756,-0.05918,0.15838,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-11,[0 1 0 ... 0 0 0],"[493.51200000000034, 493.17366682399995, 3.977400000000003, 9, 2, 124.30000000000001, 3, 7, 36, 0.47036683497548615, 0.2962962962962963, 4]",493.51200000000034,493.17366682399995,3.977400000000003,9,2,124.30000000000001,3,7,36,0.47036683497548615,0.2962962962962963,4,8.374069271658279,4.226012023547846
1254,Non-Steroid,O=C(OC)C1C2=C3C(C(C=C(C4=CC=CC=C4)O3)=O)=C(O)C=C2OC(NCCCC)=C1C(OC)=O,8.339208549911659,Inactive,479.52,9,4,2,9,3.764,124.3,0.265179967,-1662.348244,5.9757,-0.21838,-0.05881,0.15957,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-12,[0 0 0 ... 0 0 0],"[479.48500000000035, 479.15801675999995, 3.5889000000000024, 9, 2, 124.30000000000001, 3, 7, 35, 0.38632207717276545, 0.2692307692307692, 4]",479.48500000000035,479.15801675999995,3.5889000000000024,9,2,124.30000000000001,3,7,35,0.38632207717276545,0.2692307692307692,4,8.353134274100434,4.434715113015339
1255,Non-Steroid,O=C(OCC)C1C2=C3C(C(C=C(C4=CC=CC=C4)O3)=O)=C(O)C=C2OC(NCCCC)=C1C(OCC)=O,8.3528297163493,Inactive,507.58,11,4,2,9,4.462,124.3,0.258692712,-1740.986905,5.8278,-0.21691,-0.05831,0.1586,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-13,[0 0 0 ... 0 0 0],"[507.53900000000044, 507.18931688799995, 4.369100000000004, 9, 2, 124.30000000000001, 3, 9, 37, 0.320837946344199, 0.32142857142857145, 4]",507.53900000000044,507.18931688799995,4.369100000000004,9,2,124.30000000000001,3,9,37,0.320837946344199,0.32142857142857145,4,8.34598891482807,4.50828211582571
1257,Non-Steroid,OC(C=C1)=C(O)C=C1C2=C(O)C(C3=C(O)C=C(O)C=C3O2)=O,8.400359469997108,Inactive,302.25,1,3,5,7,1.504,131.36,0.343850906,-1104.156156,2.4209,-0.19425,-0.05647,0.13778,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-14,[0 0 0 ... 0 0 0],"[302.23800000000006, 302.04265266, 1.9879999999999998, 7, 5, 131.36, 3, 1, 22, 0.43419044029909815, 0.0, 3]",302.23800000000006,302.04265266,1.9879999999999998,7,5,131.36,3,1,22,0.43419044029909815,0.0,3,8.24844942810248,5.64352654183138
1259,Non-Steroid,OC1=CC(O)=C(C(C=C(C2=CC=CC=C2)O3)=O)C3=C1,8.306334405219966,Inactive,254.25,1,3,2,4,2.602,70.67,0.269487828,-878.5211417,6.276,-0.22207,-0.06996,0.15211,Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors,Nat Prod Commun. 2011;6(1):31-15,[0 0 0 ... 0 0 0],"[254.24099999999999, 254.0579088, 2.871200000000001, 4, 2, 70.67, 3, 1, 19, 0.700091545915688, 0.0, 3]",254.24099999999999,254.0579088,2.871200000000001,4,2,70.67,3,1,19,0.700091545915688,0.0,3,8.232963304721121,5.848394974866322
1260,Steroid,O=C1C=C[C@@]2(C)C(C(CC3C2CC[C@@]4(C)C3CCC4=O)=C)=C1,8.16667682215177,Active,296.44,0,4,0,2,3.326,34.14,0.206244217,-926.998094,3.286,-0.235,-0.06259,0.17241,Synthesis of some novel androstanes as potential aromatase inhibitors,Steroids. 2011;76(5):464-70,[0 0 0 ... 0 0 0],"[296.41, 296.177630008, 4.029500000000003, 2, 0, 34.14, 0, 0, 22, 0.6760895538895387, 0.6, 4]",296.41,296.177630008,4.029500000000003,2,0,34.14,0,0,22,0.6760895538895387,0.6,4,8.18734396750477,6.496149820897353
1261,Steroid,OC1CCC2C3CCC4C(C5=C(C=NN5)C[C@]4(C)C3CC[C@@]21C)=O,8.201298951770688,Active,328.5,0,5,2,3,3.285,65.98,0.209764096,-1038.924121,2.3725,-0.24814,-0.05154,0.1966,Synthesis of some novel androstanes as potential aromatase inhibitors,Steroids. 2011;76(5):464-71,[0 0 0 ... 0 0 0],"[328.45600000000013, 328.21507813599993, 3.3682000000000025, 3, 2, 65.98, 1, 0, 24, 0.7671945090550771, 0.8, 5]",328.45600000000013,328.21507813599993,3.3682000000000025,3,2,65.98,1,0,24,0.7671945090550771,0.8,5,8.32134150375989,4.77153920185581
1262,Steroid,O[C@H]1CCC2C3CCC4C(C(O)=C(C#N)C[C@]4(C)C3CC[C@@]21C)=O,8.222440820183351,Inactive,329.48,0,4,2,4,2.625,81.32,0.221885686,-1058.770851,3.0998,-0.25342,-0.08363,0.16979,Synthesis of some novel androstanes as potential aromatase inhibitors,Steroids. 2011;76(5):464-72,[0 0 0 ... 0 0 0],"[329.4400000000001, 329.199093724, 3.5145800000000023, 4, 2, 81.32, 0, 0, 24, 0.712309622979528, 0.8, 4]",329.4400000000001,329.199093724,3.5145800000000023,4,2,81.32,0,0,24,0.712309622979528,0.8,4,8.233727429241554,5.838113994874127
1269,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C\C3=CC=C(OCCCN4C=NC=C4)C(OC)=C3,8.203450829472398,Active,374.47,7,4,0,4,3.578,53.35,0.20291556,-1224.841489,4.0808,-0.21869,-0.07847,0.14022,Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy,Med Chem Res. 2011;20(6):661-669,[0 0 0 ... 0 0 0],"[374.44000000000005, 374.163042564, 4.183200000000003, 5, 0, 53.35000000000001, 3, 7, 28, 0.45976822928129435, 0.21739130434782608, 4]",374.44000000000005,374.163042564,4.183200000000003,5,0,53.35000000000001,3,7,28,0.45976822928129435,0.21739130434782608,4,8.222022292879629,5.997602890186192
1270,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C\C3=CC=C(OC)C(OCCCN4C=NC=C4)=C3,8.231147748790823,Inactive,374.47,7,4,0,4,3.578,53.35,0.20261586,-1224.839741,2.477,-0.21991,-0.07815,0.14176,Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy,Med Chem Res. 2011;20(6):661-669,[0 0 0 ... 0 0 0],"[374.4400000000001, 374.163042564, 4.183200000000003, 5, 0, 53.35, 3, 7, 28, 0.45976822928129435, 0.21739130434782608, 4]",374.4400000000001,374.163042564,4.183200000000003,5,0,53.35,3,7,28,0.45976822928129435,0.21739130434782608,4,8.222022292879629,5.997602890186192
1271,Non-Steroid,O=C(C1=CC=CC=C1C/2)C2=C\C3=CC=CC=C3OCCCN4C=NC=C4,8.224855234569844,Inactive,344.44,6,4,0,3,3.594,44.12,0.187236587,-1110.31709,4.1639,-0.22167,-0.07648,0.14519,Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy,Med Chem Res. 2011;20(6):661-669,[0 0 0 ... 0 0 0],"[344.4140000000001, 344.15247788000005, 4.1746000000000025, 4, 0, 44.120000000000005, 3, 6, 26, 0.4977538504492994, 0.18181818181818182, 4]",344.4140000000001,344.15247788000005,4.1746000000000025,4,0,44.120000000000005,3,6,26,0.4977538504492994,0.18181818181818182,4,8.216733596883689,6.071086254408283
